Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.7240338373868473,1.875218168266503,0.0,0.14694701744048175,0.1,6/38,3.83%,SLC35F1;ADGRB3;CACNA1B;DPP10;OPCML;NXPH1
prerank,PanglaoDB_Augmented_2021__Basophils,0.772865134814419,1.8449788962947486,0.0,0.10738435889881359,0.13,5/31,5.23%,CSF1R;INF2;H2AC6;CD44;SLC26A3
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.7409509044751866,1.831931219136412,0.0,0.07912531708333632,0.14,26/49,15.14%,LDB3;JPH2;RASL12;MYOM2;NOTCH1;FILIP1;HEY2;OBSCN;CKMT2;RBM20;SGPL1;PTH1R;PRKG1;SLC25A4;CPT1A;MITF;MYOCD;COL21A1;ITGA7;RYR2;SORBS2;PDLIM5;CKB;TTN;CTNNA3;LMOD1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.8090710857155251,1.8199581380764585,0.0,0.07347350872024087,0.17,5/20,7.60%,WTIP;CNOT7;CNOT6;PUM2;AGO2
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7253338520477208,1.7524542503277292,0.0,0.19668293103572174,0.56,8/33,13.17%,CSF1R;HEY2;MED24;CEBPB;CDKN1A;MED23;NFKB1;LEF1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.8930392939605304,1.7323272131435392,0.0,0.2637510569444544,0.67,3/12,4.96%,HSPA1A;HSPA8;PTGES3
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.9441795492764705,1.7278455361490448,0.0,0.24383516080783232,0.69,1/12,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.821497905865655,1.7274381434083028,0.0,0.21618166988840104,0.69,1/19,0.03%,HSPA1A
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.7947545720736438,1.7197208299329,0.0,0.22230446228175446,0.69,7/30,6.25%,SLC35F1;LDB3;ANO5;FILIP1;CKMT2;DTNA;HIF3A
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.88819634708633,1.706819385011971,0.0,0.2611135463750099,0.75,3/11,4.13%,HSPA1A;BCL2L1;TMBIM6
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.8596170572864623,1.7047698686983592,0.023255813953488372,0.24662436493507428,0.76,2/10,4.19%,ABL2;FLT1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.8200289416613343,-1.703942299724841,0.0,0.7794095430802824,0.49,19/41,13.73%,HERC6;DDX60;GBP2;IFITM3;IFIT3;EPSTI1;CMTR1;SAMD9L;IFI44;WARS1;PROCR;SP110;CD47;NCOA7;IFI44L;NUB1;OGFR;PARP9;PLSCR1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.8656625417025166,1.6946020081447108,0.0,0.26940286530754987,0.82,4/17,7.60%,WTIP;CNOT7;CNOT6;AGO2
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7415031753233101,-1.684821903148216,0.0,0.6647904926272998,0.63,30/64,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPS18;RPS3;EIF2B3;RPS20;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;TMA7;RPL37;RPS21;RPS29;RPS14;RPL13A;RPS7
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8831348026323013,1.6845934030444825,0.0,0.2991110887545901,0.84,3/9,2.17%,JPH2;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7342741884123157,-1.672645948527763,0.0,0.5746235062709534,0.7,41/67,22.83%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;SRP14;RPL15;SRP54;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;SSR1;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;RPS14;RPL13A;RPS7;SEC62;UBA52;RPLP2;RPS8;RPL24;RPL8;RPL23;RPS6;RPL35;RPS28
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.8668775415647144,1.6679053003801774,0.0,0.3358788970068154,0.87,3/14,4.96%,HSPA1A;HSPA8;PTGES3
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7418713381414372,-1.6614591226788287,0.0,0.5685104902467942,0.78,30/63,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;SRP14;RPL15;SRP54;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;RPS14;RPL13A;RPS7
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.888093185893399,1.6606073084412172,0.0,0.3556871396508071,0.89,2/13,3.78%,HSPA1A;GNAI1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.6801387285072492,1.6568838928671286,0.0,0.35182507060269186,0.9,15/58,8.87%,SLC35F1;NOL4;ADGRB3;CACNA1B;NOTCH1;LSAMP;CSRNP3;BCL2;CTNND2;OPCML;NXPH1;SOX5;NRXN1;CTNNA2;NOTCH3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.8836017786283733,1.654818218456388,0.0,0.34376293220239396,0.9,4/8,8.58%,SMARCA4;ZBTB7A;HDAC1;HEYL
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.6947601553838325,1.651714475911176,0.0,0.34601626756284376,0.92,5/33,3.24%,SLC35F1;NOL4;CACNA1B;CSRNP3;ERBB4
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7294370997606616,-1.6514444120275593,0.0,0.5850156335120238,0.86,40/68,22.83%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;SRP14;RPL15;SRP54;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;RPS14;RPL13A;RPS7;SEC62;UBA52;RPLP2;RPS8;RPL24;RPL8;RPL23;RPS6;RPL35;RPS28
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.7668172795596169,-1.6503813569780401,0.0,0.49973905997500473,0.87,18/49,13.63%,COL24A1;COL23A1;TGFB2;COL15A1;COL6A3;COL1A1;COL3A1;COL1A2;P4HA3;COL6A1;COL12A1;COL4A6;TGFBR1;COL11A1;CYP1B1;COL4A5;COL13A1;COL6A2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.7649479705584223,1.6484776317086562,0.0,0.33970342898184247,0.93,5/19,10.73%,WTIP;CD44;PDZD8;BCL9L;CAMSAP1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.7634171233197571,1.6458161344588227,0.020833333333333332,0.3351522359315603,0.93,5/18,9.12%,HSPB1;TRAK1;AP3M1;AP3D1;KIF5B
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.7404818324532705,-1.6349729397346857,0.013888888888888888,0.5567211022002019,0.91,10/46,11.06%,FGF1;TGFB2;NRP1;VEGFA;ENPP2;RIN2;ADAM9;THBS1;SASH1;BCAS3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6761903873795405,1.6323803931208944,0.0,0.381631631374731,0.96,4/28,4.19%,CSF1R;ABL2;ERBB4;FLT1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7212728450183254,1.630827202179819,0.0,0.37147794968345565,0.96,7/36,3.01%,SLC35F1;NOL4;CACNA1B;NOTCH1;CSRNP3;CTNND2;OPCML
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7680626116936862,-1.6239075733815453,0.014925373134328358,0.6006038243736295,0.98,9/29,10.81%,TGFB2;COLEC12;ERAP1;COL1A1;COL3A1;COL1A2;N4BP1;HLA-B;BIRC2
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.8344697325423693,1.623570402561779,0.0,0.39464366222309977,0.97,4/16,3.99%,CSF1R;NOX4;NCK2;GPRC5B
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.8477427527897573,1.6230674814132087,0.0,0.381968048539201,0.97,3/11,4.03%,HSPA1A;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.8648893363953373,-1.6163789898157934,0.0,0.6174146184400668,0.98,3/17,4.99%,NRP1;ACTG1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7794364026226129,1.609673717605253,0.0,0.4566661157381125,0.99,6/16,11.18%,CSF1R;NOX4;GPRC5B;DOCK3;ADAM17;FBXW7
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.9264237861194571,1.6072287681474207,0.02040816326530612,0.4543184414949805,0.99,3/5,4.54%,NFKBIZ;RC3H2;SMAD7
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.5843509612770166,1.604293611938567,0.0,0.4534006264616573,0.99,5/69,4.06%,HSPA1A;HSPB1;CNOT7;HSPA8;RC3H2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.9068167076317977,1.6036419355096012,0.0,0.4420521541135371,0.99,3/8,4.13%,HSPA1A;BCL2L1;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.9617412785255705,1.6032742313153854,0.02564102564102564,0.42992721548236446,0.99,1/6,0.16%,CSF1R
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6634856726294777,-1.5952812096991016,0.0,0.8023333531708791,0.99,34/126,11.60%,COL24A1;THSD4;LAMA1;COL23A1;TGFB2;COL15A1;JAM2;ADAMTSL3;COL6A3;CTSL;COL1A1;COL3A1;ADAMTS12;GSN;COL1A2;LAMC1;P4HA3;CD47;COL6A1;COL12A1;COL4A6;TGFBR1;THBS1;DCN;VCAN;ADAM12;COL11A1;CYP1B1;LAMA4;LAMB1;TIMP2;FN1;JAM3;COL4A5
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.7725488070448108,1.5944182275632863,0.09375,0.4777662002936689,1.0,1/15,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.8477827105105151,1.5890226953619342,0.0,0.479343996795033,1.0,3/9,4.03%,HSPA1A;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.8477827105105151,1.5890226953619342,0.0,0.479343996795033,1.0,3/9,4.03%,HSPA1A;BCL2;BCL2L1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.7412781818388335,-1.5880228704470565,0.028985507246376812,0.8285915356382897,1.0,10/35,10.11%,PRSS23;CLU;ANXA1;GSN;CPQ;PROS1;ADAM9;F3;THBS1;FN1
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.8481110881708214,1.5876173796283022,0.02857142857142857,0.47303923329907993,1.0,3/11,5.66%,PTPRK;DLC1;ARHGEF7
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6603538414917652,-1.5857057041511922,0.013157894736842105,0.7855225591044417,1.0,37/104,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;WARS1;RPL15;RRBP1;EPRS1;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;FASTKD2;RPL37A;RPS12;RPL36;RPL6;RPL7A;NARS1;RPS24;EEF2;RPL11;RPL10A;TMA7;LARS1;RPL37;RPS21;RPS29;RPS14;RPL13A;GTPBP1;RPS7
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.9008021862154962,-1.5840210014298053,0.014925373134328358,0.7455528389464784,1.0,3/10,7.71%,VEGFA;ARNT2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.8402483102399699,1.5820415757014346,0.02564102564102564,0.49270470553573287,1.0,3/11,2.05%,PDK4;NOTCH1;BCL2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),-0.9626123016336677,-1.5811287781196706,0.0,0.731597024891324,1.0,1/6,0.71%,IGFBP5
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.9743618366642391,1.5792913046119301,0.0,0.49283768926192345,1.0,1/7,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.924455777237437,1.5781210590138604,0.023255813953488372,0.4844855724586824,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.9122152256749874,-1.5769818797231157,0.0,0.7268376052725145,1.0,2/11,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.8610208855071465,1.5638257255112602,0.024390243902439025,0.5734294214881169,1.0,2/7,4.19%,CSF1R;FLT1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8179235735538547,1.5631651042722174,0.0,0.5628011275250839,1.0,6/10,11.18%,NCK2;ZFYVE28;CBLB;CBL;ADAM17;FBXW7
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.709383777247257,1.5614312178496508,0.0,0.5619926367201067,1.0,6/19,13.17%,GNAO1;GNB1;MAP3K7;AGO2;FZD3;LEF1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6673612997256181,-1.56142936025697,0.014492753623188406,0.8716778786949336,1.0,26/95,11.60%,COL24A1;THSD4;LAMA1;COL23A1;COL15A1;JAM2;ADAMTSL3;COL6A3;COL1A1;COL3A1;ADAMTS12;COL1A2;LAMC1;CD47;COL6A1;COL4A6;THBS1;DCN;VCAN;ADAM12;COL11A1;LAMA4;LAMB1;FN1;JAM3;COL4A5
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.7502587430536569,-1.5609147241434715,0.03125,0.8268753145619883,1.0,11/37,7.71%,TGFB2;TWIST1;SPRY1;PHLDB2;COL1A1;GCNT2;EPHA3;LDLRAD4;BMP5;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.7108499595786543,1.5580714164030194,0.03225806451612903,0.5798755380535934,1.0,1/21,0.03%,HSPA1A
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6484938528491753,-1.553713058611489,0.01282051282051282,0.873651873452735,1.0,24/74,14.97%,HERC6;DDX60;IFITM3;IFIT3;MT2A;RNF213;STAT1;EPSTI1;CMTR1;SAMD9L;IFI44;WARS1;XAF1;SP110;CMKLR1;ST3GAL5;PELI1;HLA-B;IFI44L;OGFR;PLSCR1;NAMPT;CFH;BTG1
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6583720367654002,1.5535857906734243,0.0,0.6026757600842273,1.0,11/42,9.89%,NOL4;CACNA1B;KCNC2;LSAMP;CSRNP3;OPCML;NXPH1;NRXN1;CTNNA2;MEIS2;TNR
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.8403096299774506,-1.5528576373678558,0.0196078431372549,0.8363571134106066,1.0,4/17,4.36%,CIRBP;MSH6;DDB2;UVSSA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6765586032336006,1.551683667193244,0.0,0.6023212912670296,1.0,4/25,4.19%,CSF1R;ABL2;ERBB4;FLT1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.8465700978633975,1.547792554545455,0.0,0.6180186726342981,1.0,1/15,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.8884440157863651,1.5473322028226422,0.0,0.608597000553324,1.0,5/8,10.36%,GUCY1A1;GUCY1B1;ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.8073305954935849,1.5449984823415643,0.02702702702702703,0.6121536435939385,1.0,3/13,2.05%,PDK4;NOTCH1;BCL2
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.8053309569564047,-1.5421106897790346,0.01639344262295082,0.9398762137144583,1.0,3/13,5.01%,VEGFA;NKD1;IFT122
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7628462404787848,1.5418696054743486,0.125,0.6212074583437088,1.0,4/10,18.49%,MYO1E;MYO1D;MYO1B;MYO5A
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.8458335681950202,-1.5395832618000642,0.01694915254237288,0.9235020636497464,1.0,2/12,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.8467272350544823,-1.5355787582026736,0.0,0.8554401798807613,1.0,4/10,6.19%,CLU;CD55;C7;PROS1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.8467272350544823,-1.5355787582026736,0.0,0.8554401798807613,1.0,4/10,6.19%,CLU;CD55;C7;PROS1
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.8467272350544823,-1.5355787582026736,0.0,0.8554401798807613,1.0,4/10,6.19%,CLU;CD55;C7;PROS1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.7289304956141704,-1.5351473130202609,0.014285714285714285,0.8267242871072739,1.0,4/33,3.32%,ABCA4;ABCA8;ABCA9;ALDH1A1
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.6587667440865016,1.5338533322883507,0.0,0.6731664514171987,1.0,7/44,4.73%,MYH11;MYOM2;GJC1;SORBS3;CKMT2;GNAO1;DTNA
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.7034181194057487,1.5332313056073468,0.07142857142857142,0.6636164986334576,1.0,9/24,12.41%,GUCY1A1;RCAN2;GUCY1B1;PPP2R1A;CAMKK2;MCU;INPP5A;P2RX4;RYR2
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.6705263132951864,-1.5324913996688954,0.0,0.8256098372628695,1.0,27/96,11.60%,COL24A1;THSD4;LAMA1;COL23A1;COL15A1;JAM2;ADAMTSL3;COL6A3;COL1A1;COL3A1;ADAMTS12;COL1A2;LAMC1;CD47;COL6A1;COL4A6;TGFBR1;THBS1;DCN;VCAN;ADAM12;COL11A1;LAMA4;LAMB1;FN1;JAM3;COL4A5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6770067780524411,-1.5321206808973784,0.014084507042253521,0.8011447111661815,1.0,31/76,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;SMG6;UPF3A;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;PPP2R2A;RPS14;RPL13A;RPS7
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.9508153012254918,-1.5300851731818075,0.019230769230769232,0.7980760741540541,1.0,1/5,1.43%,NRP1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.7832542761743103,-1.5298011784526009,0.015151515151515152,0.7727695429161098,1.0,5/21,5.18%,ABCA4;CYP3A5;AKR1C1;ALDH1A1;GPC3
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.7964336859972384,1.528319275690405,0.0425531914893617,0.6899819924089182,1.0,2/11,4.14%,INTS7;INTS2
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.7152299459324529,1.5251564689630814,0.0,0.6981113690095503,1.0,7/31,6.05%,HSPB1;BCL2;ACADVL;EPAS1;TINAGL1;CD151;BNIP3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.9252769139365355,-1.5231937536125657,0.0,0.8197554488397325,1.0,1/8,1.02%,RIMS1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6379670423732229,1.5204668633187943,0.0,0.7196635982341542,1.0,6/31,2.93%,CSF1R;GJC1;GJA4;CDH2;CTNND2;CDH10
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.890169467585047,-1.5191817948273447,0.0,0.8391593448648053,1.0,3/11,6.06%,PRAG1;COL3A1;ARHGEF3
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.9046445377136562,1.5191125404503991,0.044444444444444446,0.7162580213999813,1.0,4/8,5.40%,DNAH11;NOTCH1;RFX3;BBS7
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.8837606384860833,1.5162640986867508,0.020833333333333332,0.7259907799236572,1.0,1/6,9.09%,RNF139
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6484294088322674,-1.5158952341380822,0.014084507042253521,0.8513329972395292,1.0,35/81,22.83%,RPL30;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPL37A;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;DDX52;EXOSC10;RPS14;RPL13A;WDR12;RPS7;LAS1L;EIF2A;UBA52;RPLP2;RPL24;RPL8;MPHOSPH10;RPL23;RPS6;RPL35;RPS28
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.573468618753763,1.5134708766199594,0.0,0.7347350872024087,1.0,11/75,14.53%,CSF1R;ERBB4;FLT1;CAMKK2;MAP2K2;SMG1;EGFR;PAK2;PRKX;MAP3K13;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.7865762133470436,1.5109982260006642,0.08888888888888889,0.7398730948052228,1.0,1/10,0.45%,HSPB1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.8698114649806666,-1.5101819652124742,0.0196078431372549,0.8966683049982429,1.0,3/10,3.30%,GLCE;SULF2;EXT1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.9298216242135144,-1.5068468252238292,0.0,0.8878719131089335,1.0,2/6,3.50%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.9298216242135144,-1.5068468252238292,0.0,0.8878719131089335,1.0,2/6,3.50%,ALDH1A1;ADH5
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.7494307738274573,-1.506638028978675,0.014285714285714285,0.8649917674185096,1.0,9/29,13.32%,FGF1;TGFB2;VEGFA;NR4A1;BMP5;LAMC1;LAMB1;PRKDC;TGFBR3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.8020401746062595,1.5037631210918903,0.061224489795918366,0.78378470978213,1.0,1/9,0.51%,MYH11
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.8668004796636181,-1.5036448173368915,0.03225806451612903,0.8773004077914786,1.0,3/11,2.71%,AK5;NME3;TXNRD1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.9666532449153367,-1.5033613464521725,0.0,0.858315710444757,1.0,1/5,0.36%,CLU
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8553906500099016,1.502819213795183,0.075,0.7767766090612241,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.9023371955804285,1.5026532543621656,0.043478260869565216,0.7647481385098812,1.0,3/5,9.24%,PTH1R;IRS2;IRS1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.7756788658061551,1.5008876019008044,0.0851063829787234,0.7667300701392542,1.0,3/10,14.22%,RAB27A;KIF5B;DNM2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.8609419299418041,1.499739776091547,0.075,0.7635593098541956,1.0,1/8,0.17%,JPH2
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.8451755000620459,1.4996880053945196,0.045454545454545456,0.7510419441188809,1.0,2/7,3.57%,DNAH11;DNAH9
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6303099524812987,1.4958265554182364,0.0,0.7642703438095527,1.0,9/45,4.11%,CSPG4;SLC35F1;ADGRB3;EPN2;CTNND2;OPCML;NXPH1;GPRC5B;GFAP
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7639815989054828,1.4956970710753064,0.022222222222222223,0.7528567584618576,1.0,4/14,9.57%,ABL2;FLT1;ARHGAP6;EGFR
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.9299460677952689,-1.4946728530070066,0.0,0.9362319157000558,1.0,2/6,0.92%,TGFB2;CD55
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.6554193128455237,-1.4940246375423596,0.013888888888888888,0.9201617370365452,1.0,30/78,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;WARS1;RPL15;RRBP1;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;RPS14;RPL13A;RPS7
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.8396503540861577,-1.4937261265331783,0.05454545454545454,0.9019680594670815,1.0,3/10,5.04%,FGF1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.9390121357539563,-1.493706113483247,0.041666666666666664,0.8604425461912284,1.0,1/5,1.58%,JAM2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.9390121357539563,-1.493706113483247,0.041666666666666664,0.8604425461912284,1.0,1/5,1.58%,JAM2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.710652383482316,-1.4925507622357403,0.05555555555555555,0.8513069474553353,1.0,7/33,7.86%,NRP1;VEGFA;STAT1;NR4A1;F3;TGFBR1;THBS1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.7349644639350659,1.4916665289495188,0.05555555555555555,0.7778301259710115,1.0,4/16,7.43%,DACH1;PDGFA;CDKN1A;HMBOX1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.8963558366347387,-1.49124966789543,0.04918032786885246,0.8470602537476429,1.0,2/6,1.43%,PLXNC1;NRP1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.8779478067955463,-1.4902632967945226,0.02040816326530612,0.8408054866272715,1.0,2/10,1.43%,IGFBP5;NRP1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8108656204398573,-1.4902055848706028,0.0,0.8061539881859786,1.0,5/18,5.29%,GBP2;IFITM3;IFIT3;STAT1;XAF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8108656204398573,-1.4902055848706028,0.0,0.8061539881859786,1.0,5/18,5.29%,GBP2;IFITM3;IFIT3;STAT1;XAF1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.8397673068475653,-1.4880535376298125,0.031746031746031744,0.8093508460557557,1.0,4/14,6.27%,PARP1;XPA;DDB2;XPC
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.8208170351274087,-1.486901811275482,0.01639344262295082,0.8060011627853746,1.0,4/16,2.88%,CLU;ABCA8;AKR1C1;LIMA1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.7715844631550608,1.4869005646214217,0.09090909090909091,0.805339216292155,1.0,4/10,4.09%,NOTCH1;TNFRSF1B;DAAM2;TNFRSF21
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.8752615750576414,1.4850652244677298,0.06,0.796483202452944,1.0,3/6,10.36%,GNAI1;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.8752615750576414,1.4850652244677298,0.06,0.796483202452944,1.0,3/6,10.36%,GNAI1;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7806069963731403,1.4849667965912878,0.075,0.785767592128006,1.0,3/9,14.22%,RAB27A;KIF5B;DNM2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.7045214947634895,1.4830524932677815,0.029411764705882353,0.786830016462245,1.0,7/26,7.65%,NOL4;CACNA1B;CSRNP3;CTNND2;NXPH1;LONRF2;NRXN1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.9017992621401408,1.4789149021978998,0.027777777777777776,0.8101463587899967,1.0,1/6,0.31%,ADGRB3
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.7622055739447096,-1.4787758883676518,0.0,0.8748804698105317,1.0,9/23,11.57%,KIAA1217;VEGFA;ARNT2;SULF2;COL1A1;BMP5;TGFBR1;BRCA1;PTCH1
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.7623689200140825,1.478444377840712,0.09302325581395349,0.8028751992983202,1.0,1/11,0.45%,HSPB1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.9336841133571377,-1.4752545300782574,0.03389830508474576,0.8984370185506878,1.0,1/6,0.90%,TWIST1
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.8569972584469102,1.474485450511808,0.1111111111111111,0.8262629837492046,1.0,4/5,14.33%,SNAP29;AP3D1;SNAP23;STX2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6487849950803952,-1.4736971353084674,0.014084507042253521,0.8986133555513847,1.0,35/78,22.83%,RPL30;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPL37A;RPL36;RPL6;PRKDC;RPL7A;RPS24;RPL11;RPL10A;RPL37;DDX52;EXOSC10;RPS14;RPL13A;WDR12;RPS7;LAS1L;UBA52;RPLP2;RPL24;RPL8;MPHOSPH10;RPL23;RPS6;RPL35;RPS28
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.8997348967111614,1.4735892490436242,0.02631578947368421,0.8229962041055432,1.0,1/6,4.68%,SOX13
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.806174844845714,-1.4711190447639262,0.029411764705882353,0.9118582236037293,1.0,2/14,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.815777952641775,1.470946954908231,0.11363636363636363,0.8389116629762223,1.0,3/7,14.22%,RAB27A;KIF5B;DNM2
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.6231338825021504,1.4707794080448076,0.04,0.8292333230333646,1.0,9/38,8.44%,ADGRB3;CACNA1B;KCNC2;SATB2;OPCML;NXPH1;GFAP;NRXN1;CTNNA2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.7973151019863834,-1.470204806942248,0.05970149253731343,0.9096167843948709,1.0,3/14,5.04%,NRP1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.8826744321452159,1.4682834883707692,0.043478260869565216,0.8403346645128764,1.0,2/6,3.07%,SORCS1;SORT1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7070615626973077,-1.4667416058905498,0.034482758620689655,0.9290692746717486,1.0,1/27,0.08%,PRAG1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.8995397967528439,1.4665395352037773,0.0,0.8430736475131735,1.0,2/6,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.6999195174449507,1.4659259617911595,0.05,0.8363227195749706,1.0,6/18,9.88%,CACNA1B;GRID1;EIF4EBP2;NRG3;ABR;GRID2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.8041848719901654,1.4653455227229732,0.044444444444444446,0.8303150362289343,1.0,4/11,6.81%,TNFRSF10B;BCL2;SORT1;CASP8AP2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.7793582677532411,-1.46422489381499,0.017543859649122806,0.9381870908656776,1.0,6/18,16.47%,SLC47A1;SLC38A1;SLC6A20;SLC7A11;SLC25A13;SLC6A13
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.8047678107577633,-1.4640879417510748,0.016666666666666666,0.9243828799980552,1.0,3/18,1.33%,RPL30;GBP2;COLEC12
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.7780950532171635,1.4638576076584613,0.05555555555555555,0.8323700766748826,1.0,4/15,11.31%,TNFRSF10B;BNIP3;CASP8AP2;NFKB1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.9661412225248525,-1.4627646133078185,0.0,0.923790692735633,1.0,1/5,0.96%,COL15A1
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.8854698041874974,1.461007661816385,0.0625,0.8456779921076157,1.0,2/6,1.46%,NOTCH1;TNFRSF1B
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.7071887527845234,1.460604903133374,0.024390243902439025,0.8377082785983186,1.0,6/23,15.28%,CDH2;CNTN4;IGSF11;NPTN;KIRREL3;NECTIN3
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.6157405701757009,1.4578790640470418,0.03225806451612903,0.8498140767642318,1.0,8/42,4.11%,ADGRB3;KCNC2;LSAMP;CSRNP3;GABRB1;OPCML;NXPH1;GFAP
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.5868604943003726,1.4569917299098956,0.0,0.847367553866954,1.0,4/44,7.44%,HSPA1A;HSPA8;PTGES3;DNAJB6
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.9053693951849269,-1.4564599254441881,0.017241379310344827,0.9803749448745124,1.0,2/8,3.78%,PGR;CALCOCO1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.8398342131710101,1.454514945954222,0.08333333333333333,0.8590748711905087,1.0,2/7,5.54%,KLF15;MYO1E
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.5738631071042402,1.4540852758182623,0.0,0.8526344384046557,1.0,12/55,8.44%,SLC35F1;ADGRB3;CACNA1B;LSAMP;GJC1;CSRNP3;OPCML;FMN2;CNTN1;NRXN1;GABRB3;CTNNA2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.6575953078219772,-1.4537293778213878,0.04225352112676056,0.9964717186266525,1.0,10/44,12.10%,FGF1;NRP1;VEGFA;RIN2;THBS1;DCN;SASH1;BCAS3;BMPER;SLIT2
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6562415860629841,-1.4536511525834015,0.014492753623188406,0.9811390718775322,1.0,34/73,22.83%,RPL30;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPL37A;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;DDX52;EXOSC10;RPS14;RPL13A;WDR12;RPS7;LAS1L;UBA52;RPLP2;RPL24;RPL8;MPHOSPH10;RPL23;RPS6;RPL35;RPS28
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8814806049004649,1.4533078253615201,0.02702702702702703,0.849720153899868,1.0,4/7,10.03%,RNF185;UBQLN1;TMEM259;ATXN3
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.8558771920479226,-1.4530198561120546,0.06666666666666667,0.9716784518401431,1.0,3/11,4.82%,NRP1;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6036790262383895,-1.4529609806839607,0.02531645569620253,0.9567825236562733,1.0,46/132,17.11%,RPL30;RPS4X;RPL19;RPL23A;RPL5;NR4A2;RPS25;EXT1;RPL34;WARS1;RPL15;RRBP1;ST3GAL4;RPL27;POLA1;RPLP1;RPL35A;RPS18;RPS3;RPS20;RPA1;RPL37A;RPS12;RPL36;RPL6;BRCA1;ORC3;RPL7A;ORC5;WRN;RPS24;THRB;EEF2;RPL11;RAD17;RPL10A;RPL37;PTMA;RPS21;RPS29;TOPBP1;RPS14;APOE;RPL13A;GTPBP1;RPS7
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.750750807156868,1.4524775464231687,0.08571428571428572,0.8477712544643178,1.0,3/13,4.53%,HSPA1A;EPAS1;UBQLN1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.8520491835008175,1.4524234921697572,0.08333333333333333,0.8391347832577899,1.0,4/8,11.18%,ZBTB7A;NOTCH3;EGFR;FBXW7
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.8743562850152122,1.4522890491687084,0.0625,0.830313446409423,1.0,3/6,10.36%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.8352151108685183,1.4519971611482854,0.11320754716981132,0.8237976497593195,1.0,1/6,1.75%,CDH2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.9268266138655873,1.4517127977918205,0.02857142857142857,0.8169320392656882,1.0,1/5,0.60%,EPN2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.568931897253445,-1.4493339313347935,0.011764705882352941,0.980010515073072,1.0,30/156,11.88%,COL24A1;SHROOM3;COL23A1;TGFB2;COL15A1;ELMO1;COL6A3;TUBGCP5;COL1A1;COL3A1;GSN;COL1A2;P4HA3;HSP90AB1;COL6A1;COL12A1;COL4A6;TGFBR1;APH1B;MARCKS;SHROOM4;COL11A1;CEP126;MTM1;CYP1B1;NCKAP5;FGF13;COL4A5;TPM2;HDGFL3
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.9218040400971985,1.447969735229011,0.020833333333333332,0.8335505753571744,1.0,2/5,1.46%,NOTCH1;TNFRSF1B
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.7860979168491044,-1.4461440134506605,0.06153846153846154,0.9973941372145005,1.0,5/18,9.74%,PARP1;XPA;DDB2;XPC;RPA1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.9661987464557097,-1.4454631653872898,0.0,0.9912666058877062,1.0,2/5,3.12%,VEGFA;NR4A2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.805557783654454,-1.4453305254514404,0.034482758620689655,0.9781724611599255,1.0,2/12,3.66%,ACTG1;ANXA1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8588468859826021,-1.4449379365053192,0.017857142857142856,0.9682485815657186,1.0,2/10,4.54%,VAMP4;MYO18A
prerank,PanglaoDB_Augmented_2021__Interneurons,0.5218076786516587,1.4443690950028005,0.0,0.8531825603438772,1.0,15/96,8.44%,SLC35F1;NOL4;ADGRB3;CACNA1B;KCNC2;CSRNP3;CTNND2;OPCML;NXPH1;AGAP1;CHN1;ABR;NRXN1;ADGRL2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.7192324604157082,-1.4434035518505106,0.04411764705882353,0.9727555070443997,1.0,10/35,10.00%,FGF1;NRP1;VEGFA;NR4A1;BMP5;LAMC1;F3;NOTCH2;TGFBR1;LAMB1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.8251863417743106,1.4422986775765745,0.075,0.8578850167982781,1.0,2/8,4.14%,INTS7;INTS2
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6734483138517139,1.442119557445382,0.027777777777777776,0.8513036346912526,1.0,7/16,13.59%,BCL9;BCL9L;SMARCA4;HDAC1;PYGO1;LEF1;EP300
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.8693367062499999,-1.4421130694378168,0.05,0.971840399615431,1.0,2/9,3.66%,ACTG1;ANXA1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7720513990823811,-1.4414004937992348,0.015151515151515152,0.9664933043196509,1.0,10/18,17.14%,CYP3A5;AKR1C2;AKR1C1;LSS;CYP1B1;CYP4V2;CYP27A1;HSD11B1;LIPA;NPC1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.8193513018033733,-1.4409667613208834,0.045454545454545456,0.9576500171545647,1.0,4/14,6.27%,PARP1;XPA;DDB2;XPC
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.9386462985252251,1.4401588312694638,0.0,0.8577930177473324,1.0,2/5,6.05%,ERBB4;BNIP3
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7530483828545169,1.4401357612541799,0.025,0.8490400277703188,1.0,5/12,18.49%,MYO1E;SYNE2;MYO1D;MYO1B;MYO5A
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.8786638404454412,-1.4396846981656402,0.03076923076923077,0.9613130739613405,1.0,2/7,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.8220113298754712,-1.4396503433782672,0.029411764705882353,0.9488623472699722,1.0,6/12,14.64%,CMKLR1;CD47;THBS1;HLA-B;MAPK14;IL16
prerank,PanglaoDB_Augmented_2021__B Cells,-0.7202189263250004,-1.4385687819292479,0.046153846153846156,0.9489250861186412,1.0,6/22,6.39%,CD55;IFIT3;WDFY4;SEMA6D;BACH2;RALGPS2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.6641875858383977,-1.4384080536807875,0.04285714285714286,0.9377922309789496,1.0,8/37,13.14%,NRP1;VEGFA;ACTG1;PHLDB2;EPHA3;THBS1;BCAS3;LIMCH1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.9176084920901492,-1.4374557193639048,0.03225806451612903,0.9365845897014495,1.0,2/7,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.8543273971452316,1.4372461788507676,0.047619047619047616,0.8644412346867811,1.0,3/6,4.22%,KCNC2;GUCY1A1;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.6720724825248124,-1.4358731680735808,0.02857142857142857,0.9413270877708252,1.0,12/47,12.66%,CLU;VEGFA;PARP1;XPA;DDB2;WARS1;RACK1;RPS3;SLF1;RPA1;PSMC2;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.9635108786707685,1.4358024624334176,0.022727272727272728,0.8676656199024138,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.7847554547878591,-1.434619177527438,0.019230769230769232,0.9440024995307656,1.0,3/13,5.04%,FGF1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.911261657139709,1.4338778442357747,0.075,0.8726168278624801,1.0,2/6,2.71%,VAPB;ATL2
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8986251150939601,-1.4338652472452609,0.019230769230769232,0.9416308757213929,1.0,3/7,3.66%,TGFB2;VEGFA;ANXA1
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.8524589688898385,1.4333462905827061,0.029411764705882353,0.8678296331647154,1.0,1/6,2.82%,APC
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.9550073073990081,1.4325141642871506,0.05263157894736842,0.8663179654034078,1.0,2/5,3.24%,CSF1R;ERBB4
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.6694263793085267,-1.4324077501747134,0.01694915254237288,0.9445727991964342,1.0,4/38,1.97%,PDGFD;FGF1;VEGFA;SPRY1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.9294370724928346,1.4317576070341937,0.02,0.8630963502180958,1.0,1/5,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.8982020078192559,1.4312106919440069,0.0425531914893617,0.8598284456389215,1.0,3/6,6.79%,NOTCH1;SOX6;HDAC1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.6652349565835294,1.430954351384038,0.05714285714285714,0.8541695280829165,1.0,4/21,4.53%,SNAP29;APC;HSPA8;UBQLN1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.9258749550757586,-1.429529462111054,0.017543859649122806,0.9650095476692089,1.0,1/5,0.47%,RPL30
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.9539577278330296,-1.4291903221441564,0.0,0.9577786177852098,1.0,2/5,2.02%,JAM2;SLC8B1
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.7815032867691939,-1.4289134721719556,0.031746031746031744,0.9487760458672783,1.0,5/18,6.93%,ABCA4;AKR1C1;ALDH1A1;GPC3;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.8076355949896913,1.4288734301823844,0.08571428571428572,0.862877957191844,1.0,1/10,0.16%,CSF1R
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.5778840409873026,1.4283833703490447,0.041666666666666664,0.8594935236618491,1.0,10/59,11.15%,HSPA1A;HSPA8;PTGES3;CEBPB;CORO2B;DNAJB6;SMG1;AMFR;NUP54;MCL1
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.815895839518141,1.4273768860807947,0.09433962264150944,0.8586600595675292,1.0,4/7,8.58%,NOTCH1;HEY2;CDH2;HEYL
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.6960552705093412,1.4265965707438402,0.07692307692307693,0.8594859117987338,1.0,3/19,3.82%,ATP2B4;HCN2;SLC12A2
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.777611372471817,-1.4262665940989765,0.1016949152542373,0.96365300278517,1.0,2/11,1.43%,PDGFD;NRP1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.6489423621070436,1.4261950248589514,0.08888888888888889,0.8550014957936831,1.0,1/23,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.9583496329646626,-1.4261421639033636,0.0,0.9545790712208411,1.0,2/5,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.666920194845275,1.4256191598810193,0.05263157894736842,0.8493860568537736,1.0,3/23,8.78%,DENND3;OGA;STT3B
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),-0.8614094165348418,-1.4256094543262368,0.06060606060606061,0.9480037463829426,1.0,3/8,7.03%,SLC47A1;ABCA8;ABCB1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.9428697889936237,-1.4244992242935623,0.01639344262295082,0.9483760534109716,1.0,1/6,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.7036389398773112,1.4241603462512331,0.2,0.8543733668884647,1.0,3/13,4.13%,HSPA1A;HSPA8;TMBIM6
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.6518012565394848,1.4239094289771206,0.10526315789473684,0.8487627997911767,1.0,7/18,17.52%,BCL2;BCL2L1;SLC25A4;BNIP3;SLC25A24;ABCB10;PITRM1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.6947614959154198,1.4238156865891953,0.10256410256410256,0.8418737153028268,1.0,4/15,9.24%,PDK4;IRS2;USP7;IRS1
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.7782045200302719,1.4227559048952216,0.06976744186046512,0.8415347762705574,1.0,2/10,4.14%,INTS7;INTS2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.574737382364814,1.4226186754575794,0.058823529411764705,0.8348252318890222,1.0,6/44,3.99%,CSPG4;CSF1R;NOX4;ERBB4;CD44;GPRC5B
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5879633635281891,1.421765307661678,0.027777777777777776,0.8337854235997088,1.0,4/43,2.17%,TRPC6;CACNA1B;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.7421714611572493,1.421572620893069,0.10869565217391304,0.8285836025425483,1.0,2/15,4.33%,TRPC6;TCAF1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.7928780468690108,1.4200631534903303,0.1388888888888889,0.8335475367505275,1.0,1/8,0.16%,CSF1R
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.8275288051772058,1.4194199695916225,0.06521739130434782,0.831423048455364,1.0,2/9,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7930390235723548,1.4181085141521832,0.09302325581395349,0.8346145858158005,1.0,1/10,0.17%,JPH2
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.5635883089802602,1.417795448639645,0.07142857142857142,0.8304941817446113,1.0,7/39,9.07%,HSPB1;NCK2;EIF4EBP2;CEBPB;AGO2;EIF4B;EIF3B
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.9563201866714319,-1.4175474207717413,0.0,1.0,1.0,1/5,2.81%,STAT1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.7963657599229449,1.4173065207053166,0.02631578947368421,0.8281722415922933,1.0,4/10,16.10%,CNOT7;CNOT6;DCP1A;DIS3
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.71033135539303,1.4170860232359674,0.047619047619047616,0.8226320108652693,1.0,5/18,11.14%,BCL2;ZBTB7A;HDAC9;MSH2;ADAM17
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8285163270399245,1.416718487669567,0.1111111111111111,0.8181665439909607,1.0,4/8,14.76%,CACNA1C;RYR2;BIN1;CTNNA3
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.8662757422010005,-1.4164306096388546,0.078125,1.0,1.0,1/9,1.05%,AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.8774705660747235,-1.4159606692498883,0.07017543859649122,1.0,1.0,2/5,4.58%,CD55;GLI3
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.8795235990572172,1.4152698500097358,0.02127659574468085,0.8211588024869078,1.0,1/5,1.35%,CNOT7
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.6289726782058933,1.4152323166299219,0.08,0.8148318088481521,1.0,6/35,4.11%,ADGRB3;KCNC2;CTNND2;OPCML;NXPH1;GFAP
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.8555859585525964,1.4150263590514296,0.13333333333333333,0.8101801569795434,1.0,2/6,4.14%,INTS7;INTS2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.9206225483380053,-1.414976372254009,0.05454545454545454,1.0,1.0,3/5,5.49%,IGFBP5;IGFBP2;BMP5
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.7534902528913223,1.4149534624980453,0.08333333333333333,0.804904461802686,1.0,2/12,3.82%,JPH2;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.558714605559139,1.4142093156446132,0.02631578947368421,0.805059114926421,1.0,15/55,11.90%,HSPA1A;NOTCH1;HIPK2;LEMD3;PPM1A;SMAD7;BCL9L;ZBTB7A;PMEPA1;ACVR2A;BMPR1A;ADAM17;UBE2D1;PPARA;MTMR4
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.6888001028517159,-1.4139105989758987,0.04838709677419355,1.0,1.0,3/23,5.60%,RIMS1;ANXA1;SEPTIN4
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.8550142526990079,1.412799471331981,0.13953488372093023,0.8072666278621337,1.0,4/8,9.71%,DGKB;DGKH;DGKE;DGKG
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.8739634427990212,1.412755956444679,0.07142857142857142,0.8014519227667687,1.0,1/5,2.05%,BCL2
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.7961991349602316,1.4120656070424635,0.06976744186046512,0.7880116925074702,1.0,1/10,0.90%,GATAD2A
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.7961991349602316,1.4120656070424635,0.06976744186046512,0.7880116925074702,1.0,1/10,0.90%,GATAD2A
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.7961991349602316,1.4120656070424635,0.06976744186046512,0.7880116925074702,1.0,1/10,0.90%,GATAD2A
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.6637845708407798,-1.4109078579209338,0.0,1.0,1.0,6/37,8.22%,PRAG1;RIPOR2;NRP1;COL3A1;ARHGEF3;RALBP1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.6986514670501485,-1.410376093412288,0.05172413793103448,1.0,1.0,1/24,0.08%,PRAG1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.8486832053544902,1.4101701671583056,0.17391304347826086,0.7952960702463805,1.0,2/5,11.90%,MTMR1;MTMR4
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.8929759365749734,1.4097015577836929,0.04878048780487805,0.7923180042930769,1.0,2/5,10.50%,VAPA;YTHDC2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.7990876989648682,-1.4090390011530922,0.05263157894736842,1.0,1.0,8/13,18.72%,SLC47A1;SLC38A1;SLC6A20;SLC25A13;SLC1A1;SLC1A2;SLC7A2;SLC1A3
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.8789869423065074,-1.4074612554338208,0.11864406779661017,1.0,1.0,2/6,9.38%,CD55;SASH1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.8047071669839319,-1.4074034845738927,0.06349206349206349,1.0,1.0,4/16,6.27%,PARP1;XPA;DDB2;XPC
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.6921919875568486,1.4071731549682938,0.07894736842105263,0.7977123803911866,1.0,6/16,16.98%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.6921919875568486,1.4071731549682938,0.07894736842105263,0.7977123803911866,1.0,6/16,16.98%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.8713853948162211,-1.4056673748598614,0.07692307692307693,1.0,1.0,3/9,3.02%,FGF1;VEGFA;PKM
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.827281332693653,1.404661662981937,0.058823529411764705,0.8068056647686898,1.0,4/8,15.03%,NOTCH1;ATP2B4;P2RX4;GLRX3
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.7526189438177951,-1.4045930439340546,0.06349206349206349,1.0,1.0,2/19,0.87%,CLU;TGFB2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.7687147695590012,1.404448919146437,0.09523809523809523,0.8024771846248627,1.0,4/9,14.70%,ATP2B4;NEDD4L;UTRN;COMMD1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.8180531039026606,-1.4038238777212126,0.1206896551724138,1.0,1.0,2/9,6.20%,SLC47A1;SLC6A20
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.8449424782311119,1.4032523339824463,0.06818181818181818,0.8055605458504301,1.0,3/7,11.15%,BCL2;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.886031814453944,-1.4002017972325904,0.06779661016949153,1.0,1.0,2/6,1.52%,NRP1;VEGFA
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.5999445365635785,-1.399361483960283,0.02857142857142857,1.0,1.0,14/64,9.94%,ABCA8;COL15A1;COL6A3;PAMR1;COL1A1;COL3A1;SGCD;CPED1;THBS2;ADAMTS12;COL1A2;FBLN2;DCN;LAMA4
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.9172066965708676,-1.3990373718118936,0.022222222222222223,1.0,1.0,1/5,1.97%,SPRY1
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.8905581026438362,-1.398831369071464,0.0847457627118644,1.0,1.0,1/6,5.52%,NMD3
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.7223426511472306,1.3980230646487843,0.07894736842105263,0.8358396590311163,1.0,7/12,18.46%,DLG5;NRXN1;SEMA4D;GRID2;CLSTN2;NLGN2;PTPRD
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.6585182334486835,-1.3968497913869409,0.1016949152542373,1.0,1.0,8/28,11.63%,ISM1;TGFB2;STAT1;THBS2;THBS1;DCN;PGK1;FOXC1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.8157599672529372,-1.3961609911977355,0.05454545454545454,1.0,1.0,4/13,11.06%,RIPOR2;RACK1;GSN;BCAS3
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5340608566969425,1.3961335976220945,0.03571428571428571,0.8426261599544653,1.0,10/64,6.16%,PPM1L;ST3GAL2;VAPB;MOCS1;SLC44A2;PCSK5;SGPL1;VAPA;CERS6;HACD2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.5933060070654446,1.396130141571501,0.05714285714285714,0.8369321699323539,1.0,4/29,8.78%,DENND3;HSPA8;OGA;STT3B
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.8646587380121462,-1.396084111350589,0.06153846153846154,1.0,1.0,3/7,12.66%,CD55;CD47;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.7804475080315489,1.3960210855083406,0.08823529411764706,0.8324690794404267,1.0,4/11,7.60%,CNOT7;TOB1;EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.811956364365927,1.3959622194052994,0.1111111111111111,0.8273789188839599,1.0,3/6,8.55%,KCNC2;GUCY1B1;PDE3A
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.7846725305663818,-1.3959075327388024,0.06779661016949153,1.0,1.0,5/11,11.85%,GSN;SFRP4;THBS1;PDCD4;ANO6
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.7432230945028098,-1.3954645254361018,0.04838709677419355,1.0,1.0,7/16,12.28%,PGR;CDKL1;DKK3;NKD1;ST6GAL1;BRCA1;IL1R1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8959165096885988,-1.3951780796751512,0.07272727272727272,1.0,1.0,1/6,2.81%,STAT1
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.8431440776787537,1.3950350672942808,0.06666666666666667,0.8269847378000472,1.0,1/8,0.06%,TRPC6
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6083880788440026,1.3947757537710674,0.09375,0.8228279402218565,1.0,5/26,11.14%,NCK2;EGFR;CBL;RPS6KA5;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7731644255670626,-1.393937284775671,0.13793103448275862,1.0,1.0,1/8,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.816225409187947,1.393795032973872,0.09090909090909091,0.8188429195532108,1.0,4/8,9.24%,IRS2;SMARCA4;BRWD1;IRS1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.816225409187947,1.393795032973872,0.09090909090909091,0.8188429195532108,1.0,4/8,9.24%,IRS2;SMARCA4;BRWD1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.706289929739405,-1.3934067813281386,0.08571428571428572,1.0,1.0,7/26,7.88%,TGFB2;VEGFA;MEGF10;AFDN;CD47;ADAM9;FBLN2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.6494213508504981,-1.391917125035313,0.015151515151515152,1.0,1.0,9/37,13.49%,ABCA4;ABCA8;ABCA9;AKR1C1;ABCA10;SLCO1C1;ABCA6;PEX3;SLCO1A2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.9024046358646641,1.3916571661222448,0.025,0.8278975753836293,1.0,4/5,6.05%,BCL2;BCL2L1;SLC25A4;BNIP3
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.8260955430075989,-1.3916357860049704,0.03125,1.0,1.0,3/9,4.82%,NRP1;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6702576722727259,1.3906216880697742,0.09302325581395349,0.827733024813343,1.0,8/21,17.03%,NOTCH1;HSPA8;GFAP;RAPGEF2;RAP1A;TJP1;RAPGEF1;EZR
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.8705425246084196,1.3903005447701053,0.047619047619047616,0.8237784163809835,1.0,4/6,9.71%,DGKB;DGKH;DGKE;DGKG
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.7557030839203793,-1.3902053950618682,0.10344827586206896,1.0,1.0,2/18,6.16%,ZFPM1;ZFP36L2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7013049935417475,1.3896308217259783,0.07142857142857142,0.8227728713198571,1.0,3/13,12.31%,ABL2;FLT1;PLAA
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.7243430023070248,1.3896306035122201,0.13333333333333333,0.817532279782788,1.0,3/13,7.58%,DACH1;CDKN1A;GNL3L
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.670588601090047,-1.3889943468131976,0.0821917808219178,1.0,1.0,6/36,8.05%,CLU;VEGFA;WARS1;RACK1;RPS3;SLF1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7351653399251807,1.3889694172253353,0.11627906976744186,0.8167220794062997,1.0,2/11,1.47%,GJC1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.8477338839482385,1.3884922710942789,0.06818181818181818,0.8156377025131336,1.0,3/7,13.86%,USP7;MAP2K2;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.7900585327301253,1.3881168272932638,0.08333333333333333,0.8126593950085872,1.0,2/10,5.18%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.9027982966703137,1.3880708268979949,0.022222222222222223,0.8080330739237958,1.0,3/6,5.40%,DNAH11;NOTCH1;BBS7
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.8704921953359228,-1.388030305723961,0.10909090909090909,1.0,1.0,2/5,6.75%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.8208807874557473,-1.3868570666756683,0.04838709677419355,1.0,1.0,4/8,14.97%,RIPOR2;BOC;MAPK14;BTG1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7856827665328661,1.3865811302052873,0.058823529411764705,0.8130230993430643,1.0,3/8,3.72%,NOTCH1;ERBB4;MGAT5
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.7495542751125428,-1.3861876309194647,0.05,1.0,1.0,4/15,12.52%,HINT1;NDRG1;DDX5;FHIT
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.8287044396507774,-1.3861695493137782,0.01639344262295082,1.0,1.0,5/15,11.49%,ACTG1;ANXA1;ST3GAL4;THBS1;PLPP3
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.7978598916074089,-1.3855505684885752,0.08771929824561403,1.0,1.0,6/10,13.79%,RPL23A;RPL5;DHX30;FASTKD2;RPL6;RPL11
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.7512627317623394,-1.3854351444163007,0.11666666666666667,1.0,1.0,4/17,9.74%,PARP1;XPA;DDB2;RPA1
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.866280134607361,-1.3849787280525074,0.09523809523809523,1.0,1.0,1/8,1.05%,AFG3L2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8236232901742236,1.3839931555350908,0.10256410256410256,0.8232222954393389,1.0,2/9,4.53%,HSPB1;UBQLN1
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.694082455716186,1.3833276884218018,0.10810810810810811,0.8215799474158267,1.0,3/14,4.13%,HSPA1A;HSPA8;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.8870655151202962,1.382957159382701,0.0,0.8188613983524841,1.0,1/5,0.06%,TRPC6
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.837049141913706,1.3827826342438758,0.13793103448275862,0.8145413450523832,1.0,3/5,15.85%,RAPGEF2;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.5939734523857718,1.3824704894347608,0.06451612903225806,0.811017578522272,1.0,3/37,3.88%,VAPB;ATL2;VAPA
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.6660386136317176,1.3815952059479757,0.05714285714285714,0.8125820190607592,1.0,2/12,4.13%,SRSF12;TMBIM6
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.7358800903756364,1.3811269593394415,0.15,0.8115863038792924,1.0,2/11,2.95%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.714918012034729,1.3795552480148925,0.14285714285714285,0.8169190299881262,1.0,1/13,0.45%,HSPB1
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.7986131295900765,1.3792587388123347,0.02631578947368421,0.8135959921985827,1.0,4/9,16.10%,CNOT7;CNOT6;DCP1A;DIS3
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.9018289187620545,1.378987411944988,0.04081632653061224,0.8107716252966116,1.0,2/5,2.98%,PML;HIPK2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.5510207314684353,-1.3788853146191482,0.012048192771084338,1.0,1.0,45/181,16.08%,PRSS23;RPL30;IGFBP5;AFG3L2;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;IGFBP2;WARS1;RPL15;RRBP1;GPC3;LAMC1;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;APH1B;UBL5;FBXW2;VCAN;FBXO22;LAMB1;FN1;RPL37A;RPS12;RPL36;RPL6;PRKDC;RPL7A;SHISA5;RPS24;RPL11;RPL10A;RPL37;CALU;RPS21;RPS29;RPS14;APOE
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.6925777865127547,-1.3786894416890039,0.06557377049180328,1.0,1.0,8/33,11.97%,NRP1;FBLN1;COL3A1;CD47;ADAM9;FN1;PLPP3;ITGBL1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7825597254450497,-1.3786246343807165,0.07017543859649122,1.0,1.0,4/12,10.87%,CDC37;PELI1;BIRC2;ASAH1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.8778257766196713,-1.3781371167222731,0.06896551724137931,1.0,1.0,5/8,10.79%,XPA;DDB2;XPC;POLA1;INO80
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7878520349459858,1.377807386676488,0.13157894736842105,0.8126843054356211,1.0,4/7,11.58%,ZFYVE28;CBLB;CBL;PPARA
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.8329117527061036,-1.3777915950375774,0.06666666666666667,1.0,1.0,3/8,8.02%,PARP1;TERF2IP;SMG6
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6227068180520565,-1.3770829588157096,0.06756756756756757,1.0,1.0,9/51,12.70%,PARP1;XPA;DDB2;XPC;PSMD8;RPA1;PSMC2;ORC3;ORC5
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.9219028819356576,-1.3760462948210228,0.06060606060606061,1.0,1.0,2/5,3.66%,VEGFA;ANXA1
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7243804823638084,1.3749632074109954,0.12195121951219512,0.8196736928877861,1.0,4/12,5.74%,NOTCH1;BBS7;MICAL2;TBX3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7243804823638084,1.3749632074109954,0.12195121951219512,0.8196736928877861,1.0,4/12,5.74%,NOTCH1;BBS7;MICAL2;TBX3
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.8671947699458425,1.3743837154639693,0.027777777777777776,0.8182919358431722,1.0,3/6,12.39%,KLF15;SLC26A3;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8498717900952764,-1.3742760748217864,0.125,1.0,1.0,1/6,0.92%,CD55
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.5750736875054372,1.37426188993997,0.058823529411764705,0.8140519910099179,1.0,9/45,7.65%,CSF1R;PDK4;CHL1;NDRG2;OPCML;EPOR;GFAP;TNS1;NRXN1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.5364799389945192,1.3741073121099556,0.03571428571428571,0.8103677137242816,1.0,8/54,10.90%,CSF1R;ERBB4;FLT1;LIFR;ACVR2A;AXL;EGFR;MERTK
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.8106548259517589,1.3735266495815015,0.10204081632653061,0.8092505494197566,1.0,4/6,11.48%,PDGFA;C1QTNF1;PRKG1;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.8563300971257244,1.3733458194632062,0.09259259259259259,0.8060106704481125,1.0,2/5,6.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.8565948308203629,-1.3732154037143696,0.05,1.0,1.0,2/6,4.02%,VEGFA;NKD1
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.8650465720327973,1.3731095251899332,0.06521739130434782,0.8033686495343635,1.0,2/6,5.66%,HSPA1A;ARHGEF7
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.7109276915749592,1.372480096489065,0.15384615384615385,0.8024946797753444,1.0,2/15,4.33%,TRPC6;TCAF1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.9131715281566641,-1.3723858077057047,0.0,1.0,1.0,3/8,3.68%,CYP3A5;SPTLC3;TSHR
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.6692972635710035,1.3723059555090753,0.15384615384615385,0.7988506837149014,1.0,6/19,9.57%,WTIP;EIF4ENIF1;PUM2;AGO2;MAP2K2;EGFR
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.8599178793061756,1.371311005504356,0.08888888888888889,0.8018195951643678,1.0,3/5,10.03%,RNF185;TMEM259;ATXN3
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.588827143640274,-1.370441267202142,0.02531645569620253,1.0,1.0,35/108,15.88%,LAMA1;VEGFA;NT5E;COL6A3;FBLN1;SAT1;IGFBP2;COL1A1;COL3A1;SGCD;THBS2;NTM;COL1A2;LAMC1;SFRP4;COL12A1;NOTCH2;SPOCK1;THBS1;FBLN2;GEM;DCN;VCAN;ADAM12;COL11A1;FN1;TPM2;SLIT2;TGFBR3;COL6A2;ABI3BP;CALU;PMP22;PRRX1;TPM1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.8877240008995898,1.369932372143733,0.06666666666666667,0.80475641027384,1.0,3/5,9.57%,NCOA3;LCOR;EGFR
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.7763694895164788,1.368838200466567,0.19444444444444445,0.8068108368651099,1.0,2/6,5.33%,PACSIN2;EHD2
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.5469550002491357,1.3682397963023112,0.04,0.8063649579004634,1.0,6/60,3.01%,ADGRB3;CACNA1B;LSAMP;CSRNP3;DGKH;OPCML
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8416700283422102,-1.3681718128010705,0.061224489795918366,1.0,1.0,3/10,5.29%,IFITM3;STAT1;XAF1
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.7523506887772987,-1.3681354898004563,0.15,1.0,1.0,3/17,3.04%,TGFB2;NRP1;SEMA3C
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7989226042003279,1.3678431359722651,0.10416666666666667,0.804540933048726,1.0,3/6,16.18%,RHOA;RHOB;RBPJ
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.763310018516546,-1.3668057633884487,0.14583333333333334,1.0,1.0,3/9,5.49%,SPRY1;LDLRAD4;BMP5
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.8441398782230516,-1.3660854579342756,0.10526315789473684,1.0,1.0,2/10,7.86%,TGFB2;THBS1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.7311719543395713,1.3652027075190434,0.12121212121212122,0.8150565542038605,1.0,3/12,10.95%,EPN2;ARNT;TMEM204
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.8440441955842305,1.364934038360679,0.11363636363636363,0.8123135935758453,1.0,2/6,3.82%,HCN2;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5949904711707605,1.3630802204324308,0.05405405405405406,0.8180622722834391,1.0,4/29,4.03%,HSPA1A;TNFRSF10B;BCL2;BCL2L1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.735838237097274,-1.3628036116370903,0.05,1.0,1.0,5/13,6.41%,GBP2;IFITM3;STAT1;EPRS1;CD47
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.8043407349275897,-1.3620885967088046,0.0967741935483871,1.0,1.0,2/15,7.86%,TGFB2;THBS1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5686085399886424,-1.360388036433421,0.02531645569620253,1.0,1.0,36/109,18.24%,RPL30;RPS4X;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;SMG6;SAMD4A;UPF3A;DDX5;RPL37A;RPS12;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;RPS21;RPS29;EXOSC10;PPP2R2A;RPS14;RPL13A;RPS7;NBAS;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.8432761419261252,-1.360024388954576,0.03636363636363636,1.0,1.0,2/8,4.54%,DDX60;MYO18A
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7721549183653026,1.3599716059725853,0.16666666666666666,0.8309924483863782,1.0,3/9,8.58%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7600635322991729,-1.3598594058639593,0.09090909090909091,1.0,1.0,1/10,0.65%,FGF1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),-0.8500133345282994,-1.3595514806069953,0.09836065573770492,1.0,1.0,2/6,7.71%,TWIST1;TGFBR1
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.8657786291356547,-1.359491004948545,0.1206896551724138,1.0,1.0,2/6,2.81%,AKR1C1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6925023032167561,-1.3591892042256983,0.2033898305084746,1.0,1.0,3/26,5.86%,CLU;VEGFA;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.6931426696589278,1.3590014455335995,0.16666666666666666,0.8324264483386079,1.0,2/10,1.46%,NOTCH1;TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.5634151188630565,-1.3577908541239263,0.09333333333333334,1.0,1.0,15/70,9.94%,IGFBP5;ABCA8;COL15A1;COL6A3;PAMR1;COL1A1;COL3A1;SEMA3D;SGCD;THBS2;COL1A2;SFRP4;COL12A1;DCN;LAMA4
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.9165539658412106,1.3573510101529167,0.06818181818181818,0.8378077572469022,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.6929747462990392,-1.3569740811009943,0.125,1.0,1.0,8/24,12.10%,NRP1;VEGFA;RNF213;NR4A1;THBS1;OTULIN;BMPER;SLIT2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.7378024035082751,1.3565255366522504,0.17777777777777778,0.8378588521044272,1.0,2/12,1.89%,MYOM2;OBSCN
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.7051126207396274,-1.3556834956729562,0.10909090909090909,1.0,1.0,1/16,2.81%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8298005456773719,1.3555518331822067,0.12,0.838601483752765,1.0,3/5,15.03%,NOTCH1;P2RX4;GLRX3
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.8204311865419408,-1.3554519542887067,0.125,1.0,1.0,4/10,10.81%,CD55;ERAP1;N4BP1;BIRC2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.7400724095115745,-1.3554009276728907,0.10344827586206896,1.0,1.0,2/12,1.52%,PDGFD;VEGFA
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.7979124842187437,-1.354146125657689,0.12962962962962962,1.0,1.0,3/11,7.24%,CIRBP;SNW1;NCL
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.8286791410503989,1.354126154991045,0.08571428571428572,0.8423776505442064,1.0,2/7,6.78%,HPRT1;AK3
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.746508733106835,1.3540785484513582,0.1951219512195122,0.8381803069390649,1.0,1/10,0.71%,KCNC2
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.8171325007466136,-1.3539720212756017,0.13333333333333333,1.0,1.0,5/14,12.66%,TGFB2;ANXA1;SRP54;PPIA;LGALS3
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.7788627686145614,-1.3534409121214235,0.11666666666666667,1.0,1.0,3/14,7.86%,MEGF10;ANXA1;THBS1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.8096648586170171,1.3533716109146183,0.08888888888888889,0.837944492184765,1.0,3/7,6.41%,TNFRSF21;DLG5;CEBPB
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.7540967205090792,1.353269237429178,0.18604651162790697,0.8343199505601506,1.0,1/9,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.8930742261379325,-1.3532646868879417,0.10714285714285714,1.0,1.0,1/5,1.72%,ACTG1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.7319747190089975,-1.3526096418976103,0.09259259259259259,1.0,1.0,3/11,10.76%,GLCE;EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.9000296141551212,-1.3525942547209944,0.041666666666666664,1.0,1.0,2/5,5.75%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.9000296141551212,-1.3525942547209944,0.041666666666666664,1.0,1.0,2/5,5.75%,P4HTM;P4HA3
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.7995164053561747,-1.352506065898735,0.0847457627118644,1.0,1.0,3/12,11.06%,RIPOR2;RACK1;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.6033660020979565,1.3523278382349626,0.10810810810810811,0.8354553735536919,1.0,5/22,8.36%,HSPA1A;SMAD7;SPOPL;GNL3L;MARCHF7
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),0.8467426264594895,1.3519039980170977,0.14285714285714285,0.834061422296413,1.0,3/5,8.58%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.9135809344225254,1.3514198975110137,0.045454545454545456,0.8332380329592152,1.0,1/5,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7527149210900892,-1.351274025260281,0.14035087719298245,1.0,1.0,2/11,6.75%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7527149210900892,-1.351274025260281,0.14035087719298245,1.0,1.0,2/11,6.75%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.8104815629006432,-1.3512139627881445,0.1111111111111111,1.0,1.0,1/13,0.90%,TWIST1
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.796508632017114,-1.351129993513206,0.15873015873015872,1.0,1.0,7/10,18.72%,SLC47A1;SLC6A20;SLC6A13;SLC1A1;SLC1A2;SLC7A2;SLC1A3
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.4827823398852831,1.3505668502682575,0.0,0.8340296027579681,1.0,7/75,3.01%,ADGRB3;CACNA1B;LSAMP;FILIP1;CSRNP3;KALRN;OPCML
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.9050013772611789,-1.3505543239338482,0.057692307692307696,1.0,1.0,1/5,2.22%,MEGF10
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.8125517373723622,1.3502197525530835,0.07317073170731707,0.8316153534849328,1.0,3/9,9.96%,HDAC1;ZNFX1;MBD2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),-0.9251540527693659,-1.3496175234234218,0.05660377358490566,1.0,1.0,2/5,3.66%,MEGF10;ANXA1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5276249709229277,1.3494486826516305,0.06896551724137931,0.8314742924852951,1.0,8/47,5.24%,TRPC6;CSF1R;NOTCH1;GJA4;CDH2;APC;CD44;TNS1
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.8296142277787186,1.3493184300523295,0.13333333333333333,0.8280035769045057,1.0,3/7,10.36%,ADCY9;ADCY3;ADCY5
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5578514587035063,-1.34904740724671,0.04225352112676056,1.0,1.0,24/78,11.49%,IGFBP5;COL15A1;VEGFA;COL6A3;PAMR1;STAT1;DKK3;COL1A1;COL3A1;GLI3;SGCD;THBS2;ADAMTS12;COL1A2;PDZRN3;COL6A1;COL12A1;DCN;CREB3L2;COL11A1;LAMA4;FN1;BOC;PLPP3
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.5738414204960921,-1.3486356573452172,0.016129032258064516,1.0,1.0,7/91,3.95%,PRAG1;CLU;IGFBP5;CD55;MDFIC;SNW1;IGFBP2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.8501810769238677,1.3480607126420159,0.08888888888888889,0.8317396826651529,1.0,3/5,14.42%,CAB39;NEDD4L;BIN1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.5878113476552176,1.3477185655123356,0.0967741935483871,0.8298693542903026,1.0,5/34,12.45%,INTS7;INTS2;ELL2;ZNF143;ELL
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.65887949338827,1.347627981381875,0.22857142857142856,0.8262943826845551,1.0,4/17,8.58%,SMARCA4;ZBTB7A;HDAC1;HEYL
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.8240445358868336,1.3468498675965537,0.0851063829787234,0.8270390285257591,1.0,2/7,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.6428386063954205,-1.3463549164291944,0.11864406779661017,1.0,1.0,7/28,10.64%,FTL;FTH1;ACO1;SLC22A17;SLC11A2;ABCB7;HEPH
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.6863718114237886,1.3461616866830868,0.10810810810810811,0.8270301841506938,1.0,1/15,0.06%,TRPC6
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.7317127073137324,1.3453411431979319,0.1276595744680851,0.8273929031832976,1.0,4/10,21.40%,MAP2K2;MAP2K1;EZR;SNX3
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6832712724347475,1.34484028275748,0.16216216216216217,0.8252696622897508,1.0,5/15,14.58%,GJC1;CACNA1C;RYR2;NEDD4L;KCNQ1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.8519791799531599,-1.3447809323158348,0.13333333333333333,1.0,1.0,2/5,10.59%,RIMS1;SLC22A6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.7957802086407006,1.3447241700363637,0.15789473684210525,0.8222723981284918,1.0,3/6,9.58%,ZFYVE28;CBLB;CBL
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),-0.7300452706065645,-1.344702592971977,0.0847457627118644,1.0,1.0,5/15,11.03%,ST6GALNAC3;ST3GAL5;HEXB;ASAH1;GALC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.7520865913550226,-1.3436505227339068,0.13559322033898305,1.0,1.0,4/16,9.74%,PARP1;XPA;DDB2;RPA1
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.7354688037366642,1.3435174935608483,0.16129032258064516,0.8251116894530184,1.0,1/10,0.16%,CSF1R
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.8574094078154233,-1.3433666298312794,0.07142857142857142,1.0,1.0,1/7,2.67%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.7092282907307658,-1.3424896347280955,0.11940298507462686,1.0,1.0,3/21,5.65%,NRP1;VEGFA;RIN2
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.7856407683036237,-1.3422321429176236,0.04838709677419355,1.0,1.0,4/13,6.39%,NT5E;WDFY4;BACH2;RALGPS2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.8786702190998885,1.3411338918936362,0.06666666666666667,0.8338631177551336,1.0,3/6,7.97%,DLC1;BCL2L1;FZD3
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.7611089311075961,-1.3408899741753997,0.16666666666666666,1.0,1.0,4/11,12.52%,AK5;NMNAT2;NMNAT3;FHIT
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.7101058162396767,1.3408807035696948,0.07894736842105263,0.8310750866393937,1.0,5/9,28.54%,GRID2;GRIN2B;GRIN1;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.8365080299944334,1.3407809187709545,0.11904761904761904,0.8277963701125558,1.0,3/7,13.40%,HDAC1;HDAC9;HDAC2
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.5651913507050494,1.3406431417714886,0.043478260869565216,0.8247529804037108,1.0,1/47,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.8171009429225049,1.3400756972419836,0.1111111111111111,0.8240387740980165,1.0,2/5,4.58%,EMP2;PACSIN2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.8072821211191014,-1.3387254462664535,0.14035087719298245,1.0,1.0,4/10,9.74%,PARP1;XPA;DDB2;RPA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.8072821211191014,-1.3387254462664535,0.14035087719298245,1.0,1.0,4/10,9.74%,PARP1;XPA;DDB2;RPA1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.7950275492016715,-1.338523123070667,0.14285714285714285,1.0,1.0,1/11,1.74%,PARP1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.6304183468539171,1.3378379717257443,0.14285714285714285,0.8323433451488411,1.0,4/25,4.13%,HSPA1A;HSPB1;HSPA8;TMBIM6
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.8364148335112771,-1.3366373079843425,0.09615384615384616,1.0,1.0,1/6,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.8709982235760271,-1.3352049664667143,0.03508771929824561,1.0,1.0,2/5,5.77%,ST6GALNAC3;ST3GAL5
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.7148566761061603,1.3349504116337692,0.2,0.8444764782885223,1.0,4/14,14.98%,MTHFD2L;DLST;MTHFR;MDH1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.8450587489982067,1.3348034452792505,0.12195121951219512,0.8415138952051764,1.0,3/6,14.42%,CAB39;NEDD4L;BIN1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),0.8487716648569682,1.3337169832295206,0.10256410256410256,0.840318869985546,1.0,4/5,15.09%,SLC25A4;ABCC5;SLC25A24;SLC25A17
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.8487716648569682,1.3337169832295206,0.10256410256410256,0.840318869985546,1.0,4/5,15.09%,SLC25A4;ABCC5;SLC25A24;SLC25A17
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5819978949062418,-1.3336734694930201,0.09859154929577464,1.0,1.0,20/62,16.58%,COL15A1;COL6A3;PAMR1;DKK3;COL1A1;COL3A1;SGCD;THBS2;BMP5;COL1A2;COL6A1;FBLN2;DCN;LAMA4;COL6A2;ABI3BP;CFH;AEBP1;PRRX1;C1S
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.7607550654459714,-1.333148189025157,0.11864406779661017,1.0,1.0,1/11,0.36%,CLU
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.649807523918132,-1.3326321252298565,0.06451612903225806,1.0,1.0,11/39,12.93%,CIRBP;PARP1;XPA;MSH6;DDB2;UVSSA;N4BP1;INO80;MAP3K4;WRN;DHX36
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.605540252050628,1.332389851876387,0.15,0.8429908702981754,1.0,5/28,12.95%,RGS6;RGS12;MGRN1;RGS5;RIC8B
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.715033748977381,1.3318313178894017,0.1836734693877551,0.8426647960309948,1.0,1/8,2.87%,PISD
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5353975919977643,1.3314470317462777,0.03333333333333333,0.8410088287372953,1.0,7/51,12.05%,HSPA1A;RBM20;TMBIM6;RRP1B;HNRNPF;GRSF1;RBM23
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.8131041138699233,-1.3314446057308222,0.09230769230769231,1.0,1.0,3/7,11.06%,NRP1;BAIAP2L2;BCAS3
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.8162402393160723,-1.331343204909756,0.08928571428571429,1.0,1.0,1/9,1.43%,NRP1
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.8343115369653055,-1.331102632505733,0.1320754716981132,1.0,1.0,1/7,1.41%,PRDX1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.7416539406881003,1.3309774682982967,0.075,0.8399570150753423,1.0,2/11,3.24%,NOTCH1;ERBB4
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.8053861098733233,-1.3309401777263477,0.125,1.0,1.0,2/8,9.93%,CTSL;PGK1
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.6279833489124965,1.3309392293923856,0.13333333333333333,0.8366633713610913,1.0,1/14,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.8639172308732009,1.3304956988640242,0.16666666666666666,0.8322469739819954,1.0,2/5,13.04%,MTHFD2L;MTHFR
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.8639172308732009,1.3304956988640242,0.16666666666666666,0.8322469739819954,1.0,2/5,13.04%,MTHFD2L;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.8093524127081436,1.3303864897863291,0.14285714285714285,0.8294149537978539,1.0,3/9,8.36%,BCL2;CD44;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6622186514801156,1.32992324795555,0.18181818181818182,0.8284829552847325,1.0,3/12,9.40%,APC;CDKN1A;MYOCD
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.8674785336157449,-1.3297135444091153,0.1,1.0,1.0,1/5,2.16%,CTSL
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.7752342279006326,-1.3295061900878942,0.15254237288135594,1.0,1.0,1/10,0.36%,CLU
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.7455439353698866,1.3293912859756636,0.12903225806451613,0.8279420285124406,1.0,1/11,0.17%,JPH2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5607066797503734,1.3293213249428306,0.06896551724137931,0.8250686318412508,1.0,10/41,10.53%,CSF1R;PDGFA;ABL2;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;RICTOR;ARHGAP35
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.6343283525187895,-1.3293007206605054,0.1016949152542373,1.0,1.0,9/30,11.43%,GBP2;ADAMTS12;ZFP36L2;ADAM9;RPS3;YBX3;ASAH1;NUB1;BRCA1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.8129328407520333,-1.3292400526750594,0.11538461538461539,1.0,1.0,1/7,0.87%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.8601940670888949,1.3288466414170157,0.11538461538461539,0.8234067360587045,1.0,3/5,11.48%,C1QTNF1;PRKG1;SH2B3
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.6429847259553857,-1.328844685920581,0.07575757575757576,1.0,1.0,8/42,9.74%,PARP1;XPA;DDB2;UVSSA;XPC;POLA1;HMGN1;RPA1
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.7921510088985628,-1.3287204131918446,0.14545454545454545,1.0,1.0,1/10,0.95%,PIGG
prerank,PanglaoDB_Augmented_2021__Myocytes,0.560095339912585,1.3286156340102722,0.03333333333333333,0.821002019874259,1.0,10/41,10.72%,LDB3;JPH2;RASL12;CKMT2;MEF2D;PRKG1;NOTCH3;PXN;ITGA3;ITGA7
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.8270015589067017,-1.3284399173584274,0.2826086956521739,1.0,1.0,1/5,1.74%,PARP1
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.5877918859511524,1.3271550714301035,0.13793103448275862,0.8239394625332653,1.0,5/35,12.45%,INTS7;INTS2;ELL2;ZNF143;ELL
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.820347599442568,-1.3267125424498383,0.12903225806451613,1.0,1.0,3/8,12.75%,MTM1;SLIRP;NUBPL
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.6372697888530935,1.3266198543008856,0.15217391304347827,0.8238507377408434,1.0,5/14,15.85%,SORT1;RAPGEF2;DDIT4;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.7693511390118062,-1.326520859407126,0.125,1.0,1.0,1/13,1.74%,PARP1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.8325314088895891,-1.3262970370433405,0.1016949152542373,1.0,1.0,1/8,0.36%,CLU
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5532855908466506,1.3257520466970947,0.10714285714285714,0.8245568019316034,1.0,18/61,15.51%,WTIP;FMNL3;PDZD8;PACSIN2;MICAL2;ARHGAP10;SYNE3;BRWD1;RHOA;RHOB;KLHL20;CAMSAP1;SEMA6A;RANBP10;PPP2R3C;CECR2;BIN1;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.825224187426667,-1.325506259599094,0.13725490196078433,1.0,1.0,1/5,5.32%,PER2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.8368347074208791,1.3254476696495874,0.17391304347826086,0.8226986231251536,1.0,2/6,1.89%,MYOM2;OBSCN
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.6075841821267555,-1.3254141568629487,0.18333333333333332,1.0,1.0,7/42,12.44%,CDKL1;GSN;DYNC2LI1;NPRL3;TBC1D2B;DCDC2;TBC1D22A
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.8321647688109463,-1.3251105308849134,0.04,1.0,1.0,1/9,4.37%,CENATAC
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.8649096228958428,-1.3242640663839784,0.10344827586206896,1.0,1.0,2/6,4.68%,ANXA1;EYS
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.8633624665583268,-1.3238956386303993,0.04081632653061224,1.0,1.0,2/5,9.24%,CLU;TENM4
prerank,PanglaoDB_Augmented_2021__Neurons,0.48639876442575936,1.3238862573883028,0.08333333333333333,0.8272950307226115,1.0,15/104,8.44%,NOL4;ADGRB3;CACNA1B;DGKB;CSRNP3;OPCML;GNAI1;NXPH1;MEG3;TESC;ATP6V1H;CHN1;GNL3L;NRXN1;CTNNA2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8040842881954959,1.3236095961109844,0.16326530612244897,0.8255331187009546,1.0,3/6,9.34%,GJC1;CACNA1C;CACNB2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.8018595337973736,-1.323423996806518,0.05555555555555555,1.0,1.0,1/10,1.52%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7958162218428679,1.3232479353537105,0.1590909090909091,0.8240152794747213,1.0,1/9,1.35%,CNOT7
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7386281986332848,-1.3228066503473757,0.12307692307692308,1.0,1.0,5/11,18.07%,STAT1;CDC37;HSP90AB1;PARP9;IFNGR2
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.8899676690554231,-1.3225064705180276,0.08163265306122448,1.0,1.0,1/5,0.36%,CLU
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.7951432781630314,-1.321974210785628,0.1111111111111111,1.0,1.0,3/9,10.30%,VEGFA;IFT122;KDM2B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.8714282586190139,-1.3218417893374974,0.07272727272727272,1.0,1.0,1/5,0.87%,TGFB2
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.8538417255266353,1.3216225163397715,0.15384615384615385,0.8283217115143942,1.0,2/6,3.82%,PDK4;SLC12A2
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8153349829126476,1.3214483121868594,0.18867924528301888,0.8258021284077693,1.0,2/5,9.43%,DENND3;MADD
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.7878442509178796,-1.3206550009631115,0.1568627450980392,1.0,1.0,1/11,0.87%,TGFB2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.6866426562298937,-1.3202322563838853,0.10294117647058823,1.0,1.0,3/17,9.80%,IGFBP5;ANXA1;CYP1B1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.7459682104975389,-1.3201398228524996,0.14545454545454545,1.0,1.0,3/10,5.04%,FGF1;VEGFA;GLI2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.8829075142827795,-1.320012770215206,0.05,1.0,1.0,2/5,10.16%,SUPT6H;DDX5
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.8023460004857156,1.319610261255857,0.09302325581395349,0.831292487911678,1.0,2/8,9.40%,KLF15;MYOCD
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.8568361959433645,-1.3194771269646277,0.038461538461538464,1.0,1.0,2/6,9.80%,ALDH3A2;CYP1B1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.9022122935374337,1.3193686400550186,0.045454545454545456,0.8258395359557321,1.0,3/5,8.36%,BCL2;CD44;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.9022122935374337,1.3193686400550186,0.045454545454545456,0.8258395359557321,1.0,3/5,8.36%,BCL2;CD44;MARCHF7
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6514380924120324,1.3192999109438412,0.1891891891891892,0.8228763842935403,1.0,2/10,9.40%,APC;MYOCD
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.8245520132577079,-1.3183865463236213,0.06779661016949153,1.0,1.0,4/8,13.73%,RACK1;CD47;PIP4P2;PLSCR1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.6319863046952311,1.3178343961668042,0.0975609756097561,0.8267277624562707,1.0,1/18,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.7387071525525677,-1.3177952804774982,0.11475409836065574,1.0,1.0,6/9,23.88%,SULF2;ADAMTS12;CSGALNACT1;XYLT1;FOXL1;BMPR1B
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.7494521007718469,1.3172851624243536,0.16326530612244897,0.8260540695730534,1.0,1/10,3.97%,ARF1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.681643473683702,1.3167373214017672,0.11904761904761904,0.8255629721905074,1.0,2/13,3.24%,NOTCH1;ERBB4
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6559470205916893,-1.3164368467900291,0.1346153846153846,1.0,1.0,7/25,10.64%,FTL;FTH1;ACO1;SLC22A17;SLC11A2;ABCB7;HEPH
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.4949289078367111,1.3156048156244278,0.125,0.8284314727218505,1.0,17/71,18.46%,PPM1L;PTPRK;PPM1A;PPP2R1A;CTDSP2;PPP2CB;PPP6C;UBASH3B;CTDSP1;PPP1CC;MTMR4;PPP4R2;BTRC;PTPN9;PTPRS;PTPRZ1;PTPRD
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5152394413413219,1.3152728659721074,0.09375,0.8273631682349304,1.0,12/70,8.08%,NOL4;CMTM8;CSRNP3;CNTN4;RCAN2;KALRN;ERBB4;LONRF2;LIFR;CNTN1;NRXN1;ADGRL2
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.8432967911128464,-1.315178193260276,0.16071428571428573,1.0,1.0,1/8,0.90%,TWIST1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.853309060123423,-1.3144151200986285,0.11475409836065574,1.0,1.0,1/5,3.91%,ERAP1
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.8113564985382998,1.3143411314550355,0.175,0.8229467731156447,1.0,2/6,9.12%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.8113564985382998,1.3143411314550355,0.175,0.8229467731156447,1.0,2/6,9.12%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.8113564985382998,1.3143411314550355,0.175,0.8229467731156447,1.0,2/6,9.12%,HSPB1;KIF5B
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6616348515822623,-1.3139468934593983,0.16923076923076924,1.0,1.0,4/19,6.41%,GBP2;ANXA1;ADAMTS12;CD47
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.6493060245516916,-1.3139121291043694,0.09375,1.0,1.0,4/36,1.55%,ABCA4;SLC47A1;ABCA8;ABCA9
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",-0.8569990195902288,-1.3131437204399865,0.09090909090909091,1.0,1.0,1/6,1.43%,NRP1
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.7029362400728556,-1.312994095282504,0.08620689655172414,1.0,1.0,8/19,17.65%,ERAP1;CDC37;N4BP1;HSP90AB1;BIRC2;PARP9;PLSCR1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.6532315349875009,-1.3121256178671008,0.1111111111111111,1.0,1.0,3/28,4.20%,CLU;TWIST1;COL3A1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6957967382248134,-1.3120262587326752,0.15384615384615385,1.0,1.0,4/16,14.02%,IFITM3;N4BP1;PLSCR1;SRPK1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.7927958166864201,-1.3118838513001705,0.18,1.0,1.0,1/9,0.95%,PIGG
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.5190407388178228,1.311505346102217,0.13333333333333333,0.8357746957165979,1.0,6/46,7.96%,CSF1R;NOX4;MFHAS1;CD44;CEBPB;HDAC9
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.6518233605324724,-1.3113565627736237,0.13636363636363635,1.0,1.0,5/40,6.75%,ELMO1;ACTG1;MYO10;VAV3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.7490419119885062,1.311353330483601,0.19444444444444445,0.8336633053442245,1.0,4/13,7.60%,CNOT7;TOB1;EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.6807602229989843,-1.310551077981193,0.0967741935483871,1.0,1.0,8/18,18.58%,ENPP2;AGPAT4;AGPAT5;GPX4;PLPP3;GNPAT;LPL;PLA2G4C
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.6571234678971623,-1.3100460506160119,0.15151515151515152,1.0,1.0,5/39,6.75%,ELMO1;ACTG1;MYO10;VAV3;HSP90AB1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.6571234678971623,-1.3100460506160119,0.15151515151515152,1.0,1.0,5/39,6.75%,ELMO1;ACTG1;MYO10;VAV3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.8287181499338118,1.310035119197001,0.16666666666666666,0.8379719213328671,1.0,4/5,17.17%,APOLD1;CEBPB;PRKX;KLF7
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.7821560633507475,-1.3097970953654194,0.13114754098360656,1.0,1.0,1/10,0.36%,CLU
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.871620580301419,-1.3097401692655652,0.05172413793103448,1.0,1.0,4/5,10.11%,ANXA1;COL3A1;THBS1;FN1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.609687885271022,1.3093579522933674,0.13953488372093023,0.8387797411593931,1.0,4/22,4.67%,CSF1R;CNOT7;ERBB4;PPP2R1A
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7321196129278924,-1.3091088464096194,0.16129032258064516,1.0,1.0,4/11,19.77%,ENPP2;CYP1B1;MT3;ACBD5
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.8040887982504317,-1.3090003950759013,0.11764705882352941,1.0,1.0,2/9,2.02%,AFG3L2;SLC8B1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.8426814055611913,-1.308832654737197,0.14545454545454545,1.0,1.0,1/9,0.90%,TWIST1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6799690444825279,-1.3087954805089295,0.12698412698412698,1.0,1.0,7/28,13.46%,SLC8B1;SAT1;ANXA5;IL1R1;LGALS3;BHLHE40;S100A11
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.7062077396803053,-1.3087860970905154,0.1320754716981132,1.0,1.0,1/14,2.81%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7895274487503732,1.3084855007136538,0.10256410256410256,0.8401359812794568,1.0,4/8,14.70%,CAB39;NEDD4L;BIN1;COMMD1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.75086693102136,1.3084074654238929,0.11627906976744186,0.8373175337325773,1.0,3/7,11.43%,SMARCD3;SMARCA4;ARID1A
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.5825523025289974,-1.308106787627493,0.13432835820895522,1.0,1.0,7/52,4.39%,PRAG1;PLXNC1;FGF1;TWIST1;FBLN1;ENPP2;TMSB10
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8640455909761551,-1.308043844042947,0.047619047619047616,1.0,1.0,2/6,7.21%,VEGFA;F3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5819418349511577,1.307920921061073,0.13333333333333333,0.8364253020949577,1.0,4/17,8.90%,HSPA1A;TESC;ACVR2A;ARNT
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.8320707158844296,1.3078679862825677,0.14285714285714285,0.8335573782078762,1.0,2/5,14.56%,AXL;CDC42
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),-0.8613993463333658,-1.3076282032911628,0.11290322580645161,1.0,1.0,2/6,7.71%,TWIST1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5765198579889027,1.307521358506011,0.08333333333333333,0.8321394870957564,1.0,8/38,6.51%,HSPA1A;LEMD3;PPM1A;SMAD7;BCL9L;ZBTB7A;PMEPA1;LTBP1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.7411715338289568,-1.3070511526895112,0.11290322580645161,1.0,1.0,1/16,0.64%,CIRBP
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.5058463966302933,1.3067469654972024,0.08,0.83349520519161,1.0,17/72,13.09%,ADGRB3;INF2;WTIP;CDH2;PDZD8;EMP2;BCL9L;CHN1;ADGRA2;BCL6;SEMA4D;ARHGAP44;ARHGAP35;CAMSAP1;PAK2;NEDD4L;PDLIM5
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.6660151553737563,-1.3066873442598452,0.21311475409836064,1.0,1.0,4/19,1.97%,TGFB2;RIPOR2;ARHGAP24;SPRY1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.6584753708904437,-1.3064872336964506,0.1016949152542373,1.0,1.0,7/33,11.24%,NRP1;VEGFA;NR4A2;SPOCK1;DCDC2;GPM6A;FGF13
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.7954061525143761,1.3059550697480473,0.1282051282051282,0.8343820995967632,1.0,2/6,11.58%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7528537662915216,1.3052816290682812,0.0975609756097561,0.8348053411607458,1.0,3/9,8.11%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.5225169048371381,1.3052241195087864,0.10344827586206896,0.8319544720855452,1.0,5/34,10.13%,WTIP;IPO8;PUM2;AGO2;NUP54
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.7236327598389964,-1.305119109539887,0.15873015873015872,1.0,1.0,3/16,8.27%,SULF2;SFRP4;SLC10A7
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.44226431853283565,1.3050171770863064,0.0,0.8301557641647429,1.0,19/139,7.10%,HSPA1A;NOX4;H2AC6;NOTCH1;ZBTB7C;CNOT7;TOB1;PML;NCK2;APC;CTBP2;ERBB4;PTPRK;DLC1;TESC;TBX3;DLG5;CDKN1A;RAF1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7144381695882265,1.3036621029996267,0.11627906976744186,0.8339191859671311,1.0,5/8,28.54%,GRID2;GRIN2B;GRIN1;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.7795823982243613,-1.3034321010341208,0.15,1.0,1.0,3/7,11.26%,IGFBP2;RPS3;PRKAR1A
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.8342100279751055,1.3032530849946473,0.1590909090909091,0.8326178552299313,1.0,2/5,11.58%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.8248867620486798,-1.3028817385341687,0.09230769230769231,1.0,1.0,2/7,11.43%,TWIST1;BRCA1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.4942366350552703,1.302153327363097,0.12121212121212122,0.834957768355928,1.0,20/70,22.46%,DPP10;RAB40C;EMP2;EHD2;TESC;PACS2;CACNB2;RAPGEF2;RAP1A;ARL3;GAS6;LIN7A;EZR;MYO5A;ANK2;RAB10;LIN7C;FLNA;FCHO2;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.6400281783422694,1.3018593887812735,0.10344827586206896,0.8331741379006395,1.0,6/25,11.31%,HSPA1A;RBM20;MAP2K2;EGFR;GRSF1;NFKB1
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.8205624706348038,-1.3016124818585715,0.12244897959183673,1.0,1.0,1/6,0.95%,PIGG
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.8722627821844943,-1.3015801821536521,0.11666666666666667,1.0,1.0,1/5,0.73%,AK5
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.8028948289382345,-1.3006783255451337,0.14545454545454545,1.0,1.0,1/8,1.32%,FOXQ1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.5477221088606584,-1.2994955496141642,0.041666666666666664,1.0,1.0,19/100,11.74%,FGF1;IGFBP5;COL15A1;COL6A3;PAMR1;NR4A2;DKK3;COL1A1;COL3A1;THBS2;COL1A2;COL6A1;COL12A1;DCN;AKAP12;LAMA4;FN1;PLPP3;TPM2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7066156297145532,-1.2993872733984677,0.15151515151515152,1.0,1.0,9/18,17.31%,RPL23A;RPL5;RPL35A;RPL6;RPL7A;RPL11;RPL10A;WDR12;LAS1L
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.7634589489821949,1.2991202350047566,0.17073170731707318,0.8447731625727833,1.0,2/8,14.21%,NPTN;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),-0.8658847833337713,-1.2986165404688517,0.07547169811320754,1.0,1.0,2/5,7.60%,TWIST1;RPS3
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7049038102038232,1.2983465113632515,0.1794871794871795,0.8453894209398705,1.0,2/11,11.14%,FLT1;ADAM17
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.6044596823559775,1.2977467804250986,0.1282051282051282,0.8451565388514978,1.0,2/25,2.87%,INF2;PISD
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.7310801159617171,-1.2977203295923245,0.109375,1.0,1.0,5/17,15.57%,NRP1;WDFY4;MAP3K8;IL16;CD4
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5159356812183734,1.2972603155069895,0.09523809523809523,0.8443240522003022,1.0,10/59,11.18%,CSF1R;ERBB4;FLT1;PTGES3;UBE2N;HMBOX1;AXL;EGFR;MERTK;FBXW7
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.8027253014961342,-1.2969787198042937,0.14545454545454545,1.0,1.0,4/12,12.66%,TGFB2;SRP54;PPIA;LGALS3
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.8027253014961342,-1.2969787198042937,0.14545454545454545,1.0,1.0,4/12,12.66%,TGFB2;SRP54;PPIA;LGALS3
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.6886371310253722,-1.2966221371741726,0.14545454545454545,1.0,1.0,1/12,0.96%,COL15A1
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),0.8382724490432519,1.2959496698282789,0.08108108108108109,0.8473718333785867,1.0,1/7,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7991765206772439,1.2956650864919446,0.2,0.845900585499068,1.0,2/5,17.08%,FBXW7;SLC27A1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7362656955982441,1.2951964703643184,0.18604651162790697,0.8452725602406335,1.0,1/8,0.09%,CSPG4
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.7272789180688307,-1.295176228275263,0.20967741935483872,1.0,1.0,1/11,0.87%,TGFB2
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.7513426866960559,-1.294395542361852,0.14285714285714285,1.0,1.0,4/9,20.80%,PEX1;PEX3;LONP2;TMEM135
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.554776449398849,1.2942489964590427,0.11428571428571428,0.8465460372667237,1.0,8/30,8.41%,PPM1L;ST3GAL2;VAPB;SGPL1;VAPA;CERS6;HACD2;SAMD8
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.8369470122749745,1.293967597540864,0.09302325581395349,0.8451324310474022,1.0,2/5,2.28%,PDGFA;C1QTNF1
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.5982703656380416,1.2937475598057526,0.20512820512820512,0.8431791601693028,1.0,11/27,24.47%,MICALL2;SNX4;EHD2;VPS50;RAB14;VPS26A;EPS15;SNX3;VPS26C;VPS35L;CMTM6
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),-0.8177577988719695,-1.2936559442193982,0.13636363636363635,1.0,1.0,2/7,7.86%,MEGF10;THBS1
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.8112847248665656,1.293254049187971,0.11363636363636363,0.8397807667785622,1.0,3/6,11.43%,SMARCD3;SMARCA4;ARID1A
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.8112847248665656,1.293254049187971,0.11363636363636363,0.8397807667785622,1.0,3/6,11.43%,SMARCD3;SMARCA4;ARID1A
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.5550252368210489,1.2920888629532077,0.17857142857142858,0.8416338955545647,1.0,12/43,14.00%,CSF1R;ERBB4;FLT1;EMP2;IRS2;CAMKK2;AXL;EGFR;MERTK;RBL1;LDB2;TTN
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.7677721544116682,-1.2917934940888796,0.16923076923076924,1.0,1.0,2/10,7.49%,BACH2;RSRC1
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.8193464375995503,-1.291281313340733,0.16071428571428573,1.0,1.0,1/6,0.87%,TGFB2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5375268444263506,1.2910838980668538,0.12903225806451613,0.8432420655706043,1.0,7/49,4.17%,TRPC6;VAPB;BCL2;PML;ATP2B4;PDZD8;PTH1R
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.6736151067899383,1.2908751857336669,0.18604651162790697,0.8415214732027378,1.0,5/15,23.31%,HSPA8;NDFIP2;DNAJC1;SNX3;PTPN1
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.8153873691875512,1.2901825796463335,0.23255813953488372,0.8425039228606165,1.0,3/5,6.05%,PISD;BNIP3L;BNIP3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.7600962308337138,-1.2901733795870045,0.14754098360655737,1.0,1.0,2/12,1.10%,SHROOM3;MLPH
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,0.7139438406751999,1.2901226183509398,0.21052631578947367,0.839916198773236,1.0,2/8,4.23%,MYH11;EMP2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),0.6704519679574528,1.2898971092642546,0.175,0.8386061598214603,1.0,4/13,11.14%,ZBTB7A;HDAC9;MSH2;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.6935934421608021,1.2898303326542644,0.25,0.8360109259512101,1.0,1/11,0.17%,JPH2
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.6890511398431416,-1.2898119004965112,0.2222222222222222,1.0,1.0,2/13,5.86%,VEGFA;SFRP4
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.7338802109991733,-1.2893192171237322,0.16666666666666666,1.0,1.0,3/11,10.76%,GLCE;EXT1;CSGALNACT1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.6845703782482168,-1.288428837022439,0.14925373134328357,1.0,1.0,6/18,16.04%,FGF1;GLI2;NR2F1;MID1;HSPA12A;ZIC2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.7187352049854538,-1.2879753747774527,0.19642857142857142,1.0,1.0,1/12,0.36%,CLU
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.7254551767416143,1.2878721106647302,0.21739130434782608,0.8424987620987455,1.0,1/11,1.35%,CNOT7
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.6537466595275035,1.287811746803138,0.16216216216216217,0.8399834783920926,1.0,4/15,6.05%,BCL2;BCL2L1;SLC25A4;BNIP3
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6458444158483223,-1.2877200254807002,0.14516129032258066,1.0,1.0,3/17,6.75%,CLU;CD47;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.6705510450115946,-1.2875888042778465,0.16176470588235295,1.0,1.0,1/18,0.36%,CLU
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.781400754159824,1.287583095775983,0.12,0.8381631802470555,1.0,3/6,11.48%,C1QTNF1;PRKG1;SH2B3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.5993494455116216,1.28751404473078,0.20588235294117646,0.8357165668593103,1.0,4/23,7.09%,CNOT7;PML;CNOT6;CDKN1A
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.8021696751331423,1.2874618405639042,0.15555555555555556,0.8331364394314017,1.0,3/6,18.73%,UBASH3B;RYR2;ANK2
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.8256329171498593,-1.2874245603937926,0.08928571428571429,1.0,1.0,2/7,4.61%,TGFB2;ADM
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.5408063067152646,1.2865892189852852,0.0975609756097561,0.8346396601157396,1.0,11/52,13.45%,SATB2;SMARCD3;SMARCA4;ZBTB7A;HDAC1;MBD2;ARID1B;ARID1A;SMARCA1;HDAC2;CECR2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.8108392848576181,-1.285826284282068,0.11864406779661017,1.0,1.0,1/8,2.43%,FBLN1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.7495239555928748,-1.2849743576593742,0.1896551724137931,1.0,1.0,2/11,11.43%,SNW1;BRCA1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7729080479057686,1.2848419850446664,0.14285714285714285,0.8405205792616623,1.0,1/7,1.75%,CDH2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.9049751676959217,-1.2847220086188715,0.09803921568627451,1.0,1.0,1/5,0.87%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.8321282830243162,-1.284447886802435,0.14925373134328357,1.0,1.0,1/7,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.8321282830243162,-1.284447886802435,0.14925373134328357,1.0,1.0,1/7,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.8097920255755165,-1.2842266023696227,0.12857142857142856,1.0,1.0,2/6,14.81%,MT2A;MT3
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.8317109425185271,1.2838924007443584,0.18421052631578946,0.8429162584278228,1.0,1/5,7.65%,NRXN1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.7043708121428829,-1.2836320974449835,0.125,1.0,1.0,2/11,15.35%,HECW2;CDC27
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7182450360060791,-1.283592752425068,0.15384615384615385,1.0,1.0,6/13,20.42%,STAT1;CDC37;HSP90AB1;PARP9;IFNGR2;PARP14
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.7559637403977718,-1.2832846181113813,0.2,1.0,1.0,1/7,0.92%,CD55
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.625894443742281,1.283217152371109,0.16666666666666666,0.8430798841237092,1.0,3/15,14.67%,INTS7;TIPRL;RAD9A
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.7919697689075319,1.2831453407013227,0.23684210526315788,0.837825539747442,1.0,1/6,0.09%,CSPG4
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7919697689075319,1.2831453407013227,0.23684210526315788,0.837825539747442,1.0,1/6,0.09%,CSPG4
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6767355675691267,-1.283006534848132,0.08955223880597014,1.0,1.0,5/18,5.88%,CYP3A5;ENPP2;PDXDC1;ERAP1;CPQ
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6738096047239777,1.2829309098342019,0.12121212121212122,0.8362847313186093,1.0,2/14,2.95%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.6269582427633517,1.282742132633013,0.14634146341463414,0.8349726432678888,1.0,3/14,14.67%,INTS7;TIPRL;RAD9A
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.7409261765617523,-1.2826908974527185,0.18,1.0,1.0,1/10,1.02%,RIMS1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.7994742104674042,1.2826225993413751,0.26,0.8301636976408282,1.0,1/5,5.54%,MYO1E
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),0.7994742104674042,1.2826225993413751,0.26,0.8301636976408282,1.0,1/5,5.54%,MYO1E
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.8321332732396532,1.2825123319872398,0.14285714285714285,0.8280531243285343,1.0,1/5,3.30%,ACADVL
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.7384979076570348,1.282210654116168,0.2,0.8267479673047781,1.0,2/9,5.43%,SMAD7;IRS2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.751074158415094,-1.2822097898248654,0.1724137931034483,1.0,1.0,8/12,22.63%,TGFB2;SPRY1;SLIT2;SPRY3;SPRY4;CD2AP;ARHGAP12;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.8974908016032466,-1.2817270192058363,0.06557377049180328,1.0,1.0,1/5,1.52%,VEGFA
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7852027779718391,-1.2809360560002336,0.20754716981132076,1.0,1.0,1/7,2.81%,STAT1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.7572435577146791,1.2809076539474242,0.26,0.8304390421508251,1.0,2/5,8.55%,MGRN1;PDE3A
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.4683211237281356,1.2804564438767676,0.08333333333333333,0.8302077234119135,1.0,22/93,18.73%,DPP10;RAB40C;EMP2;EHD2;TESC;AP3D1;PACS2;NRXN1;SYNE3;CACNB2;NUP54;RAPGEF2;RAP1A;ARL3;LRRC7;GAS6;NLGN2;LIN7A;EZR;ARL5A;MYO5A;ANK2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.7983876203628381,1.2802868026636294,0.29545454545454547,0.8283019335416041,1.0,3/6,17.49%,MTMR1;MTMR4;ABCA3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7135428195636828,1.280258878023615,0.24324324324324326,0.8258393943383436,1.0,2/12,2.95%,CSPG4;CHST3
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.7163530785098062,-1.2801039965664391,0.2830188679245283,1.0,1.0,2/10,5.86%,CTSL;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.8334017364699856,-1.2798372038365562,0.12962962962962962,1.0,1.0,5/6,16.07%,SPRY1;SULF2;THBS1;SPRY3;SPRY4
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5327854999159792,1.2796588707312813,0.09090909090909091,0.8261561879973071,1.0,5/35,11.58%,PDK4;HSPA8;CLEC16A;ZFYVE1;PPARA
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5826397844721701,1.2789384468772855,0.10526315789473684,0.8272834491480967,1.0,4/31,3.92%,KCNC2;HCN2;SLC12A2;KCNH7
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6764239361690826,1.2788530607124606,0.17647058823529413,0.8250935934933927,1.0,5/16,10.65%,TRPC6;SNX4;KIF5B;CACNB2;P2RX4
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.7629524228301853,1.2786297314875226,0.2765957446808511,0.8236545318217926,1.0,2/6,17.08%,CERT1;SLC27A1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.8283049518775945,1.2784143666705439,0.13043478260869565,0.821909419292011,1.0,1/5,1.86%,DGKH
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.46457713046761456,1.2781484685645574,0.043478260869565216,0.8205239561212465,1.0,7/78,6.73%,HSPA1A;HSPB1;EIF4ENIF1;HSPA8;RC3H2;METTL14;PUM2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.6904285351505951,-1.2780573316969392,0.22807017543859648,1.0,1.0,3/10,13.34%,SGCD;BMP5;SVIL
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5392472185344627,-1.2779523321237525,0.12857142857142856,1.0,1.0,17/78,13.35%,PRSS23;THSD4;ABLIM1;MLPH;PGR;FHL2;KAZN;OLFM1;RETREG1;SLC24A3;AKAP1;ADD3;FOXC1;DYNLT3;ELOVL2;SVIL;BHLHE40
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7252116976066918,1.2777419537216823,0.22916666666666666,0.8193557010326318,1.0,3/8,9.34%,CACNA1C;HCN2;CACNB2
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.723359525096102,1.2769546736413147,0.1935483870967742,0.8203097070804429,1.0,3/13,7.17%,WTIP;DLG5;MOB3B
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.5935136889916923,-1.2765917844348,0.16923076923076924,1.0,1.0,3/36,3.75%,PRAG1;TGFB2;SNW1
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5762923754038979,1.276325524822518,0.16666666666666666,0.8209813371468929,1.0,6/31,13.90%,HSPB1;ABL2;USP10;MTMR4;EP300;SCARB2
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.6859208860060987,1.2762707735669103,0.18421052631578946,0.8186506564959297,1.0,5/10,28.54%,GRID2;GRIN2B;GRIN1;GSK3B;MEF2C
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.7270963849243584,1.2762032703571176,0.2727272727272727,0.8163685016140487,1.0,1/8,4.23%,EMP2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.6615273418854865,-1.275110813493507,0.18461538461538463,1.0,1.0,5/27,7.71%,NRP1;VEGFA;NR4A1;F3;TGFBR1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.7445980068533222,-1.2748598429183804,0.13333333333333333,1.0,1.0,5/11,11.63%,TGFB2;GLI2;COL1A2;LAMB1;FOXC1
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6720168680972791,1.2746666886942712,0.15217391304347827,0.8207453344735158,1.0,5/12,11.51%,GNAI1;MGRN1;PDE3A;PEX5L;RAPGEF2
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.792659370237456,-1.273520763367778,0.2,1.0,1.0,1/7,1.69%,NT5E
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.5654063549499381,-1.2733421038691806,0.11428571428571428,1.0,1.0,5/55,2.57%,PLXNC1;RIPOR2;VEGFA;FBLN1;ADAM22
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.8234981167406169,-1.2727167911516009,0.12698412698412698,1.0,1.0,4/5,17.71%,NRP1;ALCAM;SLIT2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.7898443752342692,1.2723977113067702,0.10810810810810811,0.8281009123667771,1.0,2/5,17.08%,ABHD5;SLC27A1
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.8111449319603706,1.2721644067207682,0.20930232558139536,0.821475116152191,1.0,2/5,4.22%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.8111449319603706,1.2721644067207682,0.20930232558139536,0.821475116152191,1.0,2/5,4.22%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.8111449319603706,1.2721644067207682,0.20930232558139536,0.821475116152191,1.0,2/5,4.22%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.683628316651072,-1.2714307793123594,0.24242424242424243,1.0,1.0,3/17,11.43%,TET1;SNW1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.48897183820569545,1.2712861275579128,0.12903225806451613,0.8228695555272167,1.0,15/59,12.31%,PDK4;TNFRSF1B;ABL2;NCOA3;GNAI1;TESC;ADCY3;LCOR;AXL;RHOA;IRS1;EGFR;ADCY5;NFKB1;PLAA
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.7083771770038219,1.2711320635114685,0.22,0.8213625070534254,1.0,2/7,6.84%,PPM1A;PPP2CB
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.808409987084672,-1.2706566559768144,0.15517241379310345,1.0,1.0,2/7,2.73%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.7259376200225406,1.2705526621931926,0.23529411764705882,0.821440871289066,1.0,4/10,11.41%,BCL2;PML;PACS2;RAP1GDS1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.8479773773574778,-1.2705489721689778,0.10714285714285714,1.0,1.0,3/5,12.38%,SPTLC3;PLPP3;KDSR
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5925178927201475,-1.2703883709633181,0.14516129032258066,1.0,1.0,8/34,10.64%,MT2A;FTL;FTH1;ACO1;SLC22A17;SLC11A2;ABCB7;HEPH
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.620860167219657,1.270146912566612,0.17073170731707318,0.8206827055051028,1.0,7/15,20.58%,ATP2B4;RYR2;ERO1A;GRIN2B;GRIN1;RYR3;SLC8A1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.8088518833309855,-1.2694615434078362,0.15254237288135594,1.0,1.0,3/7,9.24%,PHLDB2;RACK1;TENM4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.6897523937013937,1.2679971252915432,0.14285714285714285,0.8276981651747399,1.0,5/10,20.13%,SMAD7;UBE2N;FBXW7;DCUN1D4;DCUN1D1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.6663128012566848,-1.2679545045319955,0.11666666666666667,1.0,1.0,3/18,11.71%,SUPT6H;HMGN1;THOC1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.747994623893629,-1.2678686375445598,0.234375,1.0,1.0,1/10,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.5351168469586993,-1.2673219847483126,0.08955223880597014,1.0,1.0,18/78,11.86%,ISM1;FGF1;TGFB2;TWIST1;VEGFA;STAT1;WARS1;THBS2;F3;THBS1;DCN;ADAM12;SASH1;CYP1B1;PGK1;BRCA1;FOXC1;BMPER
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6759566510705413,1.2672343742503478,0.2,0.8285218600982457,1.0,8/11,25.23%,CBL;ADAM17;FBXW7;AFAP1L2;ARAP1;HIP1;AGT;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.7911439411816752,1.2670354796497116,0.1956521739130435,0.8269540365638841,1.0,1/5,4.23%,EMP2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8333792821308281,-1.2668010958120015,0.1694915254237288,1.0,1.0,1/5,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.6675830895017544,1.2667210456995812,0.21052631578947367,0.8257589482080513,1.0,2/11,5.21%,PHC1;UBE2N
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.7888684240195434,-1.2660415481746663,0.17647058823529413,1.0,1.0,3/7,17.39%,MT2A;MT3;PRKN
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.7346977379704074,-1.2658059052377482,0.2127659574468085,1.0,1.0,5/10,18.83%,MIS18BP1;ITGB3BP;RNF8;NASP;RBBP7
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.7671983065420065,-1.265088563560413,0.17307692307692307,1.0,1.0,6/11,20.02%,POLA1;RPA1;ORC3;ORC5;TOPBP1;PURA
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.5596919229531415,1.2648626376040821,0.15384615384615385,0.8320186923794219,1.0,2/27,1.86%,CSF1R;DGKH
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7434311164760926,-1.264700052676087,0.12727272727272726,1.0,1.0,1/8,0.36%,CLU
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.6208567962426425,-1.2632157508622854,0.16129032258064516,1.0,1.0,9/31,12.66%,VEGFA;AKR1C2;AKR1C1;STAT1;IFT122;PGK1;PPP2R3A;PTCH1;LGALS3
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.8402957868482882,-1.2631631723801617,0.06779661016949153,1.0,1.0,2/6,11.57%,TGFB2;PTCH1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.721766399875615,1.2627182912294113,0.175,0.838340620742176,1.0,4/9,17.11%,CNTN4;NRXN1;NLGN2;NLGN4Y
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.7238327003505908,-1.2625508159191894,0.25806451612903225,1.0,1.0,1/9,0.87%,TGFB2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),-0.8503466069240941,-1.262123378610454,0.1509433962264151,1.0,1.0,1/6,0.78%,ABCA8
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.5633814681129959,1.26163018873673,0.21212121212121213,0.8406942074705288,1.0,5/31,7.60%,CNOT7;TOB1;EIF4ENIF1;METTL14;AGO2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.7348491138176629,-1.2612198517945536,0.13559322033898305,1.0,1.0,2/10,11.43%,SNW1;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.692788979214628,-1.260380428369414,0.12698412698412698,1.0,1.0,6/15,13.79%,SVIP;UCHL5;N4BP1;HSP90AB1;FHIT;RPL11
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.49422110046696555,1.2598396924110078,0.1724137931034483,0.846529816789187,1.0,9/44,9.88%,ADGRB3;CACNA1B;CTNND2;OPCML;NXPH1;PRKG1;NRXN1;CTNNA2;GRID2
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.5916771839099079,-1.2596935632138304,0.13846153846153847,1.0,1.0,10/40,14.47%,PLXNC1;ARHGAP15;VAV3;EPHA3;RALBP1;EPHA5;EPHA4;WRN;FGD6;PLXNA2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.8145268905349241,-1.2595051901305356,0.1702127659574468,1.0,1.0,1/5,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),-0.8624160326276628,-1.2587500838494867,0.14285714285714285,1.0,1.0,1/5,1.69%,NT5E
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.664008641618668,-1.2586457802629933,0.2,1.0,1.0,3/17,13.14%,ACTG1;EPHA3;LIMCH1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.6508172932259861,1.2583773431853722,0.1794871794871795,0.8497583455890949,1.0,5/13,15.63%,PML;TBX3;CDKN1A;MAP2K1;SMC5
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.7856481931967055,-1.2581856866250916,0.24528301886792453,1.0,1.0,1/6,2.81%,STAT1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.6871411576335626,-1.2579306043846692,0.23728813559322035,1.0,1.0,5/12,23.51%,SLC6A20;ATP1B1;SLC7A2;TRPM7;PKD2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.7059666375597641,-1.2578864141118624,0.171875,1.0,1.0,2/14,7.51%,GNA14;SCN7A
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.6670937536572876,-1.2577884249565108,0.2037037037037037,1.0,1.0,2/14,0.90%,CLU;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.7325993107063206,1.2570639094081641,0.20454545454545456,0.8531307279120808,1.0,3/8,8.11%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.7366303830626928,-1.2567911510121086,0.23728813559322035,1.0,1.0,5/12,17.39%,TWIST1;FOXC1;NGF;HES1;PRKN
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6421614199349193,1.2564137693842485,0.21428571428571427,0.8535688114671492,1.0,4/14,14.56%,CTNND2;ARF1;ITGA3;CDC42
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.7326165837752419,1.2562005086633026,0.1836734693877551,0.8519374446291139,1.0,3/8,15.48%,FBH1;CECR2;KPNB1
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.7032729696480969,-1.2560567886418834,0.15384615384615385,1.0,1.0,4/10,18.83%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.6198920592049288,-1.2559082544148295,0.13333333333333333,1.0,1.0,4/28,7.29%,PRAG1;COL3A1;ARHGEF3;NOTCH2
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.7024006261024647,1.2550978452762553,0.2631578947368421,0.8540832455706808,1.0,2/9,12.76%,BCL2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6837303949506662,1.25475734596433,0.16981132075471697,0.8531019373522374,1.0,3/10,10.89%,NOTCH1;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.4771636755327441,1.2537263136179901,0.1,0.8552322819351463,1.0,14/74,13.90%,TRIM4;TOB1;SORT1;NFKBIZ;ARF1;FUBP1;ADNP;MTMR1;TOB2;SART3;PRDM10;MTMR4;UBAP2;SCARB2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.628631745862626,1.2527924826802845,0.18604651162790697,0.8573825217936496,1.0,6/17,11.48%,EPOR;CD44;RAB27A;SNAP23;GRSF1;SH2B3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.6269100527298916,1.2527283297040066,0.18604651162790697,0.8550947244559344,1.0,1/14,2.05%,BCL2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.836419078261525,-1.252588024930997,0.17307692307692307,1.0,1.0,2/5,5.37%,IFITM3;GSN
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.8033225909373551,1.251780416976932,0.21739130434782608,0.8567569947269921,1.0,3/5,8.11%,SOX6;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.7633773663669546,-1.2517145074066285,0.19047619047619047,1.0,1.0,4/12,13.32%,TGFB2;THBS1;SLIT2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.6341948495005032,-1.2512983802657403,0.1791044776119403,1.0,1.0,6/26,11.18%,PDGFD;FGF1;VEGFA;RPS3;SASH1;MAP3K4
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.670991495370584,1.2510131326173355,0.2653061224489796,0.8575550571769033,1.0,3/9,16.33%,RHOA;ADAM17;WNK1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.5084800700882387,-1.2510053364354612,0.1044776119402985,1.0,1.0,17/97,8.56%,IGFBP5;SPRY1;SULF2;NR4A2;DKK3;NKD1;APCDD1;GLI3;IFT122;GPC3;ADAMTS12;RACK1;BMP5;SFRP4;CD47;THBS1;DCN
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.7585012396622832,-1.2508658119570095,0.1509433962264151,1.0,1.0,1/7,2.43%,FBLN1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.7585012396622832,-1.2508658119570095,0.1509433962264151,1.0,1.0,1/7,2.43%,FBLN1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.7274456314045945,-1.2501406110991329,0.21666666666666667,1.0,1.0,2/13,5.37%,IFITM3;GSN
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.7984935632256774,-1.2492381922110884,0.21666666666666667,1.0,1.0,1/5,1.43%,NRP1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6864906299822097,-1.2491243335352233,0.18032786885245902,1.0,1.0,1/12,1.02%,RIMS1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.8210092436176042,-1.2491206884126291,0.23636363636363636,1.0,1.0,1/5,1.13%,GBP2
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5586116828320908,1.2489634890660506,0.11764705882352941,0.8641583412824548,1.0,2/21,2.05%,TRPC6;BCL2
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.8134756125763337,1.2488654634811722,0.23684210526315788,0.8548594340136144,1.0,1/5,2.82%,APC
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.8134756125763337,1.2488654634811722,0.23684210526315788,0.8548594340136144,1.0,1/5,2.82%,APC
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.8134756125763337,1.2488654634811722,0.23684210526315788,0.8548594340136144,1.0,1/5,2.82%,APC
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8134756125763337,1.2488654634811722,0.23684210526315788,0.8548594340136144,1.0,1/5,2.82%,APC
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.6816931506434473,1.2487285596844935,0.17391304347826086,0.8529715409471659,1.0,4/10,16.45%,HEY2;BMPR1A;RBPJ;ADAMTS9
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.7528739514360485,-1.2485621209189124,0.15,1.0,1.0,1/9,3.57%,TET1
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.699127008812534,1.2481203164517054,0.2682926829268293,0.853143577798469,1.0,3/10,9.58%,ZFYVE28;CBLB;CBL
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.7483534787618096,-1.248044024536977,0.234375,1.0,1.0,3/8,4.13%,KIAA1217;SULF2;COL1A1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.5375567590793557,1.2478541436185089,0.17142857142857143,0.8521068882771033,1.0,11/46,8.33%,NOL4;ADGRB3;CACNA1B;LSAMP;CSRNP3;CTNND2;CNTN4;MEG3;CNTN1;NRXN1;GABRB3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.7368515693050555,-1.247684056700256,0.13333333333333333,1.0,1.0,1/9,0.71%,IGFBP5
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.7297233648209087,1.247236685263034,0.22448979591836735,0.8523421158727229,1.0,2/5,16.73%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.6726910846710712,-1.2469363112769953,0.24561403508771928,1.0,1.0,1/15,1.02%,RIMS1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.8293593646915218,-1.2463846161188668,0.14545454545454545,1.0,1.0,2/6,9.97%,LIMA1;PLEKHH2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5960414732320455,1.2463303166462572,0.21212121212121213,0.8535616630325028,1.0,5/26,4.13%,HSPA1A;HSPB1;BCL2;BCL2L1;TMBIM6
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.6158882806825736,1.246033750614072,0.2682926829268293,0.8526551540824274,1.0,4/15,5.74%,NOTCH1;BBS7;MICAL2;TBX3
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6569228291688948,-1.2454208242789295,0.2608695652173913,1.0,1.0,6/24,17.39%,EPHA3;RACK1;PIP4P2;LGALS3;PLSCR1;PRKN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.6363221544712876,1.2452030445505082,0.2558139534883721,0.8534996455965609,1.0,6/15,18.73%,CACNA1C;CACNB2;BIN1;KCNQ1;CTNNA3;ANK2
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.630273594968281,-1.2450092838192346,0.25862068965517243,1.0,1.0,4/22,9.54%,PRDX1;TXNRD1;FTL;GPX4
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.6883259803203993,-1.2449691796047593,0.25396825396825395,1.0,1.0,2/15,7.06%,CSE1L;STRADB
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7394330766590423,1.2445043935455862,0.20588235294117646,0.8542479213452704,1.0,4/10,18.73%,VAPA;RYR2;UBAC2;ANK2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.704855603990737,-1.2444857860657264,0.22413793103448276,1.0,1.0,3/10,11.26%,AKAP7;AKAP12;PRKAR1A
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.7308981650392401,-1.2441369234932766,0.21818181818181817,1.0,1.0,6/12,18.72%,SLC6A20;SLC25A13;SLC1A1;SLC1A2;SLC7A2;SLC1A3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.6432324799577317,-1.2438812982488123,0.1864406779661017,1.0,1.0,4/28,10.81%,COLEC12;CTSL;PIK3R4;BIRC2
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.5233203549093258,1.2435962474131632,0.13333333333333333,0.8556319906243105,1.0,7/37,11.14%,NCK2;ERBB4;NRG2;EGFR;CBL;RPS6KA5;ADAM17
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.655737544242867,1.2435473370712564,0.225,0.8512865883523557,1.0,1/13,2.05%,BCL2
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.655737544242867,1.2435473370712564,0.225,0.8512865883523557,1.0,1/13,2.05%,BCL2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6260208557716845,-1.2434901774302256,0.16393442622950818,1.0,1.0,11/21,26.07%,AFG3L2;ATP5PF;MICOS10;ATP5MC2;HSPA9;ATP5F1E;ATP5ME;SPG7;DMAC2L;ATP5F1C;TOMM70
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.6634345495114337,-1.2432890345884273,0.2037037037037037,1.0,1.0,5/15,16.27%,THBS1;DCN;SLIT2;APOE;SP100
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5260329792528093,-1.2427860367782846,0.1267605633802817,1.0,1.0,19/79,11.49%,CLU;IGFBP5;VEGFA;MEGF10;PAMR1;SEMA6D;DKK3;COL1A1;COL3A1;THBS2;NTM;COL1A2;PDZRN3;COL6A1;COL11A1;PCDH17;HEPH;BOC;PLPP3
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.7933816297643662,-1.2426203798883764,0.09090909090909091,1.0,1.0,3/10,13.65%,TGFB2;MID1;PDCD10
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6140520098876326,-1.242617224889896,0.18571428571428572,1.0,1.0,10/22,23.05%,AKR1C1;THBS1;CYP1B1;BRCA1;MAPK14;MT3;PRKN;ARF4;TGFBR2;PDK3
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7512492840262802,1.2419344610085126,0.21428571428571427,0.8553573715720021,1.0,2/8,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.7453031716192187,-1.2418312998425716,0.14285714285714285,1.0,1.0,1/11,1.21%,LMF1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6629014644589873,-1.2417503362658344,0.18181818181818182,1.0,1.0,8/18,22.83%,RPL23A;RPL5;RPL6;RPL11;RPS14;EIF2A;RPL24;RPS28
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7447328168058196,1.2414765679213375,0.23076923076923078,0.8553672849043181,1.0,2/5,16.73%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.6794405512986021,1.2413103471843165,0.21951219512195122,0.8538439421736012,1.0,3/10,6.41%,TNFRSF10B;BCL2;CEBPB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.7964040897461808,-1.2411743697062476,0.22641509433962265,1.0,1.0,1/6,2.00%,RAD51B
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.7905415991771336,1.240553385021657,0.17391304347826086,0.8551171061829299,1.0,3/7,10.95%,HEY2;MYOCD;TMEM204
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.7809385731759237,-1.2404078215226055,0.29310344827586204,1.0,1.0,1/5,0.65%,FGF1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5331128070549257,1.2401891929930717,0.1388888888888889,0.8543500790139528,1.0,9/33,13.17%,CSF1R;MED24;CEBPB;CDKN1A;MED23;MITF;THRA;NFKB1;LEF1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.7795430474442391,-1.2401089135866243,0.2857142857142857,1.0,1.0,1/5,2.81%,STAT1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.6859595492196324,-1.2400965544368239,0.2,1.0,1.0,5/11,4.40%,NRP1;VEGFA;SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6428695059330614,-1.2398113304967084,0.16129032258064516,1.0,1.0,4/26,9.74%,PARP1;XPA;DDB2;RPA1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.5568049193225273,1.2395962077267428,0.10810810810810811,0.8542134212528594,1.0,4/23,11.49%,CNOT7;RC3H2;CNOT6;DCP1A
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5260003003003126,-1.2395207863349258,0.10294117647058823,1.0,1.0,17/81,11.49%,IGFBP5;COL6A3;PAMR1;DKK3;COL1A1;COL3A1;MRC2;THBS2;ADAMTS12;COL1A2;SFRP4;COL6A1;COL12A1;DCN;COL11A1;FN1;PLPP3
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5572078843503786,1.2374835417944556,0.1388888888888889,0.8607406673396316,1.0,4/31,4.17%,JPH2;VAPB;ATP2B4;PTH1R
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7231505042471214,1.2372102225950896,0.2916666666666667,0.8593122174734733,1.0,1/10,0.45%,HSPB1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6998088981625273,1.237176009217267,0.16666666666666666,0.8572402527689803,1.0,3/8,19.51%,PCF11;XRN1;ZC3H12C
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.7738138637944658,-1.2366517473830103,0.2909090909090909,1.0,1.0,3/5,15.57%,CTSL;PPIA;CD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.7738138637944658,-1.2366517473830103,0.2909090909090909,1.0,1.0,3/5,15.57%,CTSL;PPIA;CD4
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6310544854696536,1.2365556732696785,0.17777777777777778,0.8574516364125961,1.0,6/10,27.59%,PRELID2;ABCA3;OSBPL5;PITPNC1;OSBPL8;SCP2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.5449893823880821,1.2364843708951914,0.125,0.855513054461683,1.0,6/26,6.81%,TNFRSF10B;TNFRSF1B;BCL2;SORT1;BCL2L1;CASP8AP2
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.7807132130120887,-1.2362932545203327,0.2777777777777778,1.0,1.0,1/6,11.43%,BRCA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.6808212613511383,-1.2360509013480994,0.20967741935483872,1.0,1.0,3/16,6.41%,MEGF10;AFDN;CD47
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.7194526532803367,1.2359012285469093,0.23404255319148937,0.8556397461074844,1.0,3/10,13.48%,PTP4A3;CORO2B;CEP290
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.5392592939491293,-1.235646394873894,0.18666666666666668,1.0,1.0,13/64,19.49%,COLEC12;CTSL;ADM;AP2A2;AP4E1;CALCRL;SNAP91;APOE;SNX9;GPR107;LMBRD1;HSPH1;PDLIM7
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6757365602278158,-1.235573121551247,0.15942028985507245,1.0,1.0,12/26,20.02%,PARP1;XPA;ANXA1;DDB2;XPC;RPA1;WRN;ASCC3;GTF2H1;MRE11;UBA52;PURA
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.8056367657138637,1.2355148948552648,0.175,0.855326521602549,1.0,4/6,16.72%,AXL;MAVS;GAS6;DHX9
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.6418102002021399,-1.2354152868106252,0.2463768115942029,1.0,1.0,3/19,8.06%,CLU;HSP90AB1;AZIN1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),-0.8092786402693408,-1.2352966022280716,0.2222222222222222,1.0,1.0,2/6,11.43%,CENATAC;BRCA1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.6509111782735694,1.234949749019947,0.20930232558139536,0.8551609573886751,1.0,5/13,6.41%,TNFRSF1B;NCK2;TNFRSF21;DLG5;CEBPB
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.7921517844907836,1.2344730178276315,0.22448979591836735,0.8552293108609799,1.0,4/5,17.73%,OAZ2;MAOA;AMD1;SLC22A3
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6769553824775243,1.2344597688427033,0.20512820512820512,0.8530598360688595,1.0,2/10,11.60%,PML;HK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.8231776727330655,-1.2344460922024054,0.20588235294117646,1.0,1.0,1/5,9.37%,ZC3H14
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.6488689945399325,-1.2338600386874075,0.171875,1.0,1.0,3/20,12.03%,NRP1;HSP90AB1;ALCAM
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.7117014523921897,1.2330222940081093,0.1951219512195122,0.8562634588252767,1.0,3/8,13.21%,BNIP3;CLEC16A;ETF1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.7252130515756962,-1.2326773040179644,0.23214285714285715,1.0,1.0,2/10,10.30%,DDB2;KDM2B
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.8074556117811584,1.2326742079598867,0.1794871794871795,0.8551431784161814,1.0,1/6,2.82%,APC
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.7105389026379829,-1.2324696353839755,0.23880597014925373,1.0,1.0,2/13,8.93%,ELMO1;ABI2
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),-0.7190598423500341,-1.2324458855459695,0.21052631578947367,1.0,1.0,3/8,5.04%,TGFB2;GLI3;GLI2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.8092230382262682,-1.232433150100602,0.19148936170212766,1.0,1.0,3/6,12.66%,JAM2;ANO6;LGALS3
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.6765234810806917,-1.2320198339191848,0.15384615384615385,1.0,1.0,7/15,19.42%,SUPT6H;TERF2IP;MSH6;THOC1;ZRANB3;SPIDR;MRE11
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.735182281885778,-1.2319866306492315,0.208955223880597,1.0,1.0,1/7,12.34%,GNPAT
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.6663831236945018,-1.2318695650687699,0.20634920634920634,1.0,1.0,3/15,6.39%,WDFY4;BACH2;RALGPS2
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.7392418155128737,1.2314916900306125,0.34782608695652173,0.8573447257732346,1.0,1/6,3.19%,PCSK5
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.7264682497158543,-1.230208216078544,0.140625,1.0,1.0,2/12,12.66%,EPHA3;LGALS3
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.8406742850435205,-1.2300776368781101,0.1896551724137931,1.0,1.0,1/5,0.36%,CLU
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.7446347470335664,-1.229980899582327,0.23809523809523808,1.0,1.0,5/9,16.07%,SPRY1;SULF2;THBS1;SPRY3;SPRY4
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.765194239423158,1.2299587326444368,0.1891891891891892,0.8612895747221033,1.0,2/8,6.73%,WTIP;PUM2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.7028850026078679,1.2291287900770482,0.17142857142857143,0.8625462864795167,1.0,4/11,17.52%,DNAJC15;RALA;HK1;PITRM1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.7159976039023352,1.2289395827396028,0.20588235294117646,0.8611638940285137,1.0,3/9,8.02%,FMN2;MCM9;TOB2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7966715066102146,1.2288881808777854,0.21428571428571427,0.8592175936239201,1.0,3/5,18.81%,JADE2;JADE1;MEAF6
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6968616632727782,-1.22873986665839,0.18181818181818182,1.0,1.0,1/12,1.02%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.789959349049648,-1.2284586029363447,0.27419354838709675,1.0,1.0,2/6,13.57%,PRKDC;PARP9
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5523439559615172,1.2284522723060058,0.1951219512195122,0.8585054194662673,1.0,9/23,21.59%,EMP2;UGCG;NRXN1;STX2;NLGN2;NLGN4Y;PTPRD;UBXN2A;PICALM
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.6207189515076839,-1.228175117939163,0.25925925925925924,1.0,1.0,3/16,14.81%,FGF1;PPIA;MT3
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6973137627459721,1.2281665465961207,0.2558139534883721,0.8576264177909214,1.0,1/10,4.13%,TMBIM6
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.679591424750677,-1.2280763160694128,0.23076923076923078,1.0,1.0,5/14,13.86%,PKM;ENOSF1;ENO1;PGK1;LDHA
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.8090019613120504,-1.227890880588981,0.19298245614035087,1.0,1.0,1/5,2.03%,PGRMC1
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5371989991368241,-1.227580753774367,0.16901408450704225,1.0,1.0,14/62,9.26%,TGFB2;PRDX1;KIAA1217;SULF2;EXT1;COL1A1;GLI2;BMP5;COL1A2;CMKLR1;TGFBR1;SLC10A7;VCAN;CREB3L2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.7012194026495664,1.2274380511816136,0.2222222222222222,0.8587065829262468,1.0,1/8,0.16%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.49010883915380726,1.2265970729083855,0.038461538461538464,0.8602052328631278,1.0,9/48,12.39%,CSF1R;ERBB4;FLT1;CDKN1A;AXL;EGFR;MERTK;RAPGEF2;RAP1A
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.737957084840668,1.2264483475986225,0.2857142857142857,0.8565723291789888,1.0,2/5,16.33%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.737957084840668,1.2264483475986225,0.2857142857142857,0.8565723291789888,1.0,2/5,16.33%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.7275073419418283,-1.2263295724655836,0.21818181818181817,1.0,1.0,1/9,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7667596718576413,-1.2262390431438783,0.26785714285714285,1.0,1.0,2/7,17.39%,ANXA1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.5952413058129693,1.2262123483837069,0.24444444444444444,0.8552322024771386,1.0,3/16,11.51%,NOTCH1;RHOA;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.7714523029867868,-1.226186912556612,0.17307692307692307,1.0,1.0,1/8,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.828226954393682,-1.2259396467270938,0.10714285714285714,1.0,1.0,2/6,1.80%,PARP1;SLC25A36
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.7881072483737843,-1.2259251017858637,0.2413793103448276,1.0,1.0,3/5,21.11%,SPIDR;DDI2;FMR1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.7821504049241307,-1.2255738245889456,0.21568627450980393,1.0,1.0,1/7,1.02%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.6685543444145066,1.2254065353528028,0.1875,0.8566406764994726,1.0,3/11,10.89%,NOTCH1;ERBB4;BMPR1A
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.5495288192136888,1.2249085078320143,0.21212121212121213,0.8568699681747826,1.0,4/26,7.09%,CNOT7;PML;CNOT6;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.7477500545550662,-1.2246014207558633,0.25862068965517243,1.0,1.0,4/13,12.93%,CIRBP;SNW1;NCL;DHX36
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.7438489499336209,-1.2245809020582918,0.2542372881355932,1.0,1.0,4/10,14.35%,TMSB10;GSN;SLIT2;TMSB4X
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.5542758000458381,1.2244768481991815,0.25,0.8562907291397227,1.0,5/27,9.10%,CNTN4;GPRC5B;ZFHX3;HEYL;RHOA
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.49022244592362724,-1.2239374536982877,0.13095238095238096,1.0,1.0,22/139,16.08%,PRSS23;IGFBP5;ELOB;KLHL13;DDB2;ESCO1;GPC3;LAMC1;PSMD8;FBXW2;VCAN;FBXO22;LAMB1;FN1;NUB1;PSMC2;SHISA5;WSB1;NAE1;CALU;FBXL18;APOE
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.735191326393833,-1.2237678089571566,0.20967741935483872,1.0,1.0,1/9,1.23%,ARHGAP24
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.7794633020643896,1.2225550640026595,0.3170731707317073,0.8622132217803357,1.0,1/5,12.16%,IWS1
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.7769658186044397,-1.2216193145560599,0.26785714285714285,1.0,1.0,4/7,11.57%,TGFB2;BMP5;TGFBR1;PTCH1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.7692409521459269,-1.2214033432384077,0.288135593220339,1.0,1.0,3/7,8.61%,AK5;NMNAT2;NMNAT3
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.5046724412521053,1.2208632250214357,0.20833333333333334,0.8668045502753303,1.0,9/79,5.71%,TRPC6;KCNC2;SLC6A16;CACNA1C;ATP2B4;HCN2;SLC12A2;KCNH7;ATP6V1H
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6407713425876995,-1.2207465325704594,0.1774193548387097,1.0,1.0,3/14,11.85%,THBS1;PDCD4;ANO6
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.7006276012284403,1.2205844761047007,0.2826086956521739,0.8660670839820156,1.0,4/7,28.58%,GPRC5C;SMAD5;RHPN2;PKP2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.6136471826194518,1.2204010470032238,0.28888888888888886,0.8645612607722453,1.0,2/10,1.46%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6607239892486838,1.2203486979096294,0.23255813953488372,0.8625402135445235,1.0,8/11,25.23%,CBL;AFAP1L2;ARAP1;RBPJ;HIP1;RTN4;AGT;CCDC88A
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.6992373410469442,-1.2203479944240672,0.24615384615384617,1.0,1.0,3/11,11.34%,SFRP4;TGFBR1;SPEF2
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.7665353481055143,-1.2202801631720352,0.2857142857142857,1.0,1.0,1/8,1.02%,RIMS1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.4981821002566442,1.219902149816504,0.19444444444444445,0.862476930593537,1.0,9/48,10.30%,CACNA1B;GRID1;CDH2;SLC12A2;EIF4EBP2;NRG3;ABR;GRID2;CLSTN2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),-0.7928323717951951,-1.2197211067591023,0.24561403508771928,1.0,1.0,2/5,16.16%,ANXA1;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5337874734300007,1.219516628164609,0.25,0.8619760415851242,1.0,9/29,12.66%,JPH2;CACNA1C;ABL2;C1QTNF1;SELENOT;ADCY5;P2RX4;RYR2;NPTN
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),-0.7703613289685544,-1.2190018260260242,0.2,1.0,1.0,3/7,14.00%,TSPYL2;S100A11;RAD17
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.7368178440820815,1.2189801756398921,0.26666666666666666,0.8619963373492101,1.0,2/5,5.74%,NOTCH1;TBX3
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.7365085174061188,1.218904694411496,0.2558139534883721,0.8601371387864639,1.0,1/5,0.16%,CSF1R
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6433325220874969,-1.2188854343053122,0.19672131147540983,1.0,1.0,8/18,16.10%,FAXDC2;CYP1B1;SOAT1;CYP4V2;PRKAG2;CYP27A1;APOE;LIPA
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.8109459990134749,-1.218766195531646,0.3064516129032258,1.0,1.0,1/5,0.84%,DDX60
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6768430044491756,1.2185946595482104,0.3404255319148936,0.8593194205908349,1.0,1/8,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.7259819356924985,-1.2185640835832874,0.19607843137254902,1.0,1.0,4/9,18.83%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.7259819356924985,-1.2185640835832874,0.19607843137254902,1.0,1.0,4/9,18.83%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.7259819356924985,-1.2185640835832874,0.19607843137254902,1.0,1.0,4/9,18.83%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.489947848441193,1.218423070341755,0.09375,0.8577466284576949,1.0,7/38,10.61%,TNFRSF1B;RBM20;RC3H2;RRP1B;MITF;HNRNPF;GRSF1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.7718662293888722,-1.2183060225061688,0.24561403508771928,1.0,1.0,4/10,16.41%,PARP1;SMG6;DHX36;TNKS2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.6758660563508769,1.2182256621263978,0.3142857142857143,0.8566140359702136,1.0,4/8,22.97%,GNL3L;SAE1;EGR1;ZMIZ1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.7491108420188011,-1.2177302041120481,0.2,1.0,1.0,3/8,11.85%,THBS1;PDCD4;ANO6
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5039717632659398,-1.2174178885901759,0.1643835616438356,1.0,1.0,38/123,16.83%,CD55;COL15A1;VEGFA;NT5E;COL6A3;PAMR1;P4HTM;NR4A2;DKK3;COL1A1;COL3A1;SGCD;NR4A1;THBS2;GSN;COL1A2;LAMC1;COL6A1;COL12A1;FBLN2;FMO2;DCN;CYP1B1;LAMA4;LAMB1;FN1;PTCH1;ITGBL1;IL1R1;COL13A1;COL6A2;ABI3BP;PRRX1;PLAC9;SLC6A13;ASPN;C1S;NGF
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.734880613936168,-1.2174051175182337,0.2857142857142857,1.0,1.0,1/8,0.78%,ABCA8
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6684937152226111,-1.2173753093116064,0.21666666666666667,1.0,1.0,4/14,15.23%,PER2;FAXDC2;PRKAG2;CYP27A1
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.6190497313774965,1.2170017032603113,0.2571428571428571,0.8593446472460264,1.0,2/16,3.30%,PDK4;ACADVL
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6230826757203326,-1.21699565304209,0.24615384615384617,1.0,1.0,7/22,17.11%,RPL5;RPS25;RPL35A;RPS24;RPL11;WDR12;RPS7
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5027224329884182,1.2169500756423404,0.15384615384615385,0.8575138955473681,1.0,7/40,4.11%,SLC35F1;CSRNP3;CTNND2;OPCML;MGAT5;NXPH1;GFAP
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7116784878659956,1.216758298798557,0.2647058823529412,0.8562556793704375,1.0,2/10,6.33%,WTIP;DLG5
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.7160631067221185,1.2166877027044856,0.19230769230769232,0.8544409240492029,1.0,1/9,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.8142602281304976,-1.2163323820306753,0.12,1.0,1.0,1/6,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7661624694455245,1.2162445499637489,0.275,0.8545320465014957,1.0,2/6,14.56%,CD44;CDC42
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.7672842807803097,-1.2160518004637377,0.24528301886792453,1.0,1.0,2/7,4.14%,CD55;BACH2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.7685356020991564,1.2160387295005812,0.23076923076923078,0.8533430844071808,1.0,1/7,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.6072606234650918,1.2155716870369535,0.23076923076923078,0.8526384588428895,1.0,9/16,25.90%,SPOPL;RNF139;HDAC2;BTRC;CAMK2N1;DNAJC1;TRAF3;OGT;IST1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.5762644317848686,-1.215159490516078,0.16901408450704225,1.0,1.0,13/40,13.66%,CLU;CIRBP;RPS4X;RPL5;RACK1;PLD1;THBS1;SAMD4A;UPF3A;NSMAF;PRKDC;EPHA4;EEF2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.48261755655993005,1.215110510549533,0.1935483870967742,0.8523086217417325,1.0,10/54,6.36%,HSPA1A;BCL9;HIPK2;LEMD3;PPM1A;SMAD7;ZEB2;BCL9L;ZBTB7A;PMEPA1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.71646666111935,1.214849069880425,0.2972972972972973,0.8493558736315409,1.0,3/7,14.58%,ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.71646666111935,1.214849069880425,0.2972972972972973,0.8493558736315409,1.0,3/7,14.58%,ATP2B4;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5190917821963337,1.2147119094284282,0.11764705882352941,0.8479556957628804,1.0,5/35,2.28%,TRPC6;CACNA1C;ABL2;ATP2B4;C1QTNF1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.7299966716748166,-1.2143548052983333,0.21212121212121213,1.0,1.0,2/10,5.38%,IFT122;DYNC2LI1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.7970467718026528,-1.2143088658705723,0.23214285714285715,1.0,1.0,2/6,7.71%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),0.7761561575240248,1.2141430313684662,0.2545454545454545,0.8480867042334209,1.0,2/5,6.05%,BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.6935694142602793,1.2138159756926725,0.22916666666666666,0.8471155922412208,1.0,6/9,28.37%,RAD21;PDS5B;MAU2;RB1;POGZ;NIPBL
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.7911221162623137,1.213788840334715,0.2857142857142857,0.8432811341943297,1.0,1/5,7.60%,AGO2
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.7911221162623137,1.213788840334715,0.2857142857142857,0.8432811341943297,1.0,1/5,7.60%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.7980456826089986,-1.2134503747953942,0.2830188679245283,1.0,1.0,2/5,13.69%,RACK1;UFL1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.6510386090365212,1.2133774811387998,0.25,0.84303102809527,1.0,2/11,3.82%,HCN2;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7378497602188943,1.2132508590452113,0.25,0.8416647028995939,1.0,1/9,0.17%,JPH2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.785398312747722,1.2132060682962635,0.2571428571428571,0.8398898336277076,1.0,2/5,1.46%,CSF1R;TNFRSF1B
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.7061705279846502,1.212995320985491,0.24444444444444444,0.838795613722926,1.0,1/6,0.16%,CSF1R
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7890583117825904,-1.2129196447086652,0.21875,1.0,1.0,3/7,18.41%,MT3;HSD11B1;LPL
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.8249556016908763,-1.2127776667520616,0.2222222222222222,1.0,1.0,1/5,1.05%,AFG3L2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6797954612303144,-1.2126732350806693,0.23333333333333334,1.0,1.0,5/14,10.11%,COL6A1;COL12A1;COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.5704978325769616,-1.212383447727929,0.15625,1.0,1.0,5/34,12.36%,NACA;SRP14;ALDH3A2;SSR1;PEX3
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.707371696691241,-1.2123803712403505,0.21428571428571427,1.0,1.0,2/9,2.02%,AFG3L2;SLC8B1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5369875974702907,1.2121775287745393,0.1956521739130435,0.8402613173243143,1.0,8/26,13.43%,NOTCH1;HIPK2;LEMD3;SMAD7;ACVR2A;BMPR1A;UBE2D1;RBPMS2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.5063274605695913,1.211910988686393,0.15625,0.8390424934844117,1.0,6/60,8.61%,CSF1R;PIP5K1B;ARF1;LCLAT1;MTMR1;INPP4B
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6605711948923025,1.2118760528216306,0.23529411764705882,0.837289718954577,1.0,2/11,1.46%,PDK4;TNFRSF1B
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.7854339861824623,-1.2118737442313445,0.19402985074626866,1.0,1.0,1/7,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.7107122936799084,1.2117395732009353,0.24444444444444444,0.8357755795712173,1.0,4/8,18.73%,RYR2;NEDD4L;KCNQ1;ANK2
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.5610565840966109,-1.2116385259924292,0.14492753623188406,1.0,1.0,6/53,6.41%,TGFB2;GBP2;STAT1;EIF3J;WARS1;CD47
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.7815421456036322,-1.210921281857075,0.3220338983050847,1.0,1.0,1/6,1.52%,VEGFA
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.7942321385481453,-1.2108358399551231,0.22413793103448276,1.0,1.0,1/5,1.43%,NRP1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.7221756336459642,1.210145211024325,0.30434782608695654,0.8398945260668816,1.0,3/6,16.45%,OGA;STT3B;ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7634509993341851,1.2100843000677675,0.2127659574468085,0.8382027301475647,1.0,1/6,2.20%,TMEM30A
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.8003827213777465,1.2096476156949958,0.25,0.8377914847420953,1.0,1/5,1.81%,ABL2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5458277325512231,-1.2096070017463942,0.19117647058823528,1.0,1.0,4/52,5.18%,CLU;HECW2;NKD1;GPC3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.6693588730079256,-1.2095044069839633,0.21311475409836064,1.0,1.0,5/16,10.11%,COL6A1;COL12A1;COL11A1;LAMB1;FN1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.783513724079524,1.209342351700127,0.24390243902439024,0.8370010668420595,1.0,1/5,3.88%,VAPA
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6345786761133161,1.2093042817147863,0.18181818181818182,0.8352511049962947,1.0,5/13,20.13%,UBE2N;FBXW7;BTRC;DCUN1D4;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.5862400364704342,-1.2081455568167996,0.22058823529411764,1.0,1.0,12/37,19.82%,CD55;ANXA1;ERAP1;ADAMTS12;N4BP1;BIRC2;IL1R1;UFL1;TMSB4X;APPL2;EFNB2;CALM1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.7076465230518579,-1.2080915648402637,0.23880597014925373,1.0,1.0,6/13,22.02%,UCHL5;NUB1;EPHA4;APOE;PRKACA;PSMD14
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.688675987027815,1.2078022657856378,0.35714285714285715,0.8388699723891072,1.0,2/8,11.12%,KDM7A;PHF8
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6960631425408302,1.2073955269429943,0.23255813953488372,0.8385366032996171,1.0,4/6,20.35%,SETD7;METTL21A;SMYD3;SETD3
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.512446022713225,-1.2069892679642915,0.15942028985507245,1.0,1.0,29/97,20.02%,NT5E;PARP1;XPA;RAD51B;TERF2IP;MSH6;DDB2;XPC;POLA1;RPA1;BTG2;INO80;BRCA1;PRKDC;ORC3;ORC5;WRN;RAD17;TOPBP1;ZRANB3;SP100;MGMT;GTF2H1;TCF7L2;XRCC6;PARG;MRE11;UBA52;PURA
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5996198424030577,-1.206808503642091,0.22413793103448276,1.0,1.0,2/32,1.52%,PRAG1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.5772912042732893,-1.2067486613640344,0.171875,1.0,1.0,4/30,6.51%,TGFB2;TM7SF3;MYO18A;ADAM9
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6278205207530844,-1.2066741972825528,0.23333333333333334,1.0,1.0,6/20,7.71%,TGFB2;VEGFA;SULF2;STAT1;GLI2;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.5704837011512778,-1.2064520773683667,0.1791044776119403,1.0,1.0,10/48,8.75%,CLU;TGFB2;VEGFA;WARS1;GPC3;RACK1;RPS3;TGFBR1;SLF1;ABCB7
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.7364521923737578,1.2063803176245178,0.26666666666666666,0.8399669756555891,1.0,1/8,0.16%,CSF1R
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.6156329819754637,1.2063167425152517,0.2,0.8383013355625979,1.0,3/14,1.94%,CSF1R;ADGRF5;DDX3Y
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.7164464998908051,-1.2058970344027784,0.2676056338028169,1.0,1.0,2/6,5.49%,DKK3;BMP5
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.6460650196034728,-1.2058622534067098,0.29411764705882354,1.0,1.0,10/22,17.65%,ANXA1;ERAP1;ADAMTS12;N4BP1;BIRC2;IL1R1;UFL1;TMSB4X;APOE;APPL2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4858370643902356,1.2049282373121284,0.15789473684210525,0.8412046301134042,1.0,7/45,9.10%,GJC1;GJA4;CDH2;CTNND2;CDH10;NRXN1;RHOA
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.558823534260577,1.204837257835562,0.2777777777777778,0.8396436539421672,1.0,4/31,5.23%,TRPC6;GABRB1;SLC12A2;SLC26A3
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.7073319821802689,1.2044499459995652,0.25,0.839112634146463,1.0,2/7,8.79%,ENOX2;SDHB
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5118569303215776,-1.2042208833414512,0.18571428571428572,1.0,1.0,10/68,11.72%,CLU;TGFB2;RIMS1;VEGFA;ANXA5;PROS1;THBS1;FN1;PHACTR2;MAGED2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.49453409367525836,1.2039614262275362,0.07894736842105263,0.8391317059973834,1.0,13/48,15.43%,EBF4;ZBTB7C;RALGPS1;NDRG2;KALRN;AGAP1;ZNF704;C2ORF72;ADCY5;SORBS2;CP;KCNQ1;NEBL
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.4959101982911675,1.2037673155479378,0.21875,0.8378340089907435,1.0,7/41,10.19%,JPH2;MYH11;TINAGL1;EHD2;EGFR;PXN;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.6108702484588592,-1.2036775259178014,0.19402985074626866,1.0,1.0,6/25,7.71%,TGFB2;TWIST1;COL1A1;GCNT2;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.6620033330036742,-1.2035963519660717,0.23214285714285715,1.0,1.0,1/13,1.02%,RIMS1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.6889223370735187,-1.2035771852559167,0.22950819672131148,1.0,1.0,2/10,6.28%,SRP14;SRP54
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.5409229207892671,-1.2035163193630767,0.22857142857142856,1.0,1.0,8/45,8.44%,PARP1;XPA;MSH6;DDB2;XPC;GATAD1;GEM;HMGN1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.7729390435884713,-1.2033477557313297,0.25862068965517243,1.0,1.0,3/7,19.91%,ENO1;PGK1;UBA52
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.4962189328598343,1.2032272303978337,0.12903225806451613,0.837682280763529,1.0,14/43,20.16%,PISD;ZEB2;CLEC16A;SURF4;PAK2;MAVS;EP300;SCARB2;TJP1;PDE4DIP;EZR;MYO5A;ARMH3;PDE2A
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.673299541836221,1.2031780951447664,0.1875,0.836047153089669,1.0,4/9,18.46%,LRRTM3;NLGN2;NLGN4Y;PTPRD
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.6350080502685457,-1.2028854873173729,0.2903225806451613,1.0,1.0,4/17,12.10%,NRP1;HSP90AB1;ALCAM;SLIT2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6037915992473002,-1.202618953578481,0.16176470588235295,1.0,1.0,4/28,11.86%,TGFB2;ENPP2;SASH1;BMPER
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5151033065010288,1.2021940008828373,0.2222222222222222,0.837676976645514,1.0,5/36,9.83%,CSF1R;CDKN1A;MAP2K2;RHOA;CAB39
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.7099791832036281,-1.2020726897156515,0.28,1.0,1.0,1/7,1.23%,ARHGAP24
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.48433198551908146,-1.2018041845917267,0.14285714285714285,1.0,1.0,42/175,17.11%,RPL30;LMF1;RPS4X;RPL19;RPL23A;RPL5;NR4A2;RPS25;RPL34;WARS1;RPL15;RRBP1;RPL27;RPLP1;RPL35A;RPS18;RPS3;RPS20;FASTKD2;SMG6;RPL37A;NUP58;RPS12;RPL36;RPL6;THOC1;RPL7A;RPS24;THRB;RPL11;RPL10A;SEC13;RPL37;ADARB1;PTMA;CELF2;RPS21;RPS29;RPS14;RPL13A;NUP107;RPS7
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.7456526102295774,1.2015782626154563,0.2653061224489796,0.8382161274713721,1.0,4/7,13.04%,AKAP8;UBE2N;MYOCD;MTHFR
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.7555843247739544,-1.2014300530045219,0.2857142857142857,1.0,1.0,3/6,12.72%,LSS;FAXDC2;PRKAG2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5596941964887996,1.20068467741796,0.24324324324324326,0.8395638457979097,1.0,4/35,9.24%,CSF1R;IRS2;RHOA;IRS1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.6358617388832037,1.200409865839457,0.14705882352941177,0.8384537395924033,1.0,3/15,10.89%,NOTCH1;ACVR2A;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7374102468612398,1.200059232835399,0.23809523809523808,0.8377888396931362,1.0,3/6,10.03%,RNF185;TMEM259;ATXN3
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.5171955365269253,-1.1999430851509192,0.1506849315068493,1.0,1.0,17/59,10.11%,IGFBP5;COL15A1;COL6A3;PAMR1;DKK3;COL1A1;COL3A1;THBS2;ADAMTS12;COL1A2;COL6A1;COL12A1;FBLN2;GEM;DCN;LAMA4;FN1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.5563503755935283,-1.199808203327774,0.1746031746031746,1.0,1.0,8/51,7.21%,THSD4;SHROOM3;KIAA1217;VEGFA;FBLN1;COL1A1;COL12A1;F3
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.5430571695555257,-1.199420002628158,0.20588235294117646,1.0,1.0,15/45,26.26%,TEFM;POLA1;PSMD8;RPA1;PSMC2;ORC3;ORC5;WRN;TOPBP1;UBA52;PURA;PSMD14;SSBP1;PSMA3;MCMBP
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.37457989255747787,1.1994184019597658,0.0,0.838420746459715,1.0,31/185,11.31%,HSPA1A;HSPB1;PDK4;NOTCH1;BCL2;BNIP3L;CD44;BCL2L1;TMBIM6;FMN2;ARHGAP10;TBX3;BNIP3;MAEA;HDAC1;API5;RAF1;DNAJB6;FZD3;SEMA4D;AXL;MSH2;EGFR;CBL;KLHL20;TNFAIP8;MERTK;NAA38;PAK2;MCL1;NFKB1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.8016099689812821,1.1992160957809352,0.25,0.8372715587552914,1.0,1/5,4.73%,DTNA
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.518554933802327,1.1990361496645705,0.1794871794871795,0.8361030049405077,1.0,2/26,2.98%,MFHAS1;HIPK2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.6411723956833058,-1.1989260402311677,0.24242424242424243,1.0,1.0,1/12,2.99%,MYO10
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6566960983375016,-1.198886313675904,0.29310344827586204,1.0,1.0,4/12,9.80%,LAMA1;VEGFA;IFT122;CYP1B1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.6643896243271799,-1.1983742420066719,0.23943661971830985,1.0,1.0,3/11,9.93%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.6643896243271799,-1.1983742420066719,0.23943661971830985,1.0,1.0,3/11,9.93%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.7474490782704692,-1.1981957787630486,0.2459016393442623,1.0,1.0,2/5,14.64%,MAPK14;IL16
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7307619404773906,1.1980576316779115,0.3488372093023256,0.8382626326688953,1.0,2/6,16.33%,ADAM17;WNK1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.8021669942921934,-1.1980443254426678,0.3148148148148148,1.0,1.0,3/5,15.54%,TENM4;EPB41L3;PMP22
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),-0.635965795318036,-1.197245783548156,0.25396825396825395,1.0,1.0,6/19,17.80%,FSIP2;IFT122;TCTN1;CSNK1D;BBS4;ATP6V1D
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.6453714209647599,-1.1969780947190205,0.21875,1.0,1.0,1/16,0.11%,ABCA4
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.6321968503610494,1.1967715266120391,0.3103448275862069,0.8413085870855319,1.0,3/10,12.98%,WDR33;PCF11;CPSF2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.5110389338693582,-1.1965392038534604,0.16216216216216217,1.0,1.0,25/97,17.31%,RPL30;RPL19;RPL23A;RPL5;RPS25;RPL34;RPL15;RPL27;RPLP1;RPL35A;RPL37A;RPL36;RPL6;RPL7A;RPS24;RPL11;RPL10A;RPL37;DDX52;EXOSC10;RPS14;RPL13A;WDR12;RPS7;LAS1L
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.655501047195726,-1.1963180997081957,0.2698412698412698,1.0,1.0,2/16,1.91%,IFITM3;MDFIC
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.6484635966699139,-1.1958343983489648,0.15517241379310345,1.0,1.0,2/18,5.16%,PHLDB2;EPHA3
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.6887523283845285,-1.1955459895233036,0.1864406779661017,1.0,1.0,6/11,23.22%,GPX4;CYP1B1;PLA2G4C;PTGR1;PNPLA8;MGLL
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.7347514222201914,-1.1952921109611532,0.22641509433962265,1.0,1.0,2/8,11.43%,TGFB2;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6036444069015602,-1.1949117550408384,0.19047619047619047,1.0,1.0,2/20,1.52%,PDGFD;VEGFA
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7263066475995724,-1.194725561666819,0.23214285714285715,1.0,1.0,6/8,25.76%,ATP5PF;ATP5MC2;ATP5F1E;ATP5ME;DMAC2L;ATP5F1C
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7263066475995724,-1.194725561666819,0.23214285714285715,1.0,1.0,6/8,25.76%,ATP5PF;ATP5MC2;ATP5F1E;ATP5ME;DMAC2L;ATP5F1C
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.6239574184687455,-1.1946520548508026,0.21311475409836064,1.0,1.0,4/21,7.79%,AFG3L2;ERAP1;ADAM9;APH1B
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5288841848554674,-1.194623085588941,0.1791044776119403,1.0,1.0,18/73,12.10%,SLC47A1;IGFBP5;PAMR1;FBLN1;SEMA6D;DKK3;IGFBP2;COL3A1;COL1A2;PDZRN3;COL6A1;DCN;LAMA4;LAMB1;BOC;PLPP3;FOXC1;SLIT2
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.5146019224633036,-1.1943352515811823,0.14084507042253522,1.0,1.0,4/57,1.52%,FGF1;TGFB2;PRRC1;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.7056818258072936,1.1937154744663974,0.2727272727272727,0.8504522404827092,1.0,1/7,2.20%,TMEM30A
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.5868986156006211,1.1936103658378923,0.125,0.849024533930761,1.0,4/19,5.37%,VAPB;ACADVL;CTDSP2;GFPT1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.6235522392634558,-1.1935186849569033,0.2608695652173913,1.0,1.0,4/27,5.68%,FGF1;KLHL13;RACK1;PIK3R4
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5999235517024278,1.1933243879978086,0.19047619047619047,0.8483725106731578,1.0,2/17,1.35%,VAPB;CNOT7
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.6951645835572755,-1.192808406843239,0.22807017543859648,1.0,1.0,3/13,10.67%,CD55;FBXO38;HLA-B
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.6584470262502548,-1.1926882784512007,0.2608695652173913,1.0,1.0,3/12,9.93%,PKM;ENO1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.7883810034818097,-1.1924818229919445,0.2708333333333333,1.0,1.0,1/5,1.58%,JAM2
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.7264222887183044,-1.1922808471828057,0.18309859154929578,1.0,1.0,5/10,24.29%,DDX18;LAS1L;PRMT3;MPHOSPH10;WDR43
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7303942738070095,1.192214958131994,0.3333333333333333,0.8504591633248982,1.0,5/8,26.33%,RHOA;CDC42;EZR;RAB10;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7146097917322116,-1.1921668920113457,0.1774193548387097,1.0,1.0,2/12,3.66%,VEGFA;ANXA1
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.737268485216144,-1.1920374601458794,0.3076923076923077,1.0,1.0,5/7,26.16%,ABCB7;NUBPL;HSPA9;CIAO1;LYRM4
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.678363862859034,1.191850996237711,0.21621621621621623,0.8499026567707394,1.0,2/11,3.30%,PDK4;ACADVL
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.6542940598741028,-1.1916553468812319,0.29411764705882354,1.0,1.0,1/10,0.71%,IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7660317891803609,1.1908415945347657,0.30434782608695654,0.851738274287886,1.0,2/5,20.49%,PPARA;NFIB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.6103198130753131,-1.190816206985726,0.2727272727272727,1.0,1.0,3/18,7.86%,IGFBP5;STAT1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.756494234214082,-1.1907456338766809,0.23076923076923078,1.0,1.0,2/8,9.24%,RACK1;TENM4
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5551951017316938,1.1903664675270218,0.23809523809523808,0.8516583631697378,1.0,5/17,18.02%,CNOT7;SLIT3;SH2B3;GAS6;CCDC3
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.7298154479931735,1.1903399637298744,0.2857142857142857,0.8500319778095559,1.0,6/7,25.28%,AXL;GAS6;AP1G1;IL18;HLA-E;LAMP1
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.6902076971515713,-1.18972699288245,0.2631578947368421,1.0,1.0,4/12,10.87%,ST6GALNAC3;SPTLC3;ST3GAL5;ASAH1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7073643160120483,-1.1895357630943972,0.2545454545454545,1.0,1.0,2/8,16.22%,MTM1;TMEM39A
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.5320596077032262,1.1895287223494115,0.2,0.8516420307802193,1.0,5/41,6.05%,HSPA1A;TNFRSF1B;APC;BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.5116433693813611,1.1894988483851816,0.25806451612903225,0.8499988015759781,1.0,9/28,15.45%,DPP10;ATP2B4;GNAI1;KIF5B;EGFR;ITGA3;EFCAB7;ZDHHC5;PTPN9
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.7010397184302382,-1.1894839483984723,0.22641509433962265,1.0,1.0,3/12,18.38%,TRIM13;WRN;XRCC6
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.7056487941747971,1.1892949414508596,0.35555555555555557,0.8473936806279524,1.0,2/6,7.60%,EIF4ENIF1;AGO2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.7056487941747971,1.1892949414508596,0.35555555555555557,0.8473936806279524,1.0,2/6,7.60%,EIF4ENIF1;AGO2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5743036317820599,1.1891197704765895,0.2631578947368421,0.8465466959856471,1.0,9/18,13.45%,CACNA1B;PHC1;FRAS1;GABRB3;GRID2;CNTNAP2;SEMA6A;LEF1;CECR2
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.8173800123397887,-1.189056403149069,0.2647058823529412,1.0,1.0,4/5,17.42%,VEGFA;THBS1;PDCD10;JCAD
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.6958367114377436,-1.1889644665648977,0.3088235294117647,1.0,1.0,3/13,13.69%,TGFB2;GPM6A;UFL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.7771914670995445,-1.188734833752964,0.2549019607843137,1.0,1.0,1/5,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.7427362751019,1.1879434891625642,0.358974358974359,0.8486172632005816,1.0,3/5,21.71%,RHOA;TRAF6;ETS1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.677929490971104,-1.1877308684804562,0.27692307692307694,1.0,1.0,7/14,22.83%,RPS25;RPS24;DDX52;RPS14;RPS7;RPS6;RPS28
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.604169096278946,-1.187504659441018,0.21428571428571427,1.0,1.0,2/27,2.43%,NRP1;FBLN1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5229340395206723,1.1873280443919092,0.20689655172413793,0.8489438288135078,1.0,6/34,4.54%,GJC1;GJA4;CDH2;CTNND2;CDH10;SMAD7
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),-0.7553346686712423,-1.18723106467471,0.3492063492063492,1.0,1.0,3/5,12.10%,NRP1;ALCAM;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),-0.7553346686712423,-1.18723106467471,0.3492063492063492,1.0,1.0,3/5,12.10%,NRP1;ALCAM;SLIT2
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.5757321236586759,-1.186759747143262,0.22807017543859648,1.0,1.0,4/25,14.59%,WARS1;EPRS1;NARS1;LARS1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.6582170120474858,-1.1866952363606058,0.23880597014925373,1.0,1.0,1/14,0.65%,FGF1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6071912464817206,1.1866530838472935,0.2647058823529412,0.8497136979183009,1.0,8/19,20.75%,RHOA;LRRC7;CDC42;LIN7A;PARD3;EZR;PARD3B;LIN7C
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.5530548981875175,1.1866187917048674,0.23076923076923078,0.8481215731645095,1.0,3/19,9.27%,MGRN1;MARCHF7;RAD18
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.4631801968552741,1.1866156867524862,0.3,0.8463728688899436,1.0,8/76,3.92%,SLC35F1;NOL4;ADGRB3;DACH1;CACNA1B;CSRNP3;OPCML;KCNH7
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.6399802834967174,1.1865509988032676,0.2857142857142857,0.8448174286943049,1.0,4/10,18.33%,PUM2;AGO2;PRKRA;ZC3H7B
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.6682518150491406,1.1865077574655762,0.2647058823529412,0.8431755334955584,1.0,1/10,0.96%,PDK4
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7001558997683117,1.186422352446185,0.27586206896551724,0.8416793462696699,1.0,1/9,0.16%,CSF1R
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.7708261515100039,1.1863710637910765,0.25,0.8401892784189383,1.0,3/5,21.59%,NEDD4L;COMMD1;PICALM
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.736900274383695,-1.1861680730563053,0.3275862068965517,1.0,1.0,1/8,1.33%,COLEC12
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.6154739792050598,-1.1860859327362538,0.25757575757575757,1.0,1.0,5/20,15.62%,PKM;ENO1;PGK1;LDHA;DLD
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.6054901609832158,1.1860690828400713,0.21052631578947367,0.8393973506447111,1.0,7/16,17.08%,ATP2B4;ACADVL;FBXW7;NFKB1;RAPGEF2;EP300;SLC27A1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.7517802921035822,-1.1858920638905237,0.3103448275862069,1.0,1.0,1/7,0.87%,TGFB2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.6227869011076743,-1.185823451711957,0.2153846153846154,1.0,1.0,7/27,12.93%,PARP1;XPA;DDB2;XPC;N4BP1;INO80;DHX36
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.7830003668948204,-1.1857074501658418,0.2807017543859649,1.0,1.0,1/5,1.33%,COLEC12
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.539657605431714,1.1855867024416062,0.25,0.839230232457359,1.0,6/32,10.31%,CNOT7;PML;HIPK2;CNOT6;CDKN1A;USP10
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.38528400315598016,1.1855774149974123,0.058823529411764705,0.8375704296138529,1.0,29/147,13.40%,HSPA1A;HSPB1;BCL2;BNIP3L;CD44;BCL2L1;TMBIM6;FMN2;ARHGAP10;TBX3;BNIP3;HDAC1;API5;RAF1;SEMA4D;AXL;EGFR;CBL;KLHL20;TNFAIP8;NAA38;PAK2;MCL1;NFKB1;MECOM;CAT;ZFAND6;LEF1;HDAC2
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.49444340033990897,1.185435682715938,0.2222222222222222,0.8363759248235126,1.0,10/38,15.65%,OPA3;SMARCD3;NFYC;IRS2;TGS1;PPARA;ELOVL6;NCOA2;PANK2;FDFT1
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6755492120801492,1.1852275816644033,0.25,0.8356210105744243,1.0,1/10,2.93%,CDH10
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.631114497482489,1.1850541952024822,0.22727272727272727,0.834435270286347,1.0,1/11,2.87%,PISD
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.8101894326890795,-1.1847038450046599,0.2830188679245283,1.0,1.0,3/5,18.38%,PRKDC;LGALS3;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5855069225188451,1.1846341716850803,0.25,0.834097524553603,1.0,3/12,11.48%,PPP2R1A;SEMA4D;SH2B3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.5697441660431156,-1.184338579734683,0.23333333333333334,1.0,1.0,7/27,13.32%,TGFB2;ADAMTS12;BMP5;PDCD4;DDX5;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.6017812265777894,-1.1841771825389755,0.22807017543859648,1.0,1.0,4/22,14.59%,WARS1;EPRS1;NARS1;LARS1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7685146626614885,1.1840245909146219,0.2916666666666667,0.8345799110011575,1.0,2/5,9.38%,PAPSS2;PAPSS1
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6532389209423308,1.1839502070561216,0.3,0.8330856319304916,1.0,2/10,5.82%,CSF1R;CAMK1D
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.5425696750515474,1.1833988961875743,0.3103448275862069,0.8331603671128287,1.0,11/30,21.28%,MAP3K7;PHF20L1;PHF20;APBB1;LEF1;EP300;JADE2;JADE1;HAT1;MEAF6;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7825320023018718,-1.1832241403409438,0.2909090909090909,1.0,1.0,3/6,11.91%,IFITM3;GSN;PPIA
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.5205935079014419,1.1824023000633417,0.22857142857142856,0.8352920615986029,1.0,4/37,9.15%,VAPB;VAPA;SEC23A;PPP6C
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.7018320147506152,-1.1823074244075922,0.3137254901960784,1.0,1.0,3/8,14.35%,PARP1;ENO1;TMSB4X
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.47610282926060327,1.1818191568044114,0.22580645161290322,0.8353169701671972,1.0,15/60,12.86%,ARRDC2;NDRG2;MCAM;OPCML;GPRC5B;GFAP;MOBP;TMEM63A;NRXN1;SEMA4D;PEX5L;TNR;ADCY5;MBP;MYO1D
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.7079851796305577,-1.1817062629314914,0.24561403508771928,1.0,1.0,2/12,10.30%,DDB2;KDM2B
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5028465745882301,1.1816777291138967,0.2413793103448276,0.8342834727531856,1.0,16/61,18.46%,PPM1L;PTPRK;PPM1A;PPP2R1A;CTDSP2;PPP2CB;PPP6C;CTDSP1;PPP1CC;MTMR4;PPP4R2;BTRC;PTPN9;PTPRS;PTPRZ1;PTPRD
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.5369754460561569,-1.1797056194179807,0.21212121212121213,1.0,1.0,8/53,8.05%,CLU;VEGFA;SVIP;WARS1;RACK1;GSN;RPS3;SLF1
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6183169021280355,-1.1795799878192121,0.22388059701492538,1.0,1.0,5/24,13.12%,PARP1;GSN;HSP90AB1;EPHA5;GOSR1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.7247790564222939,1.1791867465708892,0.30952380952380953,0.840535141967631,1.0,1/6,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6893415147565873,1.1791492867829907,0.3333333333333333,0.8388898413223107,1.0,3/9,14.95%,PDK4;PPARA;PANK2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.7608324284531238,-1.178702428751162,0.27419354838709675,1.0,1.0,1/8,2.65%,HECW2
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.7176478869410766,-1.1782980507089555,0.25925925925925924,1.0,1.0,5/10,18.72%,SLC22A6;SLC25A13;SLC1A1;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.739296513585377,-1.1782145709670793,0.2857142857142857,1.0,1.0,4/8,17.12%,SPTLC3;ASAH1;PLPP3;SPTLC1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6558230404136277,-1.1778559626492244,0.2727272727272727,1.0,1.0,8/17,19.42%,PARP1;TERF2IP;RPA1;PRKDC;WRN;SP100;XRCC6;MRE11
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6220633022673456,1.1777116500396732,0.37142857142857144,0.8416382030128796,1.0,2/17,5.18%,HSPA1A;CD58
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.6585967227724814,1.177220304471222,0.3902439024390244,0.8417843586488649,1.0,2/10,3.30%,PDK4;ACADVL
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.5571827906735966,-1.1772066639253627,0.22727272727272727,1.0,1.0,7/47,9.17%,NACA;SRP14;CDC37;SRP54;AP4E1;PEX1;HPS4
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5970430541807479,-1.1769718056630163,0.21212121212121213,1.0,1.0,5/25,13.37%,LSS;AGPAT4;AGPAT5;GNPAT;PAM
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.7197145160864598,-1.1768841651412016,0.2698412698412698,1.0,1.0,4/7,20.87%,CYP1B1;TEX2;SPTLC1;ST3GAL6
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7468726292192616,1.1768665245564969,0.2727272727272727,0.8410827238571044,1.0,3/7,17.03%,RHOA;CDC42;EZR
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6342034027960365,-1.1763526809851976,0.29310344827586204,1.0,1.0,8/15,25.76%,AFG3L2;ATP5PF;ATP5MC2;ATP5F1E;ATP5ME;SPG7;DMAC2L;ATP5F1C
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.7366311694834062,1.1762729747255791,0.27906976744186046,0.8410291366138536,1.0,2/8,12.66%,CNTN4;NPTN
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.7546526649889769,-1.1758929588128892,0.32142857142857145,1.0,1.0,1/5,9.65%,GABARAPL1
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.7546526649889769,-1.1758929588128892,0.32142857142857145,1.0,1.0,1/5,9.65%,GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.7469225441181049,-1.1749431267771377,0.31746031746031744,1.0,1.0,2/8,11.63%,TWIST1;FOXC1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.4450263225582813,1.17477011337024,0.125,0.8447510346710723,1.0,11/70,9.89%,ADGRB3;LSAMP;CHL1;OPCML;GFAP;ZEB2;CDC42EP4;NRXN1;CTNNA2;EGFR;TNR
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.8006574376279462,-1.1743623904982132,0.3392857142857143,1.0,1.0,1/5,0.87%,TGFB2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.697014612888671,1.1743042774802366,0.3404255319148936,0.8443580054920955,1.0,3/7,8.58%,NOTCH1;HEY2;HEYL
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5761321453144898,1.174223838069804,0.2702702702702703,0.8429710884573052,1.0,2/15,3.54%,CACNA1C;HCN2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.5845690636783526,1.1741143179438989,0.2682926829268293,0.8416999759492739,1.0,1/17,0.64%,CACNA1B
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.5674942814807639,-1.1740165913255973,0.25,1.0,1.0,7/35,13.65%,TGFB2;MYO18A;RACK1;ADAM9;BCAS3;PPIA;PDCD10
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6858501132062037,-1.1738983925948552,0.29508196721311475,1.0,1.0,3/12,5.88%,XPNPEP1;ERAP1;CPQ
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.7928334027427091,-1.1738638841284987,0.23636363636363636,1.0,1.0,1/5,2.67%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.7928334027427091,-1.1738638841284987,0.23636363636363636,1.0,1.0,1/5,2.67%,PHLDB2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7294881567365522,-1.1728934251767518,0.3442622950819672,1.0,1.0,1/6,0.92%,CD55
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8031868130018229,-1.1728930038797196,0.23636363636363636,1.0,1.0,2/5,7.71%,TGFB2;TGFBR1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.6848790180578853,-1.1727116295793154,0.3076923076923077,1.0,1.0,4/14,7.86%,ELMO1;MEGF10;GSN;THBS1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),-0.7149245705381851,-1.1725913677519293,0.3,1.0,1.0,2/9,8.93%,GSN;ABI2
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.5891035775507667,-1.1718839046931753,0.23809523809523808,1.0,1.0,3/21,4.58%,TGFB2;TWIST1;GLI3
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.7038249976748664,-1.171528284981535,0.35,1.0,1.0,1/8,4.44%,AGBL1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.4958846621888312,1.1713156479234355,0.27586206896551724,0.8490712805595326,1.0,5/42,9.24%,PDK4;APC;IRS2;ATP6V1H;IRS1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.6253358802988204,-1.1713046679468424,0.25,1.0,1.0,8/20,19.42%,PARP1;TERF2IP;RPA1;PRKDC;WRN;SP100;XRCC6;MRE11
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.631436869394028,-1.1705862264558988,0.2638888888888889,1.0,1.0,4/15,17.39%,LIMA1;PLEKHH2;SLIT2;PRKN
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.7175034016652696,-1.169711050293831,0.27450980392156865,1.0,1.0,2/8,6.20%,SLC38A1;SLC6A20
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6456543356303092,-1.1697088167517073,0.28125,1.0,1.0,7/11,22.80%,DDX18;RPL7A;RPL10A;WDR12;LAS1L;ZNHIT6;RPL35
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.5596350006065552,-1.169232128011211,0.2903225806451613,1.0,1.0,10/34,19.06%,CDKL1;DYNC2LI1;HTT;TBC1D2B;TCHP;DCDC2;TBC1D22A;BBS4;TBC1D8;SDCCAG8
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.7046849962463284,-1.1686624530990806,0.39344262295081966,1.0,1.0,2/8,7.77%,TEFM;FASTKD2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6977816408470521,-1.1684931417175657,0.3333333333333333,1.0,1.0,1/8,1.02%,RIMS1
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.7332283693656612,-1.16830561620044,0.24561403508771928,1.0,1.0,5/6,23.51%,GPC3;FOXC1;SLIT2;ROBO2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.8060198587785443,-1.1672614928564309,0.2708333333333333,1.0,1.0,1/5,2.00%,RAD51B
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.7673450921165254,-1.1671678855955017,0.29411764705882354,1.0,1.0,2/5,8.16%,HEXB;OMD
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6150907161554511,1.1670151805501687,0.3170731707317073,0.8621976602471606,1.0,2/13,2.17%,DPP10;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.7007510592117902,-1.1670072593626097,0.3157894736842105,1.0,1.0,3/7,18.16%,BMP5;SLIT2;NBL1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5557154395955114,1.1667429102443545,0.34285714285714286,0.8613355945357468,1.0,4/16,14.22%,ATP2B4;NUS1;EGFR;DNM2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.5832112617045702,-1.1665124790542403,0.2962962962962963,1.0,1.0,9/33,10.90%,PLXNC1;RIPOR2;FBLN1;ADAM22;GCNT2;SPOCK1;TBCD;CYP1B1;JAM3
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.71567914350735,1.1664138999873734,0.375,0.8604987763982653,1.0,1/6,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.6158870704934694,-1.1662598371342907,0.25,1.0,1.0,1/16,0.48%,ABLIM1
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.7935938072187991,-1.1659948115174967,0.1956521739130435,1.0,1.0,2/5,1.32%,MLPH;FOXQ1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.6449667339623825,-1.1657052023542727,0.23728813559322035,1.0,1.0,5/17,15.42%,LSS;FAXDC2;PRKAG2;CYP27A1;HSD11B1
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.708539618368407,-1.1653065464509373,0.3181818181818182,1.0,1.0,2/8,10.11%,TGFB2;FN1
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.4914989576975397,-1.1650009467498916,0.20253164556962025,1.0,1.0,18/120,7.86%,PDGFD;FGF1;TGFB2;NRP1;VEGFA;ACTG1;CEMIP;SEMA3C;SEMA6D;ENPP2;COL1A1;SEMA3D;GCNT2;RACK1;ADAM9;F3;TGFBR1;THBS1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.6039151159415309,1.1649683204343222,0.3076923076923077,0.8636881461019716,1.0,7/14,20.27%,OPCML;NXPH1;CKB;GRM5;NLGN2;GRIN1;GRIA2
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.7333379387354692,-1.1644751799658606,0.2692307692307692,1.0,1.0,3/6,23.51%,GLI2;VIT;PKD2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.5922228495242597,-1.1643309994137334,0.2608695652173913,1.0,1.0,5/25,13.65%,TGFB2;MID1;PPIA;TGFBR3;PDCD10
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.7558260948712721,-1.1639264095483273,0.3125,1.0,1.0,1/7,4.58%,GLI3
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.704321561718061,1.1639186739599652,0.3023255813953488,0.8652722209013932,1.0,3/6,25.14%,MAP2K2;MARK3;DYRK1A
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5681596346175799,1.1636726763920677,0.2564102564102564,0.8644108752327374,1.0,4/30,9.24%,CSF1R;IRS2;RHOA;IRS1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.578892787446986,-1.1629289419215545,0.2878787878787879,1.0,1.0,11/34,20.44%,SHROOM3;KIAA1217;RPL23A;NR2F1;ATP1B1;HES1;WNK2;SLC7A2;EFNB2;DDAH1;MARK1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.7355941860249918,-1.1627832776007452,0.24561403508771928,1.0,1.0,2/9,6.16%,ANXA1;ZFP36L2
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.5327188665742313,1.1627384563556886,0.28,0.8664004843380593,1.0,10/36,10.89%,APC;HIPK2;PPM1A;SMAD7;MAP3K7;PMEPA1;HDAC1;RAB31;RHOA;BMPR1A
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.7252173112625183,-1.162631735415335,0.2878787878787879,1.0,1.0,3/6,16.72%,RPS21;EXOSC10;WDR12
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.6460226064752675,-1.162553514137376,0.2857142857142857,1.0,1.0,2/14,18.77%,GOSR1;NAPG
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.488168261090306,-1.1623742036684128,0.2676056338028169,1.0,1.0,18/76,11.74%,IGFBP5;VEGFA;COL6A3;PAMR1;DKK3;COL1A1;COL3A1;THBS2;ADAMTS12;COL1A2;PDZRN3;COL6A1;COL12A1;DCN;LAMA4;FN1;PLPP3;TPM2
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5403540415929436,-1.1615780875317,0.25806451612903225,1.0,1.0,9/34,11.63%,ISM1;TGFB2;EPN1;STAT1;THBS2;THBS1;DCN;PGK1;FOXC1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7421166923244773,1.1613806691598865,0.32432432432432434,0.8690984238344629,1.0,2/6,17.97%,CNOT6;NBDY
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.5799799940274828,-1.161253488023087,0.265625,1.0,1.0,7/27,14.35%,CMKLR1;PRMT2;OTULIN;G3BP2;CYP1B1;UFL1;TMSB4X
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.6971957685877695,1.1609958578449835,0.3902439024390244,0.8687977139300868,1.0,6/8,22.29%,SGIP1;CLTC;HIP1;EPS15;PICALM;FCHO2
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.4830200614155617,-1.160480618347864,0.2328767123287671,1.0,1.0,15/72,15.04%,CLU;TM7SF3;STAT1;SEPTIN4;SGK1;RPS3;NDRG1;DDX42;SRA1;BIRC2;ASAH1;WRN;NAE1;DAPK2;BCL2L14
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7100020159190639,-1.160364278226937,0.3076923076923077,1.0,1.0,1/7,5.10%,FTH1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6883835563278249,1.1602465492954863,0.3055555555555556,0.8695788056626478,1.0,1/9,0.81%,ANO5
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5144638099695095,1.1602133522944387,0.2571428571428571,0.8680055912757054,1.0,12/35,21.39%,CACNA1C;RCAN2;CAMKK2;EGFR;MCU;P2RX4;RYR2;GRM5;ANK2;PPP1R9A;SLC8A1;PRNP
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7091526122078915,-1.1602103586086134,0.3125,1.0,1.0,3/8,22.83%,PRKDC;RPS14;RPS28
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.7598950878253687,1.1600548756633213,0.2727272727272727,0.8653283929915002,1.0,3/5,17.11%,NRXN1;NLGN2;NLGN4Y
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.7598950878253687,1.1600548756633213,0.2727272727272727,0.8653283929915002,1.0,3/5,17.11%,NRXN1;NLGN2;NLGN4Y
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5290651057897595,-1.159434117299268,0.25806451612903225,1.0,1.0,9/52,11.72%,CLU;TGFB2;VEGFA;ANXA5;PROS1;THBS1;FN1;PHACTR2;MAGED2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),-0.6662185169206063,-1.1592228536566236,0.3076923076923077,1.0,1.0,1/11,1.72%,ACTG1
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5646387127414942,-1.158914049051971,0.22666666666666666,1.0,1.0,2/27,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.682676613880439,-1.158365182702116,0.35185185185185186,1.0,1.0,1/8,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4930223690643042,1.1583416294053646,0.2,0.8689199567262234,1.0,3/53,1.58%,HSPA1A;NOX4;SERPINB6
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5582889269881228,1.1579068894206153,0.2972972972972973,0.8686444103507499,1.0,3/17,16.33%,ATP2B4;P2RX4;WNK1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5223203079903199,1.157807153567629,0.24242424242424243,0.8673656146494162,1.0,4/22,7.58%,HSPA1A;SMAD7;SPOPL;GNL3L
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7504988342151474,1.1576723902862913,0.32558139534883723,0.8662196100646105,1.0,2/5,13.90%,TMEM30A;SCARB2
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.7623483134514106,-1.1575665667859891,0.2909090909090909,1.0,1.0,3/5,12.76%,POLA1;PPIA;WRN
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.6178005861555574,1.1572699173007825,0.2765957446808511,0.8659294184331329,1.0,7/11,32.79%,ATXN3;MINDY2;OTUD7B;OTUD7A;USP8;USP37;USP25
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.5429394066264637,-1.157038338986708,0.25396825396825395,1.0,1.0,2/23,0.87%,LAMA1;TGFB2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6612930456286812,-1.1570305403054504,0.3157894736842105,1.0,1.0,3/9,11.85%,NT5E;HSP90AB1;ANO6
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.6830760392116334,-1.1568554156828526,0.31746031746031744,1.0,1.0,3/12,16.73%,AFDN;ANO6;NUP107
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.5993945178079298,1.1568222683352556,0.32432432432432434,0.8657040599472222,1.0,4/10,14.58%,ANPEP;EGFR;ARHGEF10L;KCNQ1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.6667955327526964,-1.1566589197127992,0.2727272727272727,1.0,1.0,3/11,15.14%,VEGFA;LARS1;RRAGB
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.5864563417835678,-1.1561420195136283,0.3076923076923077,1.0,1.0,9/30,15.01%,CLU;ACTG1;ANXA5;LSS;ALCAM;LGALS3;S100A11;PLSCR1;SREBF2
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.7243685435245035,1.1554249624346065,0.32075471698113206,0.8684061870620359,1.0,1/6,3.07%,SORT1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.6657609453038332,-1.1551845794795808,0.3050847457627119,1.0,1.0,1/10,0.92%,CD55
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.5575046200842482,-1.154761891774896,0.25,1.0,1.0,3/25,7.86%,ZFPM1;FAXDC2;THBS1
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6840085375797802,-1.1547057294458662,0.31746031746031744,1.0,1.0,1/10,0.36%,CLU
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.7102840068433058,-1.1546486622963104,0.23636363636363636,1.0,1.0,1/5,3.66%,ANXA1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6476652918336049,1.154342656528683,0.3181818181818182,0.8702938166303611,1.0,4/10,10.89%,NOTCH1;HEY2;HEYL;BMPR1A
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.6325439988102175,1.1542840902112965,0.2682926829268293,0.8687516122383506,1.0,4/9,19.93%,CACNA1C;ADGRV1;CAP2;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6753775772140514,-1.1538491197491367,0.3050847457627119,1.0,1.0,2/9,11.43%,SUPT6H;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.5724156647426119,1.153613267401107,0.25,0.8698512669873064,1.0,3/13,9.10%,GPRC5B;HEYL;RHOA
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.4607413166320962,-1.1535050744953872,0.19230769230769232,1.0,1.0,25/177,7.86%,PDGFD;SRGAP3;PLXNC1;FGF1;IGFBP5;VEGFA;ACTG1;CEMIP;SEMA3C;AFDN;SEMA6D;ENPP2;ANXA1;NKD1;COL1A1;TMSB10;SEMA3D;GCNT2;RACK1;LDLRAD4;ADAM9;F3;SGK1;TGFBR1;THBS1
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6980031294804282,1.1534084780301728,0.32558139534883723,0.8690313157184199,1.0,2/9,10.07%,MFHAS1;TIPRL
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.7482032075959202,-1.1532663968923054,0.3620689655172414,1.0,1.0,1/5,11.43%,BRCA1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6768172881300205,1.152787162401076,0.3076923076923077,0.8695170598762278,1.0,2/9,4.22%,KCNC2;GUCY1B1
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7843693569069183,-1.1520654065121465,0.2765957446808511,1.0,1.0,4/6,20.42%,PARP1;PARP9;TNKS2;PARP14
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.6067696888063839,1.1518260518567809,0.2916666666666667,0.8711334604624192,1.0,1/16,0.17%,JPH2
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7236253233600226,1.151691702981153,0.3170731707317073,0.8700017006924933,1.0,4/6,26.04%,AP1G1;HLA-E;LAMP1;PIK3R6
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7674450006828046,1.151561584276187,0.3125,0.8688950188084564,1.0,3/5,13.51%,FHOD1;PLS3;SPIRE1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.7454453549549596,1.151356036672927,0.26666666666666666,0.8680218298169587,1.0,1/7,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.675651387411797,-1.1510550280146343,0.34615384615384615,1.0,1.0,2/5,26.58%,FBXL7;RBX1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6403693964025203,-1.1507258751027796,0.3275862068965517,1.0,1.0,3/13,3.66%,MLPH;PGR;ANXA1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.6477352858488985,-1.1505251063368112,0.32727272727272727,1.0,1.0,4/12,22.77%,AKR1C1;CYP27A1;NPC1;HSD17B4
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7446053115206397,-1.150512306048035,0.34615384615384615,1.0,1.0,4/6,21.39%,NKD1;CSNK1D;WNT5B;PLEKHA4
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.5096441270841059,-1.150289502693957,0.25,1.0,1.0,16/88,7.86%,PDGFD;FGF1;TWIST1;VEGFA;ACTG1;CEMIP;SEMA3C;SEMA6D;COL1A1;SEMA3D;GCNT2;RACK1;ADAM9;F3;TGFBR1;THBS1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.6139193025272012,1.1502304289166632,0.2564102564102564,0.8709197292332392,1.0,2/12,1.47%,JPH2;CACNA1C
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.6786054454120785,-1.149659496161155,0.29310344827586204,1.0,1.0,4/10,19.77%,ALDH3A2;PEX1;PEX3;ACBD5
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.4767092403647601,1.1493615136950583,0.15151515151515152,0.8725602521745122,1.0,10/48,10.16%,NOL4;CSRNP3;CNTN4;RCAN2;KALRN;CNTN1;NRXN1;GABRB3;C2ORF72;LCORL
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.5620324661090651,-1.148957266245004,0.2535211267605634,1.0,1.0,7/32,10.67%,GBP2;MT2A;STAT1;EPRS1;CD47;MID1;HLA-B
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5560631814342538,-1.1489154383125753,0.25396825396825395,1.0,1.0,11/43,18.24%,VEGFA;AKR1C1;SFRP4;THBS1;SLCO1C1;MAPK14;MT3;APOE;ANXA2;CHCHD2;EIF4G1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.4772581961877001,1.1485049044698104,0.23333333333333334,0.8738836461308761,1.0,11/49,9.54%,ST3GAL2;GALNT18;MGAT5;RPN2;TRAK1;GFPT1;NUS1;B3GNT2;OGA;STT3B;PMM2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.49493885956597233,-1.1484191386208862,0.3181818181818182,1.0,1.0,11/58,11.58%,GBP2;STAT1;ADAMTS12;ZFP36L2;RPS3;PSMD8;YBX3;BIRC2;ASAH1;BRCA1;PSMC2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.6290020081912264,-1.1482624857506647,0.2786885245901639,1.0,1.0,4/13,10.81%,CDC37;PELI1;YBX3;BIRC2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.7114884362234033,-1.1479562286351073,0.35185185185185186,1.0,1.0,5/9,18.72%,SLC25A13;SLC6A13;SLC1A1;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6536786207943045,-1.147786611089302,0.3076923076923077,1.0,1.0,6/13,24.44%,RPS20;DDX5;RPL37;RPS7;RPL23;PLA2R1
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.7559676382755813,-1.1477360027985788,0.3225806451612903,1.0,1.0,1/5,11.43%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.6816012943353692,1.1477325615087643,0.2978723404255319,0.8743326835113927,1.0,3/7,21.40%,CORO2B;NDFIP2;SNX3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.6369713799478162,-1.147617657829156,0.3333333333333333,1.0,1.0,8/12,35.64%,RPA1;UFD1;UBA52;NPLOC4;VCP;RPA3;RFC1;UBB
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.5271711950309403,-1.1474908409100388,0.2602739726027397,1.0,1.0,10/47,14.35%,FGF1;NRP1;VEGFA;RIN2;THBS1;SASH1;BCAS3;PLPP3;MAPK14;TMSB4X
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.4763161891567772,-1.1474081035059942,0.25333333333333335,1.0,1.0,17/100,12.41%,LAMA1;PLXNC1;NRP1;VEGFA;LRTM1;SEMA3C;SEMA6D;UNC5D;SEMA3D;GLI2;EPHA3;NOTCH2;NTN4;ALCAM;EPHA5;SLIT2;EPHA4
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.6679910951119001,1.1469976817684147,0.3125,0.8754620157314034,1.0,2/7,7.46%,NOX4;MMUT
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.7166652308092993,1.146520426909368,0.35,0.8754321121829711,1.0,3/8,17.03%,RHOA;CDC42;EZR
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.609226028669385,-1.1457019825678152,0.3484848484848485,1.0,1.0,7/21,12.66%,WDFY4;PPP1R14A;FTL;ANXA1;VCAN;HLA-B;LGALS3
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.658030594486565,-1.1453105633376301,0.34545454545454546,1.0,1.0,2/11,4.58%,TWIST1;GLI3
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6382998717682136,-1.145165447184099,0.2916666666666667,1.0,1.0,5/12,18.28%,EIF2S2;EIF2B3;EIF4H;EIF4G1;EIF2S3
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6101787742816565,1.1450745535886215,0.3,0.8782024849220776,1.0,3/9,7.96%,NOTCH1;HDAC1;HDAC9
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6235085986443994,1.144591652795788,0.3611111111111111,0.8781060513513319,1.0,4/9,23.42%,AGO2;PRKRA;DHX9;CELF1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.7259166695577002,-1.143718760913968,0.36363636363636365,1.0,1.0,3/7,7.29%,ZFPM1;TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5184995877334809,-1.1435122602222936,0.2833333333333333,1.0,1.0,3/52,0.90%,PDGFD;TGFB2;TWIST1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5207325056705063,1.1435000688155692,0.2978723404255319,0.8799998967090473,1.0,8/20,10.36%,GUCY1A1;PANK3;GUCY1B1;ADCY9;PAPSS2;ADCY3;PAPSS1;ADCY5
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.7540825757270964,-1.143372136905962,0.29310344827586204,1.0,1.0,1/6,7.49%,RSRC1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.7203770429606012,-1.1432265533029364,0.2982456140350877,1.0,1.0,2/8,8.22%,SLC47A1;RALBP1
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.7154898652053837,-1.1431893234334312,0.3,1.0,1.0,4/7,19.82%,PTS;PLPP3;PRKG2;CALM1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7285037645512856,-1.1430541404692305,0.3880597014925373,1.0,1.0,3/7,16.83%,ALDH3A2;PMP22;NGF
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.7060482301651066,-1.1427858080877114,0.3076923076923077,1.0,1.0,2/9,5.32%,ADM;PER2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.6548575278532995,-1.1427625562605639,0.2698412698412698,1.0,1.0,4/12,16.16%,ENO1;NPRL3;MTM1;ANXA2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.659301233207576,1.1426645491660872,0.30952380952380953,0.8810268225138359,1.0,4/10,15.63%,PUM2;RAD18;CSNK2A1;SMC5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.7269157223503685,-1.142649158992571,0.3898305084745763,1.0,1.0,1/5,6.41%,CD47
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.693656742654419,-1.1424812220208331,0.3442622950819672,1.0,1.0,1/10,0.87%,TGFB2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.7305331608313568,-1.1423806215590282,0.39655172413793105,1.0,1.0,4/6,21.60%,SPTLC3;ASAH1;SPTLC1;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.7335882492291184,-1.1423205949232504,0.375,1.0,1.0,1/5,3.10%,AFDN
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7481651310421017,1.1422393062692096,0.3157894736842105,0.8807622804969979,1.0,1/5,8.16%,FBH1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.4852421104654886,-1.1417110258108123,0.22972972972972974,1.0,1.0,17/76,15.62%,GLCE;VEGFA;NT5E;PKM;EXT1;GPC3;ENO1;DCN;VCAN;PGK1;PPIA;PAM;LDHA;GLRX;NASP;SLC25A13;DLD
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.6862012770915793,-1.1415366271763963,0.3269230769230769,1.0,1.0,1/8,1.02%,RIMS1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.6862012770915793,-1.1415366271763963,0.3269230769230769,1.0,1.0,1/8,1.02%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.6580604890478365,1.1411023546523062,0.2972972972972973,0.8829267267011894,1.0,3/13,5.43%,NOTCH1;EPOR;IRS2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.48360436484602787,-1.141050583518181,0.28,1.0,1.0,14/69,11.49%,FGF1;IGFBP5;GBP2;KIAA1217;COL1A1;COL3A1;COL1A2;COL12A1;F3;FMO2;DCN;FN1;NTN4;PLPP3
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.6701446945571011,-1.1410491123940552,0.4,1.0,1.0,2/10,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.591685155877216,-1.1406492635459435,0.3230769230769231,1.0,1.0,6/29,13.69%,PARP1;AFDN;RACK1;HSP90AB1;DZIP1L;UFL1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.6238948299946923,-1.1406129173360589,0.3333333333333333,1.0,1.0,1/12,7.60%,RPS3
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5654831749038026,-1.1395150049882572,0.2786885245901639,1.0,1.0,6/26,10.13%,RIPOR2;CEMIP;COL1A1;EYA1;COL11A1;DCDC2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.4545565733827938,1.1395126894930332,0.25,0.8866516226270177,1.0,9/45,7.09%,TNFRSF10B;TNFRSF1B;BCL2;PML;HIPK2;BCL2L1;BNIP3;CEBPB;CDKN1A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.5401229978741164,-1.139342420806819,0.2571428571428571,1.0,1.0,3/35,6.16%,ZFPM1;CMKLR1;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.5923250429871906,-1.1392148271700435,0.2903225806451613,1.0,1.0,3/21,16.22%,NPRL3;MTM1;TMEM39A
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.6889653738928467,1.1391192033166975,0.3333333333333333,0.8865003729236589,1.0,4/8,12.31%,ZNF609;RAPGEF2;SEMA6A;PLAA
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.7633673259662774,-1.1390963527988192,0.35294117647058826,1.0,1.0,2/6,2.33%,PARP1;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.6823740952939443,-1.1385437903582278,0.3492063492063492,1.0,1.0,3/9,11.43%,SULF2;CYP1B1;BRCA1
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.32897174239011595,1.1384562303984722,0.0,0.8872020036546032,1.0,138/738,14.64%,DACH1;MXD4;WTIP;EBF4;GATAD2A;NOTCH1;ZBTB7C;PTP4A3;CNOT7;SATB2;HEY2;CSRNP3;KLF15;PPARGC1B;SP4;PML;ATP2B4;PHC1;BACH1;FOXN2;SMARCD3;SOX6;HIPK2;MED24;HDX;ZNF208;CTBP2;ERBB4;KLF13;DEK;PTPRK;HSPA8;ATP8B1;MEF2D;EPAS1;RFX3;PPM1A;ZNF721;SMAD7;PPP2R1A;SOX13;ZEB2;TRAK1;NFYC;RNF14;BBS7;KLF9;TESC;TBX3;ZNF704;ZNF546;SMARCA4;ZBTB7A;VEZF1;HIF3A;CEBPB;KLF12;BRD2;ZNF611;KDM7A;HDAC1;SOX5;ZNF710;CDKN1A;BCL6;CAMKK2;HMBOX1;LCOR;MAP2K2;HDAC9;ZBTB16;NACC2;PHF2;ZFHX3;ZNF586;HEYL;MED23;USP16;ARNT;BRWD1;ZNF143;PHF20L1;ZNF562;MITF;MYOCD;MEIS2;EGFR;EBF1;RAD21;MBD2;THRA;ARID1B;PHF20;LCORL;RPS6KA5;CDK17;MTF2;CTDSP1;APBB1;ZNF609;PHF8;NFKB1;ARID1A;AEBP2;PPARA;ZNF251;SMARCA1;MECOM;RBM23;FOS;ZNF160;ZBTB11;ZNF81;NCOA2;TBX15;LEF1;PURB;NSD2;YAF2;PKNOX1;APBB2;HDAC2;CEP290;EP300;BBX;ZNF213;MAP2K1;AFAP1L2;PHC2;NFIA;DNM2;ZNF782;ACTA2;BTRC;RNF10;ACVR1B;DACH2;TRIP4
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6744249693310491,1.138075326907281,0.2857142857142857,0.8869692802083669,1.0,3/7,6.41%,TNFRSF21;DLG5;CEBPB
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),0.7171406313737905,1.1379121835804236,0.40425531914893614,0.8843263435556245,1.0,2/5,10.05%,SELENOT;EEFSEC
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),0.7171406313737905,1.1379121835804236,0.40425531914893614,0.8843263435556245,1.0,2/5,10.05%,SELENOT;EEFSEC
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.7118586406571062,-1.1375543589835118,0.3125,1.0,1.0,1/7,3.97%,SRP14
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.45583318088532604,1.1375152856308095,0.25806451612903225,0.8836970095851705,1.0,10/59,5.86%,ADGRB3;CACNA1B;LSAMP;CSRNP3;KALRN;OPCML;SLC12A2;TTLL7;LIFR;CNTN1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.5976551052512704,-1.1374353786098268,0.29411764705882354,1.0,1.0,2/31,2.31%,ELOB;SUPT6H
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.5976551052512704,-1.1374353786098268,0.29411764705882354,1.0,1.0,2/31,2.31%,ELOB;SUPT6H
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.6450754917986355,1.1372075177286038,0.38095238095238093,0.8830900284344089,1.0,2/9,8.06%,LRCH1;RRP1B
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5359177603533305,1.1368338827413123,0.2631578947368421,0.8825454359381414,1.0,1/17,1.12%,MOB1B
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.6937014649635753,-1.1366036798307513,0.35294117647058826,1.0,1.0,3/8,14.66%,LAMB1;NTN4;FLRT2
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.503138356423721,1.1363111985644285,0.23529411764705882,0.8825639470825224,1.0,4/31,3.63%,CSPG4;PDGFA;CNOT7;CD44
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.64889130455081,-1.136252910576692,0.3225806451612903,1.0,1.0,3/12,13.73%,DDX60;SASH1;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.6756098132065788,-1.1360550872647852,0.4,1.0,1.0,1/10,2.25%,CEMIP
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7275317838775269,1.1357307546695128,0.32608695652173914,0.8828624823187229,1.0,2/6,12.36%,MTARC2;PPA2
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.66023143673678,-1.1355302607612479,0.40384615384615385,1.0,1.0,3/13,12.28%,ZFPM1;CD47;IL1R1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.6086567937137366,-1.1347987678534126,0.29508196721311475,1.0,1.0,1/19,0.11%,ABCA4
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.7115185455402666,-1.134770130028419,0.4032258064516129,1.0,1.0,3/6,16.64%,IFITM3;TRIM13;LARP7
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.6560785990335912,1.1346091517521535,0.3488372093023256,0.8844580811887219,1.0,4/9,19.22%,PDK4;IRS1;FOXO3;SCD
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.42905719250786395,1.1345123626651403,0.1724137931034483,0.8833766503602207,1.0,9/87,6.70%,BCAM;MFHAS1;BACH1;BNIP3L;EPOR;TNS1;VEZF1;ELL2;KDM7A
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.5993000200811737,1.13435835405617,0.3157894736842105,0.8822393251857309,1.0,1/15,0.06%,TRPC6
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.7248082278653037,1.1343117533985065,0.40540540540540543,0.8808477427755794,1.0,1/6,0.09%,CSPG4
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.590740526275171,-1.13422196879118,0.288135593220339,1.0,1.0,3/21,6.75%,PARP1;GPC3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6683829949143154,-1.1341792491571256,0.36363636363636365,1.0,1.0,2/7,7.60%,CLU;RPS3
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.6116668339341333,-1.1339444715758424,0.34375,1.0,1.0,8/15,16.16%,CD55;PARP1;IL1R1;LGALS3;BHLHE40;S100A11;CD4;ANXA2
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.5116223908357395,1.133866937569208,0.2564102564102564,0.8808095447552547,1.0,7/21,18.46%,DLG5;NRXN1;GRID2;CLSTN2;PDLIM5;NLGN2;PTPRD
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.7065005667956532,-1.1336551729190618,0.34,1.0,1.0,1/6,5.37%,GSN
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.6886724437750956,-1.1325481463276084,0.32142857142857145,1.0,1.0,1/8,0.87%,TGFB2
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.5747932030642422,-1.1324822043837364,0.3787878787878788,1.0,1.0,4/28,7.86%,CLU;TWIST1;CD47;THBS1
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.671994862693998,-1.1322726597294621,0.3333333333333333,1.0,1.0,2/7,14.50%,SLC4A4;ATP1B1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.7166598410226644,-1.1322408960017767,0.3076923076923077,1.0,1.0,1/5,1.52%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7281970451354947,1.132053362719995,0.4,0.8829270834081877,1.0,3/5,25.28%,AP1G1;HLA-E;LAMP1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.7281970451354947,1.132053362719995,0.4,0.8829270834081877,1.0,3/5,25.28%,AP1G1;HLA-E;LAMP1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.6281990802688674,-1.1320517093432523,0.36538461538461536,1.0,1.0,4/12,6.16%,ANXA1;GLI3;LEPR;ZFP36L2
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.7515437078114687,-1.131736193248446,0.3064516129032258,1.0,1.0,3/6,11.88%,NCKAP5;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.7179216023328271,-1.1315484558665612,0.3448275862068966,1.0,1.0,1/7,0.87%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.7153615038113301,-1.131544455143523,0.4032258064516129,1.0,1.0,1/7,1.52%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),-0.6531152251180682,-1.131228496767961,0.3225806451612903,1.0,1.0,1/11,1.91%,MDFIC
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.7335805202631758,-1.1311619083175306,0.373134328358209,1.0,1.0,2/6,15.48%,SCN7A;SCN2A
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6619397701115123,-1.1302664583563198,0.30434782608695654,1.0,1.0,4/10,13.86%,PKM;ENO1;PGK1;LDHA
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.4880544926648202,-1.1296943123213274,0.2375,1.0,1.0,28/91,17.94%,IGFBP5;PRDX1;SLC2A3;TXNRD1;EIF2S2;WARS1;UCHL5;EPRS1;ENO1;CCT6A;SSR1;RPA1;PGK1;BTG2;ADD3;PSMC2;PPIA;HSPA4;BHLHE40;LDHA;NAMPT;GLRX;SLC7A11;SQSTM1;CYB5B;USO1;ATP6V1D;GTF2H1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.6200763658072801,-1.1290579239931864,0.3157894736842105,1.0,1.0,5/19,7.86%,FGF1;VEGFA;EPN1;PKM;THBS1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.746876466766339,1.128845115498811,0.3,0.892078275698218,1.0,2/6,11.51%,ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.686727314750157,-1.1287403055218854,0.38,1.0,1.0,3/14,7.71%,TGFB2;BMP5;TGFBR1
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.6880539273429359,-1.128687857192511,0.39655172413793105,1.0,1.0,3/5,23.88%,FOXC1;COL13A1;BMPR1B
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.539765105650281,-1.12844458911646,0.2982456140350877,1.0,1.0,6/36,10.81%,STAT1;CDC37;RACK1;HSP90AB1;OTULIN;BIRC2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.7582864788812413,-1.1284146438044955,0.35,1.0,1.0,4/5,21.60%,SPTLC3;ASAH1;SPTLC1;SPTLC2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.7582864788812413,-1.1284146438044955,0.35,1.0,1.0,4/5,21.60%,SPTLC3;ASAH1;SPTLC1;SPTLC2
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6630965388875605,-1.1282192732783491,0.4444444444444444,1.0,1.0,2/8,19.82%,HSP90AB1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5681535410718953,1.128106195031295,0.3333333333333333,0.8927887942484161,1.0,2/16,3.24%,CSF1R;ERBB4
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.731625949924622,-1.1279129001587689,0.4,1.0,1.0,1/5,5.32%,PER2
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.731625949924622,-1.1279129001587689,0.4,1.0,1.0,1/5,5.32%,PER2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.5416185638438299,-1.127829792182005,0.3050847457627119,1.0,1.0,7/36,12.44%,MYO10;CDKL1;DYNC2LI1;PLD1;TBC1D2B;DCDC2;TBC1D22A
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6602727007834476,-1.1277135612770133,0.3230769230769231,1.0,1.0,1/10,1.91%,MDFIC
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7462577939595185,-1.1276419779232651,0.36,0.9998700996034668,1.0,1/6,1.33%,COLEC12
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.7163765732416607,1.1275894825249044,0.3958333333333333,0.892690844411007,1.0,2/6,7.41%,PDZD8;PACS2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.44762409668958436,1.1274868284239283,0.24242424242424243,0.8917493882896542,1.0,10/55,7.96%,LDB3;NOTCH1;CACNA1C;HEY2;PCSK5;ERBB4;RBM20;MICAL2;CDKN1A;HDAC9
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),0.6813728483489911,1.1273945927882287,0.37209302325581395,0.8904977502699025,1.0,3/5,16.02%,AXL;MERTK;GAS6
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.5748769668270832,-1.1272543208128867,0.25862068965517243,0.9996877889447404,1.0,4/27,7.71%,FGF1;TGFB2;COL3A1;TGFBR1
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.6042296384979049,-1.1271668071752903,0.24615384615384617,0.9984732406035723,1.0,6/19,17.09%,ANXA1;ADAM9;RPS3;CYP1B1;PDCD10;NET1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.6541856810756319,-1.1270528377828326,0.3148148148148148,0.9973878029204717,1.0,3/11,5.04%,TGFB2;GLI3;GLI2
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.4817990159466242,-1.1268861006107547,0.2535211267605634,0.9965143739413312,1.0,16/74,12.10%,IGFBP5;COL23A1;TGFB2;MEGF10;PAMR1;SEMA6D;DKK3;ADM;NTM;PDZRN3;SCN7A;VCAN;COL11A1;BOC;PLPP3;SLIT2
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5808621624319847,-1.1267759977779868,0.3283582089552239,0.9954213002248857,1.0,8/27,14.36%,UCHL5;GLI3;IFT122;GPC3;RACK1;DCDC2;PTCH1;ARMC9
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.5512324581289141,1.126344396113897,0.2926829268292683,0.8923794720290954,1.0,6/19,13.40%,NOTCH1;HEY2;GNAI1;ADAM17;LEF1;HDAC2
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.6721115096374399,-1.125497183716814,0.3469387755102041,0.9990064651584327,1.0,1/7,4.37%,CENATAC
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5761392390373936,-1.125281323377298,0.3181818181818182,0.9983838716133585,1.0,8/28,13.29%,THSD4;ABCA8;C7;FAXDC2;COL12A1;S100A6;PLPP3;ELOVL2
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.6147210355334789,1.1251603585161738,0.4722222222222222,0.8949770320876849,1.0,1/9,1.23%,SRSF12
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.6491447932427616,1.1251572244918862,0.3333333333333333,0.8934534572336135,1.0,2/8,2.98%,PML;HIPK2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.5599187757368271,-1.1250677970751835,0.36666666666666664,0.997569531236584,1.0,4/25,7.61%,IGFBP5;STAT1;ANXA1;EIF2B3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5483161161595383,-1.125015182668519,0.2835820895522388,0.9962881198711372,1.0,8/31,18.16%,SGK1;GPM6A;SNX2;MINK1;EPB41L3;DTNBP1;NGF;NBL1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6461406183811585,1.1249769637114049,0.36585365853658536,0.8924798796567217,1.0,7/10,18.98%,LIFR;SH2B3;MAVS;TLE5;DHX9;CBFB;MAP2K5
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.6619650387900484,-1.1249058894331796,0.359375,0.9950243511324077,1.0,3/11,4.82%,NRP1;VEGFA;NR4A1
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.738489606277378,-1.1245347074730785,0.3125,0.9950585745811917,1.0,2/5,7.44%,COL1A1;COL4A6
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.6796274411381076,-1.1241596642546539,0.3620689655172414,0.9951476850603316,1.0,2/8,19.54%,LEPR;CST3
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.7114970034022069,-1.1236494323999209,0.38095238095238093,0.9955385190542003,1.0,4/8,17.14%,ABCA8;SOAT1;APOE;NPC1
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5378899241830796,1.1234572925401385,0.3333333333333333,0.8955494282554339,1.0,3/18,9.10%,NOTCH1;ATP2B4;RHOA
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.682655229816215,-1.1233399704837213,0.4166666666666667,0.9951880436819336,1.0,1/7,1.05%,AFG3L2
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.6987016642308806,-1.1233362028457092,0.3050847457627119,0.993702688392856,1.0,5/8,26.74%,SMG6;RAD17;SRPX2;PSEN1;SMG7
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.7157761859935047,-1.1228693555783629,0.37254901960784315,0.9938479501989955,1.0,2/6,7.44%,COL1A1;COL4A6
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6690110597857951,-1.1227371491059632,0.30357142857142855,0.9927920086735854,1.0,3/13,7.71%,NRP1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5790931418683087,-1.1225900265102084,0.3076923076923077,0.9918345791114807,1.0,2/18,7.17%,HSP90AB1;HTT
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.654813225021503,-1.1223561544930694,0.2978723404255319,0.9912337110984358,1.0,4/12,12.76%,PARP1;XPA;RPA1;WRN
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.765567404323688,-1.121368365846593,0.32142857142857145,0.9935688711266556,1.0,3/5,11.72%,GSN;SGK1;MAGED2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.7118885816134759,-1.1212702365461422,0.32142857142857145,0.9925467193841544,1.0,1/6,2.17%,SLC2A3
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.6348732326385241,1.1207026310938524,0.40540540540540543,0.9035719559016718,1.0,3/10,6.05%,BCL2;TNFRSF21;BNIP3
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5273616675703843,1.1206944020430976,0.2702702702702703,0.9020247436484156,1.0,10/30,11.51%,ADGRB3;PTH1R;ADCY9;GNB1;GPR161;ADCY3;ABCA1;ADGRL2;ADCY5;RAPGEF2
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.5862799932158408,1.1205374343966017,0.35,0.9010238488188173,1.0,1/17,0.16%,CSF1R
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.7139272076339189,-1.1205340086492657,0.36363636363636365,0.994114557884499,1.0,3/7,15.34%,JAM2;RNF8;BBS4
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.49784841213144115,1.1203308188772376,0.30303030303030304,0.9000842383575427,1.0,9/40,11.77%,CSF1R;PTH1R;TNS1;ZBTB7A;ABCA1;ANPEP;SEMA4D;THRA;ARHGEF10L
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.596370806388817,1.1196719871433092,0.37209302325581395,0.9002647113563048,1.0,3/12,14.22%,MTFR1;WASHC5;DNM2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.6226614047493753,-1.1196524184296281,0.34,0.9960429295293536,1.0,4/17,7.54%,SLC47A1;SLC38A1;SLC6A20;SLC11A2
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.6630944979020734,-1.1194913763738759,0.3137254901960784,0.9953322526758925,1.0,4/11,20.60%,DDB2;KDM2B;RNF8;UBR2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.6449270465274101,1.1183238173938992,0.35555555555555557,0.9029628932753622,1.0,1/8,3.07%,SORT1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.5702729207907357,-1.1183218115514992,0.30985915492957744,0.998008299185377,1.0,5/26,10.67%,GBP2;MT2A;STAT1;MID1;HLA-B
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.7457038723810311,-1.1181607374391527,0.2962962962962963,0.9972025699322057,1.0,1/5,5.30%,RACK1
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.6190673978899586,-1.1180963512369122,0.27586206896551724,0.9959824069743172,1.0,4/16,12.34%,ABCA8;AGPAT4;AGPAT5;GNPAT
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.6392310758990127,-1.1176659295261329,0.30158730158730157,0.9960009505131342,1.0,2/14,7.30%,NR4A2;SPOCK1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.6434196567753478,-1.117366630584886,0.4,0.995818353777651,1.0,2/8,12.10%,VEGFA;SLIT2
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.6802416455993541,-1.1172065485469265,0.32,0.9950339126798909,1.0,3/6,19.82%,PTS;PRKG2;CALM1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.4826357324673065,-1.1170488933517415,0.2608695652173913,0.9942383919293015,1.0,13/71,13.14%,IGFBP5;ARNT2;SEMA6D;DKK3;NTM;PDZRN3;NR2F1;COL6A1;BOC;PLPP3;SLIT2;IL1R1;LIMCH1
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.5531676658674033,-1.116619394645076,0.30434782608695654,0.9943794908643571,1.0,5/22,11.77%,ADH5;HADHA;ALDH3A2;ACAT1;CYP4V2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.6846033392974324,1.1164312933925515,0.42105263157894735,0.9074750772744704,1.0,1/5,6.84%,PPP2CB
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.5979757598614345,1.116205146943763,0.3076923076923077,0.9067416481646832,1.0,1/13,0.64%,CACNA1B
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),0.6791574611585134,1.1161594680080693,0.43137254901960786,0.9037928954687843,1.0,2/5,5.99%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),0.6791574611585134,1.1161594680080693,0.43137254901960786,0.9037928954687843,1.0,2/5,5.99%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.6153029002395286,1.116024921212229,0.3333333333333333,0.9027072129885712,1.0,1/9,0.39%,ST3GAL2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.657549679268159,-1.1157715252117135,0.31666666666666665,0.9965060213161704,1.0,2/9,2.73%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.7083418254023585,1.1157672964882033,0.2857142857142857,0.9017964529250181,1.0,4/7,14.53%,LEMD3;SMAD7;ACVR2A;ACVR1B
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.6116126258879698,-1.115113086844359,0.3382352941176471,0.9972556083185844,1.0,5/12,19.42%,MMS22L;THOC1;WRN;ZRANB3;MRE11
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.767375661347893,-1.1148450403441723,0.42857142857142855,0.9967937085654874,1.0,1/6,0.84%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.5110246086057578,-1.1147346457967289,0.2876712328767123,0.9957094588410488,1.0,11/45,11.86%,FGF1;TWIST1;VEGFA;PKM;F3;THBS1;ADAM12;SASH1;CYP1B1;BRCA1;BMPER
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.41905268064835205,1.1144589566987064,0.16129032258064516,0.9042133473945921,1.0,6/51,7.58%,HSPA1A;UBQLN1;SMAD7;UBE2N;SPOPL;GNL3L
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.6940621211827357,-1.1144187196844362,0.3582089552238806,0.9955028927666689,1.0,1/8,2.65%,HECW2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6196554742568043,-1.113883880201011,0.3333333333333333,0.995839419935629,1.0,4/18,11.66%,IGFBP5;STAT1;THBS1;PRKDC
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.6031282485853846,1.1134955162997056,0.35294117647058826,0.9055979782867273,1.0,3/11,23.42%,METTL14;ROCK1;CELF1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6193257098626186,1.1133766466686414,0.3870967741935484,0.9045544145344124,1.0,4/16,14.58%,ATP2B4;GNB1;RYR2;KCNQ1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.6675821672126266,1.1133476506029194,0.39473684210526316,0.9030417817341876,1.0,1/8,2.92%,EIF4ENIF1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.7021592611804979,-1.1133401797837619,0.35294117647058826,0.9964128035574916,1.0,4/7,22.92%,ANO6;SLIT2;NBL1;LYN
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.7208771746704455,-1.1128196984251892,0.3793103448275862,0.9967866337580774,1.0,4/6,22.80%,DDX18;WDR12;ZNHIT6;RPL35
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.5324493096980105,1.1126718164797011,0.2702702702702703,0.9036666012806408,1.0,7/18,13.59%,RNF14;SMARCA4;ZBTB7A;HDAC1;HEYL;NCOA2;EP300
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.7165010534223927,-1.1125364636572117,0.38333333333333336,0.9963820881274288,1.0,3/6,7.29%,ZFPM1;TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.7210179167109735,1.1125346563148033,0.37142857142857144,0.9025937955863437,1.0,1/5,1.91%,KLF15
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.71667885492725,-1.112453413275984,0.4067796610169492,0.9952946068316108,1.0,1/8,2.67%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.6660526046873169,1.112252939968332,0.2926829268292683,0.9019571442948602,1.0,2/8,11.18%,NOTCH1;FBXW7
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5918635480059211,-1.1121900532283604,0.32727272727272727,0.9948670842240499,1.0,4/15,15.34%,IFT122;TTC8;CSNK1D;BBS4
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6716085968842807,-1.1119115824179884,0.3220338983050847,0.9944670209774156,1.0,6/10,29.13%,DERL1;UFD1;SELENOS;NPLOC4;SEL1L;VCP
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.6386209857316348,-1.111635774681192,0.3793103448275862,0.994107398728784,1.0,4/12,17.09%,ANXA1;RPS3;CYP1B1;NET1
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6659689063880879,-1.1115824777776715,0.39344262295081966,0.9928724000665565,1.0,1/9,1.91%,MDFIC
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.7128421833904888,1.1108854969789634,0.35,0.9047024270786215,1.0,1/5,10.53%,ARHGAP35
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),0.7323816935300093,1.1103735519264153,0.36585365853658536,0.9046080138570389,1.0,2/6,9.40%,SOX6;MYOCD
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6583976602014474,-1.1099135878516941,0.3582089552238806,0.997727811943092,1.0,1/11,0.36%,CLU
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.6701675117552819,-1.1092610868416475,0.39285714285714285,0.998434646375473,1.0,4/8,21.03%,ENPP2;PLA2G4C;GPCPD1;PNPLA8
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5457969777228756,-1.1092436212324293,0.29508196721311475,0.9970554900199803,1.0,6/27,10.13%,RIPOR2;CEMIP;COL1A1;EYA1;COL11A1;DCDC2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6260881172078729,1.10908812124436,0.3877551020408163,0.9070965276795911,1.0,2/9,6.90%,PTP4A3;CORO2B
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5670313802727056,-1.108905685705535,0.3333333333333333,0.9967597787818195,1.0,1/28,0.65%,FGF1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.5473238721473397,-1.1085418147587336,0.3018867924528302,0.996750641129032,1.0,5/25,5.04%,ZFPM1;TGFB2;GLI3;IFT122;GLI2
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.6463348265739769,1.1083877406748726,0.3275862068965517,0.9078018669291961,1.0,4/10,15.48%,KPNA4;CBLB;NUP54;KPNB1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5793482645420513,1.1083244265840184,0.32432432432432434,0.9066022893725787,1.0,6/12,25.12%,PHF20;JADE2;JADE1;MEAF6;MSL2;OGT
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.6876410895953745,-1.1080721947799632,0.4318181818181818,0.9969620129301645,1.0,2/7,19.82%,HSP90AB1;CALM1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),-0.7076502007566695,-1.1078778691836115,0.3220338983050847,0.9962920988865707,1.0,1/6,1.41%,PRDX1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.4336444558177124,1.1073235044053351,0.2702702702702703,0.9078461598328381,1.0,8/56,12.44%,CSPG4;MCAM;CHST3;EHD2;ENAH;EGFR;SMARCA1;PLS3
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.5319660215473583,-1.1067294548106696,0.30434782608695654,0.9989866645009585,1.0,3/34,6.16%,FGF1;NR4A1;ZFP36L2
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.4738848890831336,1.106515967481094,0.29411764705882354,0.9090487556641949,1.0,9/37,15.15%,MYOM2;OBSCN;EPB41L5;MYH9;RHOA;TTN;EPB41L4A;LMOD1;TJP1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5288490457217594,1.1063023889671386,0.34210526315789475,0.9080943322313465,1.0,4/19,12.76%,ADGRB3;SEMA4D;RAPGEF2;NEDD4L
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5490649015175518,1.1060341697432188,0.36585365853658536,0.9074209958440039,1.0,2/18,5.99%,AP3M1;AP3D1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.6921149597223143,1.1060252893252414,0.41025641025641024,0.9044740377149814,1.0,4/5,25.57%,GSTA4;GSTP1;ESD;MGST3
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.6921149597223143,1.1060252893252414,0.41025641025641024,0.9044740377149814,1.0,4/5,25.57%,GSTA4;GSTP1;ESD;MGST3
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),-0.7281907613833483,-1.1058056744504385,0.42,1.0,1.0,1/5,2.43%,FBLN1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5701931959984874,-1.105342082088499,0.3484848484848485,1.0,1.0,1/21,0.36%,CLU
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.44667218214270726,1.105303765294505,0.2222222222222222,0.9050822508509431,1.0,1/35,0.17%,JPH2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.433634213611669,1.1052389532447826,0.25806451612903225,0.9037738637168792,1.0,10/59,12.44%,MOCS1;GALNT18;CHST3;CDC42EP4;FKBP5;KCTD3;ADGRL2;EGFR;SMARCA1;PLS3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.692205967442629,1.1052002344228902,0.41304347826086957,0.9024329717711337,1.0,1/7,1.43%,PKIA
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",-0.7077845000599174,-1.1051535263563652,0.36538461538461536,1.0,1.0,2/5,10.76%,EXT1;CSGALNACT1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.5169253600237156,1.1051048798297844,0.325,0.90137168377796,1.0,5/25,5.72%,ADGRF5;ZBTB7C;ERBB4;DNAH9;TACC2
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.5539954906595912,-1.1046850519581177,0.3728813559322034,1.0,1.0,4/20,13.68%,XPA;MSH6;RPA1;RNF8
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.606948775815448,-1.1046701498251428,0.3442622950819672,1.0,1.0,5/15,11.49%,MEGF10;AFDN;GCNT2;CD47;PLPP3
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6844477973250259,1.1045877040352379,0.3783783783783784,0.9018160994274671,1.0,1/6,5.15%,MYH9
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.7334176944649766,-1.1044163398038485,0.40350877192982454,0.9996833120962749,1.0,3/6,9.85%,ANXA1;TSHR;CALCRL
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5501734503750084,1.1042542894934406,0.30952380952380953,0.9013079634571346,1.0,2/19,1.46%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.6060938928083248,1.1041518865047273,0.35294117647058826,0.900162331019151,1.0,1/10,1.23%,SRSF12
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.5179938698583683,1.1032860463941758,0.3333333333333333,0.9012993491547961,1.0,3/27,6.05%,NOTCH1;HEY2;BNIP3
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.5707992933167233,1.1030662939428864,0.375,0.9006852863854723,1.0,4/13,17.08%,SLC44A2;CHPT1;CSNK2A1;SLC27A1
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.6812202364516489,1.1029743594510943,0.4,0.899418969473698,1.0,3/6,16.72%,DCP1A;DDX3X;DHX9
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.6319136955156017,-1.1024931269981089,0.423728813559322,1.0,1.0,2/10,18.38%,WRN;XRCC6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6115658994346418,1.1024109838017864,0.26666666666666666,0.8995175063151949,1.0,4/9,20.58%,CACNA1C;RYR2;ANK2;SLC8A1
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.6480237597046583,1.1023677229550106,0.37735849056603776,0.8981303161611298,1.0,2/6,15.48%,CECR2;KPNB1
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.7446557128968411,-1.1022346011050532,0.42592592592592593,1.0,1.0,4/6,18.72%,SLC25A13;SLC1A1;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.5161616191413176,-1.1021569283796568,0.3384615384615385,1.0,1.0,7/31,13.51%,CTSL;AKR1C2;AKR1C1;SRA1;BCAS3;SLIT2;THRB
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.7448478021977512,-1.102081095256938,0.36538461538461536,1.0,1.0,2/5,18.52%,JAM3;FARP2
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.4477480551406794,1.102039303961522,0.23333333333333334,0.897633768566891,1.0,17/66,15.46%,HSPA1A;NOX4;PTPRK;PYROXD1;CAMKK2;VKORC1L1;ERCC6L2;ARNT;EGFR;PXN;FOS;CAT;ERO1A;SLC25A24;STX2;FOXO3;PRDX6
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.655263057665655,-1.1013300355380267,0.39285714285714285,1.0,1.0,3/11,3.40%,NT5E;HINT1;PRTFDC1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6121579395494159,-1.1009652496830897,0.38596491228070173,1.0,1.0,6/12,35.64%,RPA1;UBA52;POLK;RPA3;RFC1;UBB
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6047187863582493,1.100950369463251,0.358974358974359,0.8979614761002276,1.0,3/11,7.60%,CNOT7;TOB1;AGO2
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6047187863582493,1.100950369463251,0.358974358974359,0.8979614761002276,1.0,3/11,7.60%,CNOT7;TOB1;AGO2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6829731752382723,1.100647162622904,0.4166666666666667,0.8973955718434712,1.0,3/6,23.17%,EGFR;RBPJ;MVB12B
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.376366875309587,1.099694034981576,0.18181818181818182,0.8985746320238436,1.0,33/155,15.00%,WTIP;NOTCH1;PTP4A3;PPARGC1B;PML;BACH1;FOXN2;SOX6;RFX3;PPP2R1A;SOX13;NFYC;RNF14;CEBPB;ZFHX3;MED23;ZNF143;ZNF562;MITF;RPS6KA5;MTF2;APBB1;ZBTB11;NCOA2;NSD2;YAF2;APBB2;EP300;NFIA;DNM2;ACVR1B;TRIP4;ZNF676
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.6727864478436647,-1.0994248048233783,0.45,1.0,1.0,1/9,4.50%,BORCS5
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.5146283111740744,-1.0990434320046274,0.30158730158730157,1.0,1.0,2/26,3.66%,RAD51B;ANXA1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.44480602712269185,1.098781260706938,0.27586206896551724,0.8999114293949698,1.0,14/46,20.53%,CDH2;CTNND2;NRXN1;CACNB2;APBB2;KIRREL3;CDC42;GRM5;NLGN2;PTPRS;PTPRD;GPHN;CYFIP1;ZC4H2
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.5350271674301321,1.098635038299296,0.41379310344827586,0.8989151938514414,1.0,3/17,7.18%,PTPRK;EMP2;GGA2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7585533312294018,-1.0985505367168957,0.34615384615384615,1.0,1.0,2/5,21.42%,BTG1;BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.5562288338421293,-1.0982847248585226,0.30666666666666664,1.0,1.0,7/32,12.10%,CLU;LIMA1;TBCD;PLEKHH2;FGF13;HDGFL3;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.542685722049178,-1.098207159353624,0.352112676056338,1.0,1.0,4/16,16.08%,STAT1;THBS1;PDCD10;APOE
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.7461846648706052,-1.0981787585793383,0.42,1.0,1.0,3/6,17.39%,RACK1;NONO;PRKN
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.72299276660264,-1.098170319296511,0.42857142857142855,1.0,1.0,3/6,16.08%,ST3GAL4;THBS1;APOE
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6015938953469055,-1.0980674337158098,0.3194444444444444,1.0,1.0,2/16,3.69%,TERF2IP;MSH6
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.6736022250146924,-1.0979361555709901,0.3770491803278688,1.0,1.0,4/11,12.10%,ANXA1;ZFP36L2;ADAM9;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.508205984227015,-1.0974222189409044,0.32857142857142857,1.0,1.0,10/47,12.93%,CLU;IGFBP5;EPRS1;RACK1;NCL;RPS3;SAMD4A;BTG2;LARP1;DHX36
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.4714248287865907,-1.0971987461188388,0.3150684931506849,1.0,1.0,17/70,11.57%,IGFBP5;ABCA8;KIAA1217;PAMR1;FBLN1;ALDH1A1;COL1A1;COL3A1;THBS2;COL1A2;PDZRN3;COL12A1;FMO2;DCN;SASH1;PLPP3;PTCH1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.6528454023007462,1.096952032187397,0.358974358974359,0.9026796458399603,1.0,1/7,2.36%,CTNND2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5982717579641096,-1.096516730534459,0.390625,1.0,1.0,3/15,6.20%,SLC7A14;SLC38A1;SLC6A20
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.7079701625329552,-1.0963420028767612,0.45161290322580644,1.0,1.0,1/6,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.7079701625329552,-1.0963420028767612,0.45161290322580644,1.0,1.0,1/6,2.31%,SUPT6H
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.5358101176470136,-1.0956338709585574,0.26666666666666666,1.0,1.0,6/26,13.32%,TGFB2;BMP5;PDCD4;DDX5;SMAD6;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5941281450366194,-1.0954348514048027,0.4426229508196721,1.0,1.0,2/19,0.90%,CLU;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5941281450366194,-1.0954348514048027,0.4426229508196721,1.0,1.0,2/19,0.90%,CLU;TWIST1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.7118620178110285,-1.0949187081053386,0.39285714285714285,1.0,1.0,3/7,21.03%,LPCAT2;PLA2G4C;PNPLA8
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4723132522195624,1.0948896344075645,0.36666666666666664,0.9073250645462241,1.0,4/40,6.25%,HSPA1A;BACH1;EPAS1;HIF3A
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.7705675982066508,-1.0946770951314226,0.37254901960784315,1.0,1.0,3/5,20.70%,SLC6A20;SLC6A13;SLC16A12
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.581430455621496,-1.0935101286829034,0.3684210526315789,1.0,1.0,5/20,7.71%,ANXA1;DKK3;GLI2;SRP54;TGFBR1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.5318326496114442,-1.0932764233257253,0.35294117647058826,1.0,1.0,4/23,9.32%,ABLIM1;COL1A1;EYS;COL11A1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5021262094635947,1.0931512769643168,0.3,0.9109217441238892,1.0,2/21,3.61%,HSPA1A;RBM20
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.5460408430323921,1.0930613597856802,0.3333333333333333,0.9097186343180885,1.0,5/18,15.60%,IRS2;ABCA1;FBXW7;DDX3X;ABHD5
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.40987974599306715,1.0928239740369667,0.2608695652173913,0.9091591352383169,1.0,27/105,12.39%,KCNC2;PDK4;TNFRSF1B;ABL2;ATP2B4;NCOA3;HCN2;PTPRK;GUCY1B1;GNB1;SLC26A3;TESC;CAMKK2;LCOR;AXL;ERCC6L2;PDE3A;RHOA;IRS1;EGFR;PXN;P2RX4;NFKB1;RAPGEF2;FOS;PLAA;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.578775858066519,-1.0927002639600703,0.36666666666666664,1.0,1.0,2/12,9.12%,IGFBP5;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.672299485802831,1.0926594777658383,0.46153846153846156,0.9083352166095134,1.0,1/9,0.45%,HSPB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5554240988235751,1.0923176467712912,0.36585365853658536,0.9079568124876258,1.0,5/18,13.51%,INF2;BNIP3;RALA;MCU;SPIRE1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.710804183143801,-1.092198839932869,0.3728813559322034,1.0,1.0,3/5,24.05%,EIF2B3;MT3;CDK6
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.4477438454895602,-1.091948183550145,0.2777777777777778,1.0,1.0,9/81,8.17%,IGFBP5;ARNT2;FBLN1;SEMA6D;DKK3;GLI2;NTM;PDZRN3;DZIP1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.45480155737872835,1.0916980871263138,0.2702702702702703,0.9081102789604636,1.0,3/27,9.18%,INTS7;CDKN1A;RHOB
prerank,MSigDB_Hallmark_2020__Myogenesis,0.41582653678735676,1.0910810252745893,0.1875,0.9084045610596512,1.0,14/83,5.69%,LDB3;MYH11;MYOM2;NOTCH1;PTP4A3;PKIA;SORBS3;CKMT2;GNAO1;MEF2D;ADCY9;DTNA;MYH9;TAGLN
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5541672829983125,-1.0910618041509974,0.373134328358209,1.0,1.0,4/28,9.74%,XPA;UVSSA;HMGN1;RPA1
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.5258725705521851,1.0906987032009368,0.358974358974359,0.9081688945379587,1.0,4/17,7.35%,SLC35F1;SLC26A3;PMEPA1;ANPEP
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.6026744761394459,1.0899909082848551,0.4146341463414634,0.9091136231154846,1.0,2/11,1.46%,NOTCH1;TNFRSF1B
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5787471050293982,-1.0894630786582928,0.40298507462686567,1.0,1.0,6/19,15.32%,CIRBP;FUS;YBX3;LARP1;MAPK14;ANGEL2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5239070078648561,1.089399517459448,0.35294117647058826,0.9093170743062997,1.0,9/23,13.59%,TNFRSF1B;BCL2;PML;HIPK2;BCL2L1;MSH2;MCL1;DDIT4;EP300
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7079294957838099,-1.088857217893211,0.4,1.0,1.0,2/6,17.39%,RPS7;PRKN
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.6970986046035614,-1.0886056432376086,0.45454545454545453,1.0,1.0,5/6,28.92%,FOXC1;SLIT2;ROBO2;PKD2;FGFR2
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5998414189875956,1.0882837269556105,0.358974358974359,0.9108012042527518,1.0,1/14,0.09%,CSPG4
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.559626506565805,-1.0880283981024121,0.36666666666666664,1.0,1.0,1/27,0.11%,ABCA4
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.7252574423272105,1.0877662952304574,0.40476190476190477,0.9107735833490562,1.0,1/5,8.10%,GLUD1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.6133157454274606,1.0874413137728371,0.4222222222222222,0.9104485843609368,1.0,3/10,15.60%,ABCA1;PPARA;ABHD5
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6299003316229222,1.0874340598226833,0.3,0.90904139953194,1.0,2/8,11.48%,PPP2R1A;SH2B3
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.6896089003646486,-1.0869844296619704,0.43859649122807015,1.0,1.0,2/6,8.76%,SVIP;ERLEC1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.6896089003646486,-1.0869844296619704,0.43859649122807015,1.0,1.0,2/6,8.76%,SVIP;ERLEC1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.6896089003646486,-1.0869844296619704,0.43859649122807015,1.0,1.0,2/6,8.76%,SVIP;ERLEC1
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.49907835218427504,-1.0869579659339828,0.40298507462686567,1.0,1.0,25/80,16.58%,ABCA8;COL15A1;COL6A3;MT2A;EPSTI1;COL1A1;COL3A1;THBS2;GSN;COL1A2;COL6A1;FMO2;DCN;ADAM12;CYP1B1;PLPP3;IL1R1;COL6A2;FAM114A1;CFH;CYP27A1;HSD11B1;PLAC9;ASPN;C1S
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.6099356542927403,-1.08683623788043,0.3584905660377358,1.0,1.0,7/14,25.17%,PER2;ENO1;PGK1;SLC25A13;ENO2;CRY1;GAPDH
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.47540578056746213,1.0868322100399255,0.35714285714285715,0.9094352747221648,1.0,9/55,9.89%,ADGRB3;CACNA1B;LSAMP;CNTN4;OPCML;NRXN1;CTNNA2;RNF152;TNR
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6148361637758923,1.0865685664230529,0.4523809523809524,0.908608747876621,1.0,4/8,32.20%,ADAM17;AKT3;PLCG1;FGF2
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.5510984749569607,-1.0865366945119466,0.36231884057971014,1.0,1.0,2/33,1.72%,TGFB2;ACTG1
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.5731279761536624,-1.0864456159883247,0.3382352941176471,1.0,1.0,3/12,13.37%,FAR2;ACAT1;PAM
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.4372379533987774,1.0862038541941321,0.3103448275862069,0.9086194928103822,1.0,20/55,23.56%,ABL2;HSPA8;GFAP;PACSIN2;NRG3;SEMA4D;RAPGEF2;RAP1A;CHPT1;TJP1;RASGRP2;RAPGEF1;RUFY1;HIP1;PICALM;PTPN11;ROCK1;AGT;PTPN1;TSC2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.5717580231472715,-1.0860940974418642,0.3793103448275862,1.0,1.0,8/21,16.64%,IFITM3;STAT1;N4BP1;TRIM13;PPIA;PLSCR1;SRPK1;LARP7
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.5075946724659525,1.0860405531225072,0.2972972972972973,0.9077446679393767,1.0,8/20,16.98%,IRS2;FBXW7;NEDD4L;DDX3X;ABHD5;WNK1;SLC4A10;TENT4B
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.508389030817405,1.0857618702298097,0.3939393939393939,0.9071845896186984,1.0,3/21,10.07%,MFHAS1;DLC1;TIPRL
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5446215540461847,-1.0851929587944442,0.4067796610169492,1.0,1.0,7/21,22.92%,SPRY1;PDCD4;SPRY3;SPRY4;APOE;PIK3CB;LYN
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3926225304901463,1.085121268502832,0.3333333333333333,0.9077167747136273,1.0,16/89,13.06%,HSPB1;TNFRSF10B;CXXC5;SLC44A2;VAPA;GPRC5B;PPM1A;UBE2N;MAP3K7;RHOA;MAPKBP1;PELI2;USP10;MID2;MAVS;ZFAND6
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.7419739308490405,1.0849050419245108,0.425531914893617,0.9069510460093907,1.0,2/5,15.63%,RAD18;SMC5
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7361220665151742,-1.0848712982642648,0.5166666666666667,1.0,1.0,2/5,10.87%,BMP5;ASAH1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7071037654961096,-1.0842852311950288,0.4262295081967213,1.0,1.0,3/5,21.96%,ATG10;TMCO1;SELENOS
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.5215329865151298,-1.08405141793905,0.36666666666666664,1.0,1.0,3/28,11.54%,PIGG;ATG10;HHAT
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.6470411725778544,-1.0839429667179579,0.36538461538461536,1.0,1.0,2/7,5.27%,CTSL;ADAMTS12
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6499690565711209,1.0838477935975446,0.5,0.9082585470220264,1.0,2/6,14.42%,CACNB2;BIN1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.5647390922910395,1.0835177011379813,0.45454545454545453,0.9079595673066727,1.0,2/16,4.09%,CMTM8;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5545390786346867,1.0827408754657315,0.4594594594594595,0.90884863555713,1.0,3/13,4.13%,HSPA1A;BCL2L1;TMBIM6
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),-0.6090321034482534,-1.082648363355873,0.3333333333333333,1.0,1.0,5/13,22.55%,ACTG1;KDM2B;VCL;DAG1;ARHGAP12
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6625854781670834,-1.0818486035875445,0.40425531914893614,1.0,1.0,3/8,16.27%,FBLN1;TGFBR3;SP100
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5971272403231145,-1.0816584916440897,0.38571428571428573,1.0,1.0,1/14,0.87%,TGFB2
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.5574402921509077,-1.0814476726018778,0.3728813559322034,1.0,1.0,10/25,18.63%,AKR1C1;SLC7A14;SLC38A1;SLC6A20;SLCO1C1;SLC22A6;SLCO1A2;SLC7A11;SLC6A13;SLC7A2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.35861089146378783,1.0813231689582579,0.21428571428571427,0.9116933788384155,1.0,37/222,9.49%,HSPA1A;NOX4;H2AC6;NOTCH1;ZBTB7C;CNOT7;TNFRSF1B;BCL2;TOB1;PML;NCK2;NDRG3;APC;CTBP2;BNIP3L;TP53TG5;ERBB4;PTPRK;DLC1;TNFRSF21;TMBIM6;PPP2R1A;MYH9;TESC;SMARCA4;BNIP3;DLG5;CDKN1A;RAF1;BCL6;SEMA4D;NACC2;RNF139;RHOB;RAD18;MYOCD;SLIT3
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.6827486641651034,-1.0812407917797495,0.38461538461538464,1.0,1.0,3/5,19.82%,PTS;PRKG2;CALM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6889875814901636,-1.081171209157002,0.4444444444444444,1.0,1.0,3/8,22.38%,BIRC2;APPL2;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.5262663780484944,-1.080987552486588,0.3392857142857143,1.0,1.0,2/37,0.87%,PDGFD;TGFB2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.41571124561836764,1.0806854920012339,0.25806451612903225,0.9121281132756505,1.0,8/68,5.74%,CSPG4;JPH2;C1QTNF1;TIMP3;CHST3;EHD2;PRKG1;TBX3
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6030457135959308,1.0806203920768969,0.44,0.9109687479789306,1.0,2/10,2.17%,PKIA;ATP2B4
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.6061424222630598,-1.080367224968815,0.3548387096774194,1.0,1.0,1/11,1.02%,RIMS1
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.4618337098751466,1.0799359353941138,0.25,0.9116768758043714,1.0,7/37,7.52%,ARRDC2;TMEM30A;SLC44A2;SLC12A2;MYH9;SNX4;SLC6A12
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.6794518848701687,-1.0793688957318652,0.4339622641509434,1.0,1.0,4/8,18.73%,CA5B;SLC4A4;CA4;CYB5R4
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5187069265116829,-1.0790704943674636,0.4057971014492754,1.0,1.0,10/39,28.78%,CSE1L;STRADB;THOC1;SRSF7;U2AF2;SRSF5;NEMF;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.637516690875228,1.0789557203820346,0.4666666666666667,0.9114329510790944,1.0,3/6,31.85%,ROCK1;SCPEP1;ADCY6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.637516690875228,1.0789557203820346,0.4666666666666667,0.9114329510790944,1.0,3/6,31.85%,ROCK1;SCPEP1;ADCY6
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.6261249828324401,-1.0787722634393249,0.4716981132075472,1.0,1.0,4/10,22.60%,RPL5;RPL11;RPS7;RPL23
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.6046635335290358,1.0786178177521324,0.36585365853658536,0.9111157692808184,1.0,1/11,0.51%,MYH11
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6325132844340371,1.078614036596993,0.42592592592592593,0.9084306030820449,1.0,3/7,18.46%,NLGN2;NLGN4Y;PTPRD
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6325132844340371,1.078614036596993,0.42592592592592593,0.9084306030820449,1.0,3/7,18.46%,NLGN2;NLGN4Y;PTPRD
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.7202347822080819,-1.0784440199167011,0.4482758620689655,1.0,1.0,2/5,15.35%,HECW2;CDC27
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.6063527987940545,-1.0780757542475672,0.3709677419354839,1.0,1.0,2/15,5.01%,TGFB2;IFT122
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.6063527987940545,-1.0780757542475672,0.3709677419354839,1.0,1.0,2/15,5.01%,TGFB2;IFT122
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.7416257682155417,1.0780500087394214,0.5106382978723404,0.9086108107567096,1.0,1/5,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.7545720782549366,-1.0780154989351298,0.4528301886792453,1.0,1.0,1/5,0.87%,TGFB2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.7075015446488495,-1.0773273946890365,0.5087719298245614,1.0,1.0,1/5,1.69%,NT5E
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.4833349463077807,-1.0769652160219132,0.325,1.0,1.0,10/54,10.13%,MDFIC;SULF2;NKD1;APCDD1;GPC3;RACK1;SFRP4;OTULIN;PTK7;DCDC2
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.638469098937894,-1.0765486785788576,0.373134328358209,1.0,1.0,5/11,21.08%,TRMT1L;TARBP1;TRMT44;NSUN2;NSUN6
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.5606815506989076,-1.0764784251249502,0.3728813559322034,1.0,1.0,3/16,5.18%,EXT1;GCNT2;GPC3
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.566539045529821,-1.0764319637984403,0.4057971014492754,1.0,1.0,1/19,0.48%,ABLIM1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5559803456860999,1.07607499435226,0.40476190476190477,0.9126655211483629,1.0,4/12,19.79%,SORT1;KLHL20;RAB14;EPS15
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5436634463481387,1.0756706093493593,0.29545454545454547,0.9124333489503157,1.0,3/16,9.18%,INTS7;CDKN1A;RHOB
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.49264623484784964,-1.0755614481703597,0.3333333333333333,1.0,1.0,5/52,5.72%,RIMS1;AFG3L2;ELOB;EPRS1;LAMC1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.5702271335569921,-1.0751716173555437,0.3880597014925373,1.0,1.0,6/18,16.41%,TERF2IP;SLF1;CTCF;RPA1;MRNIP;TNKS2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4779618159235905,-1.075119703064314,0.3194444444444444,1.0,1.0,13/57,14.08%,CIRBP;TGFB2;RPS4X;RPL5;GLI2;NMD3;PLD1;THBS1;SAMD4A;UPF3A;PRKDC;EEF2;NAMPT
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.6128768383137648,-1.0749929376577536,0.4262295081967213,1.0,1.0,4/15,10.90%,JAM2;ACTG1;LAMC1;JAM3
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.615106414789818,-1.0749165694818308,0.3125,1.0,1.0,1/9,1.69%,NT5E
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.5832269411019463,1.0748205451260264,0.39473684210526316,0.9131803918485598,1.0,1/10,2.05%,BCL2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6501020454297433,-1.0740809531150914,0.4117647058823529,1.0,1.0,1/8,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.6949788586215225,-1.073702331113868,0.4838709677419355,1.0,1.0,2/5,8.22%,NRP1;RALBP1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.6021650888804224,-1.0733347102297504,0.38181818181818183,1.0,1.0,5/13,11.57%,GLI3;IFT122;GPC3;RACK1;PTCH1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6338276393082065,-1.0729046646109972,0.39344262295081966,1.0,1.0,3/10,11.43%,SULF2;CYP1B1;BRCA1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.5961602924465225,-1.0728076280202465,0.36923076923076925,1.0,1.0,5/13,19.88%,ALDH3A2;PEX1;PEX3;ACBD5;LONP2
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.5117234677615721,-1.07257059572115,0.3333333333333333,1.0,1.0,2/29,3.10%,NACA;AFDN
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.4590806265260357,1.0723403286735491,0.3902439024390244,0.9184230704846527,1.0,4/35,6.05%,HSPA1A;TNFRSF1B;BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5770027130847604,1.0721992728594374,0.38095238095238093,0.917510532658942,1.0,9/12,24.40%,HACD2;ELOVL6;ELOVL5;ACSL3;SCD5;ACSL1;SCD;TECR;ACSL4
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.5956475074958201,-1.072037338496982,0.3617021276595745,1.0,1.0,4/13,18.83%,MIS18BP1;ITGB3BP;NASP;RBBP7
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.6390033195942285,-1.0719078885828506,0.4262295081967213,1.0,1.0,6/8,35.64%,RPA1;UBA52;POLK;RPA3;RFC1;UBB
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5673248102955919,1.0713219981626312,0.28205128205128205,0.9183642724437835,1.0,1/13,0.16%,CSF1R
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.44812822081382137,1.070972413767063,0.34210526315789475,0.9179241161344313,1.0,15/39,20.92%,NOTCH1;HIPK2;LEMD3;SMAD7;ACVR2A;ITGA3;BMPR1A;UBE2D1;RBPMS2;RBPJ;TRIM33;SMAD5;SKI;SKIL;SMAD2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.4303563094735722,-1.0705345571375722,0.32926829268292684,1.0,1.0,17/120,12.41%,LAMA1;AFG3L2;NRP1;LRTM1;SEMA3C;SEMA6D;UNC5D;SEMA3D;GLI2;EPHA3;HSP90AB1;NOTCH2;S100A6;NTN4;EPHA5;SLIT2;EPHA4
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.5874989448895167,1.0702370888847126,0.47058823529411764,0.9182723306380418,1.0,2/8,11.46%,PML;MID2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.6954501092110837,-1.0696847709412456,0.4745762711864407,1.0,1.0,3/6,18.38%,CD47;PRKDC;XRCC6
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6906077042892254,1.0696723069571605,0.4883720930232558,0.918469022982565,1.0,1/5,2.40%,CNTN4
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.6238152766297679,1.0694299695303113,0.42105263157894735,0.9179471792799461,1.0,2/10,10.50%,VAPA;YTHDC2
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.5951825201778198,-1.06934587148899,0.41935483870967744,1.0,1.0,3/16,15.43%,NR4A2;THRB;PTMA
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.6142589726912017,1.0693120121768174,0.43902439024390244,0.9168766989039362,1.0,5/10,21.32%,ATL2;RTN3;REEP3;RAB10;RTN4
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5638007187466035,1.0688272064811657,0.3142857142857143,0.9169413980538954,1.0,3/11,5.43%,BCL2;TNFRSF21;IRS2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6765864974994227,-1.0687591761008848,0.4067796610169492,1.0,1.0,3/7,28.09%,PRKAG2;SLC2A1;NR4A3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5613240952401468,1.0686940035689154,0.3783783783783784,0.9159586600684871,1.0,2/15,6.61%,CNOT7;CNOT6
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6057463902163913,1.0686739987985185,0.41304347826086957,0.9146966327903117,1.0,2/7,18.73%,KCNQ1;ANK2
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.6021775987758227,1.0686537021874403,0.5,0.9134217322538225,1.0,2/13,6.09%,UBE2N;MAP3K7
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.48043494097753936,-1.068159050205954,0.35443037974683544,1.0,1.0,13/61,10.28%,FGF1;IGFBP5;ARNT2;MEGF10;ASPA;TMEM132C;NTM;LAMC1;SLC22A17;PDZRN3;SCN7A;NDRG1;SLCO1C1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.635693995576738,1.0679717896743814,0.3877551020408163,0.9139214097418947,1.0,2/8,8.75%,SYNE2;SYNE3
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.5468110297472831,1.067894665353352,0.4166666666666667,0.9128827309280491,1.0,5/13,23.59%,PHF20L1;PHF20;EP300;KAT2B;KAT6A
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4694482249238016,1.0675753426431265,0.3235294117647059,0.9124411434423355,1.0,8/39,12.41%,NEURL1B;EIF4ENIF1;IPO8;IPO11;RALA;HK1;IPO9;RYR2
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.6585677510725857,-1.067553405566098,0.49206349206349204,1.0,1.0,3/7,18.58%,LPCAT2;GNPAT;PLA2G4C
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5679579453666164,-1.0674259339452092,0.4375,1.0,1.0,7/16,31.59%,PER2;CYP27A1;LPL;HSD17B4;OSBP;ALDH1A2;OSBPL3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.35997585581934155,1.0671967973675731,0.17391304347826086,0.9119678882328889,1.0,39/176,16.69%,WTIP;NOTCH1;PDGFA;PTP4A3;PPARGC1B;PML;BACH1;FOXN2;SOX6;RFX3;PPP2R1A;SOX13;NFYC;RNF14;CEBPB;ZFHX3;MED23;ZNF143;ZNF562;MITF;RPS6KA5;MTF2;APBB1;ZBTB11;NCOA2;NSD2;YAF2;APBB2;EP300;NFIA;DNM2;ACVR1B;TRIP4;ZNF676;FOXO3;ZBTB38;ZNF398;CNBP;GRM5
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.64321585268962,-1.0671723886197733,0.423728813559322,1.0,1.0,1/9,1.40%,IFITM3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5853309066546852,1.0670637662569742,0.40476190476190477,0.9110024030505647,1.0,5/11,13.59%,PML;HIPK2;MSH2;DDIT4;EP300
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.6913733841281,1.0665215305004538,0.5263157894736842,0.9111733721189264,1.0,1/5,7.60%,AGO2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.6500515622558586,-1.0663338130046498,0.39655172413793105,1.0,1.0,1/6,5.86%,SFRP4
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.688348478949194,-1.0658208448947861,0.4807692307692308,1.0,1.0,1/5,13.68%,RNF8
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6916679789968925,-1.065774805411111,0.45454545454545453,1.0,1.0,3/5,18.38%,ZFP36L2;PRKDC;XRCC6
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.49924227511155067,-1.0651843125273037,0.31343283582089554,1.0,1.0,7/32,16.76%,TUBGCP5;GOLGA8A;RPS3;INO80;CSNK1D;GOLGA8B;SMC3
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.6009219967881618,-1.0650767882408982,0.3548387096774194,1.0,1.0,3/13,12.95%,PARP1;FUS;MRNIP
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.572120713309582,1.0650615147724785,0.44680851063829785,0.9135914435869272,1.0,3/13,10.36%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.7513464446164433,-1.0649910022767708,0.42857142857142855,1.0,1.0,1/5,11.24%,FGF13
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.6693888463258265,-1.0649812080514156,0.5,1.0,1.0,1/8,2.25%,CEMIP
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6619060654880322,1.0647995012867595,0.4444444444444444,0.9131192647842824,1.0,3/6,17.49%,CDS2;SLC27A1;ABCA3
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.6136314232388467,-1.0643880864692683,0.41818181818181815,1.0,1.0,7/13,25.17%,PER2;ENO1;PGK1;SLC25A13;ENO2;CRY1;GAPDH
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.53266299747751,-1.0643869827430747,0.375,1.0,1.0,9/37,17.39%,TGFB2;FOXQ1;RETREG1;KDM2B;NAE1;MT3;APOE;NGF;PRKN
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.5598156138629444,-1.0640047409729803,0.42105263157894735,1.0,1.0,4/14,15.96%,TGFB2;CPAMD8;FOXC1;SMOC1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.45572092228624755,-1.063573208801114,0.33766233766233766,1.0,1.0,12/72,6.79%,PDGFD;IGFBP5;ARNT2;SPRY1;MEGF10;SEMA6D;DKK3;GLI3;NTM;KCNIP1;PDZRN3;FAT3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.4863736403162008,1.0634040623043355,0.34285714285714286,0.9157074632398182,1.0,2/20,2.17%,NOTCH1;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.5298576608008707,-1.0632465752363438,0.4,1.0,1.0,8/27,17.39%,FOXQ1;RETREG1;NONO;KDM2B;MT3;APOE;NGF;PRKN
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.6502411247899302,1.0628419333054255,0.4772727272727273,0.9160829960090148,1.0,2/6,16.72%,AGO2;DHX9
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.6772334616550566,-1.0625681309389297,0.46153846153846156,1.0,1.0,4/7,23.90%,YBX3;MAPK14;ANGEL2;TARDBP
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.5871832039619889,1.0624079640590234,0.35135135135135137,0.9147622855807777,1.0,4/9,18.81%,PHF20;JADE2;JADE1;MEAF6
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.5871832039619889,1.0624079640590234,0.35135135135135137,0.9147622855807777,1.0,4/9,18.81%,PHF20;JADE2;JADE1;MEAF6
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),-0.6751280215944576,-1.0621645503129047,0.4426229508196721,1.0,1.0,3/6,31.13%,NAMPT;SPTLC2;PGRMC2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.6711422554513969,-1.061717640613419,0.4838709677419355,1.0,1.0,3/9,12.66%,VEGFA;JAM3;LGALS3
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6476197491512627,-1.0617109391056931,0.4264705882352941,1.0,1.0,1/12,3.47%,CMTR1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6476197491512627,-1.0617109391056931,0.4264705882352941,1.0,1.0,1/12,3.47%,CMTR1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.6820601094519743,1.0615932407630193,0.4883720930232558,0.9159182387560298,1.0,2/5,30.78%,CHMP4B;MARK4
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.6034564251621892,1.061521236502785,0.42857142857142855,0.914780913389984,1.0,4/15,17.62%,BRD2;UBN1;SART3;HAT1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.37778426853458463,1.0613513324606962,0.32,0.9137765917320323,1.0,8/86,6.19%,HSPA1A;PPARGC1B;HIPK2;UBE2N;CAMK1D;SMARCA4;MAP3K7;ZBTB7A
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5590803679458529,1.061208591461813,0.39285714285714285,0.9127751477865675,1.0,4/16,5.66%,PTPRK;DLC1;CD151;ARHGEF7
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.6064302441183217,-1.0610282418623247,0.41379310344827586,1.0,1.0,5/16,12.25%,TUBGCP5;CCDC57;FGF13;HDGFL3;CSNK1D
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4863865813116216,-1.0607731176908355,0.4166666666666667,1.0,1.0,14/62,16.05%,RPL23A;RPL5;EIF2S2;PRPF6;HSP90AB1;SNRNP200;RPL6;PRKDC;SRSF10;EIF4H;RPL11;SRPK1;CELF2;RPS14
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.6794614208856313,-1.0603576623942692,0.47692307692307695,1.0,1.0,3/9,15.65%,DDX60;BIRC2;UFD1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.6760172803558984,-1.0599475859223855,0.40350877192982454,1.0,1.0,1/6,2.81%,STAT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.6015141487781099,-1.05972876547076,0.5,1.0,1.0,1/13,0.90%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6618148998479194,-1.0595932302245992,0.4032258064516129,1.0,1.0,4/9,17.39%,ABCB7;BRCA1;MT3;PRKN
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6645010213680371,-1.0593518274358915,0.4032258064516129,1.0,1.0,3/7,16.00%,CMKLR1;HTT;ITPR1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.4516767541279929,-1.0593449940124429,0.38271604938271603,1.0,1.0,11/77,9.89%,CLU;CIRBP;RPS4X;RPL5;GLI2;NMD3;PLD1;HSP90AB1;THBS1;SAMD4A;UPF3A
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.6769101974497201,1.0590582075025607,0.4772727272727273,0.9170968694931882,1.0,2/5,16.73%,NRXN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5833228197921667,1.0589514829669966,0.37209302325581395,0.9160289514666162,1.0,6/11,24.49%,CACNA1C;RYR2;ANK2;SLC8A1;PDE4D;AKAP6
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.5719294459641442,-1.0588866573068039,0.4406779661016949,1.0,1.0,4/19,8.79%,NRP1;VEGFA;COL3A1;VCAN
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.4564205687486114,1.0588065644823605,0.3939393939393939,0.9151575801401406,1.0,7/38,5.75%,RASL12;ZBTB7C;RALGPS1;NDRG2;KALRN;SLC12A2;ZNF704
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.4245418552803997,-1.058721843075986,0.35802469135802467,1.0,1.0,28/145,15.25%,CLU;FGF1;TWIST1;RIMS1;VEGFA;ACTG1;RPL5;AFDN;CALCOCO1;WARS1;GSN;SFRP4;F3;OLFM1;RPS3;TGFBR1;CTCF;SLC24A3;FN1;BRCA1;DHX36;PDCD10;PLSCR1;MAPK14;RPL11;KRAS;MT3;DTNBP1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),0.6265414342983374,1.0587058859643255,0.46511627906976744,0.9140632630992579,1.0,1/8,5.71%,ATP6V1H
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5588790344305118,1.0583074736675664,0.2857142857142857,0.9136473820990321,1.0,4/15,18.73%,CACNA1C;RYR2;CTNNA3;ANK2
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.4497877161585095,1.0581200717240256,0.3870967741935484,0.9127188818186391,1.0,4/39,4.81%,CSPG4;ST3GAL2;CHST3;PAPSS2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),-0.6731833338312153,-1.0580455548417729,0.4126984126984127,1.0,1.0,1/6,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6357331615197095,-1.0577678632533132,0.4727272727272727,1.0,1.0,2/6,21.42%,UFL1;BCL2L11
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.49578470790858364,1.0577323648716335,0.34782608695652173,0.9126107240256172,1.0,3/23,3.63%,CSPG4;GPC5;CD44
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.594213532859677,1.0569780164188496,0.36585365853658536,0.9137357033480381,1.0,8/15,28.07%,ABCA1;TMEM167A;CANX;ARFGAP3;RAB10;MIA2;RAB12;LTBP2
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.5621471392481017,-1.0565867860512779,0.4,1.0,1.0,5/23,7.71%,TGFB2;VEGFA;SULF2;GLI2;TGFBR1
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.5052512832074256,-1.0563669640913775,0.4153846153846154,1.0,1.0,7/42,9.24%,TGFB2;VEGFA;NR4A2;GLI2;SPOCK1;TGFBR1;TENM4
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.6227309149341365,-1.0562792801179137,0.47368421052631576,1.0,1.0,3/10,10.87%,ANXA1;ADAM9;ASAH1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.6786926786637264,-1.0556256525243615,0.49019607843137253,1.0,1.0,4/5,31.75%,HSPA4;BCL2L11;TOMM70;HSP90AA1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.49957400078228353,-1.0555537789761094,0.4166666666666667,1.0,1.0,9/35,19.42%,POLA1;RPA1;BRCA1;ORC3;ORC5;WRN;RAD17;TOPBP1;MRE11
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.5233502786474105,1.0548742644125793,0.4883720930232558,0.9178472829097135,1.0,3/15,6.95%,PDGFA;PACSIN2;PARVB
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.3629018451672433,1.0537487104364827,0.2,0.9197120693911769,1.0,26/200,10.20%,DACH1;GATAD2A;NOTCH1;CNOT7;HEY2;PML;PHC1;CTBP2;PTPRK;HSPA8;ATP8B1;RFX3;SOX13;TBX3;SMARCA4;ZBTB7A;HDAC1;BCL6;HMBOX1;HDAC9;ZBTB16;NACC2;HEYL;MBD2;THRA;RPS6KA5
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.44989920845851794,-1.053748480467333,0.4383561643835616,1.0,1.0,12/78,11.57%,ZFPM1;TWIST1;SPRY1;ADAMTS12;LDLRAD4;BMP5;ZFP36L2;TGFBR1;PDCD4;SRA1;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6480076937305875,-1.0536726995424666,0.39655172413793105,1.0,1.0,3/6,29.34%,PLA2G4C;PNPLA8;LPCAT3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5499047044985779,-1.0536347798644168,0.42857142857142855,1.0,1.0,2/15,10.16%,TWIST1;DDX5
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.5412570918390989,-1.0536207667573465,0.41818181818181815,1.0,1.0,2/17,2.81%,IGFBP5;STAT1
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.6279261011152288,-1.0534017419219175,0.46875,1.0,1.0,4/7,17.31%,PRKDC;EXOSC10;WDR12;LAS1L
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7410677764271982,-1.0533520512440468,0.3888888888888889,1.0,1.0,3/5,12.93%,PKM;YBX3;DHX36
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.6211846443174848,-1.053339179529835,0.46551724137931033,1.0,1.0,3/9,23.39%,ENO1;TPM1;PPP1R12B
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.5806182462265455,-1.053253081130427,0.4375,1.0,1.0,3/16,10.30%,TGFB2;IFT122;KDM2B
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.5721834718841403,-1.0525837914562237,0.40350877192982454,1.0,1.0,6/20,11.86%,TGFB2;LDLRAD4;BMP5;TGFBR1;SMAD6;BMPER
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.44594395100839285,1.0525354091240111,0.25,0.9213643359990106,1.0,5/29,3.01%,NOL4;CACNA1B;CSRNP3;CTNND2;OPCML
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.5107475510754361,-1.0523713392206722,0.4117647058823529,1.0,1.0,3/31,3.75%,PLXNC1;VEGFA;SNW1
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.6213011729489922,1.0521114567306233,0.4666666666666667,0.9211333190759905,1.0,1/5,1.46%,TNFRSF1B
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.6116216026649173,-1.0519501577244004,0.47692307692307695,1.0,1.0,5/9,15.34%,TRPA1;RETREG1;GNAL;TTC8;BBS4
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.44886800266666554,-1.0518783753130685,0.4084507042253521,1.0,1.0,8/55,12.28%,GBP2;ADAMTS12;CD47;PSMD8;PELI1;MAP3K8;PSMC2;IL1R1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.5740603125991396,-1.0516863123312932,0.4444444444444444,1.0,1.0,3/12,11.57%,TGFB2;GLI3;PTCH1
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.659956175631613,-1.0516499721856032,0.46551724137931033,1.0,1.0,2/6,21.01%,SRP54;CLMP
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.6197844104214626,-1.0515337123073618,0.375,1.0,1.0,6/12,29.13%,DERL1;UFD1;SELENOS;NPLOC4;SEL1L;VCP
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.6203684092217956,-1.050736776045949,0.453125,1.0,1.0,2/11,9.04%,LIMA1;BAIAP2L2
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.49219760801396,-1.050500514688142,0.37142857142857144,1.0,1.0,10/44,17.65%,CLU;CSE1L;ALDH3A2;PEX3;HSPA4;HIKESHI;SEC13;APOE;NUP107;APPL2
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.524835018421213,-1.050420536508677,0.4090909090909091,1.0,1.0,6/25,9.80%,LAMA1;NRP1;VEGFA;ADM;TGFBR1;CYP1B1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.6450230721973932,1.0500815901823641,0.48936170212765956,0.9249569917437227,1.0,2/5,20.27%,GRIN1;GRIA2
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.5790682582398679,-1.0498806264027123,0.41509433962264153,1.0,1.0,7/14,20.42%,PARP1;PARP6;PARP9;TNKS2;PARP8;ARF4;PARP14
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7116743099009286,-1.0498322043364998,0.5166666666666667,1.0,1.0,1/6,1.52%,VEGFA
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.6616415940364775,1.0497893899308453,0.4523809523809524,0.9244516881546297,1.0,1/5,1.75%,CDH2
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6585142487871055,1.0496593411023634,0.43243243243243246,0.9235673155693932,1.0,1/6,1.47%,CACNA1C
prerank,PanglaoDB_Augmented_2021__T Cells,-0.5407407462613649,-1.0493595603136368,0.421875,1.0,1.0,7/19,15.57%,IFIT3;SEMA6D;DKK3;GEM;CREM;IL16;CD4
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.5433156863473209,1.0493067538297316,0.375,0.9233345074532663,1.0,7/16,23.59%,MAP3K7;LEF1;JADE2;JADE1;MEAF6;KAT2B;KAT6A
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.46211455873041585,-1.0490097287439788,0.4230769230769231,1.0,1.0,26/76,16.58%,IGFBP5;ABCA8;COL15A1;COL6A3;PAMR1;KCNMB1;C7;COL1A1;COL3A1;THBS2;COL1A2;COL6A1;COL12A1;FBLN2;DCN;CYP1B1;LAMA4;PLPP3;TPM2;FAM114A1;SH3D19;PMP22;PRRX1;TPM1;ASPN;C1S
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.38843206990914797,1.0489414200181508,0.3076923076923077,0.923007495023678,1.0,10/71,5.24%,RASL12;DACH1;ADGRF5;GJA4;HEY2;C1QTNF1;SMARCD3;TIMP3;EPAS1;TNS1
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.6838537222749342,-1.0486885383971427,0.4074074074074074,1.0,1.0,1/7,3.66%,ANXA1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.6956317301013099,-1.0482243419254824,0.44642857142857145,1.0,1.0,1/5,1.52%,VEGFA
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.5808363886092046,-1.0480131854365489,0.423728813559322,1.0,1.0,2/19,0.90%,TGFB2;TWIST1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.32262375940439303,1.0478867436472123,0.25,0.9248442389018373,1.0,129/774,13.93%,CSF1R;TENM2;DACH1;MXD4;EBF4;GATAD2A;NOTCH1;ZBTB7C;SATB2;HEY2;CSRNP3;KLF15;PPARGC1B;CXXC5;BCL9;SP4;ATP2B4;NCK2;BACH1;SMARCD3;SOX6;HIPK2;MED24;HDX;ZNF208;CTBP2;KLF13;NCOA5;NCOA3;DEK;ACTR2;MEF2D;EPAS1;RFX3;PPM1A;ZNF721;SMAD7;SOX13;ZEB2;TRAK1;NFYC;RNF14;BBS7;KLF9;TBX3;ZNF704;ZNF546;BCL9L;SMARCA4;ZBTB7A;VEZF1;HIF3A;CEBPB;KLF12;BRD2;ZNF611;ACVR2A;KDM7A;HDAC1;SOX5;ZNF710;CDKN1A;BCL6;HMBOX1;AGO2;LCOR;HDAC9;RRP1B;ZBTB16;SEMA4D;NACC2;PHF2;ZFHX3;CBX6;ZNF586;HEYL;MED23;USP16;ARNT;BRWD1;ZNF143;PHF20L1;MITF;MYOCD;MEIS2;EGFR;EBF1;RAD21;MBD2;THRA;ARID1B;PHF20;LCORL;RPS6KA5;GABPB1;MTF2;CTDSP1;APBB1;ZNF609;BMPR1A;PRDM10;PHF8;NFKB1;UBE2D1;ARID1A;AEBP2;PPARA;FHOD1;ZNF251;SMARCA1;MECOM;MAVS;FOS;ZNF160;RBL1;ZNF81;NEDD4L;NCOA2;TBX15;PHF21A;LEF1;PURB;PKNOX1;HDAC2;EP300;BBX;LDB2;ZNF213;EFCAB7
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.5424542220891807,-1.0477451246877094,0.423728813559322,1.0,1.0,5/18,11.49%,ST6GALNAC3;SPTLC3;ASAH1;NSMAF;PLPP3
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.6405719814730633,-1.047356157910161,0.5161290322580645,1.0,1.0,3/8,11.43%,SRA1;BCAS3;BRCA1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.3502421731481104,1.0470004757493772,0.35714285714285715,0.9258245409515857,1.0,39/266,9.57%,HSPA1A;CSF1R;NOX4;H2AC6;NOTCH1;ZBTB7C;PDGFA;CNOT7;BCL2;TOB1;PML;NCK2;APC;CTBP2;ERBB4;PTPRK;DLC1;PGF;FLT1;EMP2;IRS2;TESC;LIFR;TBX3;DLG5;CNOT6;HDAC1;CDKN1A;RAF1;BCL6;ELN;NACC2;MARCHF7;RNF139;RHOA;IRS1;MYOCD;MEIS2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7071012182898274,1.04594071757,0.46511627906976744,0.9257960803503893,1.0,2/6,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7071012182898274,1.04594071757,0.46511627906976744,0.9257960803503893,1.0,2/6,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4818620163945465,1.0455212988735867,0.4827586206896552,0.9257348109396845,1.0,2/32,1.47%,CACNA1B;CACNA1C
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6678565885457085,1.0453326988579608,0.5306122448979592,0.9248114383651529,1.0,5/5,33.27%,PICALM;ALS2;RAB22A;AP2M1;RAB5A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.528910595912189,1.0452476117324887,0.3235294117647059,0.9236714399055553,1.0,4/15,18.73%,CACNA1C;RYR2;CTNNA3;ANK2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.4966561355363208,-1.045201209988834,0.48333333333333334,1.0,1.0,8/38,13.99%,NRP1;LAMC1;TBCD;ABI2;LAMB1;FN1;NTN4;TMEFF2
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.6600991625742963,-1.0451915200490938,0.4375,1.0,1.0,4/9,20.72%,PIK3R4;SQSTM1;ACBD5;NBR1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.45631039963812203,-1.0448850977845978,0.4117647058823529,1.0,1.0,20/85,11.04%,EMCN;ABCA8;CD55;COL15A1;FHL2;C7;COL3A1;SEMA3D;PROCR;COL1A2;SGK1;FMO2;DCN;SHROOM4;CYP1B1;CALCRL;LAMA4;SLCO1C1;BIRC2;GPM6A
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.6196581851835169,1.044789241375137,0.4186046511627907,0.9235039230973313,1.0,1/7,1.60%,HPRT1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.6561185211750382,-1.0446347811286099,0.5,1.0,1.0,1/5,10.67%,HLA-B
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.5377200596784925,-1.0444220927665968,0.39285714285714285,1.0,1.0,4/18,15.96%,TGFB2;CPAMD8;FOXC1;SMOC1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.5275909903013161,-1.0443407699114076,0.484375,1.0,1.0,6/26,22.02%,PSMD8;PSMC2;ORC3;ORC5;UBA52;PSMD14
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.5399198476617106,-1.0441455891096503,0.421875,1.0,1.0,4/17,15.34%,ST3GAL4;SHROOM4;TTC8;BBS4
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6131740345271084,-1.04338930679123,0.47761194029850745,1.0,1.0,5/8,26.16%,ABCB7;NUBPL;HSPA9;CIAO1;LYRM4
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.4915496487511458,-1.0433661092465678,0.4225352112676056,1.0,1.0,14/47,13.66%,CIRBP;RPS4X;RPL5;PKM;PLD1;FASTKD2;THBS1;SAMD4A;YBX3;UPF3A;LARP1;PRKDC;DHX36;EEF2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.5915770724562391,-1.043232916616153,0.49206349206349204,1.0,1.0,3/17,7.30%,TGFB2;ANXA1;SPOCK1
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.7081865065010032,1.0431585403976917,0.43478260869565216,0.9252283136308233,1.0,2/5,5.20%,ST3GAL2;ABO
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7081865065010032,1.0431585403976917,0.43478260869565216,0.9252283136308233,1.0,2/5,5.20%,ST3GAL2;ABO
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5974803184853247,-1.04309693330729,0.46875,1.0,1.0,2/15,6.25%,PIK3R4;AP2A2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.6717116453261245,-1.043095719646677,0.43636363636363634,1.0,1.0,3/6,20.67%,ENPP2;PLA2G4C;GPCPD1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6797204835582374,-1.0430332976948309,0.45,1.0,1.0,1/7,11.43%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5590361144906223,-1.042102084010621,0.40625,1.0,1.0,5/21,11.12%,CLU;SVIP;LDLRAD4;JAM3;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.6012482793422558,1.0420964644887174,0.391304347826087,0.9268810018276455,1.0,1/10,0.17%,JPH2
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5334102331290205,1.042032910196162,0.475,0.9257149004731142,1.0,1/14,0.53%,TENM2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5873370078266676,1.041720724028629,0.46153846153846156,0.925405984726618,1.0,4/8,22.24%,TMTC1;LARGE1;DPM1;TMTC4
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6570411687661268,-1.0411340667827003,0.4745762711864407,1.0,1.0,1/7,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.6860169368423297,-1.041061756371434,0.5161290322580645,1.0,1.0,2/6,15.51%,ASPA;SLC25A13
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),-0.68451337214207,-1.0410181414663395,0.4166666666666667,1.0,1.0,3/5,21.29%,EPHA4;APOE;PTN
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.44750778172421163,1.0409466470222226,0.3333333333333333,0.9260592666049733,1.0,8/33,17.34%,MFHAS1;CTNNA2;MAPKBP1;GRID2;PPARA;CASK;CRK;PTPRS
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.6270898742448705,-1.0401270737336958,0.4262295081967213,1.0,1.0,3/9,14.64%,VEGFA;F3;IL16
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.489042114945083,1.0398309404865356,0.4,0.9276707918713658,1.0,8/25,17.85%,MGAT5;RPN2;GFPT1;STT3B;PMM2;UBE2J1;UGGT1;MGAT4A
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6467857995263945,-1.0398135904725327,0.47619047619047616,1.0,1.0,4/8,14.98%,RIPOR2;JAM3;SLIT2;DAPK2
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.5453936963014454,1.0396807823456253,0.4186046511627907,0.9269429612195811,1.0,3/12,10.36%,EBF4;C2ORF72;ADCY5
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.6168246556688818,1.039301244134483,0.425,0.9266340558586579,1.0,2/8,5.58%,CWC27;FKBP5
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.6156969234261229,-1.039208367951724,0.46153846153846156,1.0,1.0,4/9,12.25%,RNF213;GPC3;SFRP4;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.498653358127782,-1.0390706612122478,0.4153846153846154,1.0,1.0,3/36,9.04%,CLU;RPS3;BAIAP2L2
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.5984532446733754,-1.0387089302373176,0.423728813559322,1.0,1.0,1/11,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.5920233244112295,-1.0383301008254724,0.43333333333333335,1.0,1.0,1/12,2.25%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.5425866209775512,1.0382120308653369,0.5142857142857142,0.9279606227810883,1.0,4/14,14.56%,CDH2;CTNNA2;MYOCD;CDC42
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.5049939282609122,1.0379288461906184,0.38095238095238093,0.9274201723224368,1.0,7/18,22.98%,CDH2;NRXN1;GRM5;NLGN2;DGKI;SYT1;GRM8
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4422380981933214,1.0374177808673155,0.36585365853658536,0.927773178559073,1.0,9/45,9.43%,DENND3;NOTCH1;RALGPS1;EPOR;DLC1;IRS2;RAF1;ARHGAP44;MADD
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.5970592264942527,-1.0373078837464242,0.47619047619047616,1.0,1.0,4/10,15.42%,SEMA6D;FHL2;IL16;HSD11B1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.5802314171570044,1.0370289773035335,0.3170731707317073,0.9277105548173391,1.0,5/11,18.73%,SMAD7;P2RX4;RYR2;C12ORF57;ANK2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5613700969121832,-1.0365646667510942,0.47058823529411764,1.0,1.0,4/16,4.40%,NRP1;SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5950113893041056,-1.0361251803692828,0.39655172413793105,1.0,1.0,1/12,6.72%,POLA1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.460145325865583,-1.036085680120413,0.38571428571428573,1.0,1.0,3/37,5.96%,ZFPM1;RACK1;ARHGAP28
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.6205166673619845,-1.036022177782909,0.4838709677419355,1.0,1.0,2/10,9.04%,LIMA1;BAIAP2L2
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.4785966299314616,1.0359292015707398,0.5,0.9296266173784031,1.0,3/24,10.31%,INTS7;TIPRL;USP10
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.633754965776018,-1.0356962348115801,0.46551724137931033,1.0,1.0,3/9,19.77%,ALDH3A2;PEX3;ACBD5
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.6068887101700106,-1.0349937603817951,0.4716981132075472,1.0,1.0,2/10,1.32%,MLPH;FOXQ1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5374414206549347,-1.0349037142845265,0.4925373134328358,1.0,1.0,7/22,22.32%,TWIST1;CD47;HLA-B;IL16;LPL;SELENOS;STAT3
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.6187343142917124,-1.0348008117534337,0.423728813559322,1.0,1.0,1/13,1.72%,ACTG1
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.4531093851593236,-1.0345353760663207,0.390625,1.0,1.0,16/67,11.74%,IGFBP5;COL6A3;PAMR1;DKK3;COL1A1;COL3A1;THBS2;NTM;COL1A2;COL6A1;COL12A1;DCN;LAMA4;FN1;PLPP3;TPM2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.6233404307427802,-1.0345272910926064,0.4642857142857143,1.0,1.0,2/10,5.55%,GNA14;CMKLR1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.5140057461250074,-1.0343784190128544,0.47058823529411764,1.0,1.0,8/25,16.76%,GLI2;ESCO1;TSPYL2;ORC3;ORC5;S100A11;RAD17;SMC3
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.561470714385832,-1.0339234566481073,0.47692307692307695,1.0,1.0,5/18,16.35%,PARP1;TERF2IP;FUS;MRNIP;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.46932045132601763,-1.0336704045925869,0.38235294117647056,1.0,1.0,8/41,12.10%,TERF2IP;FBLN1;WARS1;DNAJC10;PLPP3;PRKDC;PPIA;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.48389988039486503,-1.033339869546497,0.45,1.0,1.0,1/22,1.02%,RIMS1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6595658752191973,1.0332722390746631,0.41509433962264153,0.935672956891973,1.0,2/8,9.40%,SORT1;MYOCD
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.5939409239959272,-1.0331946337435713,0.453125,1.0,1.0,5/9,17.12%,SPTLC3;CYP1B1;ASAH1;CYB5B;SPTLC1
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.6044630553606641,-1.0331738447655383,0.4915254237288136,1.0,1.0,2/9,13.57%,STAT1;PARP9
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.429645935933775,-1.0330625098219737,0.41975308641975306,1.0,1.0,13/112,10.13%,FGF1;TGFB2;RIMS1;NRP1;SULF2;SNW1;UCHL5;HTT;F3;RPS3;TGFBR1;SASH1;DCDC2
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.47440571542263416,1.0325437787383966,0.4411764705882353,0.936379984768545,1.0,5/21,12.90%,ADGRB3;CAMK1D;SEMA4D;NEDD4L;CSMD3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.6703952985047326,-1.0321226316492091,0.45901639344262296,1.0,1.0,4/6,14.08%,NMNAT2;NMNAT3;PARP9;NAMPT
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6314368981405476,-1.0318365279546495,0.5087719298245614,1.0,1.0,4/8,17.59%,TGFB2;TGFBR1;TGFBR3;ACVR1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.6345904552553834,-1.031618204228526,0.45454545454545453,1.0,1.0,2/5,11.66%,MSH6;PRKDC
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.7047729931026205,-1.0312166017490363,0.43859649122807015,1.0,1.0,2/6,19.93%,RPS3;PRKCH
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.540600892961043,1.0311427550517254,0.4878048780487805,0.9386278926905117,1.0,3/16,8.87%,NOTCH1;HEYL;NOTCH3
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.6210979268093367,-1.0307450407319496,0.4339622641509434,1.0,1.0,2/10,0.87%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.6870463079137515,-1.0299608159049138,0.49206349206349204,1.0,1.0,3/5,13.77%,RIPOR2;ADAM9;MAPK14
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.6275686074574335,1.0296216708611299,0.4666666666666667,0.9413426242328131,1.0,2/5,13.59%,PPARA;EP300
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5567776367407057,1.029329501663097,0.43902439024390244,0.9408356676453155,1.0,9/15,25.76%,UBASH3B;PTPRQ;PTPN9;PTPRS;PTPRZ1;PTPN11;PTPN1;TNS2;DUSP1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5635008671206552,1.0292425217525056,0.4074074074074074,0.9398736712346539,1.0,2/11,8.75%,SYNE2;SYNE3
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.5755271260966874,1.0279523114393796,0.43243243243243246,0.9420896047817816,1.0,2/5,14.56%,AXL;CDC42
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5370138323160516,-1.0278404925618847,0.3968253968253968,1.0,1.0,1/18,1.43%,NRP1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6659843899938919,-1.0271287397241036,0.4909090909090909,1.0,1.0,1/6,0.36%,CLU
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.535834586119728,-1.0270210989721833,0.42857142857142855,1.0,1.0,4/14,10.08%,CTSL;GSN;LAMC1;TIMP2
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.535834586119728,-1.0270210989721833,0.42857142857142855,1.0,1.0,4/14,10.08%,CTSL;GSN;LAMC1;TIMP2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5990257358827924,1.0267812473019449,0.4642857142857143,0.9434650943194668,1.0,2/7,9.57%,ARHGAP6;EGFR
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4936390679265337,-1.0266676873119303,0.3880597014925373,1.0,1.0,3/30,5.18%,AKR1C1;LEPR;GPC3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.44174576479215977,1.0265557567174635,0.4444444444444444,0.9428519447549987,1.0,10/46,11.58%,MFHAS1;TNFRSF1B;PTH1R;ADCY9;GNB1;MYH9;ADCY3;ADCY5;ADAM17;PPARA
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.4503688767996734,1.0263738210695557,0.4375,0.9422253048055275,1.0,4/30,4.13%,HSPA1A;BCL2;BCL2L1;TMBIM6
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.43076130923640876,1.026217474926848,0.425,0.9412678810484664,1.0,3/29,2.36%,NOL4;GALNT18;CTNND2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),-0.6797911672086621,-1.0261988753086808,0.4827586206896552,1.0,1.0,1/5,8.05%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),-0.6797911672086621,-1.0261988753086808,0.4827586206896552,1.0,1.0,1/5,8.05%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),-0.6797911672086621,-1.0261988753086808,0.4827586206896552,1.0,1.0,1/5,8.05%,SLF1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.5919423196125577,-1.0260757049063705,0.44,1.0,1.0,7/13,34.52%,CSNK1D;BBS4;GOLGB1;HOOK3;DCTN2;CEP192;NUDCD3
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.3537187258614681,1.025986275108499,0.3,0.9404337467190738,1.0,2/87,0.16%,HSPA1A;CSF1R
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.5165610531220988,-1.0257190294519498,0.4507042253521127,1.0,1.0,6/21,11.06%,RIPOR2;NRP1;MYO10;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5790763187747243,1.0251291769272957,0.425,0.941515915846861,1.0,3/12,11.18%,ATP2B4;CDKN1A;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),-0.453404553422602,-1.0248135545606454,0.4393939393939394,1.0,1.0,11/52,14.72%,CIRBP;RPS4X;RPL5;PLD1;ATG10;THBS1;SAMD4A;UPF3A;PRKDC;EEF2;VGLL4
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.6682396704627526,-1.0245637564484122,0.5396825396825397,1.0,1.0,2/7,11.57%,TGFBR1;PTCH1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.652837011197846,1.0245618820511693,0.54,0.9418727348533266,1.0,1/5,0.37%,NOX4
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.6812598717411432,-1.024446562167074,0.45614035087719296,1.0,1.0,1/5,5.69%,TEFM
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4885861959570404,-1.0243671116182396,0.4461538461538462,1.0,1.0,9/40,11.43%,FGF1;TWIST1;VEGFA;F3;THBS1;ADAM12;SASH1;CYP1B1;BRCA1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.47661780516790475,1.0243658975795729,0.45454545454545453,0.9412515635337078,1.0,1/19,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.6635617332010646,-1.0243132247106135,0.6304347826086957,1.0,1.0,2/5,16.16%,EPHA4;ANXA2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.4450264442852675,1.023843911037346,0.47058823529411764,0.9414426600040671,1.0,9/27,15.45%,DPP10;ATP2B4;CNST;KIF5B;EGFR;ITGA3;ACSL3;ZDHHC5;PTPN9
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.36740643526523015,1.0235702554228878,0.36666666666666664,0.9410036051542133,1.0,7/80,5.33%,CSPG4;HSPB1;TIMP3;CHST3;EPAS1;RASAL2;EHD2
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.656858897817985,-1.0232842702441094,0.509090909090909,1.0,1.0,3/5,28.75%,TPM1;PPP1R12B;MYL9
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.40599118216287766,1.023172302084943,0.3783783783783784,0.9408501752414421,1.0,14/68,18.73%,DPP10;RAB40C;EMP2;EHD2;TESC;PACS2;CACNB2;RAPGEF2;RAP1A;NECTIN3;GAS6;EZR;MYO5A;ANK2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.6666623980076647,-1.0228538397831424,0.5555555555555556,1.0,1.0,1/7,11.57%,PTCH1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.46020144097977106,1.0226725396057348,0.45161290322580644,0.9405027768662173,1.0,6/46,5.66%,BCAM;CD44;PTPRK;DLC1;EMP2;ARHGEF7
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6574275080152197,-1.0221456018938995,0.46551724137931033,1.0,1.0,1/6,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6574275080152197,-1.0221456018938995,0.46551724137931033,1.0,1.0,1/6,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.41491296886517776,-1.0217965709230425,0.3875,1.0,1.0,22/118,16.80%,PARP1;XPA;RAD51B;MSH6;DDB2;XPC;POLA1;EYA1;RPA1;BTG2;UIMC1;INO80;BRCA1;PRKDC;WRN;PARP9;RNF8;RAD17;ASCC3;TOPBP1;ZRANB3;MGMT
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.6060850046562628,1.0215583020744665,0.43902439024390244,0.9422766577140698,1.0,2/7,16.86%,P2RX4;RYR3
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5841333741958618,1.020616273967042,0.5348837209302325,0.9437774345213324,1.0,2/5,20.92%,ITGA3;SMAD2
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.6416297189167794,1.0204071846172553,0.5121951219512195,0.9431892681200558,1.0,2/5,11.07%,BNIP3;ZDHHC6
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.5280514815729772,-1.0200817463606306,0.49122807017543857,1.0,1.0,2/22,5.38%,IFT122;DYNC2LI1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3912772486589079,1.0200125585044406,0.4411764705882353,0.9430190985623791,1.0,11/54,11.62%,PDGFA;SORBS3;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;RICTOR;ARHGAP35;PAK2;KATNBL1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6362854011720575,-1.0196172204425582,0.58,1.0,1.0,2/6,16.49%,BBS4;NINL
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.48904222039046796,-1.0190548357560285,0.3384615384615385,1.0,1.0,15/38,20.70%,SLC2A3;SLC38A1;LEPR;SLC6A20;ABCB1;SLC24A3;SLCO1C1;SLC4A4;SLC6A13;SLC1A1;SLC1A2;SLC7A2;SLC1A3;SLC2A1;SLC16A12
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.48904222039046796,-1.0190548357560285,0.3384615384615385,1.0,1.0,15/38,20.70%,SLC2A3;SLC38A1;LEPR;SLC6A20;ABCB1;SLC24A3;SLCO1C1;SLC4A4;SLC6A13;SLC1A1;SLC1A2;SLC7A2;SLC1A3;SLC2A1;SLC16A12
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.690770719912341,1.018930121724956,0.5272727272727272,0.9444684225162268,1.0,3/5,16.02%,AXL;RAPGEF2;GAS6
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.37335857249467796,1.0188070946290804,0.32,0.9435404796405493,1.0,10/69,16.72%,ADARB2;METTL14;AGO2;HNRNPF;HNRNPUL1;DDX3X;RBMX;RBMS2;PAPOLG;DHX9
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.6168900365775837,1.0187944306871337,0.5,0.9423038604011778,1.0,2/7,5.58%,CWC27;FKBP5
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5197787263579426,1.0186971954510526,0.3939393939393939,0.9412628174130093,1.0,1/14,0.03%,HSPA1A
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6139251867962794,-1.0184075400577368,0.48333333333333334,1.0,1.0,3/10,10.76%,SLC2A3;ST6GAL1;CSGALNACT1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.5196065363528382,1.0182906657643036,0.5151515151515151,0.9411701581587658,1.0,3/13,8.10%,NOX4;MMUT;GLUD1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.5994419904782281,-1.0178904642520206,0.47540983606557374,1.0,1.0,1/11,2.25%,CEMIP
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.6218408263228862,-1.017377982328883,0.5161290322580645,1.0,1.0,1/11,2.31%,SUPT6H
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.6525015602183203,1.017273182178324,0.48717948717948717,0.9426714622530041,1.0,2/6,7.27%,TNFRSF1B;BCL6
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.6069207061065752,1.017102304074488,0.5111111111111111,0.9418992857944108,1.0,2/8,12.28%,SORT1;DDIT4
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6690989712158859,-1.0170786188026375,0.4666666666666667,1.0,1.0,3/6,14.81%,MT2A;PAM;MT3
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.617513060316047,-1.0168990895363033,0.5344827586206896,1.0,1.0,2/8,5.04%,GLI3;GLI2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.47605536321103076,1.0168405855713405,0.40625,0.9413646122271407,1.0,6/19,11.06%,MICALL2;APC;MPP7;RHOA;PARD6G;PAK2
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),-0.6498942962996935,-1.0164357219559268,0.5263157894736842,1.0,1.0,1/7,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.6159917836564655,-1.0162202100045485,0.5208333333333334,1.0,1.0,2/9,1.43%,IGFBP5;NRP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6574447956341903,-1.0160343321208172,0.532258064516129,1.0,1.0,2/5,22.32%,CD46;STAT3
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.629999620421198,1.0157584363700325,0.48717948717948717,0.943315479068012,1.0,2/7,11.48%,PPP2R1A;SH2B3
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.5164050228874342,1.0154847530456859,0.5,0.9426335548339875,1.0,1/15,1.23%,SRSF12
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.4574160651252075,-1.0154790431494574,0.45161290322580644,1.0,1.0,12/65,10.65%,TGFB2;PGRMC1;AKR1C2;FBLN1;MT2A;ADH5;GCNT2;PROS1;PTS;GABARAPL1;SSR3;ACO2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.6364909929256486,-1.0153139590708653,0.45614035087719296,1.0,1.0,2/7,16.41%,MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4917591438652605,-1.0152865606566794,0.4925373134328358,1.0,1.0,4/31,11.66%,PSMD8;PSMC2;FOXC1;PRKDC
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.6202127384823846,1.0148787080126043,0.45454545454545453,0.9430089902014593,1.0,2/6,1.07%,MYH11;NOTCH1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.418066231682662,1.0148625501474255,0.45714285714285713,0.941816759946603,1.0,6/43,14.27%,MFHAS1;HIPK2;EGFR;MECOM;AIDA;MTURN
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.5408847166132633,-1.0147320655004357,0.49122807017543857,1.0,1.0,2/20,1.49%,ANO2;GABRB2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5873398215254043,-1.01467475559082,0.4426229508196721,1.0,1.0,3/11,12.10%,ARHGAP24;TCHP;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.6718560718598068,-1.0146037101430974,0.5686274509803921,1.0,1.0,1/5,6.16%,ZFP36L2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6265562966363794,-1.0140848433145093,0.5454545454545454,1.0,1.0,2/8,13.69%,RETREG1;UFL1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.40683791015880555,-1.0140672550260068,0.4810126582278481,1.0,1.0,34/185,13.79%,CLU;CIRBP;FGF1;TWIST1;RIMS1;VEGFA;RPS4X;ACTG1;RPL5;AFDN;CALCOCO1;WARS1;GSN;SFRP4;PLD1;F3;OLFM1;RPS3;TGFBR1;THBS1;CTCF;SAMD4A;SLC24A3;UPF3A;FN1;DDX5;BRCA1;PRKDC;DHX36;PDCD10;EEF2;PLSCR1;MAPK14;RPL11
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.44297669754575997,-1.013894186230668,0.45714285714285713,1.0,1.0,13/69,13.68%,PARP1;RAD51B;MMS22L;POLA1;EYA1;RPA1;UIMC1;INO80;BRCA1;PRKDC;WRN;PARP9;RNF8
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.5434519816965099,-1.0137356424931758,0.3620689655172414,1.0,1.0,1/11,1.02%,RIMS1
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.6446593136074694,-1.0133567823479825,0.5686274509803921,1.0,1.0,2/7,7.63%,CEMIP;HEXB
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.5330421991344059,-1.0132798192445676,0.4788732394366197,1.0,1.0,2/22,3.10%,VAMP4;AFDN
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.5019122640347438,-1.0132588875822381,0.44776119402985076,1.0,1.0,8/36,15.11%,TGFB2;VEGFA;TNFRSF19;MID1;SASH1;MAP3K4;PDCD10;MINK1
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.626837943659298,-1.013170507563159,0.4482758620689655,1.0,1.0,2/5,18.55%,GPC3;LMBRD1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.5670440861913104,1.0130963948251959,0.4146341463414634,0.9451168903585646,1.0,3/10,11.60%,IRS2;PMM2;HK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5633255213917111,-1.0125426047135986,0.515625,1.0,1.0,6/14,21.11%,CIRBP;FUS;LARP1;NBAS;PAIP1;FMR1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.6433341339595695,-1.0125305745484285,0.4838709677419355,1.0,1.0,1/8,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.6391733905225976,-1.0124324199673171,0.4838709677419355,1.0,1.0,2/8,8.02%,TERF2IP;SMG6
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6469517824652131,1.0123807521794101,0.5116279069767442,0.9455022662623405,1.0,4/5,20.58%,CASP7;RYR2;RYR3;SLC8A1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.46853944833901423,1.0122346875606831,0.4666666666666667,0.9446323108238452,1.0,3/25,3.92%,KCNC2;HCN2;KCNH7
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.622873824054015,-1.011823397785006,0.4444444444444444,1.0,1.0,1/7,0.71%,IGFBP5
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.43570832715642693,1.0111635653766664,0.45161290322580644,0.9464448365560926,1.0,3/41,2.17%,TRPC6;CACNA1C;ATP2B4
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.6600511764320305,-1.0110967944244793,0.5192307692307693,1.0,1.0,1/5,3.07%,KCNMB1
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.5182498217891424,1.0110488904823647,0.358974358974359,0.9454304296032103,1.0,2/13,8.06%,LRCH1;RRP1B
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.612133413793126,-1.0109366207785886,0.4666666666666667,1.0,1.0,3/8,12.95%,PARP1;FUS;MRNIP
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.6707906455909561,-1.0109333486077892,0.6271186440677966,1.0,1.0,1/6,5.06%,ESCO1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.6137537859446816,1.0108935876067187,0.4878048780487805,0.9445639210837057,1.0,5/7,34.96%,CBFB;ZMIZ1;ABL1;SOD1;ZBTB1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.6598264460481236,-1.0107109244145502,0.47058823529411764,1.0,1.0,1/5,18.53%,SLC1A2
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.6598264460481236,-1.0107109244145502,0.47058823529411764,1.0,1.0,1/5,18.53%,SLC1A2
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.6988682464811329,-1.0106238004499486,0.5272727272727272,1.0,1.0,2/5,10.90%,SHROOM3;JAM3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5364131648397219,-1.0102862048048773,0.47540983606557374,1.0,1.0,8/20,16.80%,PARP1;SLF1;FUS;PRKDC;MRNIP;PARP9;SPIDR;MGMT
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4419225448685538,-1.0099603422123968,0.375,1.0,1.0,10/62,11.12%,TGFB2;COL3A1;GCNT2;BMP5;COL1A2;ADAM9;TGFBR1;PDCD4;DDX5;SMAD6
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.5631068088026755,-1.009913968135134,0.5,0.9996858743565977,1.0,4/17,17.08%,HECW2;FGF13;GLRX;WNK2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5367510807662718,1.0095182036380421,0.4666666666666667,0.9469789920214001,1.0,4/11,19.90%,TESC;LEF1;ZFP36L1;TRAF6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.4977273663634794,-1.0094735996943922,0.4461538461538462,0.9998460329514635,1.0,3/29,7.86%,TGFB2;STAT1;THBS1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.5426320806377867,-1.0090106533245473,0.49206349206349204,1.0,1.0,4/14,11.18%,RPS3;PDCD4;SASH1;MAP3K4
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.6493874825026527,1.0087829068377574,0.5333333333333333,0.9478662297563698,1.0,1/5,9.10%,RHOA
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.6454958637201739,-1.00873491287195,0.5862068965517241,0.9997605488217622,1.0,1/7,3.57%,TET1
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.6535425998627465,1.0084710277717701,0.525,0.9474775484806163,1.0,5/6,13.59%,PML;DEK;CDKN1A;LEF1;EP300
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4491440032885754,-1.0082852643412248,0.43548387096774194,1.0,1.0,14/50,11.49%,FGF1;ABCA8;KIAA1755;SEMA6D;ENPP2;SGCD;ADM;NTM;COL1A2;TRPA1;DCN;LAMA4;HEPH;PLPP3
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.5364199253417861,-1.0081337851495582,0.49206349206349204,0.9994969099582803,1.0,3/15,5.18%,EXT1;GCNT2;GPC3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.44088612785836534,1.007821442127213,0.44,0.9478415084226549,1.0,4/56,3.88%,CSF1R;CNTN4;MICALL2;VAPA
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5167147460385582,1.0075048136495075,0.425531914893617,0.947497160396025,1.0,3/15,10.36%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.4363467281002751,1.0074474372362292,0.46153846153846156,0.9464039611274199,1.0,6/39,10.19%,DPP10;ATP2B4;BCL2L1;KIF5B;EGFR;ITGA3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.45237381134193166,1.0073533181588814,0.375,0.945428743173906,1.0,4/28,6.05%,DENND3;PISD;BNIP3L;BNIP3
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.6726206547963616,-1.0070550944310839,0.5555555555555556,1.0,1.0,1/5,0.90%,TWIST1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.403643492765573,1.0068557890607857,0.41935483870967744,0.9457071703744452,1.0,10/49,15.45%,DPP10;BCL2;ATP2B4;TCAF1;KIF5B;EGFR;ITGA3;EFCAB7;ZDHHC5;PTPN9
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.6740840333083804,-1.0064667316248574,0.5384615384615384,1.0,1.0,1/6,6.25%,AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.6740840333083804,-1.0064667316248574,0.5384615384615384,1.0,1.0,1/6,6.25%,AP2A2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6305883810027941,-1.0064466501443807,0.5079365079365079,1.0,1.0,3/7,23.51%,G3BP2;TMSB4X;PKD2
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.6369874785040942,-1.0059160400562406,0.4642857142857143,1.0,1.0,2/6,6.00%,GSN;ENO1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.6433022290114367,1.005888470038836,0.5483870967741935,0.9469184797005259,1.0,2/7,2.28%,PDGFA;C1QTNF1
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6353896434745854,1.0057543343969848,0.5641025641025641,0.9460037003284744,1.0,2/6,10.53%,CNTN4;ARHGAP35
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.4300402559565997,1.0055490233953284,0.4,0.9453204639556154,1.0,6/39,8.20%,ST3GAL2;GALNT18;C1GALT1;TRAK1;B3GNT2;OGA
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5423058933960517,-1.0049488264788982,0.4576271186440678,1.0,1.0,6/20,18.41%,AKR1C1;LIMA1;SOAT1;APOE;NPC1;LPL
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5423058933960517,-1.0049488264788982,0.4576271186440678,1.0,1.0,6/20,18.41%,AKR1C1;LIMA1;SOAT1;APOE;NPC1;LPL
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5956606869276985,-1.0048662468787288,0.5254237288135594,1.0,1.0,2/11,1.69%,GBP2;NT5E
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.5977757585657032,-1.0048354580138994,0.48,1.0,1.0,2/11,15.34%,CSNK1D;BBS4
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.5467889969794755,-1.004772090304222,0.47761194029850745,0.9992828258275337,1.0,1/14,1.02%,RIMS1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.586562880362006,-1.0044861724523817,0.49019607843137253,0.9990414759482837,1.0,4/7,17.32%,PARP1;PARP6;TNKS2;PARP8
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5270611965030115,-1.0043418642047597,0.46774193548387094,0.998438659735375,1.0,2/20,5.16%,PHLDB2;EPHA3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.44543746114215815,-1.0041361156056416,0.373134328358209,0.9979483206921941,1.0,18/67,23.00%,TGFB2;NRP1;NR4A2;PER2;SPOCK1;DCDC2;GPM6A;FGF13;BHLHE40;HES1;SDCCAG8;WNT5B;ADGRL3;MARK1;CCK;AUTS2;ASTN2;ERCC6
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5243717952462935,1.003612334700896,0.4186046511627907,0.949260562614789,1.0,5/12,19.99%,MAP2K2;MAP2K1;PDE4DIP;MYO5A;ARMH3
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.5910292930336064,1.0035012492865294,0.5609756097560976,0.9481748083432272,1.0,2/6,21.39%,RNF139;PRNP
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5743931312114845,1.0033186753521912,0.4878048780487805,0.9473772407422044,1.0,2/9,10.07%,MGAT5;TIPRL
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4040270797063343,1.0023822959272222,0.36666666666666664,0.9482209228999638,1.0,5/33,11.14%,HSPB1;ATP2B4;NUS1;P2RX4;ADAM17
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.5057115719213006,-1.0022636181505622,0.5,1.0,1.0,4/26,3.66%,VEGFA;AKR1C2;AKR1C1;ANXA1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.4560740796829964,1.0022058137920424,0.45161290322580644,0.9473683610341308,1.0,6/26,14.42%,PACSIN2;MYH9;EHD2;UGCG;STX2;BIN1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5209180137411564,1.0017716199295055,0.46153846153846156,0.9471577713398831,1.0,1/12,1.47%,CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.6639274121703478,-1.0017685492596253,0.5689655172413793,1.0,1.0,3/6,21.29%,KDM2B;APPL2;PTN
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6696702397622404,1.0017680548980867,0.5641025641025641,0.9447951465896278,1.0,3/5,21.96%,IRS1;GKAP1;PTPN11
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6696702397622404,1.0017680548980867,0.5641025641025641,0.9447951465896278,1.0,3/5,21.96%,IRS1;GKAP1;PTPN11
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.4177313920902704,1.0017187608012466,0.4666666666666667,0.9436820174380504,1.0,18/52,20.11%,SORCS1;SORT1;HSPA8;ARF1;EXOC6;SNAP23;KLHL20;ARL3;DNM2;MYO1B;COMMD1;AP1G1;RAB14;MYO5A;CLTC;EPS15;OSBPL5;RAB10
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6224013602277215,-1.001195036599894,0.5789473684210527,1.0,1.0,3/10,12.93%,PKM;YBX3;DHX36
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.6114619382917483,-1.0009204749755432,0.5084745762711864,1.0,1.0,4/8,33.20%,LARS1;UBR2;SESN3;RPTOR
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.6114619382917483,-1.0009204749755432,0.5084745762711864,1.0,1.0,4/8,33.20%,LARS1;UBR2;SESN3;RPTOR
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.527270747886641,-1.0009062020375068,0.4423076923076923,1.0,1.0,4/15,4.40%,NRP1;SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.501147816261097,-1.000653843192351,0.4666666666666667,1.0,1.0,7/28,12.76%,PARP1;RAD51B;MMS22L;RPA1;INO80;BRCA1;WRN
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.6603628818843792,-1.0005599555429174,0.5319148936170213,1.0,1.0,2/7,11.85%,AZIN1;ANO6
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.5951721718285259,1.000480875584226,0.46511627906976744,0.9457689429027715,1.0,1/8,3.78%,GNAI1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.6366937460798465,1.0004634279458404,0.58,0.9446149907659583,1.0,1/5,17.03%,EZR
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.6425257850092025,-1.000384586606526,0.5245901639344263,0.9995975626478762,1.0,1/6,0.90%,TWIST1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.549783299854587,-1.0003041731213482,0.4827586206896552,0.9989273977856709,1.0,2/16,1.49%,ANO2;GABRB2
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.465000751851414,-0.9999137500217513,0.43283582089552236,0.9990746608924148,1.0,11/55,8.56%,IGFBP5;COL15A1;COL6A3;PAMR1;C7;COL1A1;COL3A1;THBS2;COL1A2;COL12A1;DCN
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.5183070780360075,0.9998818823280917,0.5142857142857142,0.9450726743483205,1.0,2/14,13.60%,RAB27A;CADPS
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.44159906037490065,-0.9997235667431507,0.42857142857142855,0.998662847583151,1.0,9/54,11.66%,PARP1;PKM;NR4A2;TSHR;EPRS1;NR4A1;RHOQ;PRKAR1A;PRKDC
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.6586109838296736,-0.9996454737739792,0.5538461538461539,0.997858353728039,1.0,2/7,11.66%,TERF2IP;PRKDC
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.43138635812217896,0.9995209313690522,0.3888888888888889,0.9447963137449888,1.0,10/34,18.10%,BACH1;CDKN1A;PPP6C;CDK17;PHF8;RPS6KB1;ACVR1B;BRD4;CACUL1;CUL4A
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.6093093077321637,-0.9995076373100965,0.46875,0.997302300687173,1.0,4/8,23.84%,PTCH1;ROBO2;PKD2;BASP1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.6309123725518881,0.9992762441235045,0.5641025641025641,0.9444221043298554,1.0,1/6,0.42%,MOCS1
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.637759036595705,-0.9991349055656087,0.509090909090909,0.9972679358695615,1.0,2/7,18.72%,SLC38A1;SLC1A3
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.5389783859696995,-0.9989777127219682,0.5081967213114754,0.9966497095507715,1.0,2/20,1.49%,ANO2;GABRB2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.4393716910848601,-0.99853612530151,0.47692307692307695,0.9969624254828107,1.0,16/57,13.63%,IGFBP5;COL6A3;DKK3;COL1A1;COL3A1;MRC2;GLI2;COL1A2;COL6A1;COL12A1;DCN;LAMA4;TPM2;BMPER;COL13A1;COL6A2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5935634192678351,-0.9984396345424957,0.5357142857142857,0.9961909320879617,1.0,3/11,7.60%,ANXA1;IGFBP2;RPS3
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.5875380869420125,0.9984011537081274,0.4827586206896552,0.9451735637666197,1.0,1/9,0.64%,CACNA1B
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.4815471878724943,-0.9982077168851088,0.484375,0.995684775185018,1.0,4/40,2.25%,PDGFD;FGF1;VEGFA;CEMIP
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6031770495917282,0.9981208545610982,0.5,0.9447576901510265,1.0,3/6,19.59%,KCNQ1;GAS6;PPM1E
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.5746014069844241,0.9978783213228807,0.4857142857142857,0.9443428484798893,1.0,2/9,3.54%,CACNA1C;HCN2
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.5889838811215437,0.9975747954896814,0.5,0.943957048836998,1.0,3/8,8.31%,CSF1R;MYH9;AXL
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.6601229906620858,-0.9974738218282285,0.5263157894736842,0.9967336241532363,1.0,2/5,8.58%,AKR1C2;PTGFR
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.5493306784682567,-0.9972079307801637,0.5666666666666667,0.9964367431657123,1.0,3/17,14.86%,SLC38A1;ABCB1;SLC7A11
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.6177308426391176,0.9971042513113987,0.4883720930232558,0.9440758306315186,1.0,2/7,9.88%,GRID1;GRID2
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.6499366178523963,-0.996933573517864,0.5254237288135594,0.9961404494798454,1.0,3/5,33.61%,FGFR2;TBX18;ZIC1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.47575303471630614,0.9967365617856286,0.5238095238095238,0.9439428167960509,1.0,2/26,2.16%,HSPB1;PML
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.5339375281826649,0.9965477951954127,0.45652173913043476,0.9432937933418198,1.0,2/13,3.24%,NOTCH1;ERBB4
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.38463139033143057,0.9962183251825416,0.5161290322580645,0.9429669415665174,1.0,6/60,5.47%,PDE1C;EPN2;CNTN4;SGPL1;AGAP1;TESC
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5623414555355681,-0.9957476684197131,0.4716981132075472,0.998436128582255,1.0,5/11,26.09%,PER2;PRKAG2;CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.47587527006105435,0.9956764588038853,0.43243243243243246,0.9433647717780529,1.0,2/18,3.86%,CSF1R;PGF
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.38712424281464974,0.9956489285085358,0.40625,0.9422600358556996,1.0,9/64,5.38%,ADGRB3;LSAMP;CACNA1C;CSRNP3;CNTN4;OPCML;FMN2;RAB27A;PRKG1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5631907638273538,-0.9955952241314904,0.49122807017543857,0.9977401647526175,1.0,1/16,1.91%,MDFIC
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5761567231881104,0.9955747813511231,0.5348837209302325,0.9412691063284988,1.0,2/8,12.45%,ZNF143;ELL
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.47814745099848477,0.9954951998657304,0.35294117647058826,0.9403776948088292,1.0,5/16,20.92%,PUM2;AGO2;PRKRA;ZC3H7B;SMAD2
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.5598881914289952,0.9954376897270829,0.475,0.939543878007228,1.0,1/9,9.62%,MAPKBP1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.575844268249062,0.9952159295408216,0.4772727272727273,0.938961141664225,1.0,3/7,26.81%,OSBPL10;OSBPL5;OSBPL8
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.5546319843383309,-0.9952152026282396,0.5263157894736842,0.9977328357892657,1.0,5/15,24.29%,HMGN1;THOC1;ZNF326;ERCC6;WDR43
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3924310141744104,0.9951769716422406,0.4642857142857143,0.9378547232149761,1.0,12/65,12.14%,TNFRSF10B;CXXC5;SLC44A2;VAPA;GPRC5B;PPM1A;UBE2N;MAP3K7;RHOA;PELI2;MID2;MAVS
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.40004171364837265,0.9951747075191403,0.4074074074074074,0.9367372049124576,1.0,9/56,5.86%,RASL12;SORCS1;CHL1;NDRG2;RCAN2;DAAM2;GPRC5B;GFAP;CNTN1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.6330573741284392,-0.9950927580790017,0.5319148936170213,0.9970841062853757,1.0,2/5,18.18%,COX4I1;AFG1L
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.6297405127431471,0.9948670558019874,0.5789473684210527,0.9354465666596694,1.0,1/5,3.78%,GNAI1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6297405127431471,0.9948670558019874,0.5789473684210527,0.9354465666596694,1.0,1/5,3.78%,GNAI1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.6531025587795675,-0.9947245547229498,0.5737704918032787,0.9972940404059446,1.0,2/5,22.08%,PTCH1;RORA
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.39257881304223613,0.9946667838785632,0.40625,0.934789851354021,1.0,24/68,17.37%,GABRB1;CASP7;NCOA3;HCN2;GNAI1;GNB1;SLC26A3;ADCY3;TIPARP;LCOR;GABRB3;PDE3A;EGFR;ADCY5;P2RX4;RAPGEF2;RAP1A;KCNQ1;EGR1;RAPGEF1;TFPI;RYR3;EZR;ZFP36L1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.5816665206771375,-0.9943598148608261,0.576271186440678,0.9972691392333146,1.0,4/8,13.49%,AKR1C1;RALBP1;SLCO1C1;SLCO1A2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6095941814688494,-0.9939812014845347,0.5409836065573771,0.9974334421934024,1.0,1/10,2.65%,HECW2
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4890027448862586,-0.9938963852519899,0.5,0.996670571864331,1.0,9/27,16.80%,PARP1;RPS3;SLF1;EYA1;UIMC1;BRCA1;RNF8;SPIDR;MGMT
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5507940003449011,-0.9935381926078534,0.5,0.9965294886912972,1.0,3/12,16.41%,PARP1;EXOSC10;TNKS2
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3366748567719416,0.9933711437702369,0.4444444444444444,0.9372799667420652,1.0,39/285,11.58%,HSPA1A;TENM2;DACH1;MXD4;GATAD2A;NOTCH1;HEY2;CXXC5;BACH1;CTBP2;NCOA5;PPM1A;SMAD7;SOX13;ZEB2;TBX3;SMARCA4;ZBTB7A;CEBPB;KLF12;HDAC1;BCL6;HMBOX1;LCOR;HDAC9;ZBTB16;SEMA4D;NACC2;ZFHX3;CBX6;MITF;MEIS2;MBD2;THRA;MTF2;APBB1;NFKB1;UBE2D1;PPARA
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.45391942708626176,0.9931886801783583,0.47368421052631576,0.9366637743498969,1.0,8/23,22.58%,ATP2B4;RYR2;ATP2B1;RYR3;ANK2;SLC8A1;TRPC1;AGT
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.6411771802148961,-0.9929393454387118,0.6538461538461539,0.9971251176997697,1.0,3/5,17.59%,IFT122;HES1;ACVR1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.5798388892120722,-0.9929250900504447,0.49230769230769234,0.9952115574463442,1.0,3/9,13.34%,GSN;ADD3;SVIL
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.5798388892120722,-0.9929250900504447,0.49230769230769234,0.9952115574463442,1.0,3/9,13.34%,GSN;ADD3;SVIL
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.5342477265198954,-0.9926006830670346,0.417910447761194,0.9951082686514894,1.0,1/15,2.40%,GRIA4
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.5925215098164334,-0.9925621491029707,0.5370370370370371,0.9942895112270648,1.0,2/8,7.63%,CEMIP;HEXB
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.4939629944446385,0.9921545796310197,0.5277777777777778,0.9383235004563125,1.0,3/15,8.58%,TNFRSF1B;HEY2;HEYL
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.6417860536649721,-0.9921389890440728,0.5230769230769231,0.9946520546677786,1.0,1/6,0.90%,TWIST1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.5546060004644592,-0.9920591826382521,0.484375,0.993969262763681,1.0,4/19,12.93%,CIRBP;FUS;LARP1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.5104865883806371,0.9918806850320954,0.5,0.9378306995915119,1.0,2/12,2.81%,SERPINB6;TIMP3
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),-0.6806907143100008,-0.9916056234775914,0.6101694915254238,0.994358171704094,1.0,1/5,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.48037937324476065,0.991425833013209,0.4594594594594595,0.9378721510290705,1.0,3/20,4.34%,KCNC2;CACNA1C;RFX3
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.40344671488235506,0.9913483500289159,0.46875,0.9370261411259556,1.0,4/37,4.17%,VAPB;ATP2B4;SLC12A2;PTH1R
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.4085847977089702,-0.9906246888329787,0.5131578947368421,0.9960651678548885,1.0,20/153,10.11%,PDGFD;FGF1;TGFB2;VEGFA;RPS4X;MEGF10;AKR1C2;STAT1;TET1;TSHR;GCNT2;BMP5;LAMC1;CD47;TGFBR1;THBS1;PTGFR;SSR1;LAMB1;FN1
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.5740255531196649,0.9905885681779407,0.4523809523809524,0.9377229547570577,1.0,4/9,10.53%,CD44;CD151;RHOA;ARHGAP35
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.6348477724875523,-0.9904747536906385,0.5344827586206896,0.9946665656303146,1.0,2/6,22.41%,ACAT1;ACBD6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.6348477724875523,-0.9904747536906385,0.5344827586206896,0.9946665656303146,1.0,2/6,22.41%,ACAT1;ACBD6
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6425372107336434,0.9901710715565956,0.55,0.937519247507207,1.0,2/5,18.64%,FBXW7;ERRFI1
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5599360068557785,-0.9896052072600803,0.5272727272727272,0.995924040866196,1.0,2/16,1.47%,ABCA8;SPTLC3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.6097204832724641,-0.9890421865440112,0.5555555555555556,0.9964689537851644,1.0,2/7,16.49%,BBS4;NINL
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.3931292469660877,0.9890145776544617,0.4642857142857143,0.9389619241783778,1.0,9/53,7.27%,HSPA1A;NOTCH1;PML;NDRG3;TP53TG5;PPP2R1A;SMARCA4;CDKN1A;BCL6
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.5982549014345178,-0.988767560798138,0.6071428571428571,0.9962767677478022,1.0,1/9,2.02%,SLC8B1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.3828360883117046,0.9887660685836632,0.4,0.9382681186628246,1.0,8/55,7.27%,HSPA1A;PML;NDRG3;TP53TG5;PPP2R1A;SMARCA4;CDKN1A;BCL6
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.5716569272059782,0.9885029592816853,0.5,0.937847374306401,1.0,2/7,9.93%,PML;RAD21
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.5773276193474637,-0.988209381187838,0.5517241379310345,0.9968911624441332,1.0,1/13,2.81%,STAT1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.5162219582181705,-0.9875037746924593,0.49122807017543857,0.9979115120789531,1.0,2/22,5.86%,VEGFA;SFRP4
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.6595111407500838,-0.987407206473958,0.5925925925925926,0.9971437377459911,1.0,1/7,1.12%,UAP1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.6374572103491687,-0.9872545048718143,0.55,0.9965099503197818,1.0,1/5,1.52%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6018888820887629,0.9871546741762874,0.4864864864864865,0.9401925523730656,1.0,1/6,6.05%,BNIP3
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.4550870668099876,0.9865752575138009,0.4473684210526316,0.9405692097434059,1.0,3/23,11.58%,MFHAS1;MAPKBP1;PPARA
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.41662060562731196,0.9864053223321618,0.4,0.939890322353718,1.0,12/41,23.36%,DEK;TDG;PHF2;MTF2;AEBP2;EP300;DDX21;TAF1B;KAT2B;HDAC5;BAZ1B;TASOR
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.5422078319820747,-0.9857575738404525,0.5,0.9996634520046399,1.0,4/15,12.93%,TANC2;ABI2;EPHA4;DHX36
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.6086496242727402,0.9852919184893514,0.5238095238095238,0.9411307555732279,1.0,1/5,1.46%,TNFRSF1B
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5360906604540724,0.9852322903732175,0.5641025641025641,0.9401830422819001,1.0,2/9,7.61%,ST3GAL2;B3GNT2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.43462669633632295,0.9850952678782844,0.43902439024390244,0.9393453699445555,1.0,5/27,11.14%,APC;CDKN1A;MYOCD;EGFR;ADAM17
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.6236952088939752,0.9849698785473963,0.6041666666666666,0.9385096920651576,1.0,4/6,12.39%,HEY2;EMP2;RAPGEF2;RAP1A
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.5979384515835466,-0.9844738541162881,0.484375,1.0,1.0,1/8,11.43%,BRCA1
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.43052876865118433,-0.9843649241287383,0.4375,1.0,1.0,21/77,18.07%,VEGFA;SLC2A3;SAT1;NR4A2;NR4A1;F3;SGK1;GEM;MARCKS;TSC22D1;BTG2;MAP3K8;BIRC2;PLPP3;BHLHE40;NAMPT;BTG1;SQSTM1;HES1;JUN;IFNGR2
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.4002399474948571,-0.9840591826041367,0.4935064935064935,1.0,1.0,17/95,8.56%,PDGFD;IGFBP5;ABCA8;COL15A1;COL6A3;PAMR1;KCNMB1;FHL2;DKK3;COL1A1;COL3A1;SGCD;THBS2;COL1A2;COL12A1;FBLN2;DCN
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.6043634844386431,-0.9840335916412103,0.5283018867924528,1.0,1.0,2/7,15.14%,LARS1;RRAGB
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.6051587817612282,-0.983736578493975,0.5517241379310345,1.0,1.0,2/5,17.57%,OTUD6B;PSMG2
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),-0.6482071838732404,-0.9837114783172166,0.5490196078431373,0.9991710067047764,1.0,1/6,7.03%,ABCB1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),0.6445311649920188,0.9832912572161069,0.5813953488372093,0.9418426141154594,1.0,2/5,16.02%,AXL;GAS6
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.6525597059820188,-0.982913577774684,0.5423728813559322,1.0,1.0,3/5,22.58%,TGFBR1;RORA;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4976142178499755,-0.9826812642640674,0.5283018867924528,0.999793404444092,1.0,2/23,2.43%,SPRY1;FBLN1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.4579137747162494,-0.9824646434434888,0.4264705882352941,0.999373125399976,1.0,5/39,5.55%,VEGFA;TSHR;LEPR;PER2;CMKLR1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.4854037941498518,-0.9824292860383075,0.45454545454545453,0.9984991049909447,1.0,3/23,9.32%,ABLIM1;COL1A1;COL11A1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.5481848984711273,0.9823713184981553,0.4444444444444444,0.9428317176925338,1.0,3/8,30.20%,EIF2AK4;EIF2S1;HERPUD1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.5370082082808354,-0.98140179503232,0.5263157894736842,0.9999758941119767,1.0,2/14,13.69%,BRCA1;UFL1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5261913285145682,0.9802872087322839,0.4888888888888889,0.9467415926090568,1.0,4/14,15.23%,UBE2N;SMG1;MCL1;WRNIP1
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.6238089540844705,-0.9801330236231722,0.5660377358490566,1.0,1.0,3/6,7.71%,NRP1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.5155037597219253,-0.9795651091872164,0.4696969696969697,1.0,1.0,4/18,16.22%,TCHP;MTM1;BRCA1;TMEM39A
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3208229385776212,0.979450402686697,0.5,0.9473743321807653,1.0,50/207,16.36%,NOTCH1;HEY2;PML;SMARCD3;HIPK2;MED24;ERBB4;RFX3;PPM1A;RNF14;TESC;SMARCA4;CEBPB;HDAC1;CAMKK2;MAP2K2;ZBTB16;ZFHX3;USP16;MITF;MYOCD;EGFR;ARID1B;APBB1;PHF8;NFKB1;ARID1A;PPARA;SMARCA1;MECOM;RBM23;FOS;LEF1;YAF2;HDAC2;CEP290;EP300;MAP2K1;AFAP1L2;DNM2;ACTA2;BTRC;RNF10;TRIP4;KLF2;FOXO3;EGR1;BRD4;ZNF398;CNBP
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.5458073769298845,0.979188474858815,0.4782608695652174,0.9469487863080803,1.0,3/8,14.64%,PPARGC1B;ARID1A;TRIP4
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.54561281661806,-0.9790277455604218,0.5409836065573771,1.0,1.0,2/11,13.57%,STAT1;PARP9
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.5991601940087369,-0.9787852728885861,0.5789473684210527,1.0,1.0,2/7,6.82%,TAMM41;HADHA
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5256463075503576,-0.9785828200384723,0.5084745762711864,1.0,1.0,6/22,10.87%,ANXA1;COL1A1;COL3A1;COL1A2;ADAM9;ASAH1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5821918899424564,-0.9783296297269799,0.48148148148148145,1.0,1.0,3/12,12.25%,TUBGCP5;CCDC57;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),0.6093294424248646,0.9780660652498278,0.5454545454545454,0.9484482663222946,1.0,1/5,10.51%,SART3
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.35736878220853585,0.9779014729865272,0.5,0.947782238816236,1.0,13/62,12.28%,CDH2;CNTN4;SOX6;ADGRL2;CTNNA2;ZFHX3;SCYL2;MEIS2;PHF8;RAPGEF2;SMARCA1;CNTNAP2;DDIT4
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.5210904411647167,0.9769108831250981,0.5208333333333334,0.9487440100078274,1.0,3/14,10.36%,ADCY9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.37106013709453706,0.9768991497735081,0.4166666666666667,0.9476531539694818,1.0,12/87,9.71%,DGKB;PIP5K1B;DGKH;SLC44A2;PISD;ARF1;CDS2;LCLAT1;MTMR1;INPP4B;DGKE;DGKG
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.37214128634385857,0.9768290233286163,0.4482758620689655,0.9467377434952738,1.0,8/63,10.13%,HSPB1;PML;EMP2;PTGES3;ZBTB7A;CDKN1A;EGFR;NUP54
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5923095861793907,0.9767218376620563,0.5111111111111111,0.945771353413597,1.0,1/5,4.53%,UBQLN1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.5884168446578208,0.9766206131718992,0.55,0.9448603004763659,1.0,4/6,29.56%,EGFR;DYRK1A;ABL1;KDR
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.5876245175601192,0.9765298874207663,0.6176470588235294,0.9440176416651671,1.0,1/10,4.23%,EMP2
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.49291529821155206,-0.976508371234161,0.5483870967741935,1.0,1.0,2/18,1.52%,ZFPM1;VEGFA
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.526716595765677,-0.9759008676220149,0.5151515151515151,1.0,1.0,1/15,1.02%,RIMS1
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.566655117850944,0.9758237796572201,0.5714285714285714,0.9446858700019873,1.0,3/8,17.37%,ZBTB16;MEIS2;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4037108719681179,0.9757043612994664,0.47058823529411764,0.9439114893565519,1.0,6/48,3.63%,CSF1R;MFHAS1;NOTCH1;PDGFA;ERBB4;CD44
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.5855055981809849,0.9755890361472827,0.5869565217391305,0.9397661142231079,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),0.5855055981809849,0.9755890361472827,0.5869565217391305,0.9397661142231079,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5855055981809849,0.9755890361472827,0.5869565217391305,0.9397661142231079,1.0,1/6,1.15%,PANK3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5855055981809849,0.9755890361472827,0.5869565217391305,0.9397661142231079,1.0,1/6,1.15%,PANK3
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.4329054821109058,-0.9751187750154378,0.53125,1.0,1.0,14/71,13.32%,CLU;TGFB2;IFITM3;SAT1;ANXA1;GSN;DCN;PDCD4;GPX4;BTG2;TIMP2;BRCA1;LGALS3;TGFBR3
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.3861026719134973,0.975103682221846,0.6071428571428571,0.9398037246001187,1.0,9/55,12.79%,OPA3;SMARCD3;NFYC;IRS2;OAZ2;TGS1;PPARA;ELOVL6;NCOA2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.57340052209863,-0.9750448201127693,0.5588235294117647,1.0,1.0,4/10,21.29%,EPHA4;APOE;SQSTM1;PTN
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.6766394343383489,-0.9747154573808592,0.5660377358490566,1.0,1.0,1/5,3.41%,FGGY
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4056107796625912,-0.9744804576974058,0.475,1.0,1.0,19/93,17.56%,SHROOM3;FBLN1;MYO10;PRTG;GLI2;LAMC1;COL4A6;MID1;PTK7;LAMB1;ADGRA3;COL4A5;ANO6;PRDM5;SH3D19;SPRY4;HES1;UACA;NXN
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.6285809377594809,0.9744506228953719,0.5348837209302325,0.9401563310057874,1.0,1/6,3.30%,ACADVL
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6008788057245393,0.9744321959150578,0.5116279069767442,0.9391050021417187,1.0,2/5,12.76%,SMAD7;NEDD4L
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.5060952967005191,0.9744132890319218,0.4186046511627907,0.9380561097292469,1.0,10/22,25.56%,IRS1;RPS6KB1;KANK1;GKAP1;SIK2;PTPN11;PTPN1;TSC2;OGT;TNS2
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.4907945115587638,0.9739887685676345,0.4782608695652174,0.9379123646997983,1.0,1/12,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.47717010134949145,-0.9737234686239881,0.4696969696969697,1.0,1.0,2/26,2.93%,CLU;RPL5
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4413273312928672,0.9737130576865971,0.45454545454545453,0.9375860033187803,1.0,5/25,7.09%,CSF1R;PML;DEK;MYH9;CDKN1A
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.47167815047437667,-0.9732025876844929,0.5,1.0,1.0,10/31,16.75%,MT2A;ADAM9;SLC11A2;THBS1;NDRG1;PAM;PLSCR1;MT3;SLC25A13;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.43205773150617854,-0.9728438002381488,0.45161290322580644,1.0,1.0,12/53,15.88%,SRGAP3;IGFBP5;FBLN1;AFDN;LDLRAD4;CYP1B1;SLIT2;EPHA4;LIMCH1;TMEFF2;ADARB1;TPM1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.418280553409203,-0.9728180418745168,0.5,1.0,1.0,9/79,8.78%,AFG3L2;CTSL;XPNPEP1;ERAP1;ADAMTS12;CPQ;F3;APH1B;FBXW2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.4977218579159278,0.9727075281458153,0.53125,0.9387614533075934,1.0,6/18,9.49%,NOTCH1;TNFRSF1B;HEY2;ELN;HEYL;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4072533458247106,-0.972619923786388,0.5512820512820513,1.0,1.0,12/121,7.71%,TGFB2;TWIST1;VEGFA;TSHR;COL1A1;GCNT2;LEPR;PER2;CMKLR1;ENO1;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.6206851114318327,-0.9725485046318973,0.5409836065573771,1.0,1.0,3/6,29.16%,PTCH1;PKD2;ALDH1A2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.46450877870512675,-0.9724910045062038,0.5625,1.0,1.0,3/32,5.18%,HECW2;NKD1;GPC3
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.6091697140055946,-0.9720881355369313,0.5423728813559322,1.0,1.0,4/10,10.90%,TGFB2;ADAM9;CYP1B1;JAM3
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5244599288877998,-0.9720784683957043,0.48484848484848486,1.0,1.0,4/17,14.81%,NKD1;FGF13;PTCH1;MT3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.6456225516625576,-0.9719540394469145,0.6,1.0,1.0,2/5,8.75%,SLC11A2;ABCB7
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.5053084545024354,0.9716372143329904,0.5365853658536586,0.9403383579890647,1.0,2/20,3.97%,PDK4;ARF1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.6092527107953865,-0.970775067095494,0.5909090909090909,1.0,1.0,3/7,10.76%,ST6GAL1;EXTL2;CSGALNACT1
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31739505949929886,0.9693524492057259,0.4666666666666667,0.9450370532292024,1.0,31/151,19.77%,TBC1D4;HEY2;PTPRK;ARF1;EMP2;HERC2;AP3D1;GGA2;PACS2;SNX13;RAB31;EGFR;GRID2;TBC1D5;CNTNAP2;TRIM23;STX2;CEP68;GGA3;SEPTIN9;ARL6;ESAM;CNTLN;RAB14;VPS26A;ARL5A;ANK2;ARCN1;CLTC;CROCC;ARFGAP3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.5917248988736925,-0.9691882627869208,0.6,1.0,1.0,4/11,16.83%,BEX3;BIRC2;MT3;NGF
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5340792988511401,-0.9691722292852132,0.5555555555555556,1.0,1.0,6/15,19.42%,TERF2IP;HSP90AB1;RPA1;PPIA;ANKRD28;MRE11
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5774251910328755,0.9689894435782426,0.5294117647058824,0.9447300105943836,1.0,3/10,9.93%,MCM9;MSH2;RAD21
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.48084516064583027,0.9685853225295487,0.5294117647058824,0.9446575417369679,1.0,2/15,2.81%,SERPINB6;TIMP3
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.581117278913511,-0.9683645355133147,0.5490196078431373,1.0,1.0,3/8,18.28%,EIF2S2;EIF4H;EIF2S3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.4966018100273495,0.9681631650415069,0.5,0.9446111947752667,1.0,4/12,17.37%,SERPINB6;CAB39;DDX3X;ZFP36L1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.35953570899520093,-0.9680929286393085,0.574468085106383,1.0,1.0,51/455,15.11%,PRAG1;PRSS23;IGFBP5;TGFB2;ELOB;KLHL13;PARP1;CDKL1;ANXA1;DDB2;COL3A1;GCNT2;GPC3;PPM1H;ST3GAL4;PIK3R4;LAMC1;ST3GAL5;STRADB;ATG10;SGK1;TGFBR1;UBL5;THBS1;PSMD8;FBXW2;VCAN;FBXO22;PARP6;MTM1;PPP2R3A;LAMB1;FAM20A;FN1;NUB1;PSMC2;PRKDC;CSNK1D;SHISA5;PRKAG2;PARP9;UFL1;SRPK1;GLRX;WSB1;NAE1;NEK1;MT3;CALU;DAPK2;MINK1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.5607680873195299,0.967851345443869,0.475,0.9441631053541751,1.0,1/7,0.16%,CSF1R
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.5400975484630695,0.9670778104661246,0.5714285714285714,0.9449331558541648,1.0,3/7,24.49%,NEDD4L;KCNQ1;AKAP6
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),-0.4790664199182711,-0.9670295767440149,0.5166666666666667,1.0,1.0,7/30,12.76%,PARP1;RAD51B;MMS22L;RPA1;INO80;BRCA1;WRN
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.6101303143355472,-0.9660747773163701,0.5555555555555556,1.0,1.0,2/10,12.72%,CEMIP;PRKAG2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.5972325710658934,0.9659579768214062,0.5319148936170213,0.9467102338182771,1.0,1/7,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.6161341665481435,0.9658784968859236,0.5555555555555556,0.9458220555520767,1.0,2/5,16.86%,P2RX4;RYR3
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.4942134784772346,-0.9657351200550022,0.5238095238095238,1.0,1.0,9/19,25.65%,UIMC1;BRCA1;MRNIP;RAD17;NAE1;TOPBP1;MRE11;BABAM2;DONSON
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.43429030667958685,-0.9654029734588011,0.5074626865671642,1.0,1.0,14/65,12.10%,IGFBP5;TWIST1;FBLN1;COL1A1;COL3A1;GLI3;GLI2;LAMC1;COL6A1;COL12A1;LAMB1;BOC;FOXC1;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.35648483038588985,0.9650639471681154,0.4722222222222222,0.9464843457375604,1.0,16/89,12.28%,WTIP;TNFAIP8L1;BCL2;ATP2B4;BCL2L1;PPM1A;MGRN1;DLG5;PDE3A;MAPKBP1;DGKG;USP10;MCL1;SH2B3;PPARA;DDIT4
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.4261116787950089,-0.9647775409075386,0.5342465753424658,1.0,1.0,9/82,8.31%,PDGFD;FGF1;TGFB2;NRP1;VEGFA;GCNT2;DENND2B;NOTCH2;MID1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5695522698663437,0.9647436200889377,0.575,0.9461655647125976,1.0,2/10,10.50%,VAPA;YTHDC2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.5549951144162986,-0.9640717073513416,0.5737704918032787,1.0,1.0,2/11,1.72%,PRDX1;ACTG1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.4571184150128025,0.9637573741426738,0.5510204081632653,0.9470190692048709,1.0,3/16,9.57%,ERBB4;NRG2;EGFR
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),0.6299239679431033,0.9637126595043662,0.6190476190476191,0.9460574235636091,1.0,3/5,19.54%,GTF3C2;TAF1B;SPIN1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4247559598644337,-0.963425488764006,0.5492957746478874,1.0,1.0,6/70,6.93%,FSIP2;GBP2;XPA;COL1A1;IFT122;ALDH3A2
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6205868119830585,-0.963414605205598,0.5714285714285714,1.0,1.0,1/6,7.79%,APH1B
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.4989073916043365,0.9633613543172194,0.4444444444444444,0.9457402144309746,1.0,1/15,0.16%,CSF1R
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.5608860756340958,-0.9632774443447895,0.5384615384615384,1.0,1.0,2/9,5.04%,VEGFA;GLI2
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.44796853389244096,0.9631507952381015,0.5142857142857142,0.9451799470695862,1.0,6/23,14.50%,TRAK1;MYO1E;NDE1;KIF5B;MYO1D;MYO1B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.5127263857124116,0.9630717129591597,0.44680851063829785,0.9443133687482136,1.0,6/14,25.22%,MTFR1;SDHB;UQCRC2;COX10;ETFA;NDUFS1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.4722437968100073,-0.963017581655232,0.5507246376811594,1.0,1.0,3/29,11.12%,ANXA1;PELI1;SMAD6
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.550801287067244,-0.9628766238628175,0.5737704918032787,1.0,1.0,2/16,14.59%,VAV3;LARS1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5081844407089673,0.9625894023101579,0.5555555555555556,0.9442936441760726,1.0,8/16,21.96%,MAVS;DDX3X;DHX9;PTPRS;IRF3;RIOK3;TRAF3;PTPN11
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.410143410730687,-0.9625254334232924,0.524390243902439,1.0,1.0,24/108,16.80%,IGFBP5;NRP1;FHL2;COL1A1;COL3A1;COL1A2;LAMC1;F3;NOTCH2;PTGFR;AMPH;COL11A1;ADD3;PLPP3;TGFBR3;BHLHE40;MAPK14;SYNJ2;PMP22;CELF2;SYNE1;ANXA2;KCNMA1;MGMT
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.5280843601272724,0.9624168239843043,0.5476190476190477,0.943634619392206,1.0,3/12,15.85%,RAPGEF2;RAP1A;RAPGEF1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.40629232882102745,-0.9623265744431883,0.5070422535211268,1.0,1.0,20/90,14.97%,VEGFA;SLC2A3;MT2A;EXT1;XPNPEP1;ADM;GCNT2;GPC3;ENO1;F3;DCN;NDRG1;AKAP12;PGK1;BHLHE40;PAM;LDHA;GLRX;WSB1;BTG1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.2991033777341106,0.9621239516732547,0.7,0.9433602573782306,1.0,41/297,11.31%,HSPA1A;HSPB1;TNFRSF10B;CSRNP3;OBSCN;BCL2;TIAM2;KALRN;APC;BNIP3L;CD44;BCL2L1;TMBIM6;FMN2;ARHGAP10;ARHGEF7;TBX3;BNIP3;ARHGEF1;ZBTB7A;HDAC1;API5;RAF1;BCL6;ABR;RRP1B;SEMA4D;AXL;RHOB;MADD;EGFR;CBL;GRID2;KLHL20;TNFAIP8;APBB1;NAA38;ARHGEF4;PAK2;MCL1;NFKB1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.4996376888683284,0.9618071664468567,0.5121951219512195,0.9429716923997992,1.0,8/23,13.45%,SMARCA4;HDAC1;MBD2;ARID1B;ARID1A;SMARCA1;HDAC2;CECR2
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.38104174805493396,0.961757951297796,0.5714285714285714,0.9420487702933598,1.0,4/55,6.19%,HSPA1A;UBE2N;MAP3K7;ZBTB7A
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.46134719495305687,0.9615377511141593,0.4772727272727273,0.9415225350818809,1.0,2/21,11.74%,SORT1;WASHC5
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6242924845346798,-0.9614306275874341,0.532258064516129,1.0,1.0,1/5,17.39%,PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6242924845346798,-0.9614306275874341,0.532258064516129,1.0,1.0,1/5,17.39%,PRKN
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.523125912288091,-0.9612019410982702,0.5774647887323944,1.0,1.0,4/17,3.58%,DDX60L;GBP2;WDFY4;SAMD9L
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.5603272876681828,-0.9609522945223608,0.6,1.0,1.0,4/13,16.08%,ABCA8;PTCH1;SREBF2;APOE
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.4478068039036179,0.960856538998061,0.4838709677419355,0.9419002472922043,1.0,8/26,18.81%,PHF20;APBB1;LEF1;EP300;JADE2;JADE1;HAT1;MEAF6
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.5600983877357714,-0.9604364966080002,0.5254237288135594,1.0,1.0,2/9,3.66%,TGFB2;ANXA1
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6285613063991826,-0.960255067324577,0.6333333333333333,1.0,1.0,2/5,22.97%,PRMT7;MECP2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4323884377735616,-0.9599043870632558,0.5,1.0,1.0,11/49,17.65%,TGFB2;COL3A1;GCNT2;COL1A2;ADAM9;TGFBR1;SMAD6;TGFBR3;JUN;ACVR1;APPL2
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.4952938577772009,0.9598712653583173,0.5185185185185185,0.9430137509021893,1.0,5/14,11.06%,MICALL2;APC;MPP7;PARD6G;PAK2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.4608072437512336,0.9597688723983635,0.4,0.9421710435323162,1.0,2/17,4.53%,SNAP29;UBQLN1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5471985541440629,-0.9588567728361184,0.6,1.0,1.0,2/14,6.75%,CDC37;HSP90AB1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4674581960690356,0.9583193943745402,0.5306122448979592,0.9446250018166463,1.0,4/17,15.11%,RNF185;AMFR;RNF139;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6161007708289445,-0.9582864486486046,0.6290322580645161,1.0,1.0,2/8,11.45%,VEGFA;SAP30BP
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5861519946411167,0.9578639353220575,0.5428571428571428,0.9445292009984759,1.0,3/7,6.05%,HSPA1A;BCL2L1;BNIP3
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4916904595629479,0.9578133520631761,0.48717948717948717,0.9435232561057538,1.0,7/12,29.14%,MAPRE2;CAMSAP1;MAP1B;SKA2;GBA2;ABL1;CLASP1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.5631513600196695,-0.9577402968051518,0.6129032258064516,1.0,1.0,2/15,10.07%,CTSL;ALPK1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.5875469546970336,-0.956376389565018,0.5714285714285714,1.0,1.0,2/10,14.42%,HTT;GPATCH2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.6504765289554568,-0.9563330253490905,0.65,1.0,1.0,2/6,21.11%,SLIRP;FMR1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5339939626546009,0.9561424847337361,0.5238095238095238,0.9464852972932654,1.0,1/13,0.48%,PRR16
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.596300651590882,-0.9553393185465936,0.5454545454545454,1.0,1.0,2/9,14.02%,SUPT6H;SRPK1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6292250342538609,-0.9553243896237986,0.5925925925925926,1.0,1.0,2/6,13.65%,CYP1B1;PDCD10
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4974553274443366,-0.9551410051371727,0.5362318840579711,1.0,1.0,1/20,0.87%,TGFB2
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.5811172508212177,-0.9550648746002457,0.5964912280701754,1.0,1.0,3/7,7.29%,ZFPM1;TGFB2;NOTCH2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.48805892283981905,-0.9550027309385736,0.5774647887323944,1.0,1.0,8/30,19.82%,KLHL13;DCDC1;PIK3R4;SVIL;BBS4;PKN2;PKP4;CALM1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.5329204835381643,-0.9548365617992255,0.5370370370370371,1.0,1.0,3/18,1.52%,TGFB2;NRP1;VEGFA
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.5588481443246974,0.9544328308846823,0.627906976744186,0.9494407267816977,1.0,1/6,23.51%,TSG101
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.5566950372640035,0.954262628366795,0.5526315789473685,0.9488233197121717,1.0,1/8,1.23%,SRSF12
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5693296414824459,0.9541869214823719,0.5238095238095238,0.9479932994241529,1.0,3/8,24.21%,PPARA;ELOVL5;MLYCD
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.4619831953622292,-0.954149188734129,0.5223880597014925,1.0,1.0,7/26,26.58%,PSMD8;PSMC2;FHL1;FBXL7;PSMD14;PSMA3;RBX1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.4013403844412805,-0.9536683843788609,0.5285714285714286,1.0,1.0,15/91,14.02%,EIF2S2;EIF3J;RPL34;DDX18;EPRS1;RACK1;HSP90AB1;RPS3;PSMD8;PGK1;RPL6;PPIA;EIF4H;LDHA;SRPK1
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5476808223061129,0.9533910899462011,0.47619047619047616,0.9488499806732706,1.0,2/8,1.63%,MYH11;HEY2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.630898453757373,-0.9532470335197973,0.6078431372549019,1.0,1.0,1/6,19.17%,PARG
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.6285923992280952,-0.9530753210180416,0.631578947368421,1.0,1.0,2/7,22.32%,CD4;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.6285923992280952,-0.9530753210180416,0.631578947368421,1.0,1.0,2/7,22.32%,CD4;STAT3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.5095739189856826,-0.9530393125595393,0.6101694915254238,1.0,1.0,6/16,15.93%,CD55;CD47;THBS1;EPB41L2;THRB;VAMP5
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.5590910260357989,0.9530281146336981,0.5789473684210527,0.9486874326809221,1.0,2/7,21.25%,GSTA4;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.5513590010985499,-0.9525691211786549,0.59375,1.0,1.0,1/13,0.78%,ABCA8
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.49759549380919577,-0.9525677469316278,0.5172413793103449,1.0,1.0,4/20,4.82%,NRP1;VEGFA;STAT1;NR4A1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5647050064061185,0.9525552573684462,0.5,0.9487008843890745,1.0,5/9,29.93%,EP300;NAA25;KAT2B;NAA11;CREBBP
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.4085040181352105,0.9524910892833234,0.48,0.9478120220088654,1.0,5/25,8.81%,BCL9;APC;BCL9L;FZD3;SCYL2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.4121893142831096,-0.9524080186587891,0.515625,1.0,1.0,13/66,15.88%,SRGAP3;IGFBP5;PHLDB2;AFDN;COL3A1;LDLRAD4;CYP1B1;SLIT2;EPHA4;LIMCH1;TMEFF2;ADARB1;TPM1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.5090689096605953,-0.952380285824404,0.559322033898305,1.0,1.0,9/15,33.20%,LARS1;RRAGB;UBR2;FYN;SESN3;IPO5;CAPN2;SLC38A9;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.526483768199098,0.9522288210256582,0.5609756097560976,0.9473507351474282,1.0,3/7,36.71%,HLA-E;TP53BP1;RIF1
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.496699928280514,0.9517365354477169,0.5,0.9472905968578504,1.0,4/14,15.42%,MYOCD;RPS6KA5;IWS1;GLYR1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.5028601155653497,-0.9508228913994687,0.5806451612903226,1.0,1.0,5/18,13.79%,UCHL5;N4BP1;HSP90AB1;FHIT;RPL11
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.5756028621608645,-0.9505367939660284,0.5714285714285714,1.0,1.0,2/8,12.07%,VEGFA;EPHA5
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.477884490566419,-0.9504708396331958,0.5833333333333334,1.0,1.0,2/27,5.30%,ZFPM1;RACK1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.5504552211413688,-0.950307424747882,0.5576923076923077,1.0,1.0,1/9,0.36%,CLU
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.556818028785223,-0.9502358322972542,0.5686274509803921,1.0,1.0,3/11,11.57%,GLI3;GLI2;PTCH1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.49278122595762697,-0.949737689774227,0.5263157894736842,1.0,1.0,2/18,1.52%,NRP1;VEGFA
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.4144352808926033,-0.9492711367539116,0.547945205479452,1.0,1.0,6/84,8.93%,PRAG1;EPHA3;SPOCK1;PTK7;TANC2;ABI2
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.6159230398923525,-0.9490631838019316,0.5740740740740741,1.0,1.0,2/8,12.41%,GLI2;EPHA4
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.378481511329201,0.9481499054280118,0.6774193548387096,0.9543624866646638,1.0,8/53,9.09%,TNFRSF10B;NIBAN1;BCL2;RNF185;UBQLN1;CEBPB;TMEM259;RNF139
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.4538243557653204,0.9479494668358771,0.4318181818181818,0.9538331151589634,1.0,2/19,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5819728471853707,0.9477982938820304,0.5652173913043478,0.9521056286737958,1.0,1/7,11.07%,ZDHHC6
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5819728471853707,0.9477982938820304,0.5652173913043478,0.9521056286737958,1.0,1/7,11.07%,ZDHHC6
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.5413543213747206,0.9474125792890459,0.5348837209302325,0.9520157198280783,1.0,3/7,19.85%,EGFR;ADAM17;CCND3
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5655560317106996,-0.9473186629441902,0.6166666666666667,1.0,1.0,1/10,0.78%,ABCA8
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.46172565206289923,0.9472186898318598,0.475,0.9514167247536991,1.0,5/20,12.47%,FMNL3;RHOA;RHOB;FHOD1;PPP2R3C
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.4801620101566686,-0.9469581093621576,0.5166666666666667,1.0,1.0,5/24,7.71%,ZFPM1;TGFB2;VEGFA;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.642569108474013,-0.9469555819167199,0.6181818181818182,1.0,1.0,1/5,7.97%,CCT6A
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.3927653323710604,-0.9462686788569368,0.5256410256410257,1.0,1.0,16/94,8.56%,IGFBP5;ABCA8;COL15A1;VEGFA;NT5E;COL6A3;PAMR1;COL1A1;COL3A1;SGCD;ADM;THBS2;COL1A2;COL6A1;FBLN2;DCN
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.47034480342690044,-0.9459098784041682,0.5689655172413793,1.0,1.0,6/27,13.99%,NRP1;LAMC1;LAMB1;FN1;NTN4;TMEFF2
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.6030538194278143,-0.9458063380376046,0.6491228070175439,1.0,1.0,4/7,23.03%,PRMT2;NSD3;PRMT7;NSD1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.5402800365140267,-0.9452603499439144,0.5666666666666667,1.0,1.0,5/16,16.08%,LSS;SOAT1;MT3;CYP27A1;APOE
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.5446191122190684,0.944724165587936,0.5714285714285714,0.9559683322386149,1.0,5/9,22.74%,HACD2;ELOVL6;ELOVL5;ACSL1;TECR
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5431338709095188,0.9445176849396184,0.5365853658536586,0.9552795565289888,1.0,2/8,9.10%,NOTCH1;RHOA
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.49597240717791774,-0.9442399769794552,0.5714285714285714,1.0,1.0,5/19,23.11%,PIK3R4;PRKAG2;ATG14;ITFG2;SZT2
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.5053122413514994,-0.9441461163380953,0.5606060606060606,1.0,1.0,5/16,17.39%,FTL;ABCB7;HEPH;MT3;PRKN
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.6013457661239858,-0.9439372364082818,0.5535714285714286,1.0,1.0,4/7,35.64%,LRPPRC;RHOT1;OPA1;UBB
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.418658856465972,0.9436831663826776,0.5135135135135135,0.9564122585961087,1.0,8/33,10.53%,PDGFA;DLC1;CORO2B;ARHGAP44;RHOA;RHOB;RICTOR;ARHGAP35
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.49507709325270455,-0.943650805886942,0.5,1.0,1.0,4/15,15.96%,GLI3;IFT122;PTCH1;SMOC1
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.5966213898944115,-0.9435472503815616,0.6065573770491803,1.0,1.0,2/8,6.16%,ANXA1;ZFP36L2
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.587412830788764,-0.9435427418640148,0.6078431372549019,1.0,1.0,2/7,9.74%,PARP1;RPA1
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5241948382661052,0.9434364190331882,0.5641025641025641,0.9559718482689612,1.0,5/11,18.78%,ARF1;RRP1B;DDX3X;IRF3;RIOK3
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5660135802380436,-0.9432883516492361,0.6111111111111112,1.0,1.0,1/9,3.47%,CMTR1
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5098389383111326,0.9432311137195041,0.575,0.9553841564335517,1.0,4/8,17.37%,PTPRK;KLF9;CASK;ZFP36L1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.42154230618077865,0.9430942638318149,0.6060606060606061,0.9545756242953027,1.0,3/30,11.21%,SRSF12;ZBTB7A;SMU1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5494151296312284,0.943013345799534,0.5217391304347826,0.9537195486427376,1.0,1/9,3.49%,NCOA3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.44088562599019676,0.9429834053682378,0.42424242424242425,0.952705265074992,1.0,3/18,9.57%,TIMP3;FMN2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.6176855870136873,-0.9427271261783832,0.6226415094339622,1.0,1.0,2/6,16.64%,CCT6A;LARP7
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.6176855870136873,-0.9427271261783832,0.6226415094339622,1.0,1.0,2/6,16.64%,CCT6A;LARP7
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.4866563719430329,0.9426867798392414,0.5151515151515151,0.952320484249544,1.0,2/14,1.81%,CSF1R;ABL2
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.5775183258298862,-0.9426360244860045,0.5614035087719298,1.0,1.0,1/7,6.75%,HSP90AB1
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3810937372139677,0.9425064000069927,0.6060606060606061,0.9516416629460764,1.0,12/66,13.40%,SATB2;SMARCD3;SMARCA4;ZBTB7A;HDAC1;BRWD1;MTF2;ARID1A;SETD7;SMARCA1;MECOM;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.5375438897097347,-0.9419819509444545,0.5333333333333333,1.0,1.0,3/11,15.57%,ANXA1;RPS3;CD4
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.42324270726735236,0.9418567241501233,0.53125,0.9521057232909724,1.0,4/30,8.31%,VAPB;CNOT7;NELFA;AXL
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5051048150320839,-0.9415905508175213,0.546875,1.0,1.0,5/18,17.39%,GSN;HTT;DERL1;SERF2;PRKN
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.49758796351964446,0.9412815346204857,0.5,0.9525442572213975,1.0,3/13,8.58%,HEY2;PCSK5;HEYL
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.5458060715675552,0.9406616336881618,0.5882352941176471,0.9528593748624153,1.0,2/7,7.89%,CDS2;ZFYVE1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.3807759267936822,0.9406013211443378,0.5277777777777778,0.9519994086928313,1.0,9/37,15.40%,UBQLN1;SMAD7;UBE2N;MARCHF7;FBXW7;UBE2D1;COMMD1;NDFIP2;DCUN1D4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4235443769812339,-0.9400464776022531,0.5074626865671642,1.0,1.0,7/55,10.11%,ZFPM1;ANXA1;CMKLR1;N4BP1;THBS1;PDCD4;FN1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.5546852071741362,-0.9397034101724725,0.6,1.0,1.0,2/10,5.32%,TWIST1;PER2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.4006147887892839,-0.938889437878155,0.6125,1.0,1.0,10/102,7.71%,TGFB2;TWIST1;RIPOR2;COL1A1;GCNT2;CMKLR1;RIN2;HSP90AB1;OLFM1;TGFBR1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4255014594808906,0.9379334676323376,0.55,0.9571658241214647,1.0,9/27,22.57%,CDKN1A;PPP6C;PHF8;RPS6KB1;ACVR1B;CACUL1;CUL4A;EIF4E;RB1
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.6388798978699997,0.937819777765664,0.5581395348837209,0.9563274785960841,1.0,3/5,19.85%,EPOR;RASSF1;CCND3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5780755434594245,-0.9378077685800923,0.5740740740740741,1.0,1.0,3/8,17.08%,GLRX;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5402387005929947,0.9374433072033882,0.5686274509803921,0.9561006298639725,1.0,2/9,4.03%,TNFRSF10B;BCL2L1
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.6361513057733463,-0.9374324600431597,0.6212121212121212,1.0,1.0,2/5,16.80%,ASCC3;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.6361513057733463,-0.9374324600431597,0.6212121212121212,1.0,1.0,2/5,16.80%,ASCC3;MGMT
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3923463750895937,0.937095525158313,0.5789473684210527,0.9559351731373514,1.0,7/40,6.68%,EPN2;NOTCH1;ATP2B4;HIPK2;LEMD3;SMAD7;ACVR2A
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.3898444584926265,0.9369292168075466,0.5526315789473685,0.9553198747472041,1.0,4/39,7.71%,CSF1R;CHL1;ABCA1;CPM
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.3435998475105505,0.936675552606358,0.6666666666666666,0.9547423628591631,1.0,16/119,9.82%,CSF1R;HSPB1;MOB1B;PDGFA;NIBAN1;PML;ERBB4;PGF;AKAP8;CEBPB;ACVR2A;CAMKK2;SEMA4D;FBH1;EGFR;PELI2
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.4462059606827491,-0.9366403142063157,0.6071428571428571,1.0,1.0,4/41,7.79%,AFG3L2;LMF1;F3;APH1B
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),0.5209711012627822,0.9358148674905734,0.5,0.9557687526162707,1.0,2/8,10.58%,CEBPB;UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3068522085852777,0.9357964674093269,0.45454545454545453,0.9547796346952001,1.0,30/244,10.20%,DACH1;GATAD2A;NOTCH1;CNOT7;HEY2;TOB1;PML;PHC1;EIF4ENIF1;CTBP2;PTPRK;HSPA8;ATP8B1;RFX3;SOX13;TBX3;SMARCA4;ZBTB7A;HDAC1;CDKN1A;BCL6;HMBOX1;HDAC9;ZBTB16;NACC2;HEYL;RNF139;MBD2;THRA;RPS6KA5
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.38857995418426394,-0.9357581393402142,0.6891891891891891,1.0,1.0,27/90,17.56%,IGFBP5;COL1A1;COL3A1;PROCR;COL1A2;CMKLR1;CPQ;COL6A1;COL12A1;APH1B;DCN;CYP1B1;CALCRL;LAMA4;FN1;NTN4;SMAD6;PLPP3;ITGBL1;FAM114A1;SH3D19;PMP22;SMOC1;ITPRID2;C1S;UACA;NXN
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.5698509182173879,-0.9353098484382671,0.5882352941176471,1.0,1.0,1/8,3.47%,CMTR1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5280993418018889,-0.935271666354711,0.5084745762711864,1.0,1.0,9/15,29.13%,DERL1;SEC13;UFD1;SELENOS;TECPR2;LMAN1;NPLOC4;SEL1L;VCP
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.414571032278525,-0.9351113154939786,0.4852941176470588,1.0,1.0,7/55,8.31%,MYO10;COL1A1;GLI3;GLI2;ADAMTS12;COL4A6;MID1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.5057069133498193,0.934855836083642,0.5217391304347826,0.9561308986219291,1.0,4/13,15.11%,RNF185;AMFR;RNF139;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.4182088290693507,0.9345996312287655,0.6176470588235294,0.955809141525031,1.0,4/24,16.11%,PHC1;CCP110;YAF2;APAF1
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.6085361229540324,0.933702457818231,0.5952380952380952,0.9568541782294735,1.0,2/6,19.63%,PARD3;SKI
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.629649786033753,0.9336253399145819,0.7027027027027027,0.9560371988556655,1.0,2/5,5.15%,CSF1R;MYH9
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.4463999480466608,-0.9327426039120156,0.6129032258064516,1.0,1.0,6/37,19.91%,CTSL;ADAMTS12;PRKN;DDI2;CLPX;UBA52
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3781675606324778,-0.9325437255628047,0.6266666666666667,1.0,1.0,22/165,16.41%,HERC6;DZIP3;HECW2;RNF213;DDB2;RNF19A;FBXO38;PSMD8;FBXW2;FBXO22;SASH1;PELI1;BIRC2;ARIH2;BRCA1;PSMC2;RNF8;WSB1;UBE3D;CDC27;FBXL18;TNKS2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5297755467704723,-0.9324610701562629,0.6363636363636364,1.0,1.0,1/13,5.32%,PER2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.41825129313980414,0.9321881029130415,0.5862068965517241,0.957972469825848,1.0,3/25,4.54%,CDH2;CDH10;SMAD7
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.38781555142279167,-0.9320351733157128,0.5915492957746479,1.0,1.0,17/110,15.34%,ABLIM1;PTPDC1;RTTN;IFT122;GSN;TCTN1;ARMC2;SCLT1;DZIP1;CCDC57;CEP126;DCDC2;DZIP1L;TTC8;ARMC9;NEK1;BBS4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5907485938148227,-0.9320144311132748,0.6101694915254238,1.0,1.0,1/6,10.67%,HLA-B
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.3992804753238458,-0.9319861724371589,0.6125,1.0,1.0,11/79,11.58%,RNF213;DKK3;IGFBP2;NKD1;APCDD1;GLI3;RACK1;SFRP4;PSMD8;TLE4;PSMC2
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5379647796961025,-0.9318859141685573,0.5625,1.0,1.0,2/11,11.10%,VEGFA;POMZP3
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.39833393296116126,-0.9316787870917814,0.5774647887323944,1.0,1.0,9/81,8.96%,SRGAP3;ARHGAP24;ARHGAP15;RASGRF2;VAV3;ARHGAP28;ARHGEF3;RALBP1;RHOQ
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4295737588381261,0.931522898794415,0.5675675675675675,0.9582406089728381,1.0,3/19,4.53%,BCL2;BCL2L1;UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5874032470979575,-0.9313125410112778,0.625,1.0,1.0,2/6,14.35%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5874032470979575,-0.9313125410112778,0.625,1.0,1.0,2/6,14.35%,ENO1;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.45058747900225943,-0.9309868248380943,0.5652173913043478,1.0,1.0,7/36,14.64%,DDX60;CD47;THBS1;PDCD4;SASH1;PLSCR1;IL16
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.55742915745731,-0.930888551284838,0.5384615384615384,1.0,1.0,4/8,18.16%,GLI2;PTCH1;ACVR1;NBL1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.5041565145540481,0.9307556503622691,0.5428571428571428,0.958989694222867,1.0,1/10,2.90%,MTFR1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.39644885199816177,0.9306853108877082,0.5757575757575758,0.9581618944073312,1.0,6/34,6.16%,PPM1L;VAPB;SGPL1;VAPA;CERS6;HACD2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.45979765929802424,0.9297442040434152,0.5,0.9593419156257004,1.0,1/11,3.71%,DLC1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4667906661105964,0.9294077556549991,0.5526315789473685,0.9591874766540021,1.0,3/13,1.63%,NOTCH1;TNFRSF1B;HEY2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.46610648373261976,0.929024955249978,0.525,0.9590573389669225,1.0,6/15,13.97%,ARRDC2;CEBPB;CTDSP1;ELL;OSTF1;ARAP1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.3610590575362823,0.9288897954781262,0.5806451612903226,0.9583527168227638,1.0,10/62,11.15%,CSF1R;BCL2;PML;TIMP3;BCL2L1;LIFR;RHOA;KLHL20;YTHDC2;MCL1
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5282433447713799,0.9288889254449247,0.5454545454545454,0.957338586963692,1.0,2/7,10.89%,HEY2;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.4477012701147174,-0.9287731787009744,0.5522388059701493,1.0,1.0,7/27,26.58%,PSMD8;PSMC2;FHL1;FBXL7;PSMD14;PSMA3;RBX1
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.583876817968207,0.9285016156718037,0.6041666666666666,0.9572825095335987,1.0,2/5,24.49%,SUMO1;AKAP6
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.467381490208548,0.928073915201691,0.5952380952380952,0.9572862317217641,1.0,5/19,12.10%,GNAI1;ADCY9;ADCY3;ADCY5;HTR1F
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.3555242195091353,0.9278877034175754,0.5483870967741935,0.9566341455087511,1.0,6/64,6.09%,BCL2;NFKBIZ;RC3H2;TNFRSF21;UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.37305719342000376,-0.927748102077597,0.6746987951807228,1.0,1.0,26/204,11.41%,PDGFD;FGF1;DDX60;TGFB2;VEGFA;AKR1C2;TERF2IP;GCNT2;RACK1;SEPTIN4;TNFRSF19;RHEB;HSP90AB1;F3;RPS3;TGFBR1;RPS20;THBS1;DCN;PDCD4;SASH1;PELI1;ALPK1;FN1;BIRC2;TRIM13
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.419484785877268,-0.9276858405565502,0.5753424657534246,1.0,1.0,15/55,19.42%,MMS22L;CSE1L;CTCF;RPA1;BRCA1;PRKDC;ATAD2;NASP;NUP107;SMC3;XRCC6;PNN;RBBP7;SPC25;MRE11
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6503777779981028,-0.927569296081019,0.6470588235294118,1.0,1.0,3/5,10.87%,ENPP2;PDXDC1;ASAH1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5356805403531721,0.9273834722135641,0.6122448979591837,0.9557148449274797,1.0,2/6,21.22%,ATG2B;ULK2
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5356805403531721,0.9273834722135641,0.6122448979591837,0.9557148449274797,1.0,2/6,21.22%,ATG2B;ULK2
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.556904177582876,0.9270954923564702,0.525,0.9553755049608543,1.0,3/5,41.59%,PRLR;JAK2;PTK2B
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.6093254155828238,-0.9270432392473804,0.6785714285714286,1.0,1.0,3/5,10.81%,PELI1;YBX3;BIRC2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.6093254155828238,-0.9270432392473804,0.6785714285714286,1.0,1.0,3/5,10.81%,PELI1;YBX3;BIRC2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.509008821791309,-0.9270430363677693,0.5471698113207547,1.0,1.0,2/15,5.37%,WASHC3;GSN
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.5110399571105344,0.9268808094850598,0.5652173913043478,0.9549656366114307,1.0,3/11,14.76%,CD58;ITGA7;CTNNA3
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.47198747232444355,-0.9268783246590094,0.559322033898305,1.0,1.0,5/24,11.88%,WASHC3;GSN;GPX4;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4586651337030188,0.9266617912332408,0.6511627906976745,0.9545329062507233,1.0,3/18,12.28%,TNFAIP8L1;RNF152;DDIT4
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.5897567764887566,-0.92615874378958,0.6037735849056604,1.0,1.0,1/6,11.43%,BRCA1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.5092877600037384,0.9259483869083602,0.5625,0.9553214945310209,1.0,2/7,5.43%,BCL2;IRS2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.5842834779362421,0.9259445175027513,0.6111111111111112,0.954321157887533,1.0,1/8,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4700803761336363,-0.9256091771229166,0.5849056603773585,1.0,1.0,5/22,5.18%,SEMA3C;SEMA6D;PDXDC1;SEMA3D;GPC3
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.5483283492370059,-0.9255722071284951,0.5576923076923077,1.0,1.0,2/6,21.74%,BCL2L11;PIK3R1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.5792158729922351,-0.9255046345692123,0.6363636363636364,1.0,1.0,4/8,24.55%,ASPA;DLD;PHYKPL;AASS
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.5941858738939119,-0.9251897941085916,0.6607142857142857,1.0,1.0,2/5,10.98%,RACK1;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.42870615913624543,-0.9248205563168682,0.5,1.0,1.0,5/43,5.55%,VEGFA;TSHR;LEPR;PER2;CMKLR1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.5972225470413395,0.9246778336573904,0.6,0.9558295737746302,1.0,2/6,17.03%,KPNB1;EZR
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.5743056533476348,0.9240609366152222,0.5777777777777777,0.9562954242451348,1.0,2/6,11.60%,RALA;HK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.443405219671975,0.9239690949804771,0.5,0.9554623921051784,1.0,3/16,5.43%,BCL2;NCK2;IRS2
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6098863916228873,0.923788204494326,0.5909090909090909,0.95486683483363,1.0,4/5,18.38%,RPS6KB1;ACSL3;SLC27A1;ACSL1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.5847947242217743,-0.9234518149298506,0.6363636363636364,1.0,1.0,3/9,15.88%,PER2;CELF2;TPM1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6101116521493888,-0.9231759306776447,0.6140350877192983,1.0,1.0,1/6,7.97%,CCT6A
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.5253502710534765,-0.922582032563439,0.65625,1.0,1.0,4/13,23.05%,RACK1;PRKACA;ZNF236;PDK3
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.43208861831090395,0.9225760673666135,0.6097560975609756,0.956427270244828,1.0,3/21,13.12%,APC;RHOB;ARL3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3454855851166609,0.922486553676866,0.5833333333333334,0.9556319884696981,1.0,9/68,5.74%,RASL12;BCAM;C1QTNF1;TIMP3;PTH1R;EPAS1;CDC42EP4;TNS1;TBX3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.4249408335374907,0.922359917448144,0.5681818181818182,0.9548971106937175,1.0,4/28,11.06%,HSPB1;IRS2;UBASH3B;PAK2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.37871539034885743,-0.9216541640280939,0.6153846153846154,1.0,1.0,13/103,9.09%,ARNT2;ADAM22;NR4A2;GSN;DHX30;ALDH3A2;AFF2;SPOCK1;GRIK1;PTS;VCAN;MARCKS;SHROOM4
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.38228877157623703,0.9214664833977415,0.5,0.9560300883850433,1.0,4/41,3.46%,CSPG4;ST3GAL2;CHST3;GPC5
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.43792203309010025,-0.921442233263105,0.6119402985074627,1.0,1.0,12/38,28.78%,THOC1;SRSF7;U2AF2;SRSF5;FMR1;FLOT1;TGFBR2;RFTN1;CKAP5;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.4380327753312438,0.9214377665784051,0.5277777777777778,0.9551204361326557,1.0,3/13,9.57%,NCOA3;LCOR;EGFR
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5133226963273223,0.9212508720623256,0.5555555555555556,0.9545875041287063,1.0,3/9,11.43%,RNF14;PMEPA1;ARID1A
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.4674463149632645,0.9212099187632652,0.5428571428571428,0.9536461241729879,1.0,4/16,16.80%,RAB27A;PPARA;HDAC2;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.49997608699897905,0.9208873120880368,0.5333333333333333,0.9534665000053915,1.0,2/10,11.06%,PML;PAK2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.45489416149934236,0.9208549625674654,0.5555555555555556,0.952516545821686,1.0,3/17,11.12%,KDM7A;PHF2;PHF8
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.43655191576756497,-0.9208291341520124,0.6507936507936508,1.0,1.0,9/38,17.39%,RNF213;DDB2;TRIM13;BRCA1;NFX1;RNF220;RNF8;UBE3D;PRKN
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.5095318425375314,0.9207915828019805,0.5869565217391305,0.951743530914823,1.0,2/11,7.09%,PDGFA;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.3689624960167108,0.9206713130796232,0.5882352941176471,0.9510420291318475,1.0,12/50,15.45%,CSF1R;NCOA3;ACVR2A;TIPARP;RHOA;SLIT3;BMPR1A;NCOA2;LEF1;RPS6KB1;ACVR1B;PTPN9
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.46067297942366614,0.9205052235993417,0.5384615384615384,0.9504467431615412,1.0,4/16,17.52%,DNAJC15;IMMP1L;IMMP2L;PITRM1
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5944703042361443,-0.9204468817687912,0.6122448979591837,1.0,1.0,1/5,0.87%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5194901993480532,0.9203875835497302,0.6428571428571429,0.949736389706336,1.0,3/10,12.28%,NCK2;SMAD7;DDIT4
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.47352531872076487,0.9200514289472156,0.525,0.9494224840163944,1.0,11/17,28.89%,GUCY1B1;PDE3A;RAPGEF2;RIMS2;CAP2;PDE2A;PDE4D;AKAP6;PDE7B;KSR1;NUDT4
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5286575711061978,0.9195322069065057,0.5789473684210527,0.9498055442555605,1.0,1/13,0.96%,PDK4
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5660729181833091,0.9195029841185278,0.5777777777777777,0.9489009454413057,1.0,1/5,11.60%,HK1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.31219973024085745,0.9193327201476748,0.6,0.948195087079893,1.0,26/161,12.58%,HSPA1A;TNFRSF1B;SERPINB6;TMEM30A;SLC44A2;SNAP29;CD44;ACTR2;HSPA8;VAPA;RAB27A;CD58;TMEM63A;GDI2;ANPEP;RAB31;RHOA;CAB39;SNAP23;SURF4;ADAM17;CYB5R3;NFKB1;RAP1A;CAT;OSTF1
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.40048785571088286,-0.9190814410225497,0.6268656716417911,1.0,1.0,12/53,18.33%,CMKLR1;SFRP4;PRMT2;OTULIN;CYP1B1;PTCH1;BHLHE40;UFL1;TMSB4X;SP100;HES1;TCF7L2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.49999680405697544,-0.9189811043784495,0.576271186440678,1.0,1.0,2/14,5.37%,GPC3;GSN
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.523682807541616,0.9185117355408394,0.6097560975609756,0.9489484584259753,1.0,3/10,21.39%,UBASH3B;ANK2;PRNP
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5219708396653179,-0.9184759702560413,0.5915492957746479,1.0,1.0,1/11,6.09%,RMDN1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5101247456755185,-0.9174181504005702,0.532258064516129,1.0,1.0,2/12,7.79%,ADAM9;APH1B
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.4619413302344767,0.9169742459841334,0.6346153846153846,0.9512952779985632,1.0,3/16,3.24%,SEMA4B;CDH2;ERBB4
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.5035008842282147,-0.9169506768659237,0.6346153846153846,1.0,1.0,1/13,0.99%,PRRC1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.48240761989223846,-0.9164976599662068,0.5573770491803278,1.0,1.0,5/19,23.56%,POLA1;RPA1;WRN;UBA52;POLK
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5660119047426286,0.9152547952905224,0.6216216216216216,0.9541222388003182,1.0,7/8,24.40%,HACD2;ELOVL6;ELOVL5;ACSL3;ACSL1;TECR;ACSL4
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.502134381912207,0.9152276410589311,0.5897435897435898,0.9532063161930026,1.0,6/15,12.31%,NEXMIF;CTNNA2;ZNF609;RAPGEF2;SEMA6A;PLAA
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.45486089172465743,-0.9152215570849022,0.6086956521739131,1.0,1.0,1/26,0.36%,CLU
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.46025128585774344,-0.9151766250794043,0.5735294117647058,1.0,1.0,3/22,7.86%,VEGFA;BEX3;THBS1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.4437325697713114,0.9151218682777023,0.5483870967741935,0.952465099086306,1.0,3/16,7.61%,ST3GAL2;C1GALT1;B3GNT2
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.324103017592154,0.9150522269382388,0.6666666666666666,0.9517023699640915,1.0,20/151,11.45%,HSPA1A;NOTCH1;CNOT7;HEY2;TOB1;ATP2B4;EIF4ENIF1;TMBIM6;HDAC1;TIPARP;AGO2;MAP2K2;HDAC9;RNF139;RPS6KA5;MTF2;BMPR1A;FBXW7;NFKB1;AEBP2
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.5127767715215532,-0.9148762046330244,0.625,1.0,1.0,4/17,17.39%,BRCA1;MT3;APOE;PRKN
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.5072701438796534,-0.9147350303444348,0.6,1.0,1.0,5/15,11.06%,RIPOR2;NRP1;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),0.4731249560695873,0.9142305046776151,0.5945945945945946,0.9525510668845126,1.0,2/9,7.60%,EIF4EBP2;AGO2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.618763374728138,-0.9141254269199327,0.72,1.0,1.0,1/5,11.43%,BRCA1
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5063141459885964,0.9136812429007614,0.5897435897435898,0.9530534163500288,1.0,2/9,2.81%,TNFRSF1B;TIMP3
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.3093761411458363,0.9128410533332737,0.5625,0.9537154063589314,1.0,25/160,12.58%,HSPA1A;TNFRSF1B;SERPINB6;TMEM30A;SLC44A2;SNAP29;CD44;ACTR2;HSPA8;VAPA;RAB27A;CD58;TMEM63A;GDI2;ANPEP;RAB31;RHOA;CAB39;SNAP23;SURF4;CYB5R3;NFKB1;RAP1A;CAT;OSTF1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.456616117415229,-0.9124100017412141,0.5666666666666667,1.0,1.0,2/22,1.97%,EPN1;SPRY1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.43929176905536327,0.9123951074082811,0.6129032258064516,0.9537799196439195,1.0,6/23,14.56%,NDRG2;GLUD1;RHOA;MBP;CKB;CDC42
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.5302288178928731,0.9123731966921386,0.5555555555555556,0.9529166497664037,1.0,1/5,6.09%,MAP3K7
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.4733501862936958,0.9123241431645785,0.575,0.9520551273987612,1.0,2/15,3.63%,NCK2;CD44
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),-0.43389836833964435,-0.9119793111384839,0.582089552238806,1.0,1.0,3/34,6.51%,TGFB2;MYO18A;ADAM9
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.44326939491441875,-0.911972604609337,0.5555555555555556,1.0,1.0,5/35,11.57%,AFG3L2;CTSL;F3;APH1B;PTCH1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.3094470759828572,0.9119273866106935,0.5625,0.951892536947229,1.0,25/159,12.58%,HSPA1A;TNFRSF1B;SERPINB6;TMEM30A;SLC44A2;SNAP29;CD44;ACTR2;HSPA8;VAPA;RAB27A;CD58;TMEM63A;GDI2;ANPEP;RAB31;RHOA;CAB39;SNAP23;SURF4;CYB5R3;NFKB1;RAP1A;CAT;OSTF1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),0.5209745853290612,0.9118570567449817,0.6086956521739131,0.9510337894862073,1.0,2/6,21.18%,PHF8;FLNA
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.5557029394992785,-0.9112175618762411,0.6615384615384615,1.0,1.0,6/14,19.42%,ANXA1;WRN;DHX36;ASCC3;ZRANB3;MRE11
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.5562784988965952,-0.9107692553234474,0.5789473684210527,1.0,1.0,2/7,10.76%,EXT1;CSGALNACT1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.40199316683694003,0.9106394542490734,0.5833333333333334,0.95270896776498,1.0,5/39,8.70%,KCNC2;HPRT1;ATL2;NACC2;USP16
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.5346927273211625,-0.9101760797787136,0.5614035087719298,1.0,1.0,6/9,38.21%,CYP27A1;HSD17B4;OSBP;OSBPL3;OSBPL6;CYP7B1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.5165536863625952,-0.9101659025477041,0.6833333333333333,1.0,1.0,3/14,9.74%,TERF2IP;HSP90AB1;RPA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5165536863625952,-0.9101659025477041,0.6833333333333333,1.0,1.0,3/14,9.74%,TERF2IP;HSP90AB1;RPA1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.3566761248150381,0.9100358580546517,0.75,0.9530589747768218,1.0,22/81,15.31%,HSPA1A;BCL2;PML;NDRG3;TP53TG5;PPP2R1A;NRG3;SMARCA4;CDKN1A;BCL6;SLIT3;EGFR;APBB1;ADAM17;APBB2;CHPT1;ACVR1B;CDC42;CSNK2A1;DDX3X;JADE1;RASGRP2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.503793248166869,-0.9098587400701468,0.5555555555555556,1.0,1.0,2/16,11.12%,PELI1;SMAD6
prerank,PanglaoDB_Augmented_2021__Monocytes,0.45227905998605467,0.9098558410872633,0.6388888888888888,0.952463462954527,1.0,5/19,6.41%,CSF1R;TNFRSF1B;NFKBIZ;CD44;CEBPB
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.40579147473663735,-0.9093956901283178,0.5857142857142857,1.0,1.0,5/48,8.06%,HECW2;NKD1;CENATAC;GPC3;AZIN1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.4503848292465485,-0.9093899668572486,0.6229508196721312,1.0,1.0,1/32,0.36%,CLU
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.43268554204169163,-0.9088388470973258,0.631578947368421,1.0,1.0,8/39,17.08%,SPRY1;FBLN1;PPIA;SPRY3;PEBP1;SPRY4;APOE;WNK2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.3577639380166113,-0.9086942627977611,0.5769230769230769,1.0,1.0,21/191,12.53%,ABLIM1;CIRBP;PTPDC1;TUBGCP5;GOLGA8A;IFT122;GSN;TCTN1;SCLT1;RPS3;DZIP1;CCDC57;HPS4;GABARAPL1;CEP126;DCDC2;DZIP1L;INO80;TTC8;CSNK1D;VPS36
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3938663423579069,-0.9086767798177815,0.5972222222222222,1.0,1.0,5/43,7.60%,BEX3;RACK1;GSN;F3;RPS3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.4219277346281831,-0.9085933113623589,0.53125,1.0,1.0,2/39,1.02%,TGFB2;RIMS1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.3233848099862421,0.9085260351812418,0.7272727272727273,0.9541435189077682,1.0,7/101,5.99%,VAPB;ATL2;ATP8B1;VAPA;LEMD3;ARHGEF7;AP3D1
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.4746345152134868,0.9083183528012072,0.5714285714285714,0.9537185203823644,1.0,2/9,11.69%,FMNL3;FHOD1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.554146376868108,-0.908054675816566,0.6166666666666667,1.0,1.0,4/10,22.32%,PDCD4;MAPK14;APPL2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.5511132344969559,-0.9079633995155083,0.6065573770491803,1.0,1.0,3/9,11.18%,RPS3;SASH1;MAP3K4
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.5498306168019791,0.907809540126618,0.6136363636363636,0.9538504768937419,1.0,3/7,15.85%,RAPGEF2;RAP1A;RAPGEF1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.48601180704410274,-0.9077289071450142,0.6567164179104478,1.0,1.0,4/14,16.24%,MMS22L;THOC1;WRN;ZRANB3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.5891198772727406,0.9074925491437792,0.6428571428571429,0.9535626764022188,1.0,1/6,1.07%,NOTCH1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.38342472287419027,-0.9072694024730501,0.631578947368421,1.0,1.0,3/62,1.50%,SHROOM3;IGFBP5;KIAA1217
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5555233627673377,0.907188415177655,0.6046511627906976,0.9532188213188644,1.0,4/7,18.59%,NRXN1;NLGN2;NLGN4Y;GPHN
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5883723378724235,-0.907102750833216,0.6521739130434783,1.0,1.0,2/8,10.16%,RSRC1;DDX5
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.5391258474196591,0.9068756674973478,0.6595744680851063,0.9528756546340749,1.0,1/7,3.97%,ARF1
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3490269376612442,-0.9068249247059962,0.6707317073170732,1.0,1.0,22/161,12.42%,TWIST1;RIPOR2;GBP2;VEGFA;MT2A;STAT1;ANXA1;EPRS1;LEPR;ADAMTS12;COL1A2;ZFP36L2;CD47;F3;RPS3;YBX3;FN1;ASAH1;BRCA1;FOXC1;IL1R1;TXLNA
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.40099148718424565,0.9065520077184788,0.6388888888888888,0.9526009959830121,1.0,8/25,24.08%,ADGRV1;SYT17;SLC25A24;RASGRP2;RYR3;SYT1;ADD1;PRKAA2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5522182594369633,-0.9061754409395624,0.6610169491525424,1.0,1.0,2/9,12.66%,RPS3;LGALS3
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3849613627490064,-0.9061259847253855,0.6567164179104478,1.0,1.0,6/49,6.53%,IGFBP5;PGR;SEMA6D;ALDH1A1;KCNIP1;PDZRN3
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.44794841713070954,0.9060403974517713,0.6176470588235294,0.9527447021033495,1.0,5/13,22.58%,ABCA1;NFKB1;PPARA;IL18;AGT
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4508936762320179,-0.9053499313127821,0.625,1.0,1.0,9/37,15.94%,SEPTIN4;ZC3H14;JAM3;SNAP91;TLE4;PEBP1;RAD17;HSPA4L;TOPBP1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.5992872274163503,-0.9051635724776231,0.6545454545454545,1.0,1.0,2/5,13.51%,CTSL;THRB
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.5992872274163503,-0.9051635724776231,0.6545454545454545,1.0,1.0,2/5,13.51%,CTSL;THRB
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.39900731071707696,-0.9051457501224844,0.56,1.0,1.0,6/62,7.29%,PGR;NR4A2;SNW1;NR4A1;NR2F1;NOTCH2
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.5756788738109726,-0.904835314212327,0.6229508196721312,1.0,1.0,1/7,3.69%,MSH6
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.36667721188261126,-0.9047934826999485,0.6666666666666666,1.0,1.0,15/144,8.22%,PDGFD;FGF1;TGFB2;NRP1;VEGFA;CEMIP;TERF2IP;ENPP2;LEPR;RACK1;BMP5;FAXDC2;HSP90AB1;TGFBR1;RALBP1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3552869147879052,0.9045096945922072,0.7096774193548387,0.9550653649261958,1.0,9/51,15.82%,BCAM;EPAS1;CDC42EP4;GPRC5C;ARHGEF10L;MYO1D;SCARB2;DOCK1;MAOA
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.48007032260381083,0.9043935390113935,0.5238095238095238,0.9543836315627884,1.0,2/10,12.45%,GTF3C2;ELL
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.43310549177182384,-0.9041866511973562,0.5797101449275363,1.0,1.0,3/31,6.75%,VEGFA;TERF2IP;HSP90AB1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.4932448585053957,0.9038480962333012,0.5294117647058824,0.9544913570017316,1.0,5/22,10.31%,UBE2N;WDR33;MSH2;RAD18;USP10
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.4165329898799697,-0.9037334606487721,0.5147058823529411,1.0,1.0,11/43,19.70%,VEGFA;TSPYL2;SSR1;FUS;EEF2;EXOSC10;RPS14;EIF4G1;PAIP1;HSPA9;SERP1
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.5920874042483228,0.9036021797812174,0.6363636363636364,0.9541152307291288,1.0,1/5,7.15%,USP7
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.3558438072580686,0.9034883267359264,0.6176470588235294,0.9534589472342498,1.0,10/58,16.75%,NFKBIZ;RC3H2;TNFRSF21;UBE2N;MAP3K7;PAK2;NFKB1;BTRC;WNK1;PIK3CD
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.5580307495692677,0.9031562165096493,0.6458333333333334,0.953163168508217,1.0,4/5,32.99%,BDP1;TAF1B;GTF2B;TAF7
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.47571905059752273,0.9031540041182623,0.55,0.9522175701267603,1.0,4/12,16.98%,AGO2;PIWIL4;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5724028828480668,0.902888588917528,0.6739130434782609,0.9518563912364086,1.0,2/5,18.15%,BCL6;CBFB
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.5563192856216357,-0.9027081245019096,0.6101694915254238,1.0,1.0,3/8,25.95%,UBA52;TUT7;TUT4
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.42549933404622386,-0.902638707956764,0.6029411764705882,1.0,1.0,6/48,7.71%,NRP1;ACTG1;PHLDB2;ARHGAP28;CD47;TGFBR1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.5798947980141184,-0.9021122815199359,0.6229508196721312,1.0,1.0,1/5,1.21%,LMF1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.4973881215687402,-0.902000407647483,0.5942028985507246,1.0,1.0,2/23,5.18%,CLU;GPC3
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5166862062819011,0.9018037809672861,0.6,0.953488050103525,1.0,3/7,13.74%,EMP2;HMBOX1;LDB2
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5487944016727039,-0.9014265652395081,0.6785714285714286,1.0,1.0,2/8,16.08%,OLFM1;APOE
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),0.42684028915566397,0.9014190254417538,0.5897435897435898,0.9533275803910917,1.0,5/20,11.14%,ZBTB7A;HDAC9;AXL;MSH2;ADAM17
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4617506785964609,-0.9009278759352574,0.5714285714285714,1.0,1.0,3/22,7.24%,PARP1;MSH6;NCL
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.6109028356674177,-0.9009235524997468,0.6851851851851852,1.0,1.0,1/5,19.91%,UBA52
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.6109028356674177,-0.9009235524997468,0.6851851851851852,1.0,1.0,1/5,19.91%,UBA52
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.5437959867008503,-0.90064240467014,0.6,1.0,1.0,4/8,29.67%,LGALS3;PKD2;FYN;PDGFRB
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.3629035334587918,0.900603592765832,0.7352941176470589,0.9544407601314355,1.0,10/55,13.59%,PHC1;UBE2N;HDAC1;HDAC9;USP16;PHF20L1;PHF20;RPS6KA5;HDAC2;EP300
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.4903742366357038,-0.9002551372619603,0.578125,1.0,1.0,4/21,7.86%,NRP1;VEGFA;F3;THBS1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5550069633111573,-0.900125573069322,0.5714285714285714,1.0,1.0,1/8,7.71%,TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.5758716469726116,-0.8997831544944063,0.6229508196721312,1.0,1.0,1/6,3.69%,MSH6
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.4949197592041799,-0.8997021713747265,0.6666666666666666,1.0,1.0,5/19,15.51%,PER2;ENO1;PGK1;HECTD4;SLC25A13
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.4558998363492056,0.8996419729555308,0.625,0.955786071749143,1.0,4/17,9.71%,DGKB;DGKH;DGKE;DGKG
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.5487038351127386,0.8996107277060641,0.6097560975609756,0.9548546294858069,1.0,2/6,14.22%,ATP10A;DNM2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.37461612362714014,0.8994430720342664,0.6153846153846154,0.9541700270771531,1.0,4/53,2.93%,TENM2;CDH2;CNTN4;CDH10
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4559760803075618,-0.8992178178277653,0.5254237288135594,1.0,1.0,7/21,20.49%,PLXNC1;SLIT2;PLXNA2;NGF;ROBO2;ZFYVE27;GOLGA4
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.5670172237640447,-0.8991214281730654,0.631578947368421,1.0,1.0,2/5,23.82%,VCL;KIFC3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.4347105104228102,-0.8991067502112202,0.6231884057971014,1.0,1.0,12/41,13.51%,TGFB2;KCNMB1;NR4A2;FGGY;IGFBP2;SGK1;PTGFR;PLAG1;BTG2;IFI44L;EPHA5;THRB
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.357209814703666,0.8990970723903041,0.7272727272727273,0.953942922198609,1.0,8/47,6.45%,PPM1L;VAPB;SGPL1;VAPA;PPP2R1A;CERS6;HACD2;UGCG
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.30271884056768245,0.8990291655599256,0.7857142857142857,0.953216103905196,1.0,23/193,12.22%,VAPB;WTIP;ATL2;MTFR1;SORT1;FMNL3;PDZD8;ATP8B1;VAPA;PACSIN2;MICAL2;ARHGAP10;ARHGEF7;RAB31;SYNE3;BRWD1;KLHL20;GABPB1;FAM174B;CAMSAP1;SURF4;SEMA6A;RANBP10
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5324634430983585,0.8988995502126913,0.6388888888888888,0.9525129210440415,1.0,1/7,12.16%,IWS1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4434021818033937,0.8986511029544918,0.5909090909090909,0.9522437395744904,1.0,4/17,8.11%,SOX6;CD44;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.560059567290893,0.8983837006686478,0.6274509803921569,0.9518753481170995,1.0,2/8,3.07%,ADGRB3;SORT1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.4491532930587663,-0.8983559508155626,0.6923076923076923,1.0,1.0,13/40,15.48%,SLC47A1;SLC8B1;KCNMB1;SLC6A20;SCN7A;SLC11A2;SGK1;FGF13;ANO6;SLC41A1;SLC4A4;ATP1B1;SCN2A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5382940667094234,0.8981396525317619,0.6346153846153846,0.9515187494115608,1.0,3/8,16.95%,SMAD7;DDIT4;PARD3
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.455505556896612,0.8976406425126595,0.6511627906976745,0.9517601042291386,1.0,4/14,14.58%,DTNA;RYR2;TTN;KCNQ1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.39980297606479437,0.8974434305888384,0.5357142857142857,0.9512827710732683,1.0,7/26,14.56%,CDC42EP4;ARHGEF1;ARHGAP6;RHOA;RHOB;GNA12;CDC42
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),-0.5483734081183321,-0.8965841912039917,0.6363636363636364,1.0,1.0,1/7,1.10%,MLPH
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),-0.5483734081183321,-0.8965841912039917,0.6363636363636364,1.0,1.0,1/7,1.10%,MLPH
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),-0.5483734081183321,-0.8965841912039917,0.6363636363636364,1.0,1.0,1/7,1.10%,MLPH
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),-0.5483734081183321,-0.8965841912039917,0.6363636363636364,1.0,1.0,1/7,1.10%,MLPH
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.4373704557304278,0.896245427994992,0.6382978723404256,0.9526829472042772,1.0,2/17,11.74%,RAB27A;WASHC5
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.47884689349557696,0.8960913933797865,0.6818181818181818,0.9521284496642637,1.0,1/11,6.09%,MAP3K7
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.5587806965297345,-0.8960533517440246,0.6206896551724138,1.0,1.0,2/8,14.50%,GSN;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.5587806965297345,-0.8960533517440246,0.6206896551724138,1.0,1.0,2/8,14.50%,GSN;ATP1B1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.46399393214000983,-0.8959422445880264,0.6612903225806451,1.0,1.0,8/23,22.91%,UIMC1;BRCA1;PRKDC;MRNIP;RAD17;TOPBP1;MRE11;BABAM2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.4389809039997141,-0.8958590787846747,0.6571428571428571,1.0,1.0,6/36,7.86%,TGFB2;SNW1;BMP5;HSP90AB1;TGFBR1;THBS1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5205489023614178,0.8954551636107523,0.6304347826086957,0.9524564066400156,1.0,2/8,4.96%,HSPA1A;PTGES3
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.3679261552146474,-0.8952312636966405,0.6428571428571429,1.0,1.0,17/125,11.63%,THSD4;ARHGAP24;KIAA1217;VEGFA;RASSF8;IQGAP2;ADM;LAMC1;PROS1;COL12A1;MID1;PLEKHH2;LAMB1;NTN4;PLPP3;COL4A5;FOXC1
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.5643404572925946,-0.8950223210227183,0.578125,1.0,1.0,1/8,1.72%,ACTG1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.4893648376056069,0.8948376297251814,0.6052631578947368,0.9527837249459024,1.0,1/10,1.47%,CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5793777955365316,-0.8945505677857889,0.6379310344827587,1.0,1.0,3/5,30.69%,PTPN2;LRP1;APOD
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.4606967584025836,-0.8942696815128246,0.6166666666666667,1.0,1.0,6/24,21.63%,GSN;APH1B;PRKN;CST3;UBA52;SNCAIP
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3751653127699462,-0.8940632219555497,0.6,1.0,1.0,19/101,13.66%,CIRBP;IGFBP5;RPS4X;RPL5;EPRS1;RACK1;PLD1;NCL;RPS3;THBS1;SAMD4A;UPF3A;BTG2;LARP1;PRKDC;EIF4H;DHX36;EIF1B;EEF2
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.36481683355633815,-0.8940378524311895,0.6493506493506493,1.0,1.0,28/126,21.54%,RIMS1;AFG3L2;ELOB;AFDN;EPRS1;LAMC1;FN1;CNIH3;TLE4;ANO6;CSNK1D;REPS2;SEC13;SNX9;HES1;USO1;HGSNAT;ANKRD28;TCF7L2;FARP2;NAPG;TSPAN4;CD2AP;ZNHIT6;SLC2A1;FANCC;MCFD2;FBXL7
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.46576017113332335,-0.8939004694402128,0.6440677966101694,1.0,1.0,1/15,0.71%,IGFBP5
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.3734511635202591,-0.893655122393359,0.6,1.0,1.0,11/66,15.35%,XPC;PSMD8;CCDC57;BTG2;SRA1;PSMC2;FOXC1;DYNLT3;BTG1;ANGEL2;CDC27
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.4874263762479688,0.8936243685896641,0.5952380952380952,0.9543969075711983,1.0,9/13,27.88%,PDE3A;RAPGEF2;RIMS2;CAP2;PDE2A;PDE4D;AKAP6;PDE7B;KSR1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.45337746449684424,-0.8932721646156581,0.5967741935483871,1.0,1.0,9/23,20.70%,SLC6A20;SLC25A13;SLC6A13;LRRC8B;SLC1A1;SLC1A2;SLC7A2;SLC1A3;SLC16A12
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5978507738200873,-0.8931047564685809,0.6949152542372882,1.0,1.0,1/5,10.67%,HLA-B
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.5780378078601867,-0.89304980753259,0.6166666666666667,1.0,1.0,1/6,11.00%,ACAT1
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.4121543755536039,-0.8925985497773291,0.5909090909090909,1.0,1.0,11/52,17.65%,GBP2;XPA;COL1A1;CSE1L;WRN;RPL11;HIKESHI;SEC13;BBS4;NUP107;APPL2
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.43238237041793065,0.8924988374266489,0.625,0.9556774032508806,1.0,6/17,29.16%,MTF2;AEBP2;TASOR;JARID2;EED;EPC1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.46975380135967576,0.8924049901578275,0.6190476190476191,0.9550129463559077,1.0,4/13,10.11%,CACNA1B;CACNA1C;CACNB2;MCU
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.4084723658820669,-0.8922443212929353,0.6865671641791045,1.0,1.0,8/47,14.02%,PRPF6;RSRC1;NONO;FUS;WBP4;SRSF10;PRPF8;SRPK1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.5942869814235738,-0.8919828344500101,0.6779661016949152,1.0,1.0,1/5,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5330769061251224,-0.8918469722576807,0.603448275862069,1.0,1.0,2/10,15.83%,CCT6A;EXOSC10
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.515701368253217,-0.8917676961631484,0.5818181818181818,1.0,1.0,3/11,11.06%,PHLDB2;THBS1;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.515701368253217,-0.8917676961631484,0.5818181818181818,1.0,1.0,3/11,11.06%,PHLDB2;THBS1;BCAS3
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.5273032373546884,-0.8915055578695323,0.6140350877192983,1.0,1.0,1/12,0.90%,TWIST1
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.3794728494221311,0.890809491259168,0.6666666666666666,0.9576060094235617,1.0,7/39,11.93%,EIF4ENIF1;KPNA4;IPO8;CBLB;IPO11;NUP54;IPO9
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.44905884293459053,-0.8907375029912616,0.6338028169014085,1.0,1.0,3/29,9.85%,ADM;PIK3R4;CALCRL
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.43675888249993655,0.8907195265866376,0.5405405405405406,0.9569081120803704,1.0,4/12,22.35%,PPARA;ELOVL5;SLC27A1;CREB1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.5636519461884517,0.8906349591889017,0.6304347826086957,0.956167795887016,1.0,2/6,7.44%,GFAP;DNAJB6
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.40200176477673716,-0.8906023611615124,0.7,1.0,1.0,12/70,15.73%,VAMP4;GOLGA8A;MYO18A;HTT;COG4;BCAS3;CSNK1D;STX17;PDCD10;TMED4;GOLGA8B;SYNE1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.4797713213452189,0.890283667537655,0.5581395348837209,0.9559208485380186,1.0,3/8,16.80%,RAB27A;PPARA;GRIN1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.4708112113757741,-0.89015432920392,0.5857142857142857,1.0,1.0,1/22,0.62%,SERTAD2
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3680126560819288,0.8900835304974029,0.7307692307692307,0.9554013441615268,1.0,2/30,2.81%,BCL2;TIMP3
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.44959032030251894,0.8900094075232026,0.6136363636363636,0.9545991611883865,1.0,7/18,22.46%,SAMD8;FOXO3;GRM5;CYFIP1;EIF4E;PICALM;ROCK1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.4207104833969115,-0.8900031845629331,0.6825396825396826,1.0,1.0,3/34,12.66%,ZFPM1;THBS1;LGALS3
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.48228479311281075,0.8898368559694181,0.6052631578947368,0.9540710329732993,1.0,1/10,0.37%,NOX4
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.5486371879437739,0.8897402267193855,0.5581395348837209,0.9533914650879455,1.0,2/5,9.49%,RHOA;SLIT3
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.43220559684998283,0.8896313471241698,0.575,0.9527349639679655,1.0,3/15,11.58%,FMN2;EGFR;PPARA
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.43317143913483347,0.8894597712178787,0.6190476190476191,0.9521884139725062,1.0,5/20,11.17%,GUCY1A1;GUCY1B1;ELN;SGCZ;CYB5R3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.4449726451326972,-0.8894367210805423,0.5849056603773585,1.0,1.0,2/19,9.12%,IGFBP5;PDCD4
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.3849235081185953,-0.8888182894133867,0.6619718309859155,1.0,1.0,6/71,7.29%,PGR;NR4A2;SNW1;NR4A1;NR2F1;NOTCH2
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.5210451985505764,0.8887658194483464,0.6122448979591837,0.9525550214266063,1.0,1/6,2.57%,SNAP29
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.5786460273450229,-0.8886819297398924,0.6078431372549019,1.0,1.0,2/5,13.68%,MSH6;RNF8
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.46418493429551977,-0.8886519598292411,0.7166666666666667,1.0,1.0,4/26,5.32%,NR4A2;ERAP1;NR4A1;PER2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.5256196827475872,-0.8885886970499957,0.6065573770491803,1.0,1.0,2/10,5.37%,ELMO1;GSN
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.5435537511892873,0.8880528242361473,0.6326530612244898,0.9530185572258382,1.0,1/5,22.58%,AGT
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5367220736369753,-0.8878187737905284,0.6607142857142857,1.0,1.0,5/9,28.30%,SLC4A4;TM9SF4;SLC9A9;SLC9A8;CA2
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5010998317248159,-0.887724407507799,0.6349206349206349,1.0,1.0,1/13,0.28%,SLC47A1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.4145277659993554,0.8876040121667764,0.6206896551724138,0.952895973777886,1.0,8/19,29.79%,WDR33;PCF11;CPSF2;TAF1B;PAPOLA;SYMPK;SCAF8;CPSF7
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.4632945521567431,-0.8875363680089308,0.6307692307692307,1.0,1.0,4/23,17.25%,GRIA4;CNIH3;MINK1;GRIA3
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.38277770875919676,0.8874201564702521,0.6829268292682927,0.9523730180579292,1.0,2/26,1.35%,VAPB;CNOT7
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.4819156983939209,0.8873925619116244,0.6052631578947368,0.9505952632116471,1.0,5/15,15.11%,MGAT5;RPN2;STT3B;UBE2J1;UGGT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.4819156983939209,0.8873925619116244,0.6052631578947368,0.9505952632116471,1.0,5/15,15.11%,MGAT5;RPN2;STT3B;UBE2J1;UGGT1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.3872732229488188,-0.8869576463476604,0.6619718309859155,1.0,1.0,8/74,7.86%,FGF1;AKR1C2;GCNT2;RACK1;HSP90AB1;F3;TGFBR1;THBS1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.4893823785928447,0.8865532824619892,0.6216216216216216,0.9514471201965157,1.0,3/10,14.00%,CDH2;RYR2;TTN
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.5074374814629315,0.8865166622600139,0.7291666666666666,0.9506147520637742,1.0,4/10,22.57%,PHF8;TTN;CSNK2A1;RB1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4807482013432186,0.8865162762815836,0.631578947368421,0.9497085416232939,1.0,2/10,8.44%,ARF1;CTNNA2
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5573296478818618,0.8861025061788809,0.6216216216216216,0.9497406426838229,1.0,3/6,20.18%,NDUFS2;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.41184254328857783,-0.8858687817961031,0.6438356164383562,1.0,1.0,9/44,12.93%,IGFBP5;EPRS1;RACK1;NCL;RPS3;SAMD4A;BTG2;LARP1;DHX36
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3486672018650631,-0.8857925253921042,0.6923076923076923,1.0,1.0,28/246,11.99%,HERC6;ELOB;KLHL13;DZIP3;HECW2;RNF213;DDB2;UVSSA;RNF19A;RACK1;PDZRN3;OTULIN;PSMD8;FBXW2;FBXO22;SASH1;PELI1;KLHL7;BIRC2;MARCHF3;NUB1;DERL1;ARIH2;TRIM13;BRCA1;PSMC2;PRKDC;NFX1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.5980177311777353,-0.8855909244454279,0.7037037037037037,1.0,1.0,1/5,4.99%,LEPR
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.4638032869185801,0.88558489869664,0.6363636363636364,0.9498049479765661,1.0,2/11,7.61%,ST3GAL2;B3GNT2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.37502261815113336,-0.8855759818746367,0.7391304347826086,1.0,1.0,11/76,11.57%,SPRY1;ALDH1A1;ADM;PROCR;LDLRAD4;BMP5;N4BP1;RHEB;LAMA4;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.3663530401897505,0.8844916604704314,0.7111111111111111,0.9509973437119564,1.0,8/34,10.36%,KCNC2;CACNA1C;RFX3;IRS2;GLUD1;IRS1;MCU;ADCY5
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.4567009220905379,-0.8834940240212963,0.6721311475409836,1.0,1.0,2/15,11.63%,ZFP36L2;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.6092496576262213,-0.8833890170322211,0.7058823529411765,1.0,1.0,2/5,21.96%,APPL2;SELENOS
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3487265786362822,-0.8831293823192282,0.6962025316455697,1.0,1.0,20/142,15.54%,ABLIM1;NRP1;PTPDC1;IFT122;GSN;TCTN1;SCLT1;DZIP1;CCDC57;CEP126;DCDC2;DZIP1L;ANO6;TTC8;FGD6;ARMC9;NEK1;MINK1;BBS4;PMP22
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.3061293016422264,0.8829002268007028,0.85,0.953593717604669,1.0,22/128,14.49%,PDGFA;RGL3;ERBB4;BCL2L1;RASAL2;IRS2;MAP3K7;NRG2;RAF1;CAMKK2;MAP2K2;PDE6D;IRS1;EGFR;PPP1CC;NFKB1;RAPGEF2;MBP;LRRC7;MAP2K1;GRIN2B;BTRC
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.44634577401252684,-0.8827536445875019,0.6818181818181818,1.0,1.0,1/27,1.02%,RIMS1
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.36067449741546015,-0.8824985914857227,0.7105263157894737,1.0,1.0,26/99,15.42%,ABCA8;ST6GALNAC3;CD55;COL15A1;MLPH;LIMA1;EXT1;ALDH1A1;ENPP2;SGCD;GSN;COL1A2;RIN2;FMO2;DCN;SHROOM4;CALCRL;GPM6A;PLPP3;IL1R1;SLC4A4;TRANK1;CFH;EPB41L3;CYP27A1;HSD11B1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.4643195394351986,-0.8819605231612472,0.6031746031746031,1.0,1.0,1/16,5.06%,ESCO1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4893946924692599,0.8814336709697009,0.6923076923076923,0.9560135728869409,1.0,7/16,22.46%,RAPGEF2;RAP1A;PDLIM5;TJP1;RAPGEF1;CBFB;ROCK1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.5323461143976206,0.881370761971137,0.68,0.9551609705274565,1.0,4/8,22.57%,PHF8;TTN;CSNK2A1;RB1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.4726555399001116,-0.8810433349247139,0.6451612903225806,1.0,1.0,3/15,5.77%,PIGG;ST3GAL4;ST3GAL5
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.40534922728210276,-0.8810108371981391,0.726027397260274,1.0,1.0,9/62,13.34%,SHROOM3;ELMO1;GSN;MARCKS;ABI2;BAIAP2L2;SHROOM4;TPM2;SVIL
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.5305157382476797,-0.8806718350073182,0.7,1.0,1.0,1/11,0.36%,CLU
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.39193613327334015,-0.8806712378550827,0.6,1.0,1.0,14/56,13.79%,CLU;ELOB;UCHL5;RNF19A;RACK1;N4BP1;HSP90AB1;FBXO22;NUB1;ARIH2;CSNK1D;FHIT;UFL1;RPL11
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5537666801571387,-0.8804362968851639,0.6222222222222222,1.0,1.0,1/7,3.66%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5493935620336359,0.8803583405453854,0.6521739130434783,0.9565685654539052,1.0,3/5,28.12%,EIF2AK4;DNAJC3;NFKBIA
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.33839327653843354,-0.8798771333170046,0.6904761904761905,1.0,1.0,24/188,14.44%,ELOB;KLHL13;HECW2;RNF213;UVSSA;RACK1;PDZRN3;ATG10;OTULIN;EYA1;NUP58;KLHL7;MARCHF3;NUB1;DERL1;ARIH2;TRIM13;BRCA1;PRKDC;NFX1;RNF220;RNF8;UFL1;NAE1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.33842964497745276,-0.8791701231738897,0.8076923076923077,1.0,1.0,20/143,16.49%,ABLIM1;PTPDC1;IFT122;GSN;DYNC2LI1;TCTN1;SCLT1;BBOF1;DZIP1;CCDC57;CEP126;DCDC2;DZIP1L;TTC8;CSNK1D;ARMC9;NEK1;BBS4;ABLIM3;NINL
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.5134841314529849,0.8789124263284883,0.5581395348837209,0.9585616700587718,1.0,1/7,4.65%,MGRN1
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5099461063810533,-0.8788225321918826,0.6326530612244898,1.0,1.0,3/8,4.40%,SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.43988327444513164,-0.878503036633526,0.6756756756756757,1.0,1.0,2/17,2.31%,MEGF10;SUPT6H
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.35899542126561645,-0.878350129080044,0.6823529411764706,1.0,1.0,10/107,9.04%,RIMS1;AFG3L2;ELOB;ACTG1;LIMA1;EPRS1;GSN;LAMC1;RHOQ;BAIAP2L2
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.4688894717895806,0.8781718039972227,0.7073170731707317,0.9593009850925851,1.0,2/11,6.95%,PDGFA;PARVB
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.5270569730928514,-0.8769773028891316,0.5918367346938775,1.0,1.0,3/9,7.71%,TGFB2;BMP5;TGFBR1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.4822923497736135,-0.8768266969566583,0.6440677966101694,1.0,1.0,5/12,9.12%,TGFB2;SPRY1;OLFM1;TGFBR1;PDCD4
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.2809981758326877,0.8767807467573187,1.0,0.9615332441411286,1.0,75/391,17.17%,TENM2;DACH1;MXD4;GATAD2A;NOTCH1;CNOT7;HEY2;CXXC5;PML;PHC1;BACH1;CTBP2;NCOA5;PTPRK;HSPA8;ATP8B1;RFX3;PPM1A;SMAD7;SOX13;ZEB2;TBX3;SMARCA4;ZBTB7A;CEBPB;KLF12;HDAC1;BCL6;HMBOX1;LCOR;HDAC9;ZBTB16;SEMA4D;NACC2;ZFHX3;CBX6;HEYL;MITF;MEIS2;MBD2;THRA;RPS6KA5;MTF2;APBB1;NFKB1;UBE2D1;PPARA;MECOM;NEDD4L;PHF21A;LEF1;YAF2;HDAC2;EP300;LDB2;PHC2;BTRC;SARS1;KLF2;FOXO3;CPEB3;ZBTB38;MYT1L;GAS6;ZNF398;RBPJ;CNBP;TLE5;ZNF133;SCML1;EZR;ATN1;GLIS3;CUX1;KLF7
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.49596135165791727,-0.8767587990705836,0.559322033898305,1.0,1.0,1/10,1.57%,TM7SF3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.45326586868745844,0.8766468469680492,0.7027027027027027,0.9608820682517772,1.0,6/15,20.58%,SMAD7;P2RX4;RYR2;KCNQ1;ANK2;SLC8A1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.45671910459122,-0.8761959071344508,0.703125,1.0,1.0,2/22,4.65%,SLC2A3;TPK1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5062899678116043,-0.8761471879358622,0.5964912280701754,1.0,1.0,3/9,19.99%,DCN;JCAD;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.44818043413466346,0.8760905948250147,0.6285714285714286,0.9610418039769112,1.0,2/14,5.43%,BCL2;IRS2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.4060414870279963,-0.8759249042775377,0.6842105263157895,1.0,1.0,11/53,12.10%,PRTG;GLI3;GLI2;NR2F1;EYA1;DZIP1;MID1;ZFHX4;BOC;FOXC1;SLIT2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.46387003331181975,-0.8758775283772721,0.696969696969697,1.0,1.0,3/20,11.58%,AZIN1;PSMD8;PSMC2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4609823594609638,-0.8756418138257483,0.6065573770491803,1.0,1.0,5/17,17.08%,KCNMB1;ANO6;ATP1B1;KCNMA1;WNK2
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.35133469728384326,-0.8753091307797992,0.72,1.0,1.0,18/81,24.33%,HECW2;ZFP36L2;XPC;PSMD8;INO80;PSMC2;CSNK1D;CDC27;NINL;APPL2;SDCCAG8;UBA52;PRKACA;PSMD14;DYNC1H1;YWHAE;CKAP5;RGCC
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.4564995079728977,-0.87529404247967,0.7183098591549296,1.0,1.0,8/19,31.36%,NUP58;SEC13;NUP107;RANBP2;SSB;NUP133;TPR;NUP98
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.5802194802156423,0.8748446238101261,0.6956521739130435,0.9626274956058678,1.0,2/5,9.31%,TNFRSF1B;MITF
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4546495185182015,-0.8746893145687604,0.6323529411764706,1.0,1.0,8/20,31.36%,NUP58;SEC13;NUP107;RANBP2;SSB;NUP133;TPR;NUP98
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.41538349535873903,-0.8742257136791542,0.6764705882352942,1.0,1.0,6/31,17.35%,VEGFA;BEX3;THBS1;MT3;NGF;UACA
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.506846937987542,-0.8742114259199804,0.62,1.0,1.0,3/14,12.41%,TANC2;ABI2;EPHA4
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.3472916645015332,0.8742042966284663,0.7777777777777778,0.9630617648550626,1.0,7/61,8.27%,BNIP3L;UBQLN1;ATP6V1H;BNIP3;MAP3K7;CLEC16A;SMG1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.539042976134587,-0.8741961981696839,0.6415094339622641,1.0,1.0,2/7,14.35%,ANXA1;TMSB4X
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.43363612667916296,-0.873148813071612,0.6142857142857143,1.0,1.0,4/41,3.64%,ELMO1;NRP1;VEGFA;VAV3
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.4278895096036232,0.8727203707761757,0.5517241379310345,0.9654818496957043,1.0,9/30,21.22%,UBQLN1;PACS2;AMBRA1;TMEM41B;ATG2B;VMP1;PIK3C3;UBXN2A;ULK2
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.5908126365815686,-0.8726382279611401,0.7407407407407407,1.0,1.0,1/5,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3298309129592618,0.8725848309032157,0.7857142857142857,0.9648194096346776,1.0,13/114,11.90%,HSPB1;ABL2;BCL2;GFAP;UBQLN1;ATP6V1H;BNIP3;RNF152;USP10;MCL1;FBXW7;MID2;MTMR4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4548713557007837,-0.8721275977157606,0.7222222222222222,1.0,1.0,1/24,0.90%,TWIST1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.4170986741540802,0.8720757842359752,0.6111111111111112,0.9648792686519843,1.0,3/14,10.19%,BCL9;SMAD7;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.3974245712123562,0.872000288045793,0.6666666666666666,0.9641444782105287,1.0,3/21,4.03%,BCL2;PML;BCL2L1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3999446087769754,0.871957917777675,0.6875,0.9633898959595515,1.0,9/43,8.08%,ADGRB3;GNAI1;GNAO1;PTH1R;ADCY9;GPR161;ADCY3;ABCA1;ADGRL2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),-0.5540339910623195,-0.8707681986883234,0.6440677966101694,1.0,1.0,3/5,34.68%,PDCD10;GOLGA2;GBF1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5749916327985408,-0.8707470283275661,0.7166666666666667,1.0,1.0,2/7,12.93%,ZFP36L2;DHX36
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.40387194044427166,-0.8704906668766401,0.7352941176470589,1.0,1.0,9/45,15.87%,IGFBP5;GABRB2;TSHR;LARP1;BRCA1;SLIT2;LARS1;RRAGB;HCN1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.5054514862636298,-0.8703980699030092,0.711864406779661,1.0,1.0,3/11,12.76%,RAD51B;RPA1;WRN
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4649502814658641,-0.8702632706906906,0.6307692307692307,1.0,1.0,3/17,14.70%,ERAP1;HLA-B;SEC13
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.5768661070027175,-0.8701840401526819,0.746268656716418,1.0,1.0,1/8,1.09%,CYP3A5
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.4793769806713836,0.8696747924535093,0.66,0.9668028854154225,1.0,6/12,21.96%,MAVS;DDX3X;DHX9;IRF3;RIOK3;PTPN11
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3193091782475269,0.8696196830790613,0.8064516129032258,0.9659415878280293,1.0,7/83,8.36%,HSPA1A;SMAD7;PTGES3;TESC;CDKN1A;USP7;MARCHF7
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.48018697132201626,-0.8694468799189947,0.7241379310344828,1.0,1.0,5/19,20.70%,SLC38A1;SLC6A20;SLC6A13;SLC1A1;SLC16A12
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.5779278360781306,0.8693612780201231,0.7714285714285715,0.9654407436149268,1.0,2/8,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.47805874432841533,-0.8691571011157063,0.7049180327868853,1.0,1.0,6/16,19.00%,RHEB;GPR137C;LARS1;SEC13;RRAGB;GPR137B
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.45038579608122326,-0.8689075447790878,0.6811594202898551,1.0,1.0,3/21,11.58%,AZIN1;PSMD8;PSMC2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4704117767524497,-0.8687845042013477,0.6785714285714286,1.0,1.0,3/15,11.06%,PHLDB2;THBS1;BCAS3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",-0.6030070908937393,-0.8687313830250963,0.6923076923076923,1.0,1.0,1/5,2.33%,TERF2IP
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.5388035233260186,-0.8682010541531672,0.7142857142857143,1.0,1.0,1/8,10.79%,INO80
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4969401256286369,0.8678014445932077,0.6428571428571429,0.9677878268313932,1.0,3/7,21.25%,MAP2K2;MAP2K1;GSTP1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),-0.5079679830915114,-0.8677314258964766,0.671875,1.0,1.0,1/9,9.37%,ZC3H14
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.505436385641972,0.8676640926210856,0.5714285714285714,0.9672229879762271,1.0,1/5,13.12%,ARL3
prerank,PanglaoDB_Augmented_2021__Microglia,0.41451241695614044,0.8671930346134377,0.5853658536585366,0.9674801340208311,1.0,2/20,1.46%,CSF1R;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.4426815657843689,-0.8670112508451366,0.6610169491525424,1.0,1.0,1/26,1.43%,NRP1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.5335158501138668,0.8668657055438785,0.7,0.9672951719774453,1.0,2/5,21.22%,EIF2AK4;ULK2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.42330550616214135,0.8664004258604149,0.625,0.9673206581297941,1.0,5/22,12.31%,TNFRSF1B;AXL;RHOA;NFKB1;PLAA
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.3709151723979286,0.866161039834796,0.5882352941176471,0.9669892511150167,1.0,8/32,16.76%,RNF185;UBQLN1;STT3B;AMFR;UBE2J1;UBE4A;UBE4B;RNF121
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.4929715062562431,0.8656398128251789,0.631578947368421,0.9668786592813888,1.0,3/9,16.98%,GNL3L;XRN1;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.5248864579608963,-0.8651905440213474,0.7049180327868853,1.0,1.0,4/7,19.00%,GPR137C;LARS1;RRAGB;GPR137B
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.5469684778616897,-0.8650201790009353,0.6346153846153846,1.0,1.0,3/6,13.49%,AKR1C1;SLCO1C1;SLCO1A2
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.4987066267422237,0.86467035840961,0.6444444444444445,0.967962537781823,1.0,1/7,3.82%,SLC12A2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.48920139996194,-0.8638087434028637,0.6727272727272727,1.0,1.0,3/13,10.87%,ANXA1;ADAM9;ASAH1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.4388322527296536,-0.8637092323022727,0.6666666666666666,1.0,1.0,6/20,13.80%,CA5B;SLCO1C1;SLC22A6;SLC4A4;SLCO1A2;CA4
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.485392387792159,0.8636444790895853,0.5853658536585366,0.9690758080351998,1.0,2/13,6.09%,UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.4677962900386029,0.8635138386343284,0.7058823529411765,0.9684093915319075,1.0,2/8,11.31%,FBXW7;NFKB1
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.3787517076905488,-0.8633272889451533,0.75,1.0,1.0,13/75,12.72%,TWIST1;TERF2IP;FBLN1;WARS1;RACK1;LDLRAD4;DNAJC10;SMAD6;PLPP3;PRKDC;PPIA;SLIT2;PRKAG2
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.478276818110574,-0.8632772330619457,0.6363636363636364,1.0,1.0,2/14,0.87%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.33077689829000556,0.8631973050767484,0.7419354838709677,0.9682456611985447,1.0,8/65,9.24%,PDK4;TBC1D4;APC;IRS2;ATP6V1H;HDAC9;RAB31;IRS1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.5848135419788296,-0.8622917424637616,0.7333333333333333,1.0,1.0,1/5,11.46%,TSEN2
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.5848135419788296,-0.8622917424637616,0.7333333333333333,1.0,1.0,1/5,11.46%,TSEN2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4591072012221368,-0.8622566811652632,0.6911764705882353,1.0,1.0,8/18,31.36%,NUP58;SEC13;NUP107;RANBP2;SSB;NUP133;TPR;NUP98
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4591072012221368,-0.8622566811652632,0.6911764705882353,1.0,1.0,8/18,31.36%,NUP58;SEC13;NUP107;RANBP2;SSB;NUP133;TPR;NUP98
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4433750231235833,-0.8618562288465624,0.625,1.0,1.0,4/19,7.29%,ZFPM1;SGCD;BMP5;NOTCH2
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.3335919763906559,-0.8609809425608695,0.7875,1.0,1.0,32/217,15.94%,SRGAP3;FGF1;ARHGAP24;ARHGAP15;VEGFA;AKAP7;RASGRF2;RPL5;VAV3;CMKLR1;ARHGAP28;ARHGEF3;SGK1;RALBP1;RHOQ;AKAP12;RPA1;BIRC2;PRKAR1A;BRCA1;PRKAG2;WRN;UFL1;MAPK14;RPL11;RAD17;TMSB4X;DAPK2;MINK1;RRAGB;ARHGAP20;TOPBP1
prerank,PanglaoDB_Augmented_2021__Platelets,-0.40490657820459086,-0.8608740837543364,0.6666666666666666,1.0,1.0,5/37,14.30%,VEGFA;SLC2A3;THBS1;MAPK14;FHL1
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.3938519646198275,-0.8608534827747357,0.6567164179104478,1.0,1.0,10/44,21.03%,CYP3A5;AKR1C1;PER2;GNPAT;LDHA;DLD;NPC1;LPL;PTGR1;PNPLA8
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.33354919713359,0.8608267051278479,0.7,0.9718292308332052,1.0,9/80,9.57%,CSPG4;JPH2;TIMP3;CHST3;LIFR;ENAH;HEYL;NOTCH3;EGFR
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.5090367491701702,-0.8607533895691479,0.7272727272727273,1.0,1.0,4/14,11.88%,LIMA1;PLEKHH2;FGF13;HDGFL3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3783939841975607,-0.8606352885315846,0.6716417910447762,1.0,1.0,7/60,7.71%,TGFB2;COL3A1;GCNT2;COL1A2;ZFP36L2;ADAM9;TGFBR1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5037718613796505,-0.8604462065904868,0.671875,1.0,1.0,3/9,12.75%,MTM1;SLIRP;NUBPL
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.5082402966854693,0.8603613116162426,0.6410256410256411,0.9718920569475746,1.0,1/9,10.25%,INPP5A
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.41048960816729585,0.860263851369321,0.7,0.9711629931786081,1.0,2/13,10.73%,HSPA8;CAMSAP1
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.3686588911531795,-0.8601947386200209,0.6666666666666666,1.0,1.0,15/74,11.24%,TM7SF3;HINT1;SAT1;DDB2;PROCR;RACK1;XPC;PRMT2;NDRG1;TSPYL2;TSC22D1;BTG2;RPS12;RPL36;FGF13
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.3778178251169027,0.8595388155053728,0.6666666666666666,0.971819600820435,1.0,2/29,6.09%,TNFRSF10B;MAP3K7
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.43380174004745203,0.8594470741910895,0.5853658536585366,0.9711751364235703,1.0,2/12,9.12%,DPP10;KIF5B
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.4187319371745282,0.8593682759397937,0.6744186046511628,0.9695368447443413,1.0,3/17,16.11%,PHC1;YAF2;APAF1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.4187319371745282,0.8593682759397937,0.6744186046511628,0.9695368447443413,1.0,3/17,16.11%,PHC1;YAF2;APAF1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.3769633057184709,-0.8591947483399772,0.7638888888888888,1.0,1.0,11/92,15.43%,ELOB;PARP1;SUPT6H;NR4A2;TEFM;TSC22D1;DDX5;NFX1;THRB;GTF2A1;PTMA
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.47549135167259393,-0.8589790186208053,0.6721311475409836,1.0,1.0,2/16,6.41%,ANXA1;CD47
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4074896969159658,0.8587796490467097,0.6666666666666666,0.9699021665600519,1.0,2/22,6.53%,MAP3K7;AZI2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.5386659835270134,-0.8585846763857122,0.640625,1.0,1.0,1/7,1.52%,VEGFA
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),-0.5399485520352985,-0.8585415258292766,0.6290322580645161,1.0,1.0,1/7,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.5256791358454617,0.8584517503357918,0.6346153846153846,0.9695933676325603,1.0,2/5,36.37%,TNIP1;ITCH
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.4817208888694138,0.8579725881436614,0.6530612244897959,0.9695025115156045,1.0,2/10,1.07%,HSPB1;NOTCH1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.49605318388093694,0.8578913769526333,0.7419354838709677,0.9688533630006794,1.0,3/10,19.48%,LRRC7;PARD3;PARD3B
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.3584860717378282,0.8575539972445325,0.6666666666666666,0.968639360920425,1.0,11/39,16.76%,RNF185;UBQLN1;STT3B;AMFR;RNF139;ATXN3;UBE2J1;UBE4A;UGGT1;UBE4B;RNF121
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.42604143192754457,-0.8571109785181339,0.6268656716417911,1.0,1.0,9/26,22.02%,UCHL5;HSP90AB1;PSMC2;UFL1;APOE;PRKN;FMR1;PRKACA;PSMD14
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.43242401806840347,0.8571062619465705,0.6428571428571429,0.9687354378410348,1.0,5/17,15.07%,APC;CDKN1A;NACC2;RBL1;JADE1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.47916086108151873,0.8568919691765251,0.6590909090909091,0.968305349974348,1.0,6/15,25.56%,IRS1;RPS6KB1;KANK1;PTPN1;TSC2;TNS2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.3857085433197325,-0.8566313851372785,0.7083333333333334,1.0,1.0,7/59,7.86%,FGF1;AKR1C2;GCNT2;HSP90AB1;F3;TGFBR1;THBS1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.45922841597751746,-0.8563207838058391,0.6721311475409836,1.0,1.0,3/14,13.94%,PRPF6;SRSF10;PRPF8
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4255139024878454,0.8558098657369636,0.575,0.9695247049991141,1.0,5/18,10.89%,NOTCH1;HEY2;SMAD7;HEYL;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.514623998640476,0.8553666731695293,0.6511627906976745,0.9695270604940627,1.0,1/7,0.45%,HSPB1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.46475803773456736,-0.8548307062727492,0.7017543859649122,1.0,1.0,3/16,16.64%,SUPT6H;RNF8;LARP7
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.48125590203541513,-0.8546587293047254,0.6774193548387096,1.0,1.0,1/10,1.43%,NRP1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.45323236124940697,-0.8536921109003073,0.6901408450704225,1.0,1.0,4/21,12.93%,PARP1;N4BP1;INO80;DHX36
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.38521493397785306,-0.8536046042808261,0.6986301369863014,1.0,1.0,10/61,12.64%,PRSS23;PGR;ALDH3A2;OLFM1;SGK1;PDCD4;SLC24A3;ADD3;FOXC1;DYNLT3
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.594120545204387,-0.8533438790217567,0.7192982456140351,1.0,1.0,3/5,37.07%,ERCC6;ERCC8;APTX
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.512250006702432,-0.8533345252668927,0.6274509803921569,1.0,1.0,2/12,21.53%,NCKAP5;SPAG16
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.49417830461291523,0.8528046209176315,0.6216216216216216,0.9737464115729494,1.0,1/8,0.16%,CSF1R
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.39273994306713456,0.8524245672088789,0.7419354838709677,0.9734983005051775,1.0,6/22,11.83%,NOTCH1;EMP2;CORO2B;RHOA;ATXN3;RSU1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.42490501334035224,0.8523945284800888,0.673469387755102,0.9726962393183514,1.0,1/12,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.31509812734140863,0.8518328268306018,0.78125,0.972900855592088,1.0,20/87,15.85%,RGS6;TBC1D4;TIAM2;ARHGEF7;MMUT;ABR;SNX13;MAPRE2;SEMA4D;RANGAP1;TBC1D5;RAP1GDS1;RAPGEF2;RSU1;RAP1A;DOCK11;ARAP1;RALGAPB;RASGRP2;RAPGEF1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.43965756723866395,-0.8517252263039341,0.6461538461538462,1.0,1.0,2/21,8.89%,RPS3;TBCD
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.4713957455799587,-0.8513426402676672,0.7377049180327869,1.0,1.0,3/13,9.74%,MSH6;XPC;RPA1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.41089448364609393,-0.8513180085252594,0.6818181818181818,1.0,1.0,4/39,7.03%,PRDX1;SEMA3C;ALDH1A1;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3875114696063754,-0.8512913702701038,0.6764705882352942,1.0,1.0,8/41,12.10%,TERF2IP;FBLN1;WARS1;DNAJC10;PLPP3;PRKDC;PPIA;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.38786154741194434,0.8511010503571577,0.5588235294117647,0.9735150234854986,1.0,1/16,2.16%,PML
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.34047777737602214,0.851066095617973,0.7419354838709677,0.9726741715320739,1.0,11/40,15.85%,ABL2;CAMK1D;RETREG3;ARHGAP35;RAPGEF2;RAP1A;NPTN;EP300;LRRC7;SCARB2;RAPGEF1
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.45192778811093276,-0.8509882333355591,0.7213114754098361,1.0,1.0,6/12,34.01%,CDC27;RGCC;PHIP;PDGFRB;ANAPC5;EDN3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.36495838262525465,0.850137913055677,0.6976744186046512,0.97361477751011,1.0,6/34,14.95%,SGPL1;PPP2R1A;MTHFD2L;CPM;MTHFR;PANK2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.36265578598647275,0.8501246692275116,0.7272727272727273,0.9727651356228301,1.0,3/31,6.81%,TNFRSF10B;DLC1;CASP8AP2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.5943877401136066,-0.8500213709030426,0.7413793103448276,1.0,1.0,3/7,14.36%,UCHL5;DCDC2;ARMC9
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.4636388850234432,-0.8497125533934484,0.6491228070175439,1.0,1.0,4/15,29.53%,CSNK1D;VPS13C;GCC2;ZDHHC15
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.42654373214574853,-0.8496681935453901,0.6875,1.0,1.0,5/23,15.60%,PRPF6;SNRNP200;SRSF10;SRPK1;CELF2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.3537918762654291,-0.8491503313370187,0.75,1.0,1.0,27/140,17.52%,CLU;TGFB2;RASGRF2;VAV3;RACK1;SEPTIN4;SFRP4;ARHGEF3;PRMT2;HTT;OLFM1;RPS3;TGFBR1;APH1B;CYP1B1;ANO6;SLIT2;ITGB3BP;PTRH2;BTG1;DAPK2;MTCH2;SQSTM1;KCNMA1;NGF;NET1;JUN
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.41865317694406096,0.8491247487461312,0.7272727272727273,0.9740511352708244,1.0,4/15,28.09%,RNF139;PTPN1;LAMP1;TTC21B
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.37925993501383887,-0.8490693547442704,0.671875,1.0,1.0,5/47,6.51%,TGFB2;SLC8B1;MYO18A;PER2;ADAM9
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4286071583931693,-0.8489127528075576,0.7246376811594203,1.0,1.0,5/33,12.93%,PSMD8;PSMC2;FOXC1;PRKDC;DHX36
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),-0.5782841480833935,-0.848893371425396,0.7543859649122807,1.0,1.0,2/5,30.60%,LYN;PRKCA
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.4219922578846362,0.8488372176200413,0.6511627906976745,0.9737433296764164,1.0,4/14,5.72%,ZBTB7C;DNAH9;SLC12A2;TACC2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.5460792995821764,-0.8479753181560801,0.6984126984126984,1.0,1.0,3/6,15.34%,LEPR;MT3;BBS4
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.47214775822064253,-0.8474854048956455,0.6666666666666666,1.0,1.0,5/20,17.62%,PIP4P2;MTM1;PLPP3;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.3750033037709946,0.8471491926395737,0.7692307692307693,0.9753290050159099,1.0,4/27,10.13%,IPO8;PUM2;AGO2;NUP54
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.3750033037709946,0.8471491926395737,0.7692307692307693,0.9753290050159099,1.0,4/27,10.13%,IPO8;PUM2;AGO2;NUP54
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.32817607275639177,0.8471458516554141,0.72,0.9744511211230064,1.0,6/59,4.11%,ADGRB3;RCAN2;OPCML;DAAM2;GPRC5B;GFAP
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.539944109861592,-0.8470142464404552,0.76,1.0,1.0,2/9,12.93%,STAT1;DHX36
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.44763485285579735,-0.8469971748360512,0.6521739130434783,1.0,1.0,7/21,25.50%,DTWD2;TARBP1;TRMT44;NSUN2;NSUN6;SSB;THUMPD2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.4027223193168938,-0.8466372169200879,0.6779661016949152,1.0,1.0,2/33,1.97%,EPN1;SPRY1
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.294160865844295,0.8458622195999211,1.0,0.9759432898065311,1.0,13/159,8.17%,ARRDC2;NEURL1B;TBC1D4;ARF1;MYH9;SNX4;ATP6V1H;HERC2;AP3D1;ABCA1;GGA2;SNX13;RAB31
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.4777068946536867,0.8457123714637842,0.7027027027027027,0.9753507992212002,1.0,4/12,10.36%,ADCY9;ADCY3;RAF1;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.540019318193077,-0.8457032075939556,0.7272727272727273,1.0,1.0,1/6,1.52%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.5219527796855953,-0.8450938895481874,0.6666666666666666,1.0,1.0,2/7,7.71%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3573984850591793,-0.8450591770972556,0.7466666666666667,1.0,1.0,8/85,7.35%,TGFB2;VEGFA;PGR;TET1;RACK1;HSP90AB1;NOTCH2;OLFM1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.4236854985927241,0.8449122516720063,0.75,0.9762712564575688,1.0,3/13,9.12%,TNFRSF1B;EPOR;KIF5B
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.4823209973186281,-0.8446845942568367,0.6417910447761194,1.0,1.0,1/10,1.52%,VEGFA
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.499844542502763,-0.8446421423447739,0.65,1.0,1.0,1/9,7.71%,TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5409252308275041,0.8443116114298328,0.6341463414634146,0.9763689030488304,1.0,2/5,16.33%,PPARA;WNK1
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.48923512279454084,-0.8440221669550507,0.6451612903225806,1.0,1.0,2/10,12.10%,SLC8B1;SLIT2
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.3875355208597383,-0.8437440737598273,0.6615384615384615,1.0,1.0,6/43,16.75%,KCNMB1;ADAM9;THBS1;CARF;SLC25A13;KCNMA1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5397620022122405,-0.8431986489779284,0.6825396825396826,1.0,1.0,3/8,12.52%,NT5E;PRPSAP2;FHIT
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.48295341927723523,0.8430659357059581,0.6829268292682927,0.9778438763260953,1.0,1/7,7.09%,CDKN1A
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.42704386252946536,0.8429422261750523,0.6904761904761905,0.9772113274676372,1.0,2/15,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.5182151011282501,0.8426483219212,0.7837837837837838,0.9760102306385747,1.0,2/9,12.76%,SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.5182151011282501,0.8426483219212,0.7837837837837838,0.9760102306385747,1.0,2/9,12.76%,SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.4660315314063673,-0.8425839822683244,0.7121212121212122,1.0,1.0,5/17,15.32%,ZFP36L2;BTG2;FOXC1;BTG1;ANGEL2
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.5614692067656606,-0.8424199170754911,0.71875,1.0,1.0,1/5,18.38%,XRCC6
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.3678143787591589,0.8423147316946514,0.7317073170731707,0.9758250839481662,1.0,4/27,7.52%,SLC6A16;HCN2;SLC12A2;SLC6A12
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.4132597156594078,0.8422545824738334,0.6,0.9750856744329943,1.0,3/16,6.79%,SERPINB6;TIMP3;HDAC1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.5394160081511357,-0.8421173601068227,0.660377358490566,1.0,1.0,1/6,2.62%,MT2A
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),0.5485148593744511,0.8420845176689793,0.6744186046511628,0.9745692224819993,1.0,2/5,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.33368282540748506,-0.8418796721318713,0.8461538461538461,1.0,1.0,17/197,15.11%,PRAG1;TGFB2;CDKL1;FGGY;PIK3R4;STRADB;SGK1;TGFBR1;PGK1;FAM20A;PRKDC;CSNK1D;PRKAG2;SRPK1;NEK1;DAPK2;MINK1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.389938733750595,0.8418053289976573,0.65625,0.9741543458392536,1.0,5/25,12.31%,TNFRSF1B;AXL;RHOA;NFKB1;PLAA
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5117757906358957,-0.8415604886269287,0.6779661016949152,1.0,1.0,4/9,22.08%,APOE;LPL;PNPLA8;RORA
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.4853354164945286,0.8414741172776252,0.7142857142857143,0.9737502640096856,1.0,1/8,6.79%,HDAC1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.5217907145746032,-0.8413802169481289,0.6727272727272727,1.0,1.0,2/7,15.88%,ADM;TPM1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.561868010106474,-0.8409888651590351,0.7666666666666667,1.0,1.0,2/5,7.86%,VEGFA;THBS1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3355615279819327,0.8409834814062113,0.7931034482758621,0.9736885209644285,1.0,14/69,18.46%,PANK3;PPM1A;GFPT1;INPP4B;INPP5A;PAK2;HK1;PLAA;PPA2;ITPK1;PANK2;PIK3CD;IP6K1;PTPRD
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5268569625524018,-0.8409020369465189,0.7647058823529411,1.0,1.0,1/6,6.51%,ADAM9
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4542891840812162,0.8408999116014835,0.7551020408163265,0.9729643310116772,1.0,2/9,7.09%,PRKG1;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5241458247254869,0.8407478832414148,0.75,0.9724420227931138,1.0,3/6,13.86%,MAP2K2;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4704102642140013,-0.8406094050120707,0.6724137931034483,1.0,1.0,1/16,2.81%,STAT1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4740805900143453,-0.840608726473709,0.7307692307692307,1.0,1.0,2/14,6.51%,ERAP1;ADAM9
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.4350675817658698,0.8404149727505807,0.6585365853658537,0.9722413106309997,1.0,4/14,8.11%,SOX6;CD44;SOX5;ZBTB16
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.547809852059267,0.840177449597477,0.6511627906976745,0.971820688687086,1.0,1/5,3.49%,NCOA3
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.49830732706496483,-0.8401366421352047,0.7017543859649122,1.0,1.0,2/13,7.86%,NRP1;THBS1
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5362754877591364,0.840034719938609,0.7692307692307693,0.9712407599965074,1.0,3/5,15.37%,CHST3;OGA;LARGE1
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5160906754428463,-0.8398004805592514,0.7017543859649122,1.0,1.0,1/8,17.39%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5482934745276451,0.8394601805756946,0.6888888888888889,0.9714913883754734,1.0,3/5,21.25%,GAS6;CCDC3;GSTP1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.43627707447660957,0.8390383205398813,0.65,0.971402066025245,1.0,3/13,20.18%,ATP6V1H;HVCN1;ATP6V1A
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.46969621270122935,0.8386958459197186,0.6486486486486487,0.9712430643525248,1.0,1/8,1.46%,TNFRSF1B
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.4890479809080172,-0.8386833282526299,0.7076923076923077,1.0,1.0,1/11,3.66%,ANXA1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.4574135650061415,-0.8385813795248541,0.6949152542372882,1.0,1.0,2/21,7.69%,GRIA4;GRIK1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.5166336591094256,0.8368415299156293,0.6875,0.9739451349935281,1.0,2/5,34.91%,ROCK1;PPP1R12A
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5116025553745343,0.8367529796832706,0.6666666666666666,0.9732165022908381,1.0,2/5,3.27%,NOTCH1;NEXMIF
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.4855050034478233,0.8365849048428617,0.6,0.9727279611962768,1.0,3/6,36.57%,EIF2S1;HERPUD1;EIF2AK3
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.46837774139493904,-0.836289119628264,0.7580645161290323,1.0,1.0,5/16,11.03%,ST6GALNAC3;ST3GAL4;HEXB;ASAH1;GALC
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.49372849396452,0.8360124889796593,0.6486486486486487,0.9729660173780574,1.0,2/5,11.48%,SLIT3;SH2B3
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.35024615842027307,-0.83588450968214,0.7692307692307693,1.0,1.0,18/86,19.00%,PLXNC1;ARHGAP15;AFDN;VAV3;EPHA3;RACK1;RALBP1;BCAS3;EPHA5;EPHA4;FGD6;PLXNA2;LARS1;SNX9;NET1;ASAP3;PKP4;GPR137B
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5122051909453452,-0.8358249398021717,0.6949152542372882,1.0,1.0,4/8,22.08%,APOE;LPL;PNPLA8;RORA
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),0.531580030210642,0.8355803596226018,0.7551020408163265,0.9728659372847469,1.0,1/6,3.30%,ACADVL
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.4638520686527623,0.8354574195496967,0.6666666666666666,0.9723293699431782,1.0,2/8,11.58%,ABCA1;PPARA
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),0.544439521017783,0.8352855131963881,0.7368421052631579,0.9709321336404838,1.0,3/6,14.72%,HACD2;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.544439521017783,0.8352855131963881,0.7368421052631579,0.9709321336404838,1.0,3/6,14.72%,HACD2;ELOVL6;ELOVL5
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.34021103427241906,-0.8352166201104276,0.8214285714285714,1.0,1.0,27/198,14.28%,PDGFD;FGF1;TGFB2;COLEC12;VEGFA;RPS4X;AKR1C2;TET1;TSHR;GCNT2;BMP5;CD47;HSP90AB1;TGFBR1;THBS1;PTGFR;TENM4;SSR1;FN1;INO80;TRIM13;EPHA4;DHX36;PDCD10;UFL1;NAMPT;KRAS
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.34683143072238914,0.8348999070801337,0.75,0.9708341850744153,1.0,3/29,11.15%,BCL2;SMG1;MCL1
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5089481837057841,0.8344006812974376,0.6666666666666666,0.970894638752224,1.0,1/5,18.36%,IRF3
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.5215978664315815,-0.8339239493949412,0.6851851851851852,1.0,1.0,2/6,17.08%,ATP1B1;WNK2
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3755653589527106,0.8335561642791974,0.7894736842105263,0.9718442572884255,1.0,5/40,5.40%,HSPA1A;UBQLN1;SMAD7;RNF14;BBS7
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.5107687502537809,0.833446665636464,0.6041666666666666,0.9710645900917398,1.0,1/5,6.79%,HDAC1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.425230195975393,-0.8326984111675114,0.6984126984126984,1.0,1.0,2/24,1.97%,EPN1;SPRY1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),-0.5466227393061127,-0.8322577932451498,0.6666666666666666,1.0,1.0,2/5,28.50%,TRERF1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.5221589972613767,-0.8319672219760744,0.6792452830188679,1.0,1.0,2/5,17.08%,ATP1B1;WNK2
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.4041368556653056,-0.8317949503039763,0.803030303030303,1.0,1.0,9/35,28.26%,HTT;COG4;PLPP3;NBAS;ARF4;ERGIC2;RER1;ATP9B;UVRAG
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.39856395567390435,-0.8317530023111883,0.7285714285714285,1.0,1.0,3/30,11.58%,PSMD8;HLA-B;PSMC2
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.4170480294622139,-0.8312265890113959,0.6714285714285714,1.0,1.0,6/32,19.84%,NT5E;WRN;TOPBP1;DDX24;LSM8;HNRNPA3
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4283968128992383,0.8310967058716814,0.7435897435897436,0.9745374692679875,1.0,5/11,28.95%,NRXN1;LRRC7;FLNA;SAV1;NLGN1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5334610063692165,-0.8308666329767191,0.7090909090909091,1.0,1.0,1/6,4.08%,SVIP
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.5390196362269172,-0.8307858855060316,0.6271186440677966,1.0,1.0,3/5,13.73%,F3;ANO6;PLSCR1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.4736356792458236,-0.8306648007714929,0.640625,1.0,1.0,3/11,16.41%,SMG6;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.3523600987503686,-0.8303408147390182,0.8125,1.0,1.0,9/67,5.49%,ZFPM1;TGFB2;VEGFA;COL3A1;SGCD;IFT122;GLI2;GPC3;BMP5
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.49477999104199355,-0.8301513675296255,0.7540983606557377,1.0,1.0,1/7,15.35%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.49477999104199355,-0.8301513675296255,0.7540983606557377,1.0,1.0,1/7,15.35%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.49477999104199355,-0.8301513675296255,0.7540983606557377,1.0,1.0,1/7,15.35%,CDC27
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.40822768845332713,0.829764742665951,0.7368421052631579,0.9762402585119418,1.0,2/26,1.07%,EPN2;NOTCH1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.388443403099214,-0.8297420766128667,0.7222222222222222,1.0,1.0,4/40,10.93%,AFG3L2;TBCD;DCDC2;S100A6
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.5390164185512505,-0.8297130222989123,0.6785714285714286,1.0,1.0,1/5,9.12%,PDCD4
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.4307826873939358,0.8295083150934915,0.7631578947368421,0.9758821928131591,1.0,5/15,9.49%,NOTCH1;HEY2;ELN;HEYL;SLIT3
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5097244229615019,0.8288005195957701,0.6888888888888889,0.9763904755941871,1.0,3/8,13.86%,MAP2K2;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.4224996581791959,0.8287683431461514,0.717391304347826,0.9756102450215691,1.0,3/15,9.12%,TRAK1;NDE1;KIF5B
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.4276051913908027,-0.8284828679161432,0.7,1.0,1.0,5/24,15.88%,MSH6;DNAJC10;PLSCR1;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.3658888966197615,0.8280135058012342,0.8571428571428571,0.9762946533310949,1.0,10/45,11.18%,HSPA1A;RNF185;SMAD7;RNF14;BBS7;TMEM259;ZER1;ATXN3;RNF180;FBXW7
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.5540979184837467,-0.8278899307077101,0.7592592592592593,1.0,1.0,1/7,7.97%,CCT6A
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.4376280357716832,-0.8276556238006333,0.6623376623376623,1.0,1.0,4/21,16.41%,CCT6A;MAP3K4;DHX36;TNKS2
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.4400281809136557,0.827429121470098,0.6285714285714286,0.9764676407323039,1.0,5/13,13.94%,EIF4EBP2;SMG1;TIPRL;RICTOR;RPS6KB1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5151382990184791,-0.8271908487332003,0.6875,1.0,1.0,2/7,24.44%,DDX5;PLA2R1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.5282037157758015,-0.8271730113490127,0.7333333333333333,1.0,1.0,1/5,8.75%,ABCB7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.43298403212442377,-0.8268548251145491,0.6440677966101694,1.0,1.0,1/23,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.3789470012055944,0.8266684931812924,0.7368421052631579,0.9768364012121957,1.0,2/21,5.21%,UBQLN1;UBE2N
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.5177405214875332,0.8255911487266565,0.7222222222222222,0.9780762919933625,1.0,2/7,22.66%,SYT17;SYT1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.3501316219372569,0.8254692660912822,0.7666666666666667,0.9775524331708265,1.0,6/35,12.31%,TNFRSF1B;AXL;RHOA;ADAM17;NFKB1;PLAA
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.5037182742139582,-0.8252681388095967,0.7419354838709677,1.0,1.0,2/6,15.11%,CNIH3;MINK1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5233512999914602,0.8249621340460923,0.7894736842105263,0.9775281696516476,1.0,2/6,20.35%,SETD7;SETD3
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.5048795772623776,-0.8248261894567439,0.7288135593220338,1.0,1.0,2/8,2.73%,AKR1C2;AKR1C1
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.5289334042419264,-0.8238016583787691,0.7543859649122807,1.0,1.0,2/5,19.42%,RAD17;MRE11
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.5359550046732213,-0.8236479820810214,0.7755102040816326,1.0,1.0,1/5,6.51%,ADAM9
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3901349927878649,0.8233893557281077,0.6764705882352942,0.9795555984743344,1.0,6/24,16.86%,HPRT1;USP16;UPB1;GRIN2B;GRIN1;RYR3
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.38734997445571423,-0.8230195457676758,0.7166666666666667,1.0,1.0,5/37,15.11%,ACTG1;EPHA3;THBS1;LIMCH1;MINK1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.45909333583173784,0.8229159190440952,0.6666666666666666,0.9795589309930771,1.0,3/8,15.79%,BACH1;CDK17;BRD4
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.3067820180538558,0.822673280433296,0.967741935483871,0.9791721415669667,1.0,11/81,14.56%,CTNND2;CNTN4;MICALL2;VAPA;ADGRV1;CAMSAP1;RAPGEF2;CNTNAP2;ATXN10;DNM2;CDC42
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.3687704867621088,-0.8226409961441843,0.782051282051282,1.0,1.0,7/60,11.58%,TWIST1;ELOB;VEGFA;PSMD8;NDRG1;PGK1;PSMC2
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.45653808552620884,0.8220101371303623,0.7105263157894737,0.9794194113357307,1.0,4/13,9.71%,DGKB;DGKH;DGKE;DGKG
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.4239197136874872,0.821920393383435,0.6896551724137931,0.9786926447460482,1.0,7/17,20.70%,CEBPB;ACVR2A;ADGRV1;BMPR1A;ATP2B1;SLC8A1;NELL1
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.4287965522265006,-0.8217490831536504,0.7142857142857143,1.0,1.0,2/22,5.60%,ANXA1;SEPTIN4
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.45763507742888065,-0.8217278581426539,0.7166666666666667,1.0,1.0,3/13,4.40%,SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.3153908550004465,0.82158939388486,0.8055555555555556,0.9784048766812005,1.0,9/65,14.49%,BACH1;PPP2R1A;CDKN1A;CEP70;NDE1;CCP110;CEP290;DNM2;BTRC
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.4142293385313995,0.8213868161702377,0.7142857142857143,0.9779620937139543,1.0,2/11,4.11%,DNAH9;GFAP
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4570118304338247,0.8212215406520692,0.6976744186046512,0.9773938284000534,1.0,1/10,0.45%,HSPB1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.4687205710118659,0.8212139938603448,0.7567567567567568,0.9765645664157838,1.0,3/13,6.41%,NOTCH1;HEY2;CEBPB
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.4599706929474696,0.8210964392503493,0.6274509803921569,0.9758918364997714,1.0,1/10,3.30%,ACADVL
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.5323607833132087,-0.8209667317994132,0.7288135593220338,1.0,1.0,2/7,23.12%,ABI2;WASF2
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.4133839178306069,0.8207168741154665,0.7,0.9757239339441651,1.0,5/16,20.18%,ATP6V1H;RAB31;ATP6V1G1;RAB14;ATP6V1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.4727857780762029,0.8206068719559524,0.6744186046511628,0.9751401754689398,1.0,5/8,28.33%,MYOCD;ATP2B1;SETD3;PLCE1;CTTN
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.30547997158166246,0.8204755803721508,0.9166666666666666,0.9745380767742945,1.0,16/89,17.76%,HIPK2;CAMK1D;MAP2K2;SMG1;CAB39;RPS6KA5;RICTOR;PAK2;PRKX;RPS6KB1;MAP3K13;CSNK2A1;GAS6;WNK1;CSNK1G2;VRK2
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.332839652630083,-0.8204705507545712,0.8735632183908046,1.0,1.0,13/199,7.79%,PDGFD;FGF1;ELMO1;NRP1;VEGFA;ACTG1;SULF2;VAV3;COL1A1;EPHA3;AP2A2;COL4A6;APH1B
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.4686181174459927,0.819437984266876,0.7111111111111111,0.9755600907355376,1.0,2/6,11.12%,KDM7A;PHF8
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.31655186027670773,-0.8187175545715107,0.8817204301075269,1.0,1.0,25/205,12.42%,TWIST1;GBP2;IFITM3;VEGFA;IFIT3;MT2A;STAT1;ANXA1;LEPR;XAF1;COL1A2;F3;PSMD8;MID1;PDCD4;PELI1;FN1;MAP3K8;HLA-B;BIRC2;PSMC2;FOXC1;PPIA;IL1R1;TXLNA
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.4150289737875412,-0.8184408215358503,0.7258064516129032,1.0,1.0,3/24,10.79%,TGFB2;TGFBR1;INO80
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.5147433487784837,-0.8176797775287133,0.7258064516129032,1.0,1.0,1/6,14.81%,MT3
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.4365048719761597,-0.8174356463883032,0.6617647058823529,1.0,1.0,6/22,20.04%,RACK1;EEF2;MRPS25;GTPBP1;GTPBP2;GFM1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.44428577977999306,-0.8169955091668313,0.71875,1.0,1.0,2/18,6.75%,CENATAC;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.3728349854596391,-0.8169634631657191,0.7530864197530864,1.0,1.0,9/53,12.93%,IGFBP5;EPRS1;RACK1;NCL;RPS3;SAMD4A;BTG2;LARP1;DHX36
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.38076248646110944,-0.8169161144276168,0.7419354838709677,1.0,1.0,12/37,17.09%,ANXA1;EYA1;UIMC1;INO80;TRIM13;BRCA1;MRNIP;RNF8;MAPK14;TOPBP1;SPIDR;NET1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.4086717964447901,-0.8168497864170994,0.7076923076923077,1.0,1.0,5/22,23.05%,RACK1;PRKACA;PIK3R1;ZNF236;PDK3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.41525840661829916,0.8167955234565311,0.6136363636363636,0.9788141217499458,1.0,5/15,9.71%,DGKB;DGKH;LCLAT1;DGKE;DGKG
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.41525840661829916,0.8167955234565311,0.6136363636363636,0.9788141217499458,1.0,5/15,9.71%,DGKB;DGKH;LCLAT1;DGKE;DGKG
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.5051379721485925,-0.816535244232257,0.6851851851851852,1.0,1.0,4/8,19.17%,EXTL2;CSGALNACT1;GMDS;PARG
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.3867424866616109,0.8161203217819295,0.8888888888888888,0.9792131403511414,1.0,5/20,15.14%,NCK2;CDC42EP4;SPIRE1;BIN1;LMOD1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.45691155897377633,0.8159314913578058,0.65,0.9786486498298314,1.0,1/8,6.84%,PPP2CB
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.5029064066642526,-0.8159164192267516,0.7450980392156863,1.0,1.0,2/10,12.93%,STAT1;DHX36
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.4663382350034098,-0.8157845977113282,0.7272727272727273,1.0,1.0,3/10,14.81%,LEPR;PRKAG2;MT3
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4494027940004309,0.8146423680084867,0.6428571428571429,0.9803843238860553,1.0,2/13,6.09%,UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.33888853584899,0.814350094048377,0.7407407407407407,0.9801273788857877,1.0,6/37,16.98%,WDR33;PCF11;GRSF1;CPSF2;PAPOLG;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.437378567405485,-0.814241567583794,0.6885245901639344,1.0,1.0,9/25,28.99%,NMD3;CCT6A;PARP9;LARP7;PIK3R1;PSEN1;WWTR1;TPR;IPO5
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4508560911673133,0.8142087683172192,0.7380952380952381,0.9795635504146303,1.0,1/9,2.99%,MED24
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.5373362918748967,0.8141445846101302,0.6976744186046512,0.9788567452083704,1.0,1/5,0.31%,ADGRB3
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.41603685380432354,-0.8140041897037683,0.7719298245614035,1.0,1.0,5/20,8.89%,FBLN1;GCNT2;SPOCK1;THBS1;TBCD
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.4376133824794577,-0.8137319845388505,0.75,1.0,1.0,9/21,23.05%,RACK1;EIF2B3;THBS1;TCF7L2;LPL;PRKACA;SELENOS;ZNF236;PDK3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.36310787089965185,0.8134368177510817,0.8484848484848485,0.9793112217953944,1.0,4/20,17.17%,CTNND2;CTNNA2;CDC42;KLF7
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),-0.5304436898271778,-0.8134306376865335,0.7719298245614035,1.0,1.0,3/5,29.47%,DMGDH;SLC44A1;ALDH7A1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.46516764921254217,-0.8129765611124871,0.6727272727272727,1.0,1.0,1/9,0.87%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.44224897080892156,-0.8127057303900357,0.7424242424242424,1.0,1.0,1/19,0.87%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.5330718635686573,-0.8121357000948621,0.7666666666666667,1.0,1.0,4/6,25.95%,ZNF91;UBR2;TUT7;TUT4
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.414042577294012,0.8115212542911531,0.6578947368421053,0.98171911266968,1.0,4/17,12.11%,NOTCH1;NEXMIF;PPARA;MBP
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.43073278529410813,-0.8103942420961785,0.7457627118644068,1.0,1.0,8/19,33.19%,RPA1;UFD1;UBA52;POLK;NPLOC4;VCP;RPA3;RFC1
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.36903670246963355,-0.8102265914117985,0.7971014492753623,1.0,1.0,4/42,6.75%,VEGFA;TERF2IP;RACK1;HSP90AB1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.4793231841480782,0.810199681466487,0.7272727272727273,0.9830796623035734,1.0,1/7,8.10%,GLUD1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.503604006501543,-0.8100403284776474,0.7647058823529411,1.0,1.0,3/10,17.52%,MT2A;MT3;JUN
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.503604006501543,-0.8100403284776474,0.7647058823529411,1.0,1.0,3/10,17.52%,MT2A;MT3;JUN
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.3780731719965756,-0.810008525270704,0.7121212121212122,1.0,1.0,3/38,2.81%,IFITM3;IFIT3;STAT1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.33180704414418644,0.8099041871986085,0.7878787878787878,0.9828313044000151,1.0,7/33,16.38%,APC;RHOA;RHOB;ARL3;CECR2;SPIRE1;SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5171982977844751,-0.8095428248847325,0.8541666666666666,1.0,1.0,1/7,5.04%,GLI2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.4296459608435344,-0.8093785559930837,0.7833333333333333,1.0,1.0,3/21,7.86%,VEGFA;BEX3;THBS1
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.49622534119606443,-0.8093552287958794,0.7407407407407407,1.0,1.0,3/8,22.61%,APH1B;APOE;PSEN1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3992945645412134,-0.8091384474134036,0.7272727272727273,1.0,1.0,13/55,21.11%,CIRBP;SNW1;NCL;DDX5;SRSF10;SRPK1;CELF2;LARP7;SRSF7;KHDRBS2;U2AF2;DDX17;FMR1
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.34533515026191797,-0.8091287954646845,0.726027397260274,1.0,1.0,21/83,16.50%,IFITM3;NRP1;NT5E;SLC2A3;ST3GAL4;COL6A1;ABCB1;NDRG1;GPX4;GABARAPL1;MAP3K8;PTCH1;ALCAM;UCK2;BHLHE40;PTRH2;PLSCR1;PLAGL1;PHTF2;SPRY4;SNX9
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.4070669246837841,0.8088750304665748,0.8095238095238095,0.9836726413591725,1.0,4/18,20.29%,MAP3K7;NFKB1;BTRC;MAP3K5
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.35559604361082164,0.808643557671556,0.6857142857142857,0.983271450574814,1.0,5/35,13.48%,PPP2R1A;CEP70;NDE1;CCP110;CEP290
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4469392140842613,-0.8082733136459389,0.8245614035087719,1.0,1.0,2/16,7.60%,ANXA1;RPS3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.41015259385558767,-0.8078979941517922,0.7301587301587301,1.0,1.0,2/26,9.13%,TGFB2;CCDC57
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.43645807381943114,-0.8067133401626653,0.7121212121212122,1.0,1.0,5/14,14.97%,RIPOR2;SRA1;BOC;MAPK14;BTG1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.4667954658688204,-0.8066285111102449,0.7627118644067796,1.0,1.0,1/8,0.92%,CD55
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.37977004187331753,-0.8063321530710187,0.7758620689655172,1.0,1.0,4/38,8.53%,NRP1;ANXA1;GSN;PTK7
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.4744943220187214,-0.8060535428966574,0.7647058823529411,1.0,1.0,1/12,3.10%,AFDN
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.45354153177679213,-0.805972070555664,0.7101449275362319,1.0,1.0,4/12,14.81%,VEGFA;CHD6;CARF;MT3
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.49503469928320026,0.8058219253670065,0.775,0.9873828446791111,1.0,1/6,4.70%,AKAP8
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.4501321278248032,-0.8049327360925542,0.6896551724137931,1.0,1.0,7/15,25.65%,UIMC1;BRCA1;MRNIP;TOPBP1;MRE11;BABAM2;DONSON
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),-0.5103430643747864,-0.8048504828630443,0.7068965517241379,1.0,1.0,2/7,11.63%,GLI2;FOXC1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.49724286872806234,-0.8044833564925861,0.6721311475409836,1.0,1.0,1/6,12.81%,SPRY3
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.47807472905126247,-0.804198935085845,0.7142857142857143,1.0,1.0,2/9,9.24%,RIMS1;TENM4
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5098606732001971,-0.8041581884039456,0.7333333333333333,1.0,1.0,1/7,8.75%,ABCB7
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5006938654309421,-0.8034475249524848,0.7166666666666667,1.0,1.0,3/6,26.09%,CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.46186935609143587,0.8033614889390657,0.6818181818181818,0.9910107618656021,1.0,2/8,9.96%,HDAC1;MBD2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4851504876693842,-0.8031513316164206,0.7540983606557377,1.0,1.0,2/10,3.10%,VEGFA;AFDN
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.5527678275072999,-0.8029456743821733,0.7580645161290323,1.0,1.0,1/5,12.59%,SLC41A1
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.5422161761638132,-0.802870299330062,0.75,1.0,1.0,2/6,13.90%,METTL15;DIMT1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.40181542404879195,0.802427474148316,0.7105263157894737,0.9915947788246052,1.0,1/16,1.63%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31790872993297864,0.8022459102198182,0.8918918918918919,0.9910740924383593,1.0,8/39,15.40%,UBQLN1;SMAD7;FBXW7;UBE2D1;SAE1;COMMD1;NDFIP2;DCUN1D4
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.33498014281468536,0.8018024285342956,0.7352941176470589,0.9910486368700563,1.0,4/27,14.95%,PDK4;OAZ2;PPARA;PANK2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.39889711362026015,0.8016531845823355,0.717948717948718,0.9904342961539492,1.0,4/17,8.30%,BCL2;BCL2L1;FBH1;NACC2
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.42139351708223854,-0.8014814523389642,0.7704918032786885,1.0,1.0,2/18,9.06%,ANXA1;TSPYL2
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.44901503269127296,-0.801319432288963,0.6981132075471698,1.0,1.0,4/21,18.55%,AP2A2;SNAP91;GPR107;LMBRD1
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.4372606400983111,0.8011556832853669,0.717391304347826,0.9904568748350601,1.0,2/15,10.51%,BRD2;SART3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.40018915936733523,0.8008578354731398,0.7021276595744681,0.9902328602340877,1.0,1/18,0.42%,MOCS1
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.4285542475856523,-0.8002300404391861,0.7580645161290323,1.0,1.0,3/20,7.86%,VEGFA;ANXA1;THBS1
prerank,MSigDB_Hallmark_2020__Complement,-0.35914893086008653,-0.7999079538989158,0.7681159420289855,1.0,1.0,10/65,10.11%,CLU;CD55;CTSL;ANXA5;XPNPEP1;CPQ;ADAM9;F3;TIMP2;FN1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.42559100245123627,-0.7998845828081469,0.765625,1.0,1.0,4/18,12.52%,HINT1;SNW1;DDX5;FHIT
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.4376454712276082,-0.7998260969011307,0.7714285714285715,1.0,1.0,4/16,15.11%,VEGFA;SASH1;MAP3K4;MINK1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.3441465920573282,0.7992404825538121,0.8823529411764706,0.9921600350933397,1.0,7/30,15.14%,SORBS3;NCK2;CDC42EP4;KATNBL1;BIN1;CDC42;LMOD1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.48368272412472874,0.7987910994203187,0.6666666666666666,0.9912089482182583,1.0,3/8,17.03%,RAPGEF2;RAP1A;EZR
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.48368272412472874,0.7987910994203187,0.6666666666666666,0.9912089482182583,1.0,3/8,17.03%,RAPGEF2;RAP1A;EZR
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.5104738087734466,-0.798711565061043,0.7288135593220338,1.0,1.0,1/5,11.24%,FGF13
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.5023947055124752,-0.798315159794177,0.7777777777777778,1.0,1.0,2/7,7.71%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.32067148725571987,0.7980045562884174,0.8888888888888888,0.9916371857403027,1.0,10/46,18.22%,BCL9;APC;BCL9L;FZD3;LEF1;BTRC;DDX3X;ARL6;CSNK1G2;VPS26A
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),-0.49324540915399384,-0.7977762208553245,0.7258064516129032,1.0,1.0,2/7,16.08%,SGK1;APOE
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.3646380799128869,0.7976276769939722,0.7878787878787878,0.9915264402811969,1.0,2/29,4.84%,NCK2;CDC42EP4
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.36269219310912715,0.7973162764392342,0.7948717948717948,0.9912743486117614,1.0,6/29,15.48%,RAD21;PHF8;PDS5B;TTN;CSNK2A1;KPNB1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3810836362740528,-0.7968571920271917,0.7887323943661971,1.0,1.0,4/38,5.16%,CLU;VEGFA;SVIP;EPHA3
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.31659512878026513,0.7966747919343389,0.8333333333333334,0.9913903513840778,1.0,15/56,15.85%,RGS6;ARHGEF7;MMUT;SNX13;MAPRE2;SEMA4D;RHOA;RAP1GDS1;RAPGEF2;RSU1;RAP1A;DOCK11;ARAP1;RASGRP2;RAPGEF1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.39159351661027214,0.7964694410315261,0.7804878048780488,0.990959819343341,1.0,3/15,15.01%,MRPS27;ETF1;GFM2
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.43786683378678903,-0.7963751521341769,0.7222222222222222,1.0,1.0,1/11,1.57%,TM7SF3
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.4152818714053159,-0.7960933809050321,0.734375,1.0,1.0,6/22,13.79%,RPL5;UCHL5;N4BP1;HSP90AB1;FHIT;RPL11
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.38115516520930703,0.7960913860657127,0.7954545454545454,0.9907935357059472,1.0,4/29,10.11%,KCNC2;ATL2;NACC2;MCU
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.3889626609763981,0.7960269055622033,0.7435897435897436,0.9900632883112351,1.0,2/17,8.27%,CLEC16A;SMG1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.38181331275386643,0.795550743175811,0.6923076923076923,0.9900107806497525,1.0,2/16,3.78%,CACNA1B;GNAI1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),-0.5027341439953097,-0.7955095810064252,0.660377358490566,1.0,1.0,1/7,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.45829174625316815,-0.7954908326751793,0.7166666666666667,1.0,1.0,3/12,15.88%,GSN;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.2891770449873332,0.7954171053442757,0.8947368421052632,0.9893293383492899,1.0,14/119,9.57%,TMEM131L;CTNND2;APC;GPC5;DAAM2;GPRC5B;PPM1A;SOX13;ZEB2;HDAC1;ADGRA2;SCYL2;AMFR;EGFR
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.45694764150192485,-0.7953209432108636,0.65625,1.0,1.0,1/12,7.17%,HTT
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.4196965812866674,-0.7951752342444863,0.7333333333333333,1.0,1.0,4/17,4.40%,LRTM1;SEMA3C;SEMA6D;SEMA3D
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.34692020028941384,0.7951710609789795,0.7560975609756098,0.9889304449171981,1.0,4/38,11.06%,HSPB1;CDKN1A;UBASH3B;PAK2
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3682860490042607,0.794704335017578,0.8,0.9888696343947306,1.0,7/29,11.14%,PTH1R;ADCY9;GNB1;MYH9;ADCY3;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.47754190676292707,0.7944973155581468,0.7631578947368421,0.9883500371294807,1.0,2/6,35.39%,SENP2;SENP6
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.3266718611933477,0.7938109238338101,0.875,0.9885985986109842,1.0,10/51,16.30%,HSPB1;CDKN1A;CAMKK2;UBASH3B;PAK2;RAPGEF2;RAP1A;TTN;GAS6;CACUL1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.35798236000396166,-0.7931297919393692,0.7246376811594203,1.0,1.0,3/36,9.34%,CTSL;AP2A2;ACTR10
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.3832787202195783,-0.7929172264756678,0.8194444444444444,1.0,1.0,11/55,14.08%,CD55;ADM;GPC3;CMKLR1;F3;SLC11A2;CALCRL;BTG2;IL1R1;SLC4A4;NAMPT
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.48711876163586093,-0.7926568466497673,0.7796610169491526,1.0,1.0,4/8,30.35%,DIMT1;WDR43;USP36;SHQ1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.42110185054110444,-0.7924700288541757,0.734375,1.0,1.0,2/19,0.87%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.42265489268130285,0.7909636226369846,0.6862745098039216,0.9925959220314784,1.0,2/9,11.99%,SETD7;MECOM
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.31342164540980794,0.7900360847686305,0.8787878787878788,0.9932983134400218,1.0,8/78,8.98%,PDK4;HSPA8;ATP6V1H;CLEC16A;CEBPB;CDKN1A;ZFYVE1;RNF152
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.34696911152556004,0.789553599416913,0.8157894736842105,0.9931501401046344,1.0,8/41,11.18%,HSPA1A;SMAD7;RNF14;BBS7;RNF139;ZER1;RNF180;FBXW7
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4257885719528374,0.7893865365683158,0.75,0.9925731961234266,1.0,2/11,10.73%,APC;CAMSAP1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.2907994103424938,-0.7893608780922315,0.9775280898876404,1.0,1.0,31/383,11.66%,FGF1;ZFPM1;TGFB2;TWIST1;VEGFA;ARNT2;PARP1;PGR;SUPT6H;STAT1;NR4A2;TET1;SNW1;CALCOCO1;PRPF6;GLI3;NR4A1;GLI2;BMP5;NR2F1;CEBPZ;DCN;RHOQ;PLAG1;HSF2;NCOA7;INO80;BCAS3;BRCA1;FOXC1;PRKDC
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),0.5035579071222358,0.7893494776427395,0.7111111111111111,0.9918108288556886,1.0,1/6,3.38%,DNAJC15
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.5212253175129368,0.7891762443078456,0.7619047619047619,0.9911986943739097,1.0,3/6,35.65%,GAS6;KDR;ANGPT1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.41025901976928864,-0.7885051949271562,0.6792452830188679,1.0,1.0,5/21,11.91%,ACTG1;MEGF10;FN1;PLPP3;PPIA
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.3760945889471071,0.7882498079472761,0.7777777777777778,0.992057502864725,1.0,5/23,14.56%,ARF1;RALA;HNRNPF;PAK2;CDC42
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.5157770205603358,0.788182621130069,0.7254901960784313,0.9913625106892117,1.0,4/6,24.10%,TTN;EZR;MYOM1;PRKACB
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.42718055689988166,-0.7879443791352926,0.8392857142857143,1.0,1.0,4/19,9.38%,TERF2IP;RPS3;PDCD4;SASH1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3572218686975458,-0.7868278868171152,0.7014925373134329,1.0,1.0,3/38,9.34%,CTSL;AP2A2;ACTR10
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.46169865763855944,0.7867438982632134,0.75,0.9929906854536314,1.0,2/7,17.62%,UBN1;HAT1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),0.5156390619811118,0.786590774195104,0.6888888888888889,0.9923888730556419,1.0,1/5,4.53%,UBQLN1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.29682102307271263,-0.7860703812170943,0.9886363636363636,1.0,1.0,61/399,15.25%,CLU;FGF1;TGFB2;TWIST1;RIMS1;VEGFA;ARNT2;ACTG1;HINT1;PGR;TERF2IP;RPL5;AFDN;CALCOCO1;WARS1;GCNT2;RACK1;GSN;SFRP4;AFF2;F3;NOTCH2;OLFM1;RPS3;TGFBR1;CTCF;NONO;NFXL1;PLAG1;FUS;YBX3;SLC24A3;ZNF138;FN1;RPL6;LARP1;BRCA1;FOXC1;NFX1;ZNF331;YY1AP1;CREM;SRSF10;PRDM5;DHX36;BHLHE40;PTRH2;PARP9;PDCD10;PLSCR1;MAPK14;RPL11;ZNF680;KRAS;ATP1B1;FAM50A;GON4L;MT3;BTG1;DENND4A;DTNBP1
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.5185009590394819,-0.7855723849587654,0.7843137254901961,1.0,1.0,1/6,1.43%,NRP1
prerank,MSigDB_Hallmark_2020__DNA Repair,0.33736719076888,0.7853703425406708,0.8518518518518519,0.993624074387416,1.0,2/42,1.60%,BCAM;HPRT1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.5306753955548527,-0.785303232148345,0.7962962962962963,1.0,1.0,2/5,21.96%,NAMPT;SELENOS
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4185783403624531,-0.7850044540131169,0.7692307692307693,1.0,1.0,8/18,23.22%,GPX4;CYP1B1;ELOVL2;PLA2G4C;PTGR1;PNPLA8;HSD17B4;MGLL
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.4646110252333575,0.7847265869877135,0.6976744186046512,0.993801011203248,1.0,2/6,10.59%,ARHGEF7;EML2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.41954866808882835,-0.7846384106585115,0.8333333333333334,1.0,1.0,5/14,19.11%,SLC7A14;CREM;PDE10A;HCN1;MCF2L2
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.440530236430246,-0.7845625622594198,0.8166666666666667,1.0,1.0,1/12,3.07%,KCNMB1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.43799317235731916,-0.7843636286877889,0.7,1.0,1.0,4/17,17.62%,PIP4P2;MTM1;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4266833857386889,-0.784089073804588,0.7931034482758621,1.0,1.0,3/17,13.77%,AKR1C1;THBS1;MAPK14
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.4398613772828972,0.7838158893242242,0.7,0.994597922177166,1.0,2/10,13.59%,USP7;EP300
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.534004285327279,-0.7834668309485637,0.7288135593220338,1.0,1.0,1/5,5.66%,ST3GAL4
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.4438858161234142,0.7833734909410912,0.7727272727272727,0.9943575181794957,1.0,2/10,7.27%,NOTCH1;BCL6
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),-0.4704767598463837,-0.7829551849334428,0.8,1.0,1.0,1/8,3.66%,ANXA1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.331494836187321,-0.7827228582427064,0.8378378378378378,1.0,1.0,6/75,8.93%,ELMO1;COL1A2;ARHGEF3;PLD1;G3BP2;ABI2
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.46431981296393177,-0.782530328811963,0.7454545454545455,1.0,1.0,2/12,2.95%,ARHGAP15;EPSTI1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.4752113635333518,-0.7824397247277047,0.7647058823529411,1.0,1.0,1/9,0.87%,TGFB2
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.4004730897664837,0.7823977478398169,0.8409090909090909,0.9951896410405605,1.0,4/11,20.61%,USP7;USP16;BRCC3;USP22
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.4283723684402253,0.7821656991766458,0.717948717948718,0.9946351570759305,1.0,3/11,16.98%,AGO2;PRKRA;TENT4B
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.417269449326758,-0.7820544414539247,0.6964285714285714,1.0,1.0,3/16,14.35%,ENO1;SLC4A4;TMSB4X
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.3871862607250576,-0.7816318503265693,0.7466666666666667,1.0,1.0,4/31,9.93%,TWIST1;VEGFA;NDRG1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.3900409795426099,0.7816118248032116,0.7567567567567568,0.9946075425980939,1.0,3/24,5.30%,NFKBIZ;GPRC5B;SNX4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5130139912884046,-0.7815519154287865,0.8113207547169812,1.0,1.0,3/6,17.11%,RPL5;RPL11;RPS7
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.44303024150158793,-0.7815075126794508,0.7794117647058824,1.0,1.0,2/12,12.10%,TBCD;SLIT2
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5223724962503398,-0.7814139109807359,0.7321428571428571,1.0,1.0,3/7,8.61%,NMNAT2;PRPSAP2;NMNAT3
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4371624192899094,-0.7814063290793251,0.703125,1.0,1.0,1/14,7.17%,HTT
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.496423911606521,0.7810450742972868,0.7857142857142857,0.9946168528313998,1.0,3/6,16.72%,AGO2;DDX3X;DHX9
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),0.5080486885317533,0.7809038226694115,0.7916666666666666,0.9941010409996204,1.0,2/5,13.03%,PPP2R3C;DOCK11
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.5001702743919717,-0.7807113014571475,0.7321428571428571,1.0,1.0,2/6,23.81%,VPS36;TMEM50B
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),-0.47585016578783434,-0.7804789183267151,0.7966101694915254,1.0,1.0,1/9,1.74%,PARP1
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.32736651624909874,-0.7800691006581216,0.835820895522388,1.0,1.0,16/89,15.57%,FGF1;VEGFA;TERF2IP;SVIP;LEPR;RACK1;FAXDC2;ATG10;RALBP1;FAM20A;PPIA;CSNK1D;LIMCH1;KRAS;MT3;CD4
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3416021291036227,-0.7799165829040345,0.8507462686567164,1.0,1.0,10/85,14.87%,CD55;VAMP4;PROS1;ACTR10;COG4;CNIH3;GOSR1;STX17;SEC13;TMED4
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.49867624498474944,0.7796774932905746,0.6956521739130435,0.9952153364839643,1.0,1/5,9.83%,CAB39
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.4460062144396823,0.7793954800678319,0.7755102040816326,0.9948838252824005,1.0,4/13,15.11%,RNF185;ZER1;ATXN3;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.291247256325947,0.779256973348348,0.96875,0.9942036356961274,1.0,10/74,13.93%,BCL2;TMEM30A;MICALL2;TCAF1;OAZ2;FBXW7;MAVS;SAE1;CEP290;EFCAB7
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3603163386393314,-0.7782724460012811,0.7384615384615385,1.0,1.0,4/38,7.29%,ZFPM1;TGFB2;ZFP36L2;NOTCH2
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.4631948206421583,0.7776229456278984,0.7435897435897436,0.9958477153307309,1.0,4/8,18.98%,SMAD7;ABCA1;KLF2;MAP2K5
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.3982518476905723,0.7776091278167718,0.7804878048780488,0.9950577474071284,1.0,4/15,9.82%,ZBTB7C;GPRC5B;GPRC5C;PELI2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.3197669501197269,0.777252407934603,0.8214285714285714,0.9948832882073718,1.0,13/62,20.97%,SORT1;EMP2;KLHL20;TBC1D5;MYO1D;HEATR5B;VPS50;AP1G1;RAB14;VPS26A;CLTC;EPS15;PIK3C3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.35072980878662885,0.7763020697416617,0.8,0.995661766655851,1.0,2/27,2.16%,TNFRSF10B;PML
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4113797299215558,-0.7759224184127144,0.7121212121212122,1.0,1.0,4/19,4.82%,NRP1;VEGFA;ANXA1;NR4A1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.4360386625493515,-0.7754597977926391,0.7241379310344828,1.0,1.0,3/8,27.95%,STAT3;LYN;STAT6
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5342232991851437,-0.7753396646841034,0.7818181818181819,1.0,1.0,4/6,43.67%,PCCA;BTD;MCCC2;MCCC1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.27920966139560016,0.7749159312589817,1.0,0.9970979806892607,1.0,13/93,12.11%,CACNA1B;GRID1;GABRB1;HSPA8;DTNA;CAMKK2;NRXN1;GABRB3;CACNB2;GRID2;ATXN3;HTR1F;MBP
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.38182182157208966,0.7748255430938064,0.75,0.9963644296804585,1.0,6/16,18.46%,DLG5;NRXN1;GRID2;CLSTN2;NLGN2;PTPRD
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.37119211769469324,-0.7747546390343354,0.821917808219178,1.0,1.0,10/36,20.87%,PARP1;UBL5;FBXW2;FBXO22;PRKDC;CHRM3;GGCX;SERP1;UBA52;ST3GAL6
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.46738900668670236,0.7746560543472772,0.6981132075471698,0.9958787887392588,1.0,3/5,10.19%,MCAM;MYO1E;ITGA3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.41292450169117134,-0.7744600798979591,0.8032786885245902,1.0,1.0,2/22,0.87%,ZFPM1;TGFB2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.48703008686128035,0.7743055199430804,0.6956521739130435,0.9955765432878868,1.0,3/6,26.66%,ITGA3;PRNP;INSR
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.4958830325864864,-0.7740910046943119,0.7457627118644068,1.0,1.0,2/5,12.66%,ANXA1;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3626593278182025,0.7738251084478593,0.8205128205128205,0.9954572492694658,1.0,7/29,11.14%,PTH1R;ADCY9;GNB1;MYH9;ADCY3;ADCY5;ADAM17
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.3895058552745213,-0.7735587114935257,0.8095238095238095,1.0,1.0,6/22,17.52%,FOXC1;SP100;NGF;HES1;PRKN;JUN
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.3269041937381899,-0.7733612351851058,0.8714285714285714,1.0,1.0,14/63,23.71%,RAD51B;PSMD8;PSMC2;CSNK1D;FHL1;NINL;SDCCAG8;PRKACA;FBXL7;PSMD14;DYNC1H1;MECP2;YWHAE;CKAP5
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.3136956145874721,-0.7733160928399246,0.958904109589041,1.0,1.0,25/153,16.80%,PARP1;XPA;RAD51B;VAV3;MSH6;DDB2;XPC;POLA1;RPS3;SLF1;RPA1;BTG2;INO80;BRCA1;PRKDC;WRN;MRNIP;RNF8;UFL1;MAPK14;RAD17;TOPBP1;ZRANB3;SPIDR;MGMT
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.3632482433408767,-0.772712541365147,0.765625,1.0,1.0,3/39,2.81%,IFITM3;IFIT3;STAT1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5024654502408408,0.7720755302780322,0.7209302325581395,0.9972160065684902,1.0,1/6,4.87%,TRAK1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5105492838607304,-0.7718378333755137,0.7843137254901961,1.0,1.0,2/5,5.77%,ST6GALNAC3;ST3GAL5
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.45552940395188446,0.7718152455572019,0.6904761904761905,0.996822329490416,1.0,1/8,4.53%,UBQLN1
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.38276973050427066,-0.771262022381682,0.7794117647058824,1.0,1.0,7/27,23.98%,GCNT2;LARP1;PARP9;ATG14;EIF2A;RBM4B;ZC3H7A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.49138984455974577,-0.7709674514323244,0.7704918032786885,1.0,1.0,1/7,21.51%,STX8
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.38934829202930454,0.7707652975252229,0.717948717948718,0.9974668163905562,1.0,3/13,10.65%,ADGRA2;ZSWIM8;P2RX4
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.3287488063013964,-0.7707250945573577,0.8507462686567164,1.0,1.0,8/73,7.71%,NRP1;VEGFA;ANXA1;NR4A1;ADAMTS12;RACK1;ZFP36L2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.5033448931478951,-0.7706771254777003,0.8076923076923077,1.0,1.0,3/7,25.12%,CST3;CLASP2;LRP1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3181276602806748,0.7706008278218337,0.9411764705882353,0.9969189760461818,1.0,7/37,15.66%,ATP2B4;CDKN1A;FBXW7;UBE2D1;ANAPC16;BTRC;ANAPC1
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.4788337142664711,-0.7703642544809064,0.7966101694915254,1.0,1.0,2/8,17.90%,PRMT2;PRMT3
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),-0.52673702572373,-0.7703010851173099,0.819672131147541,1.0,1.0,3/7,12.93%,TGFB2;FOXC1;DHX36
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5008805827238476,0.7700032104408173,0.8292682926829268,0.9969172069914057,1.0,1/5,15.03%,GLRX3
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.46996856048187896,0.7692207606508935,0.7,0.9972422923464711,1.0,2/6,1.63%,NOTCH1;HEY2
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.487081679275107,0.7689473851834022,0.75,0.9968864616299677,1.0,1/7,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.46809656643234065,-0.7687473044048883,0.8301886792452831,1.0,1.0,1/9,0.87%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4420380868175988,-0.7686625522127534,0.8253968253968254,1.0,1.0,3/11,7.86%,SNW1;HSP90AB1;THBS1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4420380868175988,-0.7686625522127534,0.8253968253968254,1.0,1.0,3/11,7.86%,SNW1;HSP90AB1;THBS1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.46780108044145063,0.7685146295195496,0.7142857142857143,0.9968212703654863,1.0,3/6,21.40%,SERGEF;NDFIP2;SNX3
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.3962759146133047,-0.7683142486197818,0.8153846153846154,1.0,1.0,5/27,20.13%,SUPT6H;SRSF10;SRPK1;LARP7;KHDRBS2
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.34193106999294004,0.7683026362923506,0.7317073170731707,0.9962489700031378,1.0,8/27,18.69%,PML;DEK;UBE2N;EGFR;WRNIP1;DHX9;RNF168;BRCC3
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3071581771818047,0.7670254613102252,0.9130434782608695,0.9971346575460269,1.0,2/69,2.25%,HSPA1A;NCK2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.4738310813787522,0.766353055612744,0.8292682926829268,0.997485397279371,1.0,1/7,4.87%,TRAK1
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.4584358554216341,0.7663422311896496,0.7619047619047619,0.9966970825067467,1.0,2/6,5.66%,CD44;ARHGEF7
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.4299115510969116,-0.7662753107619636,0.8253968253968254,1.0,1.0,1/11,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.5183318192949419,-0.7661260327688283,0.8301886792452831,1.0,1.0,2/5,30.60%,PTPN2;PRKCA
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.40817840445049064,-0.7660665517972026,0.8059701492537313,1.0,1.0,3/20,11.18%,HSP90AB1;SMG6;MAP3K4
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.4517115492528412,0.7656752144899389,0.6938775510204082,0.9967948149136047,1.0,2/5,20.70%,RHOA;NELL1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.4383142062453356,-0.7647601576452485,0.7741935483870968,1.0,1.0,1/10,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.505472679460498,-0.7646696001953771,0.8064516129032258,1.0,1.0,1/5,1.52%,VEGFA
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.38113968471564946,0.7641234631945021,0.7948717948717948,0.9984440450156669,1.0,3/17,10.03%,USP7;USP16;ATXN3
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.36363155280429726,0.7641210240638857,0.8214285714285714,0.9976478376432462,1.0,3/14,13.00%,FLT1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3949722224994232,-0.7638906599490819,0.7792207792207793,1.0,1.0,3/14,7.60%,TERF2IP;MSH6;RPS3
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.3289645108037749,-0.7638521356932476,0.88,1.0,1.0,20/73,22.24%,ACTG1;LIMA1;ADAM9;VCAN;JAM3;MYL12B;SLIT2;EPB41L2;MAPK14;TSPAN4;NEXN;ITGA10;PIK3CB;BMP1;MYH10;FBN1;VCL;ARPC2;EVL;ITGA9
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.49489096570514207,-0.7638382594922396,0.851063829787234,1.0,1.0,3/8,6.67%,PARP1;ST3GAL4;ST6GAL1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.45183091977663636,-0.7632764782697431,0.7758620689655172,1.0,1.0,5/14,23.03%,PRMT2;NSD3;PRMT3;PRMT7;NSD1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.32997597954299046,0.7632762517264995,0.8611111111111112,0.9981408809533673,1.0,7/30,13.59%,NOTCH1;HEY2;HEYL;NOTCH3;ADAM17;SORBS2;EP300
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.4491598887882545,-0.7632050937810685,0.8360655737704918,1.0,1.0,5/10,29.48%,TPM2;TPM1;VIM;TPM3;TMOD1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.4491598887882545,-0.7632050937810685,0.8360655737704918,1.0,1.0,5/10,29.48%,TPM2;TPM1;VIM;TPM3;TMOD1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.44903645704268424,-0.7628836077116198,0.7659574468085106,1.0,1.0,2/13,11.63%,CTSL;FOXC1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.33458982046727753,-0.7628716895797468,0.9253731343283582,1.0,1.0,7/77,7.29%,PDGFD;NRP1;SPRY1;FBLN1;GCNT2;DENND2B;NOTCH2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.4111628001186689,0.7625898944140097,0.7608695652173914,0.9985251428245279,1.0,1/9,3.82%,SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.4819944181204377,0.7622398102269681,0.7555555555555555,0.9982613307672651,1.0,1/6,4.70%,AKAP8
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.3072036906243616,0.762228072901029,0.8484848484848485,0.9974857710714663,1.0,4/51,3.99%,MFHAS1;TNFRSF1B;NFKBIZ;GPRC5B
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.36105243098043927,-0.762073023019602,0.855072463768116,1.0,1.0,3/32,11.58%,PSMD8;HLA-B;PSMC2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.2936594625594418,0.7617946529355524,0.96875,0.9972232036495233,1.0,6/67,11.06%,PDGFA;FLT1;MAP2K2;EGFR;PELI2;PAK2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2768749904134905,-0.7616755059828291,0.9895833333333334,1.0,1.0,40/484,11.71%,SERTAD2;FGF1;ZFPM1;TWIST1;VEGFA;ARNT2;PARP1;MDFIC;PGR;STAT1;NR4A2;TET1;SNW1;CALCOCO1;COL1A1;PRPF6;GLI3;NR4A1;GLI2;BMP5;XPC;NR2F1;PRMT2;CEBPZ;HIVEP3;TGFBR1;HMGN1;CTCF;DCN;RHOQ;PLAG1;CREB3L2;HSF2;NCOA7;INO80;BCAS3;BRCA1;FOXC1;PRKDC;THOC1
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.49042338551806414,-0.7615936317524507,0.7368421052631579,1.0,1.0,1/5,7.58%,SGK1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.3868260229237907,-0.7610665764340122,0.835820895522388,1.0,1.0,5/24,13.55%,FTH1;SLC11A2;ABCB7;HEPH;ATP6V1E1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4001329043137759,-0.760923775191677,0.7857142857142857,1.0,1.0,6/20,15.26%,MSH6;BCAS3;WRN;MAPK14;MT3;YWHAB
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.3567215808351791,-0.7600585619257219,0.819672131147541,1.0,1.0,9/46,17.39%,HECW2;NKD1;GPC3;ADAM9;VGLL4;SH3D19;APOE;SNX9;PRKN
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.3006659831607465,0.7599818867407445,0.9411764705882353,0.9990064693612435,1.0,8/58,9.83%,ACTR2;ARF1;UBE2N;MAP3K7;CDKN1A;RAF1;EGFR;CAB39
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.4944364995354046,-0.7598308351299337,0.8541666666666666,1.0,1.0,1/6,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.3981976669169779,0.759593833635055,0.75,0.9987520764462633,1.0,7/18,22.35%,SOX13;CEBPB;ZBTB16;WDFY2;ZFP36L1;LMO3;CREB1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.3477878528185946,-0.7595383358208296,0.8769230769230769,1.0,1.0,12/62,18.18%,AFG3L2;PARP1;SLC25A36;MTM1;SLIRP;NUBPL;VPS13C;NIPSNAP2;COX7A2;CHCHD2;PRKN;AFG1L
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.35890529844230745,-0.7593514004023295,0.821917808219178,1.0,1.0,2/38,1.52%,ELOB;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.34070255375212644,-0.7592180332850962,0.835820895522388,1.0,1.0,7/40,13.77%,TSHR;COL3A1;ADM;CALCRL;PRKAR1A;LGALS3;MAPK14
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.33410661771057004,-0.7589925111433555,0.8701298701298701,1.0,1.0,16/69,16.84%,NRP1;CMKLR1;ST6GAL1;ABCB1;ATG10;AVL9;AKAP12;SNAP91;ITGBL1;GLRX;CFH;EPB41L3;HSD11B1;PRRX1;NGF;PRKG2
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.33741896294020934,-0.7586550068199038,0.8873239436619719,1.0,1.0,7/62,9.44%,UAP1;SAT1;IQGAP2;SGK1;NDRG1;AKAP12;TSC22D1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.4315371102853595,-0.7579696638284278,0.8548387096774194,1.0,1.0,3/15,11.57%,TWIST1;SMAD6;PTCH1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.4303225603576993,-0.7578617195039473,0.8125,1.0,1.0,3/13,8.53%,SNW1;EPHA3;PTK7
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.40039703966731605,0.7576198321493908,0.775,1.0,1.0,2/15,1.63%,MYH11;HEY2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.4615348591140424,0.7573731259188388,0.775,1.0,1.0,4/7,31.36%,DHX9;TRAF3;RNF216;ILRUN
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4681990211959124,0.7568880275271626,0.7297297297297297,1.0,1.0,2/7,9.26%,IRS1;SERGEF
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.4097801998128239,-0.7565007122888047,0.7611940298507462,1.0,1.0,1/19,1.02%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.4853498954457343,0.7562345324063098,0.7619047619047619,1.0,1.0,3/5,28.95%,SGIP1;MEF2C;NLGN1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3684132646349768,-0.7560398141152276,0.8933333333333333,1.0,1.0,2/35,5.68%,KLHL13;PIK3R4
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4773881628999552,-0.7558818004811926,0.7868852459016393,1.0,1.0,1/7,3.44%,IQGAP2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.313453381598547,-0.7556177048129312,0.8970588235294118,1.0,1.0,14/81,14.66%,FBLN1;RASSF8;SEMA6D;GLI2;NTM;DZIP1;ABI2;AKAP12;LAMA4;LAMB1;SLIT2;LIMCH1;PDE10A;FLRT2
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.48210060687991674,-0.7551164145734688,0.8166666666666667,1.0,1.0,2/6,14.81%,LEPR;MT3
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4045893207747745,-0.7547313398083562,0.8253968253968254,1.0,1.0,6/17,15.04%,NR4A2;RPS3;TGFBR1;PPIA;DAPK2;BCL2L14
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.3909790018274917,-0.7546328170601971,0.8,1.0,1.0,5/21,20.49%,OLFM1;MT3;APOE;ZFYVE27;GOLGA4
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.34911897205500175,0.7545389764127268,0.8275862068965517,1.0,1.0,4/29,9.54%,ST3GAL2;NUS1;B3GNT2;PMM2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.3884523809248109,0.7541118403294186,0.7916666666666666,1.0,1.0,2/13,5.37%,ACADVL;GFPT1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.378046982674523,0.7541001886284611,0.8,1.0,1.0,4/21,10.75%,PDGFA;UBE2N;SMG1;YLPM1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.39385380856595636,0.7540237355302607,0.8378378378378378,1.0,1.0,3/11,16.98%,XRN1;DIS3;TENT4B
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.4182689610734312,-0.7528893465969344,0.7916666666666666,1.0,1.0,4/15,13.73%,RACK1;CD47;PIP4P2;PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.44360303192195805,-0.7527239659274988,0.8269230769230769,1.0,1.0,2/10,16.08%,VGLL4;APOE
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),-0.41328013412137743,-0.7526430564809087,0.7878787878787878,1.0,1.0,5/20,23.60%,PHLDB2;DHX36;NR2C2;DAG1;CLASP2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.3106897059598898,-0.7519099092191428,0.9420289855072463,1.0,1.0,22/126,17.52%,CLU;RASGRF2;VAV3;RACK1;SEPTIN4;SFRP4;ARHGEF3;PRMT2;HTT;OLFM1;APH1B;CYP1B1;ANO6;SLIT2;ITGB3BP;DAPK2;MTCH2;SQSTM1;KCNMA1;NGF;NET1;JUN
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.39058132728611394,0.7517439120173909,0.851063829787234,1.0,1.0,2/15,1.07%,SEMA4B;NOTCH1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.3876442024033329,0.7516207175286044,0.8461538461538461,1.0,1.0,5/18,10.36%,GNAI1;GNB1;KLF9;ADCY3;ADCY5
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.3249981416809422,-0.7511766197632996,0.9054054054054054,1.0,1.0,19/104,15.57%,FGF1;NRP1;VEGFA;LEPR;EPHA3;RACK1;FAXDC2;THBS1;RALBP1;FAM20A;PPIA;EPHA5;CSNK1D;EPHA4;SLC4A4;LIMCH1;KRAS;MT3;CD4
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.31880152350233143,0.7510745534110642,0.8863636363636364,1.0,1.0,4/21,20.70%,ACVR2A;BMPR1A;IL6R;NELL1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.3694272676759498,-0.750931638097765,0.8235294117647058,1.0,1.0,9/34,14.81%,SLC8B1;MT2A;SLC10A7;STIM2;SLC24A3;SLC41A1;TMCO1;ATP1B1;MT3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.35196650189369205,0.7507880424943061,0.84375,1.0,1.0,5/25,8.58%,NOTCH1;HEY2;TBX3;DLG5;HEYL
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.3969130869836214,-0.7505980132882771,0.803030303030303,1.0,1.0,5/21,11.57%,AKR1C2;PTGFR;LARP1;BRCA1;PTCH1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.44570378863038684,-0.750593693755192,0.8541666666666666,1.0,1.0,3/7,20.22%,SPEF2;BBS4;VPS51
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.43164189843771744,-0.7504815535124465,0.78125,1.0,1.0,3/12,8.53%,SNW1;EPHA3;PTK7
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.34603255826179735,-0.7504282086293448,0.8484848484848485,1.0,1.0,3/43,6.34%,NRP1;SEPTIN4;PLD1
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.4535083445642228,0.7503682160672532,0.7837837837837838,1.0,1.0,1/6,6.48%,NUS1
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.4988304563385059,-0.7500973650118296,0.8035714285714286,1.0,1.0,3/5,41.05%,PIP4K2B;PIP4K2A;RUBCN
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.44241150277546804,-0.7500627868049541,0.8125,1.0,1.0,3/11,7.71%,TWIST1;VEGFA;TGFBR1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.34135942814993137,-0.7491885222758246,0.8260869565217391,1.0,1.0,13/41,24.40%,TWIST1;DDX5;SMAD6;PTCH1;SMOC1;ACVR1;CCN1;CRIM1;NBR1;PRKACA;BMPR1B;CDK6;CCN4
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.40466991881583053,-0.7491129145574126,0.7857142857142857,1.0,1.0,4/18,15.04%,BRCA1;CREM;UBE3D;BCL2L14
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.36714731538469547,0.7490791516725958,0.8409090909090909,1.0,1.0,4/16,8.36%,PML;HIPK2;PSME3IP1;MARCHF7
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.40527383681796564,-0.7489574199977194,0.8,1.0,1.0,3/20,8.05%,TWIST1;TERF2IP;SLF1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.43604252735062177,-0.7484928789768341,0.7666666666666667,1.0,1.0,3/11,22.04%,HSP90AB1;TM9SF4;MAP1A
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.25330173195930755,0.748269429453355,1.0,1.0,1.0,32/163,17.04%,LSAMP;CDH2;CNTN4;KALRN;APC;SOX6;ERBB4;ZEB2;TRAK1;MOBP;TBX3;ADGRA2;NRXN1;ZBTB16;AXL;ADGRV1;ATXN3;MERTK;SEMA6A;MBP;ATXN10;EP300;LDB2;KIRREL3;NDUFS2;ACVR1B;MYT1L;BTBD2;APAF1;SCD5;NLGN2;ATN1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.5032088957956946,-0.7479093912106114,0.7450980392156863,1.0,1.0,3/5,26.09%,CALM1;PYGB;PGM2L1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5032088957956946,-0.7479093912106114,0.7450980392156863,1.0,1.0,3/5,26.09%,CALM1;PYGB;PGM2L1
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.28368987968510445,0.7477096802692156,0.9565217391304348,1.0,1.0,14/89,12.67%,TOB1;ATL2;DNAJC15;UBQLN1;CD151;LIFR;MTARC2;ABCA1;BCL6;SDHB;DBT;ITGA7;CAT;ELOVL6
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.48569255476931494,-0.7477074244135132,0.8088235294117647,1.0,1.0,3/6,19.03%,SQSTM1;PRKN;ATG14
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.38666489240661783,-0.7475090258652751,0.7777777777777778,1.0,1.0,6/17,16.90%,PER2;RHEB;NOTCH2;FBXO22;BHLHE40;HES1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.37391404361564073,-0.7473534898999777,0.847457627118644,1.0,1.0,3/33,10.11%,NRP1;FBLN2;FN1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.37776025084887765,0.7470825375059947,0.8888888888888888,1.0,1.0,3/14,9.43%,TNFRSF10B;BCL2L1;MADD
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.355834802929481,0.7470811807817607,0.8571428571428571,1.0,1.0,11/33,24.26%,UBQLN1;PACS2;AMBRA1;TMEM41B;ATG2B;VMP1;PIK3C3;UBXN2A;ULK2;TRAPPC8;SMURF1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.4382209519122718,-0.7459501615041,0.819672131147541,1.0,1.0,1/8,3.75%,SNW1
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.4112307674591954,-0.7459196504735423,0.7846153846153846,1.0,1.0,4/18,24.07%,FASTKD2;MRPS25;GFM1;MRPL3
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.47552905607956414,-0.7457388963985714,0.7884615384615384,1.0,1.0,4/6,34.01%,RGCC;PHIP;PDGFRB;EDN3
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.3372058639110326,0.7455741245861941,0.8787878787878788,1.0,1.0,3/31,5.29%,ABL2;PACSIN2;CD151
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.3394652942378574,-0.7454865301763617,0.8484848484848485,1.0,1.0,15/47,27.65%,RMDN1;CEP126;ITGB3BP;SEC13;NUP107;SPC25;EML4;DYNC1H1;MECP2;CLASP2;CKAP5;RANBP2;NEK9;NUP133;DYNLL1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.356690862810512,0.7451142604019692,0.8787878787878788,1.0,1.0,3/19,11.62%,SORBS3;SURF4;KATNBL1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.4417290382175495,-0.7448861306310902,0.7727272727272727,1.0,1.0,3/10,19.62%,PRDM5;WDR82;SETDB2
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.4410280745921049,-0.7447990798814947,0.8103448275862069,1.0,1.0,2/9,5.66%,ST6GALNAC3;ST3GAL4
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.39533169060143414,0.7447312369256789,0.6774193548387096,1.0,1.0,3/11,13.00%,FLT1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.3849108170591447,0.7437925594912679,0.7741935483870968,1.0,1.0,3/12,13.00%,FLT1;IRS1;AMBRA1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.2745994648383229,0.7436865996782634,1.0,1.0,1.0,17/55,18.46%,ABL2;TIAM2;CAMK1D;RETREG3;RHOA;ARHGAP35;RAPGEF2;RAP1A;NPTN;EP300;LRRC7;SCARB2;MAP3K13;RAPGEF1;CUX1;CBFA2T2;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.38097979587841174,0.7436223317146406,0.8679245283018868,1.0,1.0,1/17,1.46%,TNFRSF1B
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.40987043455441535,-0.743179794986823,0.859375,1.0,1.0,1/19,2.51%,VAMP4
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.42441224182410947,0.7429182726216923,0.8409090909090909,1.0,1.0,1/9,0.51%,MYH11
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.4081451704670252,-0.7428960542508595,0.7868852459016393,1.0,1.0,5/17,25.93%,NDUFB7;NUBPL;NDUFB9;COA1;NDUFC1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.4081451704670252,-0.7428960542508595,0.7868852459016393,1.0,1.0,5/17,25.93%,NDUFB7;NUBPL;NDUFB9;COA1;NDUFC1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.354172977411476,0.742674187608224,0.8,1.0,1.0,3/18,13.48%,EHD2;OAZ2;CEP290
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.380627195310113,-0.7422083897418398,0.8181818181818182,1.0,1.0,3/21,11.00%,HINT1;RHOQ;ACAT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3375041972273527,-0.7417014949424384,0.8235294117647058,1.0,1.0,3/39,9.34%,CTSL;AP2A2;ACTR10
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.26980379047096886,0.7411607813973883,1.0,1.0,1.0,23/118,17.23%,NCK2;APC;RASAL2;CDC42EP4;MYH9;MYO1E;ARHGAP10;ARHGEF7;ABR;KIF5B;KLC1;PXN;RICTOR;SORBS2;PDLIM5;PPP4R2;BIN1;CDC42;RANBP9;SEPTIN9;PLEKHG2;EZR;PREX1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.28035859669620855,0.7405439320605539,0.9166666666666666,1.0,1.0,6/55,9.10%,GNAO1;GNB1;MAP3K7;AGO2;FZD3;RHOA
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3789354551224075,0.740403680326771,0.825,1.0,1.0,2/15,4.03%,BCL2;BCL2L1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.4658059874741714,-0.7398438629014743,0.7719298245614035,1.0,1.0,3/7,34.74%,SLC25A46;TMCC1;SH3GLB1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.4089417867323453,0.7395911605114178,0.75,1.0,1.0,3/10,8.11%,SOX6;SOX5;ZBTB16
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.32926417002538017,-0.7395209819648775,0.8571428571428571,1.0,1.0,9/52,15.62%,ALDH1A1;ALDH3A2;PTS;GABARAPL1;ACO2;SUCLG2;CA4;LDHA;DLD
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),0.45412196525441684,0.7391647691347074,0.775,1.0,1.0,2/6,6.20%,RFX3;VEZF1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.37983564502677464,0.739156726276315,0.7857142857142857,1.0,1.0,1/11,4.03%,BCL2L1
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.40050526451218194,-0.7390107755306197,0.8208955223880597,1.0,1.0,2/15,9.26%,SULF2;CREB3L2
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.34638444559186776,-0.7385170486994406,0.8095238095238095,1.0,1.0,7/48,11.41%,COLEC12;IFITM3;OTULIN;AKAP1;ALPK1;NUB1;TRIM13
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.44767965530157466,0.7383715547345401,0.8076923076923077,1.0,1.0,1/7,18.27%,IP6K1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3483509368851375,-0.7383361593973349,0.8769230769230769,1.0,1.0,7/30,15.32%,NR4A1;TSPYL2;PDCD4;BTG2;FOXC1;BTG1;ANGEL2
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.4121673157668842,0.7381918022079812,0.7906976744186046,1.0,1.0,2/8,16.80%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.4507098350905261,-0.7379939362405294,0.8490566037735849,1.0,1.0,1/7,7.79%,APH1B
prerank,MSigDB_Hallmark_2020__Apical Surface,0.4036572850364279,0.7376255545534731,0.8571428571428571,1.0,1.0,2/14,3.85%,HSPB1;ATP8B1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.4205262193264288,0.7375443378597459,0.8,1.0,1.0,2/9,16.55%,AGO2;PRKRA
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.47875682435943506,-0.7372676827054926,0.8070175438596491,1.0,1.0,1/5,5.37%,GSN
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.44357869487697976,-0.7368383047135335,0.8823529411764706,1.0,1.0,3/11,13.32%,TGFBR1;SLIT2;TGFBR3
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.43261253014712364,0.736789925541828,0.8888888888888888,1.0,1.0,2/10,12.76%,SLC12A2;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.4675211068757562,-0.7354162903564299,0.8615384615384616,1.0,1.0,4/8,15.11%,VEGFA;SASH1;MAP3K4;MINK1
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.4872054785529807,-0.7352551667488749,0.7678571428571429,1.0,1.0,3/5,26.01%,APH1B;PSEN1;GALNT11
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.3143741467370894,-0.7348404284915256,0.8823529411764706,1.0,1.0,15/54,23.48%,IGFBP2;NR4A1;ABCB1;OLFM1;BTG2;NUP58;BTG1;SQSTM1;CYB5B;EIF2S3;CCK;PRKACA;BCL2L11;LYN;ENO2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3514153575407119,-0.7345624970321737,0.8771929824561403,1.0,1.0,8/41,22.02%,FBXO38;PSMD8;PSMC2;FBXL18;FBXL4;FBXL13;FBXL7;PSMD14
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34875426220101147,0.7345325822240093,0.7878787878787878,1.0,1.0,2/29,2.56%,BCL2;MICALL2
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.396078069047729,0.7339067648000263,0.8717948717948718,1.0,1.0,3/12,16.80%,TMBIM6;CPEB3;GRIN1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.4007845926501895,0.7338432949810981,0.8181818181818182,1.0,1.0,6/12,26.44%,RAB27A;STAM2;VTA1;TSG101;IST1;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.4526289979600195,-0.7337622092956174,0.7586206896551724,1.0,1.0,3/7,34.74%,ANXA2;PIP4K2B;SH3GLB1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.3480140236055994,-0.7332950180103549,0.819672131147541,1.0,1.0,1/22,0.81%,ZFPM1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.3707852962436875,-0.7331864789417116,0.85,1.0,1.0,2/24,5.66%,ST6GALNAC3;ST3GAL4
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.46733304485222116,0.7330273847046274,0.813953488372093,1.0,1.0,2/7,14.81%,PPM1A;DDX3X
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.37435961133404666,-0.7330092919198247,0.8461538461538461,1.0,1.0,3/26,7.71%,NRP1;CD47;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.36443017034722414,-0.7325323755974932,0.8714285714285714,1.0,1.0,4/28,7.58%,ANXA1;GPC3;CD47;SGK1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4816506959030623,0.7323266520241584,0.7333333333333333,1.0,1.0,1/6,1.63%,HEY2
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.40929641474370193,-0.7320600671219181,0.7580645161290323,1.0,1.0,3/13,15.88%,SGCD;ATP1B1;TPM1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.49407724944915654,-0.7315500469214076,0.8541666666666666,1.0,1.0,2/6,21.42%,BTG1;BCL2L11
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.3982476612957786,0.7310489587470347,0.825,1.0,1.0,2/10,9.57%,VAPA;EGFR
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.3599356102584439,-0.730912111894627,0.8382352941176471,1.0,1.0,7/40,11.06%,RIPOR2;NRP1;HTT;ABI2;RHOQ;GPM6A;BCAS3
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.4505297322690001,0.7309080287573099,0.8809523809523809,1.0,1.0,1/8,1.04%,MFHAS1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.36261216577016925,-0.730854625562381,0.8208955223880597,1.0,1.0,6/26,24.55%,ASPA;ACAT1;DLD;DDAH1;PHYKPL;AASS
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.385565255237258,-0.7306635623757749,0.7818181818181819,1.0,1.0,1/15,5.30%,RACK1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.3757427930148729,-0.7305614429644969,0.859375,1.0,1.0,3/25,7.71%,NRP1;CD47;TGFBR1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3727791831937948,-0.7303686998617701,0.7894736842105263,1.0,1.0,6/14,23.11%,GPR137C;LARS1;RRAGB;GPR137B;ITFG2;SZT2
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.3696662698512082,-0.7300053773297345,0.8142857142857143,1.0,1.0,3/24,10.16%,PGR;CALCOCO1;DDX5
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.43556612160812125,-0.7299589442790624,0.8461538461538461,1.0,1.0,4/10,22.07%,ACTR10;DLG2;MAP1A;DYNC1H1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3125988164838885,-0.7299012503495638,0.9305555555555556,1.0,1.0,17/86,15.48%,ELMO1;PARP1;SEPTIN4;TNFRSF19;NOTCH2;FASTKD2;PDCD4;TCHP;AKAP1;THOC1;PPIA;PLSCR1;NAE1;PLAGL1;DAPK2;BCL2L14;SCN2A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.384231226929476,-0.7295379083197149,0.8,1.0,1.0,1/17,1.74%,PARP1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.413278702765123,0.7290209752099859,0.8125,1.0,1.0,3/11,10.79%,SRSF12;SART3;TGS1
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.4815675323249025,-0.7289922966701298,0.8253968253968254,1.0,1.0,1/5,8.45%,CTCF
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.33933112607954,-0.7286423208268114,0.9210526315789473,1.0,1.0,7/51,12.41%,ACTG1;VAV3;EPHA3;AP2A2;APH1B;EPHA5;EPHA4
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.38756218431225137,0.7285458021303347,0.8,1.0,1.0,1/12,1.35%,CNOT7
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.383248367818896,0.7283859352791249,0.868421052631579,1.0,1.0,4/16,15.07%,APC;CDKN1A;RBL1;JADE1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4024308464920755,0.7283426583769054,0.875,1.0,1.0,5/14,25.23%,CTNNA2;DISC1;GSK3B;FBXO7;CCDC88A
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.39078927321688445,0.7280505234022031,0.8695652173913043,1.0,1.0,3/13,17.37%,IRS1;PIK3CD;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.3796932225681928,0.7280195096261044,0.8205128205128205,1.0,1.0,1/12,4.03%,BCL2L1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.48001118837972945,-0.7279027046016147,0.7833333333333333,1.0,1.0,2/7,13.79%,RPL5;RPL11
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.3674148910057761,-0.7278432121066145,0.8032786885245902,1.0,1.0,5/17,25.93%,NDUFB7;COX4I1;AFG1L;NDUFB9;NDUFC1
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.3674148910057761,-0.7278432121066145,0.8032786885245902,1.0,1.0,5/17,25.93%,NDUFB7;COX4I1;AFG1L;NDUFB9;NDUFC1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4716382262338439,0.7277492293802467,0.7837837837837838,1.0,1.0,3/6,16.33%,NEDD4L;COMMD1;WNK1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.40574057952008724,-0.7269075259648061,0.8070175438596491,1.0,1.0,1/14,4.54%,MYO18A
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.37102506531613094,-0.7267358329237915,0.8611111111111112,1.0,1.0,5/19,21.08%,DTWD2;ADARB1;NSUN2;PUS7L;NSUN6
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.42411786509362964,-0.7262919369243608,0.8709677419354839,1.0,1.0,3/9,35.05%,SETDB2;TPR;MPHOSPH8
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.45821476619321466,0.7259502071454947,0.8260869565217391,1.0,1.0,2/5,15.60%,PPARA;ABHD5
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.28403815332758814,-0.7259223713092571,0.9880952380952381,1.0,1.0,20/230,15.11%,PRAG1;TGFB2;CDKL1;EPHA3;PIK3R4;STRADB;SGK1;TGFBR1;ABI2;FAM20A;PRKDC;CSNK1D;EPHA4;PRKAG2;TGFBR3;MAPK14;SRPK1;NEK1;DAPK2;MINK1
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.3429389616827936,-0.7254050129546873,0.8360655737704918,1.0,1.0,11/42,16.97%,CYP3A5;SPTLC3;PLD1;FMO2;SLC22A6;PLEKHA5;THRB;CACNA1D;ATP1B1;NIPSNAP2;ATP5MK
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.443249240850899,-0.7253147557244828,0.8387096774193549,1.0,1.0,1/8,1.21%,LMF1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.3576178107401265,-0.7246709397997481,0.8615384615384616,1.0,1.0,4/26,11.09%,HADHA;ALDH3A2;ACAT1;AIG1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.2938703413195429,-0.7246084324573246,0.9375,1.0,1.0,11/150,10.16%,ELOB;PARP1;PGR;SUPT6H;NR4A2;SNW1;NR4A1;NR2F1;NOTCH2;TSC22D1;DDX5
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4692480066935203,0.7245815678549756,0.8409090909090909,1.0,1.0,1/6,1.46%,TNFRSF1B
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),-0.48983458597348195,-0.7243996625194024,0.8545454545454545,1.0,1.0,2/6,15.57%,PPIA;CD4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.4210891505081882,0.723541994630849,0.7837837837837838,1.0,1.0,5/11,18.38%,CPT1A;RPS6KB1;ACSL3;SLC27A1;ACSL1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.3182631842643625,-0.7230011601020547,0.9154929577464789,1.0,1.0,6/57,8.17%,FOXQ1;ARNT2;KAZN;TNFRSF19;NR2F1;DZIP1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.35078082469940564,-0.7227860017190998,0.8032786885245902,1.0,1.0,2/23,4.59%,COL6A3;SGCD
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.3638737158901272,-0.7227267086583812,0.803030303030303,1.0,1.0,2/29,4.78%,RIMS1;SLC38A1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.37128213034886065,0.7225538192470454,0.7567567567567568,1.0,1.0,1/14,4.03%,BCL2L1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.39537866449039377,-0.7224653687723107,0.7910447761194029,1.0,1.0,6/21,21.08%,CMTR1;TARBP1;DIMT1;TRMT44;NSUN2;NSUN6
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.2837307177114264,0.7224584143471405,0.96875,1.0,1.0,9/66,14.49%,PPP2R1A;AKAP8;CDKN1A;CEP70;NDE1;CCP110;CEP290;DNM2;BTRC
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.4217315815476674,-0.722455462773079,0.8518518518518519,1.0,1.0,1/9,6.75%,HSP90AB1
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.3918887971121216,0.7223386145894402,0.775,1.0,1.0,1/9,5.21%,UBE2N
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3131226665152749,-0.721864902583687,0.9452054794520548,1.0,1.0,3/67,1.52%,CLU;TGFB2;VEGFA
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.3726818016451241,0.7212848863763798,0.8787878787878788,1.0,1.0,2/13,10.73%,APC;CAMSAP1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.3632676999654112,-0.720876807023695,0.9324324324324325,1.0,1.0,5/28,16.41%,CCT6A;SMG6;MAP3K4;EXOSC10;TNKS2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.4429405427372092,0.7203770788404266,0.8125,1.0,1.0,3/10,15.11%,RNF185;ATXN3;UGGT1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.32254671544152047,-0.719610095410958,0.8461538461538461,1.0,1.0,8/68,11.58%,DKK3;IGFBP2;NKD1;GLI3;SFRP4;PSMD8;TLE4;PSMC2
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.3454272418277338,-0.7193901954952575,0.8732394366197183,1.0,1.0,1/35,1.05%,AFG3L2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.43645111571548645,0.7192396554598525,0.7962962962962963,1.0,1.0,2/5,20.58%,ACTA2;SLC8A1
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.43645111571548645,0.7192396554598525,0.7962962962962963,1.0,1.0,2/5,20.58%,ACTA2;SLC8A1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.4386991132029968,0.7190701092679443,0.7708333333333334,1.0,1.0,3/7,28.16%,HAT1;KAT6A;ABL1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3831368339016527,-0.7185707653262114,0.8070175438596491,1.0,1.0,1/16,3.66%,ANXA1
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.43201979797447987,0.7184951576349984,0.8108108108108109,1.0,1.0,2/5,9.58%,CBLB;CBL
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.37492861198416294,-0.7184945189873421,0.7846153846153846,1.0,1.0,8/18,23.60%,PHLDB2;ARHGAP28;TMEFF2;PRKN;PIK3R1;ARHGEF18;WASF2;CLASP2
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.4672351355146335,0.7182428027569823,0.7906976744186046,1.0,1.0,3/5,18.38%,SLC25A17;SLC27A1;ACSL1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.3601830342407968,-0.7179781017705733,0.8412698412698413,1.0,1.0,12/20,28.29%,UBL5;HPS4;ARIH2;SREBF2;ABLIM3;PRKN;CSNK2A2;UBE2L3;LMAN1;USP36;NPEPPS;ATG13
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3227896811147788,-0.7172545453954416,0.9041095890410958,1.0,1.0,7/77,8.56%,VEGFA;PHLDB2;ENPP2;BMP5;HSP90AB1;RALBP1;DCN
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.36428302834759946,0.7172525408397978,0.8604651162790697,1.0,1.0,2/19,7.09%,PDGFA;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.32132339318555564,-0.7170144743633251,0.9452054794520548,1.0,1.0,9/67,12.66%,MEGF10;SUPT6H;PHLDB2;EPHA3;HSP90AB1;TGFBR1;DDX5;BIRC2;LGALS3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.33610963714862235,0.7170089618724589,0.8823529411764706,1.0,1.0,10/26,27.99%,PPP2R1A;RANGAP1;KPNB1;SUMO1;REEP3;UBXN2A;IST1;CHMP4B;AHCTF1;NSFL1C
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.32367466134590195,-0.7165736401764499,0.9154929577464789,1.0,1.0,10/56,23.29%,VAV3;PSMD8;PSMC2;JUN;CALM1;PIK3CB;PIK3R1;PSMD14;LYN;MAPK9
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),-0.458590513584857,-0.7161638211509876,0.8461538461538461,1.0,1.0,2/5,12.41%,SLIT2;EPHA4
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.31154695415840566,-0.7158324049817308,0.9565217391304348,1.0,1.0,13/74,15.35%,MT2A;SLC38A1;NCL;NOTCH2;CTCF;MARCKS;UCK2;SRSF10;ORC5;WRN;MAPK14;NASP;CDC27
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.33708393517493096,-0.7157972364542278,0.9122807017543859,1.0,1.0,2/29,9.69%,TUBGCP5;CEP126
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.38793214049765445,-0.7157345416560084,0.8421052631578947,1.0,1.0,4/17,19.82%,CEMIP;PRKAG2;EIF4G1;CALM1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.41830091154067034,-0.7156007028897332,0.8055555555555556,1.0,1.0,3/15,8.89%,ACTG1;AFDN;TBCD
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4353037929119196,0.7150191928597561,0.7380952380952381,1.0,1.0,1/7,18.02%,CCDC3
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.3441831377685173,0.7148108234189462,0.8292682926829268,1.0,1.0,7/22,20.11%,PCSK5;ABCA1;TMEM167A;RIMS2;CANX;ARFGAP3;RAB10
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.448853104501191,-0.7147077087396717,0.8070175438596491,1.0,1.0,2/7,13.32%,ANXA1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.4276998505685717,-0.714681106041856,0.9076923076923077,1.0,1.0,2/12,6.47%,VEGFA;CHD6
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.2995709621208424,-0.7143699354436901,0.9615384615384616,1.0,1.0,15/123,12.64%,TGFB2;NR4A1;RACK1;PER2;HSP90AB1;NOTCH2;TGFBR1;THBS1;TSPYL2;PDCD4;SRA1;BIRC2;BRCA1;YY1AP1;DYNLT3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.41521561884177527,0.7142329283772509,0.8,1.0,1.0,2/9,9.10%,CD44;RHOA
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.3203419093380469,0.7137229992317657,0.9375,1.0,1.0,6/25,14.58%,DPP10;GNB1;CAB39;NEDD4L;BIN1;KCNQ1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.4236877551975876,-0.7136047893459181,0.8253968253968254,1.0,1.0,2/11,15.62%,ACAT1;DLD
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.4236877551975876,-0.7136047893459181,0.8253968253968254,1.0,1.0,2/11,15.62%,ACAT1;DLD
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.3791963838742741,-0.7126449430256616,0.85,1.0,1.0,1/13,1.23%,ARHGAP24
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.4625747078764811,0.7124955390956166,0.85,1.0,1.0,1/6,6.98%,ABCA1
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.4799966042996497,-0.7122708742254127,0.7735849056603774,1.0,1.0,2/5,21.29%,EPHA4;PTN
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3447599916752334,-0.7121542753331753,0.8813559322033898,1.0,1.0,6/30,13.68%,RPS3;EYA1;DDX5;UIMC1;BRCA1;RNF8
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.5026905329149823,0.7120735931573573,0.875,1.0,1.0,3/5,25.88%,SARS1;AARS1;YARS2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.285677624111801,-0.7115352463641798,0.975,1.0,1.0,10/123,9.04%,RIMS1;ACTG1;EPN1;VAMP4;FNBP1;AP2A2;SUN1;LPCAT2;AMPH;BAIAP2L2
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.363385138090224,-0.7114991350048069,0.8545454545454545,1.0,1.0,3/17,11.06%,PHLDB2;THBS1;BCAS3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),-0.46541528547481004,-0.7113759881254954,0.7833333333333333,1.0,1.0,2/5,23.14%,TCHP;ODF2L
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.42881480935234506,0.7112998037606704,0.7804878048780488,1.0,1.0,2/7,16.56%,BNIP3;CALCOCO2
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.41828312117521443,-0.7112010994792709,0.8360655737704918,1.0,1.0,1/11,6.53%,PDZRN3
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.375923725134894,-0.7111339311105135,0.8571428571428571,1.0,1.0,2/22,2.81%,NRP1;STAT1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),-0.3156108961770592,-0.7109585030310573,0.9047619047619048,1.0,1.0,6/42,13.88%,ARHGAP24;TBC1D2B;BCAS3;TBC1D22A;TBC1D9;GARNL3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.333319075568804,0.7107846005389481,0.8863636363636364,1.0,1.0,4/19,20.29%,GRIN2B;DDX3X;GRIN1;MAP3K5
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.4484742434775143,0.7102684996821285,0.8292682926829268,1.0,1.0,1/5,23.36%,TASOR
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.415634717204578,-0.7101980340791092,0.8421052631578947,1.0,1.0,1/10,2.67%,PHLDB2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.3085082914874856,-0.7100362691041153,0.9661016949152542,1.0,1.0,7/54,14.28%,RIN2;PLD1;RHEB;G3BP2;RALBP1;MAPK14;KRAS
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3411889510541204,-0.7099206915458602,0.9206349206349206,1.0,1.0,5/39,14.35%,STAT1;PSMD8;BIRC2;PSMC2;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.36717771885374734,-0.7098793349402555,0.8888888888888888,1.0,1.0,1/18,2.81%,STAT1
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.4331785373754211,-0.7096161374093249,0.8947368421052632,1.0,1.0,5/8,23.22%,GPX4;CYP1B1;PLA2G4C;PNPLA8;MGLL
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.40930360160979223,0.709442585186794,0.8536585365853658,1.0,1.0,1/6,8.90%,ARNT
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.4463510797425009,0.7093917077302776,0.84,1.0,1.0,1/7,15.87%,LTBP3
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.39006557839878786,0.7086217929392675,0.8333333333333334,1.0,1.0,2/18,5.15%,HSPB1;MYH9
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.41240895324535437,0.7079889464396854,0.851063829787234,1.0,1.0,1/6,14.49%,BTRC
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.43507672658899227,-0.7075729124222926,0.7258064516129032,1.0,1.0,1/5,11.58%,PSMC2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3128318661009819,0.7074030501285554,0.8809523809523809,1.0,1.0,3/19,10.19%,BCL9;SMAD7;ITGA3
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.34076403511223347,0.7064769372267804,0.8823529411764706,1.0,1.0,6/19,24.24%,RHOA;KIFC2;KPNB1;FLNA;LSM14A;ZNF207
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.41541948249797933,-0.7062782477078853,0.8412698412698413,1.0,1.0,2/7,23.26%,BMPER;LOXL2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.32115414810708376,-0.7058892100729887,0.96875,1.0,1.0,3/56,5.52%,ZFPM1;RACK1;NMD3
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.35643476316766776,-0.7050743266153569,0.896551724137931,1.0,1.0,3/25,8.93%,WASHC3;GSN;ABI2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.4264749438182265,0.7035493646474826,0.8604651162790697,1.0,1.0,3/9,16.86%,RYR2;ERO1A;RYR3
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3718798030043319,-0.7033889755118303,0.9047619047619048,1.0,1.0,2/18,16.08%,OLFM1;APOE
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.34226069775542417,-0.7033501218930278,0.9193548387096774,1.0,1.0,5/39,11.66%,PARP1;PKM;EPRS1;RHOQ;PRKDC
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.36023154468688817,0.7032689396649617,0.8888888888888888,1.0,1.0,1/11,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.4063007440717594,-0.702279531932826,0.8363636363636363,1.0,1.0,2/10,10.24%,GSN;NCKAP5
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2880324373500293,-0.7022169162777067,0.963855421686747,1.0,1.0,27/140,21.62%,CMTR1;SNW1;PRPF6;RSRC1;UBL5;PRMT9;NONO;FUS;DDX42;SNRNP200;DDX5;PPWD1;THOC1;WBP4;SRSF10;PRPF8;EFTUD2;GTF2H1;PNN;SRSF7;LSM8;HNRNPA3;U2AF2;SRSF5;DHX8;PRKACA;RBM4B
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.4322243898734637,0.7020951995347332,0.8648648648648649,1.0,1.0,2/6,18.46%,PTPRS;PTPRD
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.36555076122813834,0.7020851229199396,0.8529411764705882,1.0,1.0,4/18,16.86%,HPRT1;USP16;UPB1;RYR3
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.31674536810366244,-0.7019779597104323,0.9142857142857143,1.0,1.0,10/57,23.29%,VAV3;PSMD8;PSMC2;JUN;CALM1;PIK3CB;PIK3R1;PSMD14;LYN;MAPK9
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.34776389185539763,0.7019220790182878,0.9,1.0,1.0,9/18,24.98%,HACD2;FADS3;ELOVL6;ELOVL5;SCD5;SCD;TECR;MLYCD;ABHD2
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.4198621883786738,0.7016226909065216,0.775,1.0,1.0,1/7,1.23%,SRSF12
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.43108239696724215,0.7007273216066732,0.967741935483871,1.0,1.0,4/11,21.32%,AP3M1;SCARB2;GGA3;RTN4
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.31779850037289137,0.7007245765196692,0.8333333333333334,1.0,1.0,7/29,12.50%,PTPRK;CAMKK2;ERCC6L2;EGFR;PXN;FOS;CAT
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.40288900436997477,0.7005261488518403,0.8095238095238095,1.0,1.0,2/9,14.10%,CPT1A;CERT1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.3545159190635546,-0.7003927793375346,0.8548387096774194,1.0,1.0,8/23,23.22%,GPX4;CYP1B1;AIG1;ELOVL2;PLA2G4C;PNPLA8;HSD17B4;MGLL
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.38703051536195,-0.6995252148402935,0.8412698412698413,1.0,1.0,4/13,28.78%,RNASEH2B;NUDT5;ENTPD4;NCBP1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.31839787804978836,-0.6994268315271337,0.9859154929577465,1.0,1.0,14/74,22.04%,AFG3L2;SGK1;DCDC2;S100A6;GPM6A;ALCAM;MINK1;EPB41L3;DTNBP1;NGF;NBL1;PAK3;CCK;MAP1A
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.45638267424070134,-0.6993851220617503,0.8135593220338984,1.0,1.0,1/5,16.59%,SQSTM1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.35964204880772643,-0.6992435877344515,0.8548387096774194,1.0,1.0,3/20,9.94%,ALDH1A1;RHEB;LAMA4
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.473942526883129,-0.6992266284489044,0.8214285714285714,1.0,1.0,1/6,16.08%,APOE
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.28634439122737443,0.699206306453607,1.0,1.0,1.0,2/40,2.82%,PKIA;APC
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.43505892763517046,0.6991331992128568,0.8837209302325582,1.0,1.0,2/7,7.34%,SLC25A4;CAMKK2
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.37513727347597614,-0.6988031093193131,0.9322033898305084,1.0,1.0,5/25,15.29%,SUPT6H;CTCF;INO80;RNF8;NASP
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.3380638112864788,0.698526714366696,0.967741935483871,1.0,1.0,4/35,6.09%,BNIP3L;SLC25A4;BNIP3;MAP3K7
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.4512241720810197,0.6982417317450292,0.8292682926829268,1.0,1.0,1/5,1.75%,CDH2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.3344367540741646,-0.6979541948103275,0.8666666666666667,1.0,1.0,13/42,22.61%,NMD3;DERL1;FOXC1;PARP9;RPL11;APOE;NGF;HES1;PRKN;TCF7L2;ZNF618;FLOT1;PSEN1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.3670519216954164,0.6979206306993152,0.9090909090909091,1.0,1.0,3/14,13.40%,UGCG;HDAC1;HDAC2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.38111384840868123,-0.6977321031613635,0.8873239436619719,1.0,1.0,3/19,16.41%,CCT6A;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.46855171898690684,-0.6975481701419832,0.8727272727272727,1.0,1.0,3/7,24.22%,DAG1;CLASP2;GCC2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.36467925929590284,0.6969950469802745,0.9655172413793104,1.0,1.0,3/16,10.73%,APC;EML2;CAMSAP1
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.38597152317017014,-0.6969539224470249,0.8070175438596491,1.0,1.0,1/15,3.66%,ANXA1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.32718297926653,0.6964524729409967,0.8787878787878788,1.0,1.0,6/28,12.92%,PCSK5;ANPEP;CPM;ENPEP;RHD;GSTA4
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2395678816594536,0.6959509812706812,1.0,1.0,1.0,11/115,11.34%,SRSF12;CWC27;TXNL4A;HSPA8;METTL14;WDR33;HNRNPF;PCF11;SART3;SMU1;HNRNPUL1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.40894793388629713,0.6957706427426691,0.8421052631578947,1.0,1.0,4/7,22.46%,RANBP9;PRNP;PICALM;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.45060910917260416,-0.6949667136069743,0.8148148148148148,1.0,1.0,1/5,14.50%,ATP1B1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.39052432720551633,-0.69494596212692,0.7966101694915254,1.0,1.0,2/13,9.00%,SRP54;PEX1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.46904644125394707,0.6945200214999123,0.8780487804878049,1.0,1.0,1/5,6.19%,ZBTB7A
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.3262983687846532,-0.6942691224318928,0.9117647058823529,1.0,1.0,1/34,0.87%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.37058650879490534,0.694243629135114,0.8536585365853658,1.0,1.0,2/11,11.31%,ARNT;NFKB1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.3891518613859101,-0.6941410002515356,0.7833333333333333,1.0,1.0,1/12,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.31255064977577224,-0.6935716618357758,0.9242424242424242,1.0,1.0,13/43,26.58%,ZFP36L2;PRMT2;PSMD8;PSMC2;FHL1;RBL2;FBXL7;PSMD14;PKD2;CDK6;RGCC;PSMA3;RBX1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.3365502550230698,0.6931226346086261,0.8787878787878788,1.0,1.0,5/23,19.34%,PPP2R1A;RANGAP1;KPNB1;SUMO1;REEP3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.3365502550230698,0.6931226346086261,0.8787878787878788,1.0,1.0,5/23,19.34%,PPP2R1A;RANGAP1;KPNB1;SUMO1;REEP3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.3511726648340297,-0.6930375927158021,0.9298245614035088,1.0,1.0,3/20,14.69%,AMPH;SNAP91;SYNJ2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.44348529230822764,-0.6927731694667412,0.8421052631578947,1.0,1.0,1/7,3.75%,SNW1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.41735151877117105,0.6924435431940015,0.7727272727272727,1.0,1.0,1/6,10.10%,PXN
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.2941865646997955,-0.6923464433240748,0.9864864864864865,1.0,1.0,9/74,12.73%,SULF2;COL1A1;GPC3;SFRP4;PSMD8;PTK7;PSMC2;CSNK1D;RNF220
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.4175513690099931,-0.6920919537238405,0.8833333333333333,1.0,1.0,1/8,19.62%,SETDB2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3628375123738027,0.6918060402122966,0.8604651162790697,1.0,1.0,5/14,13.59%,SMARCA4;HDAC1;RRP1B;LEF1;EP300
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.37425466337024194,-0.6911768125302808,0.875,1.0,1.0,2/15,7.71%,RACK1;TGFBR1
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.40366252046737794,-0.6910672844542345,0.8888888888888888,1.0,1.0,2/14,3.75%,STAT1;SNW1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.40669209970981024,-0.6906554181606502,0.8695652173913043,1.0,1.0,1/14,5.68%,PIK3R4
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.34485755560925135,0.6901703962625564,0.9111111111111111,1.0,1.0,4/16,10.96%,HEY2;MYOCD;TMEM204;SGCZ
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.4011224160390156,0.690065784115502,0.7021276595744681,1.0,1.0,1/5,12.45%,ELL
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.38613861727196463,-0.6892457643947287,0.9,1.0,1.0,2/11,14.69%,AMPH;SYNJ2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.377238244124877,-0.6887764429340854,0.9206349206349206,1.0,1.0,2/20,7.17%,BORCS5;HTT
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.3959997524843374,0.6885523419832053,0.8421052631578947,1.0,1.0,2/7,17.32%,EIF3B;CCT3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.410185845920914,-0.6883867429378484,0.8813559322033898,1.0,1.0,1/9,10.67%,HLA-B
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.4235590631005278,0.6876747470189053,0.8823529411764706,1.0,1.0,1/9,4.26%,TDG
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.4362615077352455,-0.6876387960058514,0.8461538461538461,1.0,1.0,1/7,7.86%,THBS1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.4402541341072848,-0.6872057911190539,0.8771929824561403,1.0,1.0,2/7,7.54%,ACO1;SLC11A2
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.4152572859822727,-0.6866223609259406,0.8888888888888888,1.0,1.0,2/6,24.05%,CD4;CDK6
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.39673324971245943,-0.6865865303354202,0.8703703703703703,1.0,1.0,2/10,12.10%,SFRP4;SLIT2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.37130846235109205,-0.6865471751478612,0.8571428571428571,1.0,1.0,6/21,25.93%,NDUFB7;NUBPL;NDUFB9;COA1;TTC19;NDUFC1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.23827231898103038,0.6864554782891483,1.0,1.0,1.0,23/104,21.73%,PML;RNF185;MAEA;SPOPL;ZSWIM8;RNF139;ATXN3;KLHL20;ZNRF1;FBXW7;PLAA;NEDD4L;BTRC;KLHL42;UBE4B;AREL1;CUL4A;PSMB2;SIAH1;RNF34;UBXN2A;PPP2R5C;PSMD11
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3633166832196788,-0.6863086699720563,0.8666666666666667,1.0,1.0,3/17,13.69%,PRMT2;DDX5;UFL1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.2966172750316047,-0.6857937344131005,0.9436619718309859,1.0,1.0,12/67,15.94%,RPL5;SGK1;RPS20;RPA1;BRCA1;PRKAG2;WRN;MAPK14;RPL11;RAD17;RPL37;TOPBP1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.447284804543314,0.6856967610954975,0.875,1.0,1.0,1/5,15.56%,NAA25
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3810175317998646,-0.685408728029259,0.8769230769230769,1.0,1.0,4/15,16.47%,AKR1C1;SLCO1C1;SLCO1A2;SLC6A13
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,0.3166960982923256,0.685334650576907,0.9655172413793104,1.0,1.0,3/33,4.09%,TNFRSF1B;CD44;TNFRSF21
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.36800141243065887,0.6851288222201417,0.8936170212765957,1.0,1.0,6/16,25.56%,IRS1;RPS6KB1;KANK1;PTPN1;TSC2;TNS2
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2425228243800749,0.6849695850005459,1.0,1.0,1.0,26/156,18.10%,PML;RNF185;UBQLN1;MAEA;SPOPL;ZSWIM8;STT3B;AMFR;FBXL20;ATXN3;KLHL20;ZNRF1;FBXW7;UBE2D1;ANAPC16;PLAA;NEDD4L;UBE2J1;UBE4A;BTRC;KLHL42;ANAPC1;UBE4B;RNF121;AREL1;CUL4A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.3674066626801716,-0.6844178845073752,0.8688524590163934,1.0,1.0,2/17,5.96%,PHLDB2;ARHGAP28
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.4034527504706496,-0.6836606094801835,0.8653846153846154,1.0,1.0,4/10,12.10%,TGFB2;NOTCH2;SMAD6;SLIT2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.4063440091753677,0.6835415331774419,0.8297872340425532,1.0,1.0,2/7,20.18%,ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.45310391780522996,-0.683446642200286,0.8596491228070176,1.0,1.0,2/5,8.56%,RACK1;DCN
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.4152558419446946,-0.6826412366547049,0.8846153846153846,1.0,1.0,3/11,16.08%,SOAT1;CYP27A1;APOE
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.41427259496724766,0.6823299077335275,0.7894736842105263,1.0,1.0,2/10,16.02%,PPARA;GAS6
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.2852080928259138,0.682166118373703,0.9629629629629629,1.0,1.0,7/42,14.49%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2852080928259138,0.682166118373703,0.9629629629629629,1.0,1.0,7/42,14.49%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.2852080928259138,0.682166118373703,0.9629629629629629,1.0,1.0,7/42,14.49%,MAP3K7;RAF1;RPS6KA5;PAK2;NFKB1;EP300;BTRC
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.3718777871999061,0.6814932942147418,0.8,1.0,1.0,4/10,13.59%,SMARCA4;RRP1B;LEF1;EP300
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.4404115140811909,0.6814031535428935,0.8333333333333334,1.0,1.0,1/5,4.23%,EMP2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4023451577389449,0.6813314873349806,0.8780487804878049,1.0,1.0,4/11,17.70%,HDAC1;HDAC9;HDAC2;ELK4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.3242828785576433,-0.6811724511005993,0.9117647058823529,1.0,1.0,8/31,26.07%,STAT1;PRKDC;DHX36;XRCC6;MRE11;FLOT1;GAPDH;TOMM70
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.4089374047770511,0.6810106393070096,0.8983050847457628,1.0,1.0,3/5,28.95%,BTRC;THRAP3;NLGN1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.40390821691853374,0.6799871126714733,0.875,1.0,1.0,1/8,2.05%,BCL2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.3590836926134907,0.6798315114063137,0.9024390243902439,1.0,1.0,1/10,2.81%,TIMP3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.39956602732956314,0.6797089991650065,0.8947368421052632,1.0,1.0,7/10,24.40%,HACD2;ELOVL6;ELOVL5;ACSL3;ACSL1;TECR;ACSL4
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.4538343211428124,-0.6794403890266111,0.8490566037735849,1.0,1.0,2/5,10.65%,ACO1;ACO2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.3888821485094229,-0.6790846772500986,0.8928571428571429,1.0,1.0,1/13,1.07%,RIPOR2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.3541382714995988,0.6782470464805298,0.8666666666666667,1.0,1.0,6/16,20.70%,ACVR2A;ADGRV1;BMPR1A;ATP2B1;SLC8A1;NELL1
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.4311681218010324,0.6771108121145089,0.8409090909090909,1.0,1.0,1/5,10.65%,P2RX4
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.3779729262116359,-0.6768732405643043,0.8852459016393442,1.0,1.0,2/12,14.69%,AMPH;SYNJ2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.3635142028138959,0.6757869899955873,0.8780487804878049,1.0,1.0,2/13,10.33%,PML;RANGAP1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.3170472255808884,0.6753643748183031,0.926829268292683,1.0,1.0,3/16,15.66%,UBE2D1;ANAPC16;ANAPC1
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.4157023647032715,-0.6750377315114656,0.9423076923076923,1.0,1.0,2/8,16.08%,ATG10;APOE
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.298921210351228,0.6750059009699458,0.9090909090909091,1.0,1.0,13/40,17.39%,KCNC2;MOBP;NRXN1;CTNNA2;CACNB2;TNR;RPS6KA5;CADPS;KCNQ1;XKR4;MYT1L;SLC4A10;UNC80
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.39425635297484163,-0.6739818726024812,0.8653846153846154,1.0,1.0,1/7,19.82%,CALM1
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.42428736287944235,0.6736084471783274,0.8846153846153846,1.0,1.0,2/5,33.59%,NEK4;PNPT1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.4095553790615124,0.6735397388605651,0.8421052631578947,1.0,1.0,3/9,11.58%,IRS2;IRS1;PPARA
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.29295877491113737,-0.6731300447005061,0.9696969696969697,1.0,1.0,9/64,12.07%,TGFB2;GLI2;TBCD;TENM4;BTG2;LAMB1;GPM6A;HDGFL3;EPHA5
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.3952645964675112,0.6720125340807858,0.8787878787878788,1.0,1.0,5/11,17.39%,AP3D1;NEDD4L;WNK1;SLC4A10;UNC80
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3237196592716144,-0.6719703576977137,0.9411764705882353,1.0,1.0,6/35,19.42%,POLA1;PRKDC;DHX36;UFD1;XRCC6;MRE11
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.40824678312793683,-0.6717470485017675,0.8113207547169812,1.0,1.0,3/8,20.35%,SNAP91;PIK3CB;AAK1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.35193152007717576,0.6715189757921773,0.8378378378378378,1.0,1.0,5/13,10.90%,RAB27A;CAMK1D;RAB31;TUB;MERTK
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.465022373538313,-0.6709770500315435,0.8983050847457628,1.0,1.0,3/5,27.68%,PHF14;ING5;BRD1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.36351599803908996,-0.6706783215837213,0.9,1.0,1.0,2/17,7.71%,TGFB2;TGFBR1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.22389382725645257,0.6700237418138812,1.0,1.0,1.0,40/180,21.84%,PML;RNF185;RC3H2;UBQLN1;RNF14;MAEA;SPOPL;ZSWIM8;AMFR;CBL;ATXN3;KLHL20;ZNRF1;FBXW7;UBE2D1;FBXO11;ANAPC16;PLAA;NEDD4L;UBE4A;BTRC;NDFIP2;KLHL42;ANAPC1;UBE4B;AREL1;CUL4A;ARIH1;RNF168;CNOT4;PSMB2;SIAH1;RNF34;RBBP6;UBXN2A;USP9X;MIB1;PPP2R5C;PSMD11;RNF149
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.33966198514125917,-0.6697226919924499,0.8852459016393442,1.0,1.0,3/22,9.94%,ALDH1A1;RHEB;LAMA4
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.297043933729192,-0.6690370682441688,1.0,1.0,1.0,12/71,17.03%,TWIST1;SVIP;TPCN1;ADAM9;DCN;SLC4A4;UFL1;VGLL4;SH3D19;APOE;SNX9;GTPBP1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.37626424963989397,0.6687169907053115,0.9230769230769231,1.0,1.0,1/8,4.54%,SMAD7
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.38326896893687845,0.6686008578493918,0.875,1.0,1.0,2/11,17.66%,SEC23A;SEC24D
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.3719534472620555,-0.6683838374674395,0.8939393939393939,1.0,1.0,3/13,16.75%,KCNMB1;FHL1;KCNMA1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.2897623537143412,-0.6681343456541765,0.9701492537313433,1.0,1.0,17/78,17.80%,AFG3L2;HADHA;ATP5PF;NDUFB7;ABCB7;GPX4;ACO2;ACAT1;NQO2;COX4I1;ATP6V1E1;LDHA;ATP1B1;DLD;COX7A2;ATP5MC2;ATP6V1D
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.4157186665246256,0.6673236993992783,0.8913043478260869,1.0,1.0,1/7,3.30%,ACADVL
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.4432309225724935,-0.6671735614111841,0.8245614035087719,1.0,1.0,2/5,18.24%,ABCB1;EIF4G1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.4006287806871849,-0.6668011257380486,0.8448275862068966,1.0,1.0,1/9,3.44%,IQGAP2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.38031870522569067,-0.6663288610737091,0.9206349206349206,1.0,1.0,4/13,26.15%,CDC27;PRKN;UBE2E3;UBE2L3
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.3093618354071809,-0.6659969058286981,0.9180327868852459,1.0,1.0,7/50,13.69%,SVIP;TPCN1;HTT;DCN;LARP1;TRIM13;UFL1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.3985058401898916,0.6659481295921997,0.918918918918919,1.0,1.0,1/7,6.48%,NUS1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.374831550354056,0.665407067361271,0.8378378378378378,1.0,1.0,1/9,9.24%,IRS1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.367846033281112,-0.6648618813634313,0.9491525423728814,1.0,1.0,1/11,7.40%,NDUFB7
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.34151668664520546,-0.6647639571687793,0.9666666666666667,1.0,1.0,8/35,18.24%,FOXQ1;RETREG1;KDM2B;MT3;APOE;NGF;PRKN;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.3808137398949087,0.6642180208466656,0.868421052631579,1.0,1.0,2/13,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.357030248324524,0.6641312725812915,0.8717948717948718,1.0,1.0,3/9,19.91%,SLC4A10;SHISA6;GRIK2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.2986339317170638,0.6635918639444824,1.0,1.0,1.0,8/32,19.62%,NCK2;CDC42EP4;WASHC5;BIN1;LMOD1;PLEKHG2;ESAM;KANK1
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.4308095894540499,0.6633221864347447,0.9047619047619048,1.0,1.0,1/5,6.44%,CPT1A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.36215014484884295,0.6628991466720743,0.918918918918919,1.0,1.0,6/11,28.54%,CTNNA2;PDLIM5;ARHGAP22;ABL1;YWHAZ;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.4318945260058867,-0.6618832735844498,0.8421052631578947,1.0,1.0,2/6,11.63%,SFRP4;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.35719988120859986,0.6615781908035888,0.8409090909090909,1.0,1.0,2/10,11.12%,SMARCA4;PHF8
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.22387892013013502,0.6614446604984108,1.0,1.0,1.0,13/125,11.65%,APC;WDR20;SMAD7;DESI2;MAP3K7;USP7;USP16;RHOA;INO80D;ATXN3;USP10;UBE2D1;CCP110
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.40981797879894455,0.6611844352580176,0.8205128205128205,1.0,1.0,1/5,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.40981797879894455,0.6611844352580176,0.8205128205128205,1.0,1.0,1/5,2.17%,ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.37011124506764015,0.6608346418856998,0.8,1.0,1.0,3/8,16.02%,AXL;PPP2R3C;GAS6
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.34132239983291723,0.6604449999988068,0.875,1.0,1.0,3/12,19.80%,OSBPL10;SLC27A1;OSBPL5
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.32260337424344726,-0.6603520525410655,0.9830508474576272,1.0,1.0,4/29,9.38%,TERF2IP;RPS3;PDCD4;SASH1
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.38780448668886425,-0.6596883173664646,0.8214285714285714,1.0,1.0,5/10,26.92%,APH1B;EPHA4;STAT3;LYN;FYN
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.3901088749364382,-0.6586366882211293,0.8888888888888888,1.0,1.0,5/8,33.55%,EIF4G1;LRFN5;GPC6;GPC4;APP
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.3901088749364382,-0.6586366882211293,0.8888888888888888,1.0,1.0,5/8,33.55%,EIF4G1;LRFN5;GPC6;GPC4;APP
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.3241594720333951,-0.658498995644146,0.8947368421052632,1.0,1.0,8/31,19.96%,PLXNC1;SLIT2;EPHA4;PLXNA2;NGF;ROBO2;OMG;PAK3
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.37335801675897756,-0.6582227449245318,0.8793103448275862,1.0,1.0,3/10,14.64%,NR4A1;MAP3K8;IL16
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.27471786442922624,0.6581322022737579,1.0,1.0,1.0,1/39,1.07%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3270642019604292,-0.6580259423953327,0.96,1.0,1.0,7/24,23.77%,NUP58;PRKAG2;SEC13;COX7A2;NUP107;AK4;RANBP2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.28928854690211947,-0.6575802964081033,1.0,1.0,1.0,18/72,21.71%,GABRB2;GRIA4;KCNMB1;GRIK1;AMPH;PRKAR1A;MINK1;PMP22;GRIA3;CHRM3;SLC1A1;SLC1A2;SLC1A3;SLC12A6;CALM1;PLP1;PRKACA;DLG2
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.37750646997815873,0.6573663194333613,0.8048780487804879,1.0,1.0,2/6,16.56%,CLEC16A;CALCOCO2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),0.41213919723279546,0.6571456735218858,0.8333333333333334,1.0,1.0,2/5,20.22%,MTERF4;NSUN3
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.3914108119725471,-0.6564153200681475,0.9,1.0,1.0,2/8,23.51%,YWHAB;PKD2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.45034543689200535,0.6563642792512455,0.8157894736842105,1.0,1.0,1/5,4.23%,EMP2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.3972043077222184,-0.6558999542722165,0.9180327868852459,1.0,1.0,5/8,21.96%,EIF2B3;THBS1;TCF7L2;LPL;SELENOS
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.33118325379072,0.6555379027431671,0.9333333333333333,1.0,1.0,4/19,20.97%,SMG1;PIK3CD;IP6K1;PIK3C3
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),-0.4344266126562519,-0.6549463199335619,0.8813559322033898,1.0,1.0,2/5,17.39%,DTNBP1;PRKN
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.3466367224419786,-0.6545864151179874,0.9365079365079365,1.0,1.0,11/28,16.47%,SLC6A20;SCN7A;SGK1;SLC24A3;FGF13;ANO6;SLC4A4;ATP1B1;SCN2A;HCN1;SLC6A13
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),0.4163904315203867,0.6545583410553908,0.9074074074074074,1.0,1.0,2/5,11.74%,ARF1;WASHC5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.3170638789730912,-0.6536749807302238,0.9538461538461539,1.0,1.0,7/27,17.52%,ANXA1;RPS3;CYP1B1;AGAP3;TPM1;NET1;JUN
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.3138293014458768,-0.6535687402573654,0.971830985915493,1.0,1.0,6/40,13.77%,ANXA1;CD47;N4BP1;POLA1;HLA-B;MAPK14
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.3868963126099527,0.6531576326443284,0.8666666666666667,1.0,1.0,1/8,9.34%,CACNB2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.33950095706367633,-0.6523475679777179,0.9420289855072463,1.0,1.0,6/21,25.85%,DTWD2;TSEN2;NSUN2;NSUN6;SSB;TRMT10B
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.41168008956321317,0.652124603912431,0.9047619047619048,1.0,1.0,3/6,30.23%,IGF2BP2;PCBP1;PCBP3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.41399935667370896,0.6517733849919222,0.8679245283018868,1.0,1.0,1/5,4.34%,RFX3
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.3418884248821497,0.6510449757344638,0.8648648648648649,1.0,1.0,1/14,2.16%,PML
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.342990832799577,-0.6508355116761861,0.8571428571428571,1.0,1.0,5/16,16.36%,UBL5;HPS4;ARIH2;SREBF2;ABLIM3
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.23319114616819292,0.6503652501038708,0.9583333333333334,1.0,1.0,26/105,21.84%,RNF185;RC3H2;UBQLN1;RNF14;AMFR;CBL;ATXN3;UBE2D1;FBXO11;ANAPC16;NEDD4L;UBE4A;BTRC;NDFIP2;ANAPC1;UBE4B;AREL1;ARIH1;RNF168;CNOT4;SIAH1;RNF34;RBBP6;MIB1;PSMD11;RNF149
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.32595552133601147,-0.6490706436723471,0.9342105263157895,1.0,1.0,4/27,16.41%,HSP90AB1;CCT6A;MAP3K4;TNKS2
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.39806236898470265,0.6486910735226589,0.8333333333333334,1.0,1.0,1/5,7.43%,HMBOX1
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.33014327346824734,-0.6481522318653121,0.9047619047619048,1.0,1.0,5/28,13.32%,TGFB2;TGFBR1;DDX5;FOXC1;TGFBR3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.4097626599252082,-0.6470707120183754,0.8771929824561403,1.0,1.0,3/7,23.22%,PLA2G4C;GPCPD1;MGLL
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.2874621168565301,0.6470330339850594,0.9705882352941176,1.0,1.0,8/28,24.24%,NDE1;RHOA;KIFC2;KPNB1;FLNA;EPS8;LSM14A;ZNF207
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.2724198368121519,0.6469939405071414,1.0,1.0,1.0,12/48,19.20%,SLC12A2;BNIP3;ADGRV1;EGFR;P2RX4;FOS;SYT17;SLC25A24;RASGRP2;RYR3;HVCN1;SUMO1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.36573720489535766,-0.6469012741567993,0.8833333333333333,1.0,1.0,5/11,26.69%,HTT;SREBF2;PRKN;CSNK2A2;USP36
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),-0.40242904931353046,-0.6465181143766219,0.859375,1.0,1.0,2/6,17.39%,DTNBP1;PRKN
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.2284294772679772,0.6463571279724449,1.0,1.0,1.0,14/95,16.30%,PPP2R1A;CDKN1A;CEP70;NDE1;PPP6C;PHF8;CCP110;CEP290;RPS6KB1;DNM2;BTRC;ACVR1B;ANAPC1;CACUL1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.42037388183315877,0.6461765331002918,0.8775510204081632,1.0,1.0,1/6,8.98%,RNF152
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.251242190940328,0.6453023011766362,1.0,1.0,1.0,12/68,19.77%,ARF1;ATP6V1H;BNIP3;ABCA1;EGFR;SNAP23;AP1G1;SEC24D;RAB14;ARCN1;CLTC;ARFGAP3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.39994471466830595,0.6450124756295983,0.8627450980392157,1.0,1.0,1/7,0.60%,EPN2
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3367042697232416,0.6443624784644296,0.8571428571428571,1.0,1.0,2/14,9.09%,RNF185;RNF139
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.26612018507827867,0.6436517767406222,1.0,1.0,1.0,13/44,20.83%,STT3B;EIF3B;GTF3C2;GANAB;DDX21;UGGT1;ZDHHC5;KPNB1;ABCB10;DHX9;CUL4A;POLR2B;IMMT
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),-0.43686925555911993,-0.6433408811359034,0.8571428571428571,1.0,1.0,2/5,18.41%,SREBF2;LPL
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.4090408542164037,-0.6427388335545483,0.9047619047619048,1.0,1.0,2/8,14.81%,ZFP36L2;MT3
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.4195009724615953,0.6419005287709375,0.8260869565217391,1.0,1.0,1/5,7.09%,CDKN1A
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.30069505779894173,0.6415685404325464,0.9230769230769231,1.0,1.0,3/19,15.09%,ACADVL;HADHB;SLC25A17
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.41741418731874064,-0.6414610522801486,0.9245283018867925,1.0,1.0,2/5,23.67%,ATP1B1;YWHAE
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.3065364525748406,-0.6412690039645046,0.9696969696969697,1.0,1.0,11/39,23.11%,RHEB;NPRL3;LARP1;ATP6V1E1;LARS1;SEC13;RRAGB;ATP6V1D;ATP6V0D1;ITFG2;SZT2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3973579555821988,-0.6405075999624954,0.8627450980392157,1.0,1.0,2/6,8.56%,ADAMTS12;DCN
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.3428343458472235,0.6403376492241165,0.8648648648648649,1.0,1.0,1/13,2.16%,PML
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.41655508617583553,-0.6403308691364364,0.8709677419354839,1.0,1.0,1/6,11.38%,ARIH2
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.43918512402935167,-0.6393604436242222,0.8888888888888888,1.0,1.0,3/5,28.71%,PLSCR1;CSNK2A2;TPR
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35368359513373,-0.6387241023490139,0.9272727272727272,1.0,1.0,1/9,8.58%,PTGFR
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.33720988429527304,0.6384095647921817,0.9411764705882353,1.0,1.0,4/13,13.51%,BNIP3;RALA;MCU;SPIRE1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.3300728829280901,0.6377406245786216,0.9655172413793104,1.0,1.0,2/16,7.43%,PTGES3;HMBOX1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.42033231502811047,-0.637471515499533,0.9152542372881356,1.0,1.0,2/5,24.49%,SLC6A13;SLC13A4
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.2625774121161954,0.6374544057834198,1.0,1.0,1.0,5/34,13.59%,ZBTB7A;ARNT;NUP54;PPARA;EP300
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.3958851517094317,-0.636766788052229,0.8571428571428571,1.0,1.0,2/6,11.15%,NPRL3;LARP1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.32798145005244383,-0.6357094747742923,0.9855072463768116,1.0,1.0,5/33,14.35%,VEGFA;ANXA1;THBS1;MAPK14;TMSB4X
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.43504290100735027,-0.6356507418435077,0.8947368421052632,1.0,1.0,1/5,7.24%,NCL
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.3724810532952583,-0.6356287313579805,0.9,1.0,1.0,1/10,9.17%,HPS4
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.4164981875080389,-0.6355766285942674,0.9230769230769231,1.0,1.0,2/5,11.57%,SMAD6;PTCH1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.37204584839688537,-0.6353306409494448,0.9491525423728814,1.0,1.0,2/11,9.24%,JAM2;TENM4
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.30838384893584453,0.6351621120276572,0.9782608695652174,1.0,1.0,6/22,13.51%,BNIP3;CAMKK2;RALA;MCU;ZDHHC6;SPIRE1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.3103283989888116,-0.6345326380938319,0.921875,1.0,1.0,2/22,8.33%,ENPP2;LPCAT2
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.3872719723955477,0.6343117624121147,0.8936170212765957,1.0,1.0,4/8,20.39%,MAVS;DHX9;RIOK3;HLA-E
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4348621860695353,-0.6342119787790147,0.9074074074074074,1.0,1.0,1/6,7.24%,NCL
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3380713643643013,-0.6338002601404015,0.9076923076923077,1.0,1.0,3/15,14.50%,FHL1;CACNA1D;ATP1B1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3024092192418015,0.6333178997349412,0.95,1.0,1.0,3/24,13.40%,HDAC1;HDAC9;HDAC2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.3924547806422809,0.6332881601985243,0.8717948717948718,1.0,1.0,2/7,10.53%,CNTN4;ARHGAP35
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.38617264802644835,-0.6330144147731553,0.9016393442622951,1.0,1.0,1/8,11.00%,ACAT1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.31003837755030633,-0.6328939848997444,0.967741935483871,1.0,1.0,3/28,15.34%,HTT;G3BP2;BBS4
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.3802180312147088,-0.6319960348228425,0.8695652173913043,1.0,1.0,2/9,23.84%,SVIL;BASP1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.31889707336823514,0.6310775505105117,1.0,1.0,1.0,5/17,20.18%,ATP6V1H;DNM2;ATP6V1G1;CLTC;ATP6V1A
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.3035744766635771,-0.6304841388427023,0.9393939393939394,1.0,1.0,6/32,21.48%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.3035744766635771,-0.6304841388427023,0.9393939393939394,1.0,1.0,6/32,21.48%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3035744766635771,-0.6304841388427023,0.9393939393939394,1.0,1.0,6/32,21.48%,CNIH3;CSNK1D;SEC13;USO1;ANKRD28;MCFD2
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.3458090986528971,0.6296230533278928,0.9285714285714286,1.0,1.0,1/8,4.09%,TNFRSF21
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.3729768457274356,0.6291919315468462,0.8809523809523809,1.0,1.0,2/6,14.22%,AP3D1;DNM2
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.38688805728446474,0.6289863486388353,0.9069767441860465,1.0,1.0,1/6,6.20%,VEZF1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.36240908744628175,0.6288899667300667,0.972972972972973,1.0,1.0,2/16,9.24%,IRS2;IRS1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),-0.42154291420634515,-0.6286233793093672,0.92,1.0,1.0,1/5,24.26%,PTPN2
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.29072154516963533,0.6283362356745293,0.975,1.0,1.0,5/33,11.60%,PDK4;SELENOT;IRS1;MCU;HK1
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),-0.41545481106014065,-0.6282609732434108,0.8846153846153846,1.0,1.0,1/5,15.57%,CD4
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.4010954880501827,0.6275342366112843,0.8666666666666667,1.0,1.0,1/5,3.85%,ATP8B1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3976218991127899,0.6271299903044344,0.9,1.0,1.0,2/5,20.01%,IL18;MTDH
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.36892349329946594,-0.6266014635880255,0.95,1.0,1.0,3/11,16.27%,WARS1;BMPER;SP100
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.2673695826909804,-0.6265281420036861,1.0,1.0,1.0,20/90,22.10%,PRPF6;RSRC1;FASTKD2;PRMT9;NONO;FUS;TSEN2;THOC1;WBP4;PRPF8;SRPK1;ADARB1;CELF2;SRSF7;U2AF2;DDX17;SRSF5;DHX8;PRKACA;MPHOSPH10
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.31189617229775574,0.6252286349452857,1.0,1.0,1.0,2/22,6.23%,RC3H2;METTL14
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.35552161504155144,0.625207153271594,0.9428571428571428,1.0,1.0,2/11,12.45%,ZNF143;ELL
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.3246249372935789,-0.6232103375762493,0.9375,1.0,1.0,3/24,11.24%,GABRB2;GPM6A;FGF13
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.38857118595967416,0.6228248464599828,0.8775510204081632,1.0,1.0,3/6,17.34%,CASK;CRK;PTPRS
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.3934305845187216,0.6227387015504707,0.9555555555555556,1.0,1.0,1/9,4.87%,TRAK1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.4324127423331162,-0.6219986259615926,0.9038461538461539,1.0,1.0,3/5,39.84%,PRKCA;TGFB1;IL34
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.27560460783960117,-0.6208874580853718,1.0,1.0,1.0,8/64,12.73%,COL1A1;GPC3;SFRP4;PSMD8;PTK7;PSMC2;CSNK1D;RNF220
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.3616893343798142,-0.6207809614152809,0.9482758620689655,1.0,1.0,4/7,20.42%,PARP6;PARP9;PARP8;PARP14
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.28675376543282205,-0.6205479227490315,0.987012987012987,1.0,1.0,16/51,28.78%,SMG6;NUP58;THOC1;SEC13;NUP107;SRSF7;U2AF2;SRSF5;FMR1;RANBP2;SMG7;NUP133;FYTTD1;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),-0.4040285293655561,-0.6204416780045212,0.9,1.0,1.0,2/5,23.67%,ATP1B1;YWHAE
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.30113683304997446,0.6201270151373126,0.9487179487179487,1.0,1.0,4/23,16.33%,P2RX4;NEDD4L;SYT17;WNK1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.3723763126136508,0.6193673505051581,0.9047619047619048,1.0,1.0,1/7,7.41%,PACS2
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.360785606865334,0.6191118398363236,0.9285714285714286,1.0,1.0,1/8,8.79%,SDHB
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.381654508769207,0.6189528061807594,0.9148936170212766,1.0,1.0,5/5,61.86%,RAB3GAP2;ATL3;RAB3GAP1;TMEM33;LNPK
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.39128184204790517,-0.6179533919196961,0.8333333333333334,1.0,1.0,2/6,17.48%,SOAT1;NECAB1
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.3574003003192681,0.6173244749754172,0.8837209302325582,1.0,1.0,1/8,4.42%,LEMD3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.3019907988963533,-0.6170968773255211,1.0,1.0,1.0,11/32,31.20%,INO80;SVIL;PLSCR1;PKN2;PKP4;DYNC1H1;RGCC;PHIP;TPR;PDGFRB;CDC14B
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.35681322340116817,0.6169493148418519,0.9130434782608695,1.0,1.0,2/9,15.42%,RPS6KA5;GLYR1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.29075580858391376,-0.6168336981656892,0.9863013698630136,1.0,1.0,15/48,28.78%,SMG6;NUP58;THOC1;SEC13;NUP107;SRSF7;U2AF2;SRSF5;RANBP2;SMG7;NUP133;FYTTD1;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.29075580858391376,-0.6168336981656892,0.9863013698630136,1.0,1.0,15/48,28.78%,SMG6;NUP58;THOC1;SEC13;NUP107;SRSF7;U2AF2;SRSF5;RANBP2;SMG7;NUP133;FYTTD1;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.3887848698124052,0.6146233153215965,0.8372093023255814,1.0,1.0,4/5,37.44%,SLC22A3;ANTXR1;SLC22A2;ADAM10
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.3441665697459658,0.6142609459914913,0.96,1.0,1.0,1/9,4.31%,EPAS1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.26638747729523204,-0.6142471605334688,1.0,1.0,1.0,23/64,31.64%,RMDN1;CEP126;ITGB3BP;SEC13;NUP107;SMC3;SPC25;EML4;DYNC1H1;MECP2;CLASP2;CKAP5;RANBP2;MAP9;NEK9;NUP133;DYNLL1;GOLGA2;VCP;CENPC;NUP98;DCTN2;RAB11A
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4008807460129984,-0.6142060414600184,0.8703703703703703,1.0,1.0,2/6,31.08%,RER1;ANKRD13C
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2950554170205947,-0.6136824978843209,0.9836065573770492,1.0,1.0,7/34,18.24%,ANXA1;PRMT2;INO80;FHL1;RBL2;APPL2;EIF4G1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3682139767500018,0.6135473584501555,1.0,1.0,1.0,2/9,15.48%,CECR2;KPNB1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.31675612661681246,-0.6125744890356336,0.9836065573770492,1.0,1.0,2/24,9.85%,ADM;CALCRL
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.2771749620810454,-0.6125430347229615,0.9848484848484849,1.0,1.0,8/64,12.10%,GLI2;LAMC1;COL12A1;MID1;LAMB1;FN1;SMAD6;SLIT2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.298804900172821,-0.6116810966764151,0.9701492537313433,1.0,1.0,1/33,2.51%,VAMP4
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4008072027320707,0.6114197790871561,0.85,1.0,1.0,6/6,59.96%,TP53BP1;RIF1;SHLD2;KMT5B;NECTIN2;PAXIP1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.3262728165194031,0.6109088296530498,0.9375,1.0,1.0,6/10,29.98%,TET2;KDM6A;OGT;ASH2L;KMT2C;TET3
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.43056293807580176,-0.6107941021828452,0.896551724137931,1.0,1.0,1/5,7.86%,THBS1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.3469856300768287,-0.6106450481571155,0.9298245614035088,1.0,1.0,1/15,7.17%,HTT
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4191971946075246,-0.6106057202097386,0.8813559322033898,1.0,1.0,4/6,18.72%,ABCB1;SLC1A1;SLC1A2;SLC1A3
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.28448854866614587,-0.6105795296881372,0.96875,1.0,1.0,5/36,17.39%,FBXO38;PELI1;ARIH2;RNF8;PRKN
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.3456735736216,-0.6102798168487041,0.9230769230769231,1.0,1.0,2/15,11.91%,HSP90AB1;PPIA
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.39405962220694774,-0.6096634488222287,0.9242424242424242,1.0,1.0,3/7,28.71%,KHDRBS1;NEDD4;TPR
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.3605324271370615,-0.609463850908179,0.95,1.0,1.0,1/11,9.17%,HPS4
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.3395318128273694,-0.6091113433782804,0.9137931034482759,1.0,1.0,2/14,17.39%,PDCD4;PRKN
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),-0.4177665505783415,-0.6087647689900333,0.9791666666666666,1.0,1.0,2/5,15.34%,GNAL;BBS4
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.29116660413713147,0.6086224273749296,0.9523809523809523,1.0,1.0,2/26,3.99%,NFKBIZ;GPRC5B
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.35255266391292583,-0.6083670794094637,0.9454545454545454,1.0,1.0,4/11,28.19%,SUCLG2;ACBD6;SUCLA2;ACACB
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.3453124021136421,0.6074115816094381,0.9285714285714286,1.0,1.0,2/10,17.85%,GANAB;MGAT4A
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.2678703515349975,0.6072986266947307,1.0,1.0,1.0,4/23,13.90%,ZBTB7A;NUP54;EP300;SCARB2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.36396066716047604,0.6067197160716553,0.9428571428571428,1.0,1.0,1/7,6.98%,ABCA1
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.3604235676058911,-0.6063583340740611,0.875,1.0,1.0,1/8,5.18%,GPC3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.3539994182857855,-0.6061473836903649,0.9259259259259259,1.0,1.0,1/12,5.96%,ARHGAP28
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.38311584815709654,0.6050572784519581,0.9,1.0,1.0,1/5,4.33%,TCAF1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.28063321596804197,-0.6047503727219927,0.9722222222222222,1.0,1.0,5/33,22.02%,PSMD8;PSMC2;CDC27;UBA52;PSMD14
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.35944356573978425,-0.6037442557865317,0.9245283018867925,1.0,1.0,2/11,14.44%,ATG10;NAE1
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.3978854750546945,-0.6028490831551309,0.9285714285714286,1.0,1.0,2/5,22.92%,EPHA4;LYN
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.41209772013072543,-0.602485633650569,0.9444444444444444,1.0,1.0,2/5,23.11%,LMBRD1;SZT2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.333611446683934,-0.6011116325397378,0.9298245614035088,1.0,1.0,3/18,11.45%,TET1;BRCA1;SAP30BP
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.27633741269618306,-0.6010253412266024,0.9836065573770492,1.0,1.0,6/31,21.03%,PER2;GPX4;GNPAT;LPL;ACBD5;PNPLA8
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.37722468345240234,0.5995148654710409,0.9047619047619048,1.0,1.0,1/6,14.02%,ITPK1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.37722468345240234,0.5995148654710409,0.9047619047619048,1.0,1.0,1/6,14.02%,ITPK1
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),0.3719622824171006,0.599502298984503,0.8936170212765957,1.0,1.0,1/5,6.51%,LTBP1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.29204048475747635,0.598858092585159,1.0,1.0,1.0,4/25,10.11%,PDK4;SELENOT;IRS1;MCU
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.34582329957307095,-0.5986574572081871,0.9538461538461539,1.0,1.0,3/11,18.91%,SVIL;PKN2;PKP4
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.27142316816529494,0.5986505997416288,0.972972972972973,1.0,1.0,8/33,20.29%,UBE2N;MAP3K7;NFKB1;MAP3K13;BTRC;ZFP36L1;TRAF6;MAP3K5
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2438422563873189,-0.5972925410290384,1.0,1.0,1.0,25/125,21.67%,SNW1;PRPF6;RSRC1;UBL5;NONO;FUS;DDX42;SNRNP200;DDX5;PPWD1;WBP4;SRSF10;PRPF8;SRPK1;EFTUD2;PNN;SRSF7;LSM8;HNRNPA3;U2AF2;DDX17;SRSF5;DHX8;RBM4B;PRMT7
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.27864942248101104,0.596767244098328,1.0,1.0,1.0,3/23,14.42%,LEMD3;NUP54;BIN1
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.34996964124790847,-0.5951304210355643,0.921875,1.0,1.0,1/14,5.96%,ARHGAP28
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.24005316636616303,-0.5948780922491598,1.0,1.0,1.0,12/121,13.28%,DDB2;UCHL5;TGFBR1;OTULIN;PSMD8;USP31;UIMC1;INO80;BIRC2;BRCA1;PSMC2;USP40
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.35211129093096005,-0.5947832044902455,0.9733333333333334,1.0,1.0,3/13,12.93%,TERF2IP;SMG6;DHX36
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.3677740007093683,-0.5946119214024033,0.9354838709677419,1.0,1.0,3/10,13.57%,PRKDC;MRNIP;PARP9
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.3346850176447429,-0.594608072456609,0.9333333333333333,1.0,1.0,2/11,15.34%,HTT;BBS4
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.2727059188271145,0.5931735624921368,1.0,1.0,1.0,4/32,11.51%,HIPK2;PPP2CB;AMFR;RAPGEF2
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.35169039063538027,-0.5914285619468123,0.9107142857142857,1.0,1.0,1/8,6.75%,HSP90AB1
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.28617757493160434,0.5913289697227988,0.9777777777777777,1.0,1.0,5/19,23.59%,ZDHHC6;EP300;ZDHHC5;KAT2B;KAT6A
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.2563729137360485,0.5908599097780283,1.0,1.0,1.0,5/34,16.33%,HIPK2;MAP2K1;ACVR1B;CSNK2A1;WNK1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.2954666878547437,0.5905960452267295,0.9487179487179487,1.0,1.0,2/21,6.09%,UBE2N;MAP3K7
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.36014459846405,0.5902611193572146,0.9130434782608695,1.0,1.0,4/6,18.98%,CD44;MBP;WNK1;MAP2K5
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.3955546922434965,-0.5895224332239056,0.9107142857142857,1.0,1.0,1/6,7.97%,CCT6A
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.34363489501370614,-0.5891267697252999,0.8333333333333334,1.0,1.0,1/10,14.64%,IL16
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.3684819230118003,0.5888876594681218,0.925,1.0,1.0,2/7,11.90%,MTMR1;MTMR4
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),-0.4036156829318511,-0.588573271522352,0.9056603773584906,1.0,1.0,2/5,17.39%,NONO;PRKN
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.30727488006840964,-0.5881657661341947,1.0,1.0,1.0,6/31,17.65%,BACH2;CSE1L;HIKESHI;SEC13;NUP107;APPL2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.3153963756138649,0.5874451690988062,0.9545454545454546,1.0,1.0,3/12,16.73%,PAK2;TJP1;NLGN2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3547410890562923,-0.58710157101873,0.9791666666666666,1.0,1.0,1/8,13.34%,SVIL
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.3644307551858306,-0.5858131794901664,0.9,1.0,1.0,2/6,30.38%,ANKRD13A;LRPAP1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.3342297288029048,-0.5850935645324423,0.9344262295081968,1.0,1.0,1/11,4.50%,BORCS5
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.2727549892908605,0.5848318739012255,1.0,1.0,1.0,2/27,7.58%,APC;GNL3L
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.38184003967840496,-0.5843636707658241,0.9464285714285714,1.0,1.0,2/8,17.65%,KDM2B;APPL2
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.3888312577026869,0.5838328023227319,0.9574468085106383,1.0,1.0,2/5,6.36%,SMAD7;PMEPA1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.2984513095501523,-0.583571421421033,1.0,1.0,1.0,4/22,16.73%,NUP58;PRKAG2;SEC13;NUP107
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.3946816327357273,-0.5827656022780637,0.9607843137254902,1.0,1.0,1/5,9.38%,SASH1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.38122354585070584,0.5826775926541691,0.9069767441860465,1.0,1.0,2/6,8.72%,MICAL2;DSTN
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.3795364928106938,-0.5823692687709274,1.0,1.0,1.0,1/5,12.72%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.29462214609606757,-0.5815992980961469,0.9722222222222222,1.0,1.0,4/23,16.73%,NUP58;PRKAG2;SEC13;NUP107
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.3269178542813087,0.5815928441950403,0.9117647058823529,1.0,1.0,2/11,14.22%,EGFR;DNM2
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.37263786124329695,0.5814976553985035,0.8888888888888888,1.0,1.0,2/5,21.39%,IL18;PRNP
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.2863342009183177,-0.5814173428829804,0.9558823529411765,1.0,1.0,3/26,16.73%,EYA1;NUP58;NUP107
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.35017720428762283,-0.5796093498107923,0.9827586206896551,1.0,1.0,3/11,16.87%,SLC22A6;SLCO1A2;LRRC8B
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.33740621599591814,-0.5793312550998347,0.9811320754716981,1.0,1.0,3/9,17.08%,GLRX;ATP1B1;WNK2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.3808628797694739,0.5790446161301701,0.8936170212765957,1.0,1.0,2/5,25.06%,BIN1;SESTD1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.36914001862775536,0.5788489875466548,0.8780487804878049,1.0,1.0,6/6,63.12%,TP53BP1;RIF1;SHLD2;KMT5B;PAXIP1;TGFB1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.37680327332340335,-0.578385118100542,0.9649122807017544,1.0,1.0,1/7,12.93%,DHX36
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.3885520597981222,-0.5783740487028934,0.9056603773584906,1.0,1.0,2/5,24.26%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.3885520597981222,-0.5783740487028934,0.9056603773584906,1.0,1.0,2/5,24.26%,LGALS3;PTPN2
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.36050297482726523,0.5772618268293562,0.98,1.0,1.0,2/5,28.41%,SMC5;SMC6
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.3131234067719765,-0.5766978766176405,1.0,1.0,1.0,1/16,5.30%,RACK1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.35196706602969535,0.5766892466015067,0.7804878048780488,1.0,1.0,1/5,14.22%,DNM2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.35196706602969535,0.5766892466015067,0.7804878048780488,1.0,1.0,1/5,14.22%,DNM2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.3785254699062883,-0.5758254291973757,0.9464285714285714,1.0,1.0,2/5,23.54%,SNAP91;DNM3
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.2779618357227351,-0.5752924151264192,0.9852941176470589,1.0,1.0,7/36,13.68%,RPS3;EYA1;UIMC1;BRCA1;WRN;DHX36;RNF8
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.26364547714639086,0.574807519082413,1.0,1.0,1.0,5/28,16.02%,TNFAIP8L1;RICTOR;DDIT4;GNA12;GAS6
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),-0.37274837620137014,-0.5740074566964195,1.0,1.0,1.0,2/6,17.62%,SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),-0.37274837620137014,-0.5740074566964195,1.0,1.0,1.0,2/6,17.62%,SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.37274837620137014,-0.5740074566964195,1.0,1.0,1.0,2/6,17.62%,SYNJ2;INPP5B
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.3538495302589749,0.5737162156086665,0.88,1.0,1.0,2/6,16.73%,SYN3;NLGN2
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.33580227352313774,0.5723512579698457,0.9333333333333333,1.0,1.0,4/10,24.67%,TJP1;CBFB;ROCK1;NPHP1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.28509372820844464,-0.5715694238648948,0.9846153846153847,1.0,1.0,11/34,23.73%,POLA1;UIMC1;BRCA1;PRKDC;RNF8;XRCC6;MRE11;PSMD14;BABAM2;ERCC6;SMARCAL1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.25273671306185014,-0.5715646645912383,1.0,1.0,1.0,14/58,23.19%,PIK3R4;ATG10;GABARAPL1;VPS36;PRKAG2;STX17;SQSTM1;PRKN;ATG14;ACBD5;NBR1;VPS37A;ARL8B;CSNK2A2
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.27577530166469244,-0.5712438506106798,0.9545454545454546,1.0,1.0,3/44,10.20%,ESCO1;EYA1;NUP58
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.3227488377458196,0.570951395084747,0.9111111111111111,1.0,1.0,4/9,27.99%,UBXN2A;TOR1AIP1;CHMP4B;NSFL1C
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2771125851631837,-0.5696967842290726,1.0,1.0,1.0,3/36,11.58%,AP2A2;PSMD8;PSMC2
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.36955325120839144,-0.5695065347480343,0.9523809523809523,1.0,1.0,2/5,32.27%,PTGR1;LTA4H
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.23106703664915015,-0.5688369751968892,1.0,1.0,1.0,25/155,18.77%,CSE1L;CDC37;STRADB;AP4E1;FAM91A1;HPS4;TBC1D2B;TBC1D22A;VPS36;TBC1D9;STX17;RPL11;HIKESHI;SEC13;TMED4;SCFD2;SNX27;SNX9;NUP107;USO1;TBC1D8;APPL2;ARF4;ARL17A;NAPG
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),0.29899183010539776,0.5682779486828017,0.9459459459459459,1.0,1.0,2/12,15.01%,MRPS27;GFM2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.37841971925744466,-0.5682489651699202,0.9814814814814815,1.0,1.0,1/5,19.77%,ACBD5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.2503647755498538,-0.5681524725336052,1.0,1.0,1.0,9/48,23.71%,TCTN1;SCLT1;CSNK1D;NINL;SDCCAG8;PRKACA;DYNC1H1;YWHAE;CKAP5
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.2513946536080462,-0.5670259781745502,1.0,1.0,1.0,3/65,9.75%,PIGG;PIK3R4;MTM1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.28305111076588463,0.5669390932845182,0.9777777777777777,1.0,1.0,11/11,71.74%,ATG2B;ULK2;WDR45B;WIPI2;ULK1;RB1CC1;ATG7;ATG12;WIPI1;ATG5;ATG13
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.32849114634723053,0.5664583208656208,0.9534883720930233,1.0,1.0,3/7,18.98%,NFKB1;KLF2;MAP2K5
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.27437328672607536,-0.5662993385323825,0.984375,1.0,1.0,10/38,23.11%,RHEB;NPRL3;ATP6V1E1;LARS1;SEC13;RRAGB;ATP6V1D;ATP6V0D1;ITFG2;SZT2
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.3778569678580608,-0.5658127356962539,0.9272727272727272,1.0,1.0,3/5,30.60%,NEK9;AKAP8L;PRKCA
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.3420816431756776,-0.5652407541546052,0.9666666666666667,1.0,1.0,5/11,22.61%,TANC2;APOE;SRGAP2C;FMR1;PSEN1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.2982964199443808,0.5652291198232338,1.0,1.0,1.0,1/13,5.23%,SLC26A3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.3675502808254377,-0.5647951517218862,0.9433962264150944,1.0,1.0,1/6,17.39%,PRKN
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.3422097185981843,-0.5646463507057342,0.9375,1.0,1.0,4/9,25.95%,EXOSC10;TUT7;SSB;TUT4
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.2645481463612381,-0.5639694581300366,0.9868421052631579,1.0,1.0,15/50,28.78%,SMG6;NUP58;THOC1;SEC13;NUP107;SRSF7;U2AF2;SRSF5;RANBP2;SMG7;NUP133;FYTTD1;SRSF11;TPR;NCBP1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.2784936078077873,-0.5638341534413371,1.0,1.0,1.0,3/34,11.58%,AP2A2;PSMD8;PSMC2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.35534394090845656,-0.563811717049083,0.9354838709677419,1.0,1.0,2/8,10.90%,TBCD;JAM3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.34152752086117394,0.5636819949995602,0.975609756097561,1.0,1.0,4/7,33.17%,GAS6;GSTP1;ILRUN;IRAK3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.34152752086117394,0.5636819949995602,0.975609756097561,1.0,1.0,4/7,33.17%,GAS6;GSTP1;ILRUN;IRAK3
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.3147406687072335,0.5635438003906386,0.925,1.0,1.0,2/8,17.08%,CPT1A;SLC27A1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3338970739051086,-0.5610825579356568,0.9649122807017544,1.0,1.0,4/9,26.64%,RHOQ;GTPBP1;AK4;MFN1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3338970739051086,-0.5610825579356568,0.9649122807017544,1.0,1.0,4/9,26.64%,RHOQ;GTPBP1;AK4;MFN1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.3288719807485694,-0.5603852012109278,0.9365079365079365,1.0,1.0,2/8,28.50%,WNK2;NEDD4
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.37305622169120356,0.5599447306788322,0.875,1.0,1.0,2/5,22.98%,GRM5;GRM8
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.29598420116690755,-0.5594133886716632,1.0,1.0,1.0,5/18,21.96%,RHOQ;PRKAG2;APPL2;PIK3R1;SELENOS
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.29049777258605114,-0.5578020155234207,0.9827586206896551,1.0,1.0,2/14,19.91%,BIRC2;UBA52
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.29049777258605114,-0.5578020155234207,0.9827586206896551,1.0,1.0,2/14,19.91%,BIRC2;UBA52
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3470904253631785,-0.5570388666673493,0.9682539682539683,1.0,1.0,4/8,34.07%,GTF2H1;POLR1C;TAF1;TAF1D
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.3470904253631785,-0.5570388666673493,0.9682539682539683,1.0,1.0,4/8,34.07%,GTF2H1;POLR1C;TAF1;TAF1D
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.33413416720159644,-0.5569869997849953,0.9830508474576272,1.0,1.0,3/11,17.90%,BMP5;BRCA1;PRMT3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3100490802433995,0.5559583690825665,0.9767441860465116,1.0,1.0,3/9,21.18%,KCNQ1;ANK2;FLNA
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.3340719681145247,-0.5558243243786872,0.967741935483871,1.0,1.0,3/11,19.70%,ALDH3A2;EMC3;SERP1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),0.335033944808352,0.5552239156264591,0.8947368421052632,1.0,1.0,1/5,19.54%,SPIN1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.2932814382653669,0.5547373746805461,1.0,1.0,1.0,4/10,29.95%,RHOA;PDLIM1;ITGB5;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.2932814382653669,0.5547373746805461,1.0,1.0,1.0,4/10,29.95%,RHOA;PDLIM1;ITGB5;PHACTR1
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.3204612358230793,-0.5547103178897134,0.9710144927536232,1.0,1.0,2/9,32.51%,TRIM62;EXOC7
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.35629052976322256,0.552727315050509,0.925,1.0,1.0,1/6,8.37%,PHF2
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.34688809560763606,0.5524009812458567,0.9591836734693877,1.0,1.0,5/5,65.34%,KDM5D;KDM5B;KDM5A;KDM5C;KDM1A
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.35941120404027904,-0.5519398419175717,0.9583333333333334,1.0,1.0,3/5,36.63%,HOOK3;NUMB;CEP120
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31000988748260944,-0.5513775950177203,0.9180327868852459,1.0,1.0,3/9,20.38%,RPS21;RPS14;RPS8
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.3381586054308395,-0.5510084367054039,0.9692307692307692,1.0,1.0,1/7,16.16%,ANXA2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.30919103023984507,-0.5502174606738282,0.984375,1.0,1.0,2/15,17.65%,THBS1;APPL2
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.34248202257244376,0.5490839851658442,0.9565217391304348,1.0,1.0,1/5,8.16%,FBH1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.3560848229666889,0.5478732450871867,0.9148936170212766,1.0,1.0,1/5,6.98%,ABCA1
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),-0.32915114291577025,-0.547869903386463,0.9629629629629629,1.0,1.0,1/7,14.50%,ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.32137029060725225,0.5478196347343713,0.9318181818181818,1.0,1.0,1/8,8.31%,AXL
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.3465994739585353,-0.547560615510922,0.9166666666666666,1.0,1.0,1/8,12.93%,DHX36
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),-0.32787159961304,-0.5453608464223553,0.9803921568627451,1.0,1.0,1/10,15.23%,CYP27A1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.28255662125570913,0.5438177631207293,1.0,1.0,1.0,3/12,21.18%,MAVS;EFCAB7;FLNA
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.28255662125570913,0.5438177631207293,1.0,1.0,1.0,3/12,21.18%,MAVS;EFCAB7;FLNA
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.3610948411975098,0.5435279573288205,0.9361702127659575,1.0,1.0,1/5,16.98%,TENT4B
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.31176602797824515,0.5432113974526785,0.9545454545454546,1.0,1.0,2/6,17.17%,ADCY5;KLF7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.31231912419766866,-0.5430423581022833,1.0,1.0,1.0,2/19,8.93%,ENPP2;ABI2
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.22802597826789317,-0.5427105504874731,1.0,1.0,1.0,15/90,23.45%,PARP1;SGK1;TGFBR1;PRKDC;CSNK1D;MAPK14;PKN2;PRKCH;MARK1;PRKACA;TGFBR2;PDK3;CSNK2A2;MAPK9;LATS2
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.37965555365232045,0.5419344423888689,0.9574468085106383,1.0,1.0,1/6,4.02%,RNF185
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.23591518357837396,0.5416741053775884,1.0,1.0,1.0,4/33,16.98%,WDR33;PCF11;CPSF2;TENT4B
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.286389423305935,0.5414783277822202,0.9772727272727273,1.0,1.0,3/13,20.18%,ATP6V1H;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.2871154767960386,-0.541355983724716,1.0,1.0,1.0,3/16,18.84%,FGF13;MT3;OMG
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.26466931124890664,-0.5411185463305349,0.9836065573770492,1.0,1.0,7/27,28.24%,PER2;PRDM5;MIDEAS;TRERF1;MORF4L2;SIN3B;RCOR3
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.3278801842431439,-0.539415502647709,0.9354838709677419,1.0,1.0,2/7,16.83%,FGF13;NGF
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.34179295938024834,-0.5387840107730693,0.9827586206896551,1.0,1.0,4/7,29.47%,DLD;PHYKPL;AASS;ALDH7A1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.34179295938024834,-0.5387840107730693,0.9827586206896551,1.0,1.0,4/7,29.47%,DLD;PHYKPL;AASS;ALDH7A1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.2533732586195432,-0.5382261333364945,1.0,1.0,1.0,7/44,24.22%,TMEM87A;SNX2;GOSR1;DENND2A;VPS51;RHOBTB3;GCC2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.37801919879149515,0.5372307596577188,0.9375,1.0,1.0,2/5,23.31%,UBASH3B;PTPN1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.3571004078777168,-0.536323810090274,0.96,1.0,1.0,2/5,20.66%,DDX5;DDX17
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.33772920105801046,-0.5354035386511922,0.9464285714285714,1.0,1.0,2/6,21.11%,PRKN;FMR1
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.29032439411122835,0.533662741046158,0.96875,1.0,1.0,3/11,16.98%,CPSF2;XRN1;TENT4B
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.29843109737785817,-0.5335729946896149,0.9411764705882353,1.0,1.0,3/9,21.14%,HES1;ACVR1;FBN1
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.3490702477136165,-0.5311595620527008,0.9574468085106383,1.0,1.0,1/5,15.01%,SREBF2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.3490702477136165,-0.5311595620527008,0.9574468085106383,1.0,1.0,1/5,15.01%,SREBF2
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),0.3313673754462205,0.5309260403192899,0.975609756097561,1.0,1.0,5/5,66.89%,SLC39A11;SLC30A5;SLC39A10;SLC30A10;SLC30A6
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.341209566688215,-0.5301799400820045,1.0,1.0,1.0,1/7,11.93%,SNX2
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.2373871727530234,-0.5296683386305256,1.0,1.0,1.0,5/46,12.28%,PSMD8;PELI1;MAP3K8;PSMC2;IL1R1
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.256218513449728,0.5284361823323991,0.9743589743589743,1.0,1.0,5/18,21.22%,KIF5B;KLC1;GFM2;ATG2B;ULK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.28831152209811073,-0.5282691257408673,1.0,1.0,1.0,5/24,19.12%,CD47;PDCD4;PPIA;ANXA2;HSPA9
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.33494323917662305,-0.5273921483372506,1.0,1.0,1.0,1/7,11.63%,FOXC1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.2483475286780709,-0.5243650286578107,1.0,1.0,1.0,10/37,22.52%,RETREG1;UFL1;SQSTM1;PRKN;ATG14;ACBD5;UBA52;NBR1;DYNC1H1;VIM
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3081986644819111,0.5239461445981739,1.0,1.0,1.0,3/9,27.68%,PSMB2;PSMA7;PSMB1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.31542290672428536,-0.5238957079664961,0.9833333333333333,1.0,1.0,2/8,15.25%,HPS4;DTNBP1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.25709585766335563,0.5237013078401815,1.0,1.0,1.0,3/17,20.18%,ATP6V1H;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.2869374389796057,0.5234146830670102,1.0,1.0,1.0,3/16,18.36%,MAVS;PTPRS;IRF3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.299426238347541,0.5225391266794699,0.96875,1.0,1.0,4/14,20.42%,ACTR2;CDC42;ACTR3;CYFIP1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.3506906781501126,-0.522078597774099,0.9622641509433962,1.0,1.0,2/5,17.39%,BIRC2;PRKN
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.2715482544034745,-0.521163552680091,0.9852941176470589,1.0,1.0,4/21,19.03%,GABARAPL1;SQSTM1;PRKN;ATG14
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.2940559664816579,-0.5194927665474495,0.9848484848484849,1.0,1.0,6/17,23.12%,ABI2;SLIT2;PIK3R1;ARPC2;AUTS2;WASF2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.2611304052712334,-0.5194908889963639,1.0,1.0,1.0,3/23,19.82%,PLCH1;INPP5B;CALM1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.36153454374366695,-0.5188558795838408,0.98,1.0,1.0,2/5,22.61%,MAP1A;PSEN1
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.2897944408589916,0.5184120918387651,0.9024390243902439,1.0,1.0,6/10,34.37%,TET2;SETD3;OGT;TET3;KMT2A;SETD2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.3415151266983568,-0.5176326735960508,0.9473684210526315,1.0,1.0,3/8,31.36%,NUP107;TPR;NUP98
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.28323383394185486,0.5168977658945239,0.9787234042553191,1.0,1.0,2/11,15.29%,ZDHHC6;ZDHHC5
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.320443959293011,-0.5167035561878122,0.9538461538461539,1.0,1.0,3/7,34.07%,GTF2H1;POLR1C;TAF1D
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.2561540682941898,-0.5134987880334022,1.0,1.0,1.0,3/24,19.82%,PLCH1;INPP5B;CALM1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.3334316709335923,0.5133995925603335,0.9761904761904762,1.0,1.0,1/5,16.02%,GAS6
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.3192582307912017,0.5123532862702558,0.926829268292683,1.0,1.0,1/5,11.58%,PPARA
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.31511952809686444,0.5112174860606412,0.9318181818181818,1.0,1.0,6/6,68.52%,LRSAM1;RAB3GAP2;RAB3GAP1;PIP4K2A;SH3GLB1;PIP4K2B
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.22906161123820115,0.5108877482403568,1.0,1.0,1.0,5/39,16.33%,HIPK2;MAP2K1;ACVR1B;CSNK2A1;WNK1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.3043833352888388,-0.5102041497594132,0.9672131147540983,1.0,1.0,2/9,22.92%,PRKCH;LYN
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.3469862814866798,0.5098147393391954,0.9555555555555556,1.0,1.0,2/5,21.39%,EZR;PRNP
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.28328861274434824,-0.5093508007840135,0.9824561403508771,1.0,1.0,1/10,11.15%,LARP1
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.26835579389464426,0.5077380741385481,0.9545454545454546,1.0,1.0,2/9,17.43%,NFKB1;CD38
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),-0.34019786293135346,-0.5076237471804799,0.967741935483871,1.0,1.0,1/5,17.91%,CHRM3
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.34732017041342717,-0.5076223546535039,0.9672131147540983,1.0,1.0,2/5,25.92%,PDCD10;ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.27661922753574325,-0.5041054837058893,0.9508196721311475,1.0,1.0,3/14,18.89%,CCDC57;HES1;PKN2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.2878248829543001,0.5035850868947871,0.9473684210526315,1.0,1.0,3/6,26.40%,AKAP6;SPPL3;CAMTA1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.2878248829543001,0.5035850868947871,0.9473684210526315,1.0,1.0,3/6,26.40%,AKAP6;SPPL3;CAMTA1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.3078561466988109,-0.501736777073794,0.9672131147540983,1.0,1.0,2/7,13.46%,LGALS3;S100A11
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.2967647353155646,-0.500564330662747,1.0,1.0,1.0,2/8,24.33%,CLASP2;RGCC
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.3216385559019859,-0.5000044496186885,0.9629629629629629,1.0,1.0,2/8,21.29%,LGALS3;PTN
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.32505433095312014,-0.49938654542442734,0.9836065573770492,1.0,1.0,6/6,67.54%,PPP3CB;NFATC3;PPP3CA;NFATC4;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.32505433095312014,-0.49938654542442734,0.9836065573770492,1.0,1.0,6/6,67.54%,PPP3CB;NFATC3;PPP3CA;NFATC4;NFAT5;PPP3CC
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),0.3122562523811516,0.49928881834437067,0.9743589743589743,0.9997510552430323,1.0,1/6,13.40%,HDAC2
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),0.3122562523811516,0.49928881834437067,0.9743589743589743,0.9997510552430323,1.0,1/6,13.40%,HDAC2
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),0.3122562523811516,0.49928881834437067,0.9743589743589743,0.9997510552430323,1.0,1/6,13.40%,HDAC2
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.3073616197066493,-0.496962189952472,0.9814814814814815,1.0,1.0,2/5,21.74%,RBL2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.28702266376901586,0.4949145699870024,0.96,1.0,1.0,6/6,71.32%,DYNC1LI1;DUSP1;PCID2;CDK5RAP2;LCMT1;TPR
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.24689905557594422,-0.4944987853747686,0.9836065573770492,1.0,1.0,4/25,17.39%,PELI1;ARIH2;RNF8;PRKN
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2862086344885275,0.4939279296162989,1.0,0.9998469679080746,1.0,2/11,15.42%,RPS6KA5;GLYR1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.22611549406877723,0.49376495324991587,1.0,0.9992148594123076,1.0,6/23,23.46%,MAVS;EFCAB7;GAS6;DHX9;FLNA;GSK3B
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.2882014525354814,0.49182572265212593,1.0,0.9991534983771964,1.0,1/10,8.31%,AXL
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.2849233391945494,-0.49152430233463107,0.9491525423728814,1.0,1.0,1/9,10.44%,FAR2
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.32639449498702355,0.4911373985969858,0.9777777777777777,0.9986833002525526,1.0,1/5,14.45%,ACTA2
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),-0.33637651886138165,-0.490019642543709,0.9830508474576272,1.0,1.0,2/6,17.59%,TGFBR1;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.29736374079621153,-0.48892113553354594,0.9803921568627451,1.0,1.0,3/7,28.71%,TCF7L2;YWHAE;TPR
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.3008294639829746,0.4886392283781607,0.9534883720930233,0.9978541139643236,1.0,1/5,11.77%,ARHGEF10L
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.3008294639829746,0.4886392283781607,0.9534883720930233,0.9978541139643236,1.0,1/5,11.77%,ARHGEF10L
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.31306157364871484,-0.4878434987434882,1.0,1.0,1.0,2/7,33.55%,DLGAP1;APP
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.25677463999627903,-0.4849460626291385,1.0,1.0,1.0,3/12,23.67%,ANO6;CHRM3;YWHAE
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.2981163535383633,-0.4841377509229501,0.9830508474576272,1.0,1.0,2/8,16.64%,RNF8;LARP7
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.3021229405197088,-0.48363215180605185,1.0,1.0,1.0,2/7,16.64%,RNF8;LARP7
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.30115747394757864,0.4822433388366555,0.9512195121951219,0.9989015575275163,1.0,2/7,22.35%,PPARA;CREB1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.2810527528444855,-0.4811335199656136,0.9649122807017544,1.0,1.0,2/11,16.66%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.33024040716407804,-0.4801434204476617,0.9827586206896551,1.0,1.0,1/5,16.75%,KCNMA1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2969741047189671,0.47790820473678286,0.9772727272727273,0.9992411752469159,1.0,3/5,26.44%,SEC63;SEC61A1;CHMP4B
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.24877071060934763,-0.4765076662626756,0.9836065573770492,1.0,1.0,8/23,30.04%,EPHA4;VIM;RPL23;PSEN1;LRP1;FYN;GJA1;IGF1R
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.2750539008570029,-0.47547926788476635,1.0,1.0,1.0,4/11,22.83%,DDX52;RPS14;RPS8;RPS28
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.28660145940071424,0.47524445727162734,0.9473684210526315,0.9991218057871856,1.0,7/7,71.37%,NAA11;NAA35;NAA50;METAP1;NAA15;METAP2;NAA16
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.3097126824857596,-0.4748713755951597,0.9655172413793104,1.0,1.0,2/6,26.58%,NAE1;RBX1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.25624571386858314,0.4732165092797815,0.9743589743589743,0.9988134689555367,1.0,3/8,19.57%,KLF2;MAP2K5;MTSS1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.3037946997107856,-0.4730571519554972,0.9516129032258065,1.0,1.0,4/9,22.61%,DHX36;APOE;FMR1;PSEN1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.2556134366938248,-0.47266387115930747,1.0,1.0,1.0,3/19,17.39%,GABARAPL1;SQSTM1;PRKN
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.278882661233794,-0.47157963067058956,0.9824561403508771,1.0,1.0,4/11,29.11%,VPS36;VPS37A;NEDD4;UBAP1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.29637679534080796,0.47137505983016437,0.9736842105263158,0.9985491439399781,1.0,1/6,9.34%,CACNB2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.24520829926251017,0.47105445818447117,0.9777777777777777,0.9980091063372959,1.0,4/16,21.25%,MECOM;AIDA;EZR;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.26249405585943025,0.46845798457220966,0.975609756097561,0.9973156369805225,1.0,1/10,8.90%,ARNT
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.26249405585943025,0.46845798457220966,0.975609756097561,0.9973156369805225,1.0,1/10,8.90%,ARNT
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.29093212351827547,0.46827097013112107,0.9583333333333334,0.9967629286827251,1.0,1/5,15.71%,CPEB3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.3062293801606649,-0.46801730812945946,1.0,1.0,1.0,3/5,39.66%,WDR1;CRACD;SEMA5A
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.25238307793530274,-0.46365193164340074,0.9836065573770492,1.0,1.0,6/16,30.04%,EPHA4;PSEN1;LRP1;FYN;GJA1;IGF1R
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.26959273435915976,-0.4614592378518296,0.9655172413793104,1.0,1.0,4/11,33.55%,PSEN1;ANKRD13A;LRPAP1;APP
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.26480049863354943,-0.45867192374830784,1.0,1.0,1.0,5/12,34.01%,RGCC;PHIP;PDGFRB;LCMT1;EDN3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.2724074039823235,0.45812390719970597,1.0,0.998138340555288,1.0,3/7,23.82%,ARHGEF4;EZR;FGD5
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.2589642889794417,-0.4575534213956187,1.0,1.0,1.0,2/17,13.65%,BCAS3;PDCD10
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.2596690538104918,-0.45679396404700834,0.9846153846153847,1.0,1.0,3/13,24.07%,MRPS25;GFM1;MRPL3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.25539873738946933,-0.4561499331111424,1.0,1.0,1.0,1/11,14.72%,VGLL4
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.29326908953769404,-0.45568243770800887,0.9811320754716981,1.0,1.0,2/6,21.03%,ELOVL2;PNPLA8
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.3072553941085244,0.4553213482149518,0.9361702127659575,0.9980854607437994,1.0,2/5,20.97%,PIK3CD;PIK3C3
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.234591568163726,0.45154769646570375,0.9333333333333333,0.9982208010312249,1.0,1/10,10.13%,NUP54
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.2893814378894457,-0.44795947554217547,0.9814814814814815,1.0,1.0,3/7,29.75%,ELOVL2;HSD17B4;FADS2
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.2911687102281545,0.4442273251305354,0.9591836734693877,0.9987103361612663,1.0,5/5,70.91%,IFNAR1;PNPT1;TRAP1;IDE;VCP
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.25807394861750754,0.4395180048939869,0.9743589743589743,0.9988306490897116,1.0,2/8,24.53%,SIDT2;RBFOX1
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.2825598338257156,-0.4388901980151333,1.0,1.0,1.0,1/6,17.60%,WDR82
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.2923107355141219,0.43830459451477555,0.9347826086956522,0.9984163241500453,1.0,3/6,31.96%,CBFB;ELF2;RC3H1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.27597869461930474,-0.437367096138529,1.0,1.0,1.0,4/8,30.27%,PDCD10;ARHGAP21;UVRAG;HOOK3
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.2744915385809657,-0.4346857540042532,1.0,1.0,1.0,7/7,72.60%,LATS2;WWC2;PTEN;WWC1;WWC3;SOD1;LATS1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.20937603797034532,0.4340878742982717,1.0,0.9983273449335962,1.0,6/24,22.58%,NFKB1;FOXO3;GRM5;CYFIP1;EIF4E;AGT
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.2380508980219777,-0.4335070485850875,1.0,1.0,1.0,4/11,27.95%,PIK3R1;STAT3;LYN;STAT6
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),-0.276697554868191,-0.43311538590568915,0.9824561403508771,1.0,1.0,1/5,23.79%,CRY1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.24328153384010626,0.43107305216265995,1.0,0.9979787918538986,1.0,2/8,24.08%,RPS6KB1;PRKAA2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.25223339485752927,-0.4284138677439716,1.0,1.0,1.0,3/9,23.70%,MAPK14;EFNB2;NRG1
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.26991654528347586,-0.4281395057404008,0.9836065573770492,1.0,1.0,3/7,23.29%,LPL;PRKCH;MAPK9
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.2786823381907479,0.4274198041179067,0.9743589743589743,0.9977820710812225,1.0,2/5,18.98%,KLF2;MAP2K5
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),-0.2653970322399122,-0.4259464383891501,0.9807692307692307,1.0,1.0,2/5,28.82%,LRP1;MIA3
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.2872934434098052,-0.41857481420857306,1.0,1.0,1.0,2/6,23.60%,DYNC1H1;CLASP2
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.2652498624467395,-0.41743445116725036,1.0,1.0,1.0,2/7,24.46%,MORF4L2;BRD8
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.2474434206073309,-0.4122839068804015,1.0,0.9999281016002605,1.0,2/11,22.35%,VPS36;VPS37A
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.26001241850357043,0.4078548827522361,0.9814814814814815,0.9994947523952167,1.0,6/6,74.02%,GALNT1;GALNT16;EOGT;GALNT2;GALNTL6;GALNT11
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.240914332178635,0.4056349136596731,1.0,0.9990381254307324,1.0,3/9,23.56%,GAS6;ZFP36L1;TSC2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),-0.2612680943653331,-0.40360098061021754,0.9807692307692307,1.0,1.0,2/5,26.92%,APOE;FYN
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.25116423470971755,0.395635403139938,1.0,0.9991864743153435,1.0,6/6,74.91%,VMP1;PRKCB;ZDHHC17;ZDHHC3;MIA3;LRP1
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.24548843193236036,0.39484682649004155,1.0,0.9985796218933266,1.0,3/6,29.14%,EPS8;CHMP4B;CLASP1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.20965676510169787,0.3931622883864241,1.0,0.9981172615497381,1.0,4/12,25.47%,RANGAP1;GAS6;GSK3B;UHMK1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.23268300668343034,-0.39040412730460267,1.0,1.0,1.0,2/8,21.96%,TMEFF2;SELENOS
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.25063857075172896,-0.38978413355810515,0.9818181818181818,0.9999641047239299,1.0,1/6,19.82%,CALM1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.22465455674584692,-0.3594441020093375,1.0,1.0,1.0,7/7,77.57%,VCL;ZDHHC21;ROCK2;IKBKB;PPP1R12A;TNFRSF1A;ROCK1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.22042763922365477,-0.3579651821349921,1.0,1.0,1.0,5/10,37.47%,TRERF1;UBE2L3;AKR1C3;ATP1A1;ATP1A2
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),-0.20403797089538467,-0.3497663225480348,1.0,0.9997482157653554,1.0,4/10,29.67%,ROBO2;PKD2;LRP1;PDGFRB
